WO2017160711A1 - Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system - Google Patents

Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system Download PDF

Info

Publication number
WO2017160711A1
WO2017160711A1 PCT/US2017/022091 US2017022091W WO2017160711A1 WO 2017160711 A1 WO2017160711 A1 WO 2017160711A1 US 2017022091 W US2017022091 W US 2017022091W WO 2017160711 A1 WO2017160711 A1 WO 2017160711A1
Authority
WO
WIPO (PCT)
Prior art keywords
gaba
bacteria
dna sequence
subject
bacteroides
Prior art date
Application number
PCT/US2017/022091
Other languages
French (fr)
Inventor
Philip STRANDWITZ
Kim Lewis
Original Assignee
Holobiome, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holobiome, Inc. filed Critical Holobiome, Inc.
Priority to EP17712676.0A priority Critical patent/EP3429604A1/en
Priority to JP2018549231A priority patent/JP7216998B2/en
Priority to AU2017234120A priority patent/AU2017234120A1/en
Priority to CA3016911A priority patent/CA3016911A1/en
Priority to US16/084,511 priority patent/US11116804B2/en
Priority to CN201780029600.2A priority patent/CN109715177A/en
Priority to EP23219448.0A priority patent/EP4368254A2/en
Publication of WO2017160711A1 publication Critical patent/WO2017160711A1/en
Priority to US17/396,330 priority patent/US20220040242A1/en
Priority to JP2023004452A priority patent/JP2023038274A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01019Aminobutyraldehyde dehydrogenase (1.2.1.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y113/00Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12001Arginine 2-monooxygenase (1.13.12.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • C12Y206/01082Putrescine aminotransferase (2.6.1.82)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/03Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
    • C12Y305/03011Agmatinase (3.5.3.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01015Glutamate decarboxylase (4.1.1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01017Ornithine decarboxylase (4.1.1.17)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present disclosure relates to compositions and methods for treating at least one symptom of a disease in a subject.
  • the disease is a mental disorder or a disease of the central nervous system.
  • the present disclosure teaches treatment of the disease by modulating (e.g., increasing) the amount of endogenous GABA in a subject's body.
  • the present disclosure teaches modulating (e.g., increasing) the amount of GABA produced in the subject's gut by bacteria in the gut.
  • the present disclosure teaches administration to a subject in need thereof bacteria that are capable of producing GABA (e.g., inside a human gut).
  • the present disclosure also relates to methods of culturing previously uncultured bacterial strains.
  • the present disclosure teaches the previously uncultured bacterial strain Evtepia gahavorous KLE1738.
  • newly uncultured bacterial strains such as Evtepia gahavorous KLE1738 can be cultured by providing growth factors necessary for the bacteria's growth and reproduction.
  • methods of identifying bacterial strains capable of producing certain growth factors For instance, described herein are methods of identifying bacterial strains capable of producing GABA, for instance under physiologically relevant conditions such as at a physiologically relevant pH.
  • the gut microbiome affects certain gastrointestinal and metabolic disorders, such as irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis, celiac disease, obesity, heart disease, type 1 and II diabetes, and colon cancer.
  • IBS irritable bowel syndrome
  • Crohn's disease Crohn's disease
  • ulcerative colitis celiac disease
  • obesity obesity
  • heart disease type 1 and II diabetes
  • colon cancer colon cancer
  • Microbiological studies have so far been limited, by necessity, to cultivable microorganisms. By some estimates, in external environments, 99% of bacteria are thought to be uncultured. The development of new techniques for culturing previously uncultured or uneuiturable bacteria can thus help to expand the scope of microbiology research.
  • the present disclosure provides compositions and methods for treating diseases such as mental illness or diseases of the central nervous system.
  • the present disclosure teaches therapeutic compositions comprising one or more bacteria (e.g. , purified bacteria) that are capable of producing GABA.
  • the bacteria can be capable of producing GABA under physiologically relevant conditions, including within a human gut.
  • the present disclosure also provides methods of treating a subject in need thereof comprising administering to a subject a therapeutic composition comprising GABA- producing bacteria.
  • the GABA-producmg bacteria can produce GABA in the subject's gut.
  • the GABA can diffuse into other systems of the subject's body (e.g., the circulatory and nervous systems).
  • the endogenous GABA can act as a neurotransmitter.
  • increased levels of GABA e.g., in the nervous sy stem
  • the present disclosure also provides methods for identifying bacteria that produce GABA in humans at a physiologically relevant pH range and uses for these bacteria to modulate GABA levels in humans to treat mental illness.
  • the present disclosure also relates to a method of culturing previously uncultivated bacterial species. For instance the present disclosure teaches the isolation and characterization of a bacterial species KLE1738, provisionally named Evtepia gabavorous. Growth of E. gabavorous requires the presence of the growth factor GABA, which can be supplied by GABA-producing bacteria such as Bacteroides fragilis KLE1758.
  • the present disclosure provides a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in a subject in need thereof.
  • the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. 1-31 set forth in Table 1.
  • the at least one purified bacterial population consists of bacteria selected from the group consisting of: Bacteroides caccae KLE1911; Bacteroides darns KLE1930; Bacteroides dorei KLE1912; Bacteroides finegoldii KLE1931; Bacteroides fragilis LE1958; Bacteroides massi!iensis KLE1932; Bacteroides ovatus KLE1770; Bacteroides stercoris KLE1933; Bacteroides thetaiotaomicron KLE1934; Bacteroides uniformis KLE1913; Bacteroides vulgatus KLE1910; Bacteroides xylanisolvens KLE1935; Bifidobacterium adoiescentis KLE 1879; Blautia obeum KLE1914; Blautia wexlerae LE1916; Butyricimonas virosa KLE1938; Clostridium perfringens KLE1919
  • KLE 1862 Clostridium sp. KLE1918; Coprobacillus sp. KLE1779; Coprococcus sp, KLE1880; Dorea longicatena KI.E1917; Eggerthella lenta KLE 1926; Eubacterium rectale KLE1922; Gordonihacter pamelaeae KLE1915; Oscillibacler sp, KLE 1928; Parabacteroides distasonis KLE2020; Parabacteroides merdae KLE1863; Ruminococcus gnavus KLE1940; Turicibacter sanguinis KLE1941, and combinations thereof.
  • the at least one purified bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. 32-274 set forth in Table 2.
  • the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to the 16S rDNA sequence selected from one of Seq. ID. Nos. 305-221 7 set forth in Table 10.
  • the at least one purified bacterial population consists of bacteria comprising a DNA sequence which encodes an enzyme selected from: glutamate decarboxylase; putrescine aminotransferase; garnma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
  • the glutamate decarboxylase; putrescine aminotransferase; gamma- aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof is encoded by a DNA sequence at least 70% similar in DNA sequence to any one of Seq. ID. Nos. 275-304 set forth in Table 3.
  • the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 4.
  • the putrescine aminotransferase is encoded by a DN A sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 5.
  • the garnma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 6.
  • the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 7.
  • the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 8.
  • the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 9.
  • the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to a reference bacterium selected from the group consisting of: Escherichia coli MG1655; Escherichia coli Nissle 1917; or a combination thereof.
  • the bacterial population consists of bacteria capable of producing GABA at a physiologically relevant pH. In some embodiments, the bacterial population consists of bacteria capable of producing GABA at a pH range between about 4.5 and about 7,5. In some embodiments, the bacterial population consists of bacteria capable of producing GABA inside the human gut.
  • the composition is in the form of a probiotic, prebiotic, a capsule, a tablet, a caplet, a pill, a troche, a lozenge, a powders, a granule, a medical food, or a combination thereof.
  • the composition is administered as a fecal transplant.
  • the bacteria are capable of producing GABA via expression of any combination of glutamate decarboxylase, putrescine aminotransferase, gamma-aminobut raldehyde dehydrogenase, arginine decarboxylase, agmatinase, and/or ornithine decarboxylase.
  • the therapeutic composition further comprises a purified bacterial strain that is cytotoxic or cytostatic to a GABA-consuming bacteria.
  • the GABA-consuming bacteria is Evtepia gabavorous or Firmicutes bacterium MGS: 114.
  • the therapeutic composition further comprises a prebiotic capable of stimulating the growth or GABA-production levels of a GABA- producing bacteria.
  • the present di sclosure provides a m ethod of treati ng a disease or disorder in a subject in need thereof, the method comprising administering to the subject a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in a subject in need thereof.
  • the present disclosure provides the use of a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in the manufacture of a medicament for the treatment of a disease.
  • the present disclosure provides the use of a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA for the treatment of a disease.
  • the disease or disorder is a mental disease or disorder.
  • the mental disease or disorder is selected from the group consisting of depression, bipolar disorder, schizophrenia, anxiety, anxiety disorders, addiction, social phobia, treatment-resistant major depressive disorder (TR-MDD), major depressive disorder and its subtypes (melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder), Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic tremor, Lafora disease, restless leg syndrome, neuropathic pain, pain disorders, dementia, epilepsy, stiff-person syndrome, premenstrual dysphoric disorder, autism spectrum disorder, sleep disorders, and attention deficit hyperactivity disorder (ADHD), and combinations thereof.
  • TR-MDD treatment-resistant major depressive disorder
  • major depressive disorder and its subtypes melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder
  • Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic
  • treating a disease or disorder comprises decreasing at least one symptom of the disease or disorder, such as fatigue, insomnia, motor dysfunction, stress, persistent anxiety, persistent sadness, social withdrawal, substance withdrawal, irritability, thoughts of suicide, thoughts of self-harm, restlessness, lo " sex drive, lack of focus, seizures, memory loss, anger, bouts of emotional reactivity, confusion, pain, and muscle spasms, loss of appetite, altered intestine motility, and combinations thereof.
  • symptom of the disease or disorder such as fatigue, insomnia, motor dysfunction, stress, persistent anxiety, persistent sadness, social withdrawal, substance withdrawal, irritability, thoughts of suicide, thoughts of self-harm, restlessness, lo " sex drive, lack of focus, seizures, memory loss, anger, bouts of emotional reactivity, confusion, pain, and muscle spasms, loss of appetite, altered intestine motility, and combinations thereof.
  • the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. of 1 -31 set forth in Table 1 .
  • the at least one purified bacterial population consists of bacteria selected from the group consisting of: Bacteroides caccae KLE1911; Bacteroides darns KLE1930; Bacteroides dorei KLE1912; Bacteroides finegoldii KLE1931; Bacteroides jragilis KLE1958; Bacteroides massiiiensis KLE1932; Bacteroides ovatus KLE1770; Bacteroides stercoris KLE1933: Bacteroides thetaiotaomicron KLE1934; Bacteroides uniformis KLE1913; Bacteroides vulgatus KLE1910; Bacteroides xylanisolvens KLE1935; Bifidobacterium aaoleseentis KLE 1879; Blautia obeum KLE1914; Blautia wexlerae KLE1916; Butyricimonas virosa KLE1938; Clostridium
  • KLE1862 Clostridium sp. KLE1918; CoprobaciHus sp. KLE1779; Coprococcus sp. KLE1880; Dorea longicatena KLE1917; Eggerthella lenta KLE1926; Eubacterium rectale KLE 1922; Gordonihacter pamelaeae KLE1915; Oscillibacter sp. KLE1928; Parabacteroides distasonis KLE2020; Parahacteroid.es merdae KLE1863; Ruminococcus gnavus LE1940; Tiiricihacter sanguinis KLE1941, and combinations thereof.
  • the at least one purified bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID, Nos. of 32-274 set forth in Table 2,
  • the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to any one of Seq ID Nos. 305-2217 set forth in Table 10.
  • the at least one purified bacterial population consists of bacteria comprising a DNA sequence which encodes an enzyme selected from: glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
  • the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof is encoded by a DNA sequence at least 70% similar to a DNA sequence selected from one of Seq. ID. Nos. 275- 304 set forth in Table 3,
  • the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 4.
  • the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 5.
  • the gamma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 6.
  • the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 7.
  • the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 8.
  • the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 9.
  • the bacteria is genetically engineered to produce GABA.
  • the bacteria is engineered to produce GABA via expression of glutamate decarboxylase; putrescine aminotransferase; gamma- aminobutyraidehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
  • the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldeh de dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof is encoded by a DNA sequence at least 70% similar in DNA sequence selected from one of Seq, ID. Nos. of 275- 304 set forth in Table 3.
  • the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 4.
  • the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 5.
  • the gamma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK DDB J ID found in Table 6.
  • the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 7.
  • the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 8.
  • the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 9.
  • the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to a reference bacterium selected from the group consisting of: Escherichia coli MG1655; Escherichia coli Nissle 1917; or a combination thereof.
  • the bacterial population consists of bacteria capable of producing GABA at a physiologically relevant pH.
  • the bacterial population consists of bacteria capable of producing GABA at a pH range between about 4.5 and about 7.5.
  • bacterial population consists of bacteria capable of producing GABA inside the human gut.
  • the composition is administered as a fecal transplant.
  • the composition is administered as a probiotic.
  • the bacteria are capable of producing GABA via expression any combination of glutamate decarboxylase, putrescine aminotransferase, gamma-aminobutyraldehyde dehydrogenase, arginine decarboxylase, agmatinase, ornithine decarboxylase, and combinations thereof.
  • the at least one bacterial strain is cytotoxic or cytostatic to a GABA-consuming bacteria.
  • the GABA-consummg bacteria is Evlepia gabavorous or Firmicuies bacterium MGS: 1 14.
  • the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA in the subject's stool.
  • the initial amount of GABA in the subject's stool is below about 8 ⁇ ig per gram of wet or dry stool.
  • the amount of GABA in the subject's stool is increased relative to the initial amount after administering the therapeutic composition.
  • the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA- producing bacteria in the subject's stool.
  • the initial amount of GABA-producing bacteria in the subject's stool is less than about 10% of total bacteria as measured by 16S sequence mapping.
  • at least one GABA- producing bacteria is increased in the subject's stool relative to the initial amount of GABA-producing bacteria in the subject's stool after administering the therapeutic composition.
  • the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA in the subject's blood or serum.
  • the amount of GABA in the subject's blood or serum is below about 10 g per liter of blood.
  • the amount of GABA in the subject's blood or serum is increased relative to the initial amount after administering the therapeutic composition.
  • the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an amount of GABA in the subject's brain.
  • the amount of GABA in the subject's brain is below about 1.0 mM/kg.
  • the amount of GABA in the subject's brain is increased relative to the initial amount after administering the therapeutic composition.
  • the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of expression of GABA-producing enzymes in the subject's stool.
  • the GABA-producing enzymes are selected from glutamate decarboxylase, putrescine aminotransferase, gamma-aminobutyraldehyde dehydrogenase, argmine decarboxylase, agmatinase, ornithine decarboxylase, and combinations thereof.
  • the initial amount of enzyme expression is measured by qPCR.
  • the expression of enzymes is increased relative to the initial amount of enzyme expression after administering the therapeutic composition.
  • the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABAergic response in the subject's brain. In some embodiments, the amount of the GABAergic response in the subject's brain is increased relative to the initial amount after administering the therapeutic composition.
  • the therapeutic composition comprises a prebiotic capable of stimulating the growth or GABA production of GABA-producing bacteria.
  • the present disclosure provides a method of culturing a GABA-dependent bacteria, comprising disposing at least one live GABA-dependent bacterial cell on a suitable substrate, and providing a source of GABA.
  • the suitable substrate is agar.
  • providing a source of GABA comprises co-culturing with another bacterial strain, said strain is capable of producing GABA.
  • GABA is added to the substrate.
  • the GABA-dependent bacteria is E. gabavorous.
  • the present disclosure provides a method of identifying a bacterial strain or strains capable of producing GABA at a physiologically relevant pH of the human intestinal tract, comprising:
  • the substrate is being buffered to maintain the pH at a physiologically range found in the human gastrointestinal tract, in some embodiments, the GABA-dependent bacteria is E.gabavorous. In some embodiments, the pH range is between about 4.5 and about 7.5.
  • the present disclosure provides compositions and methods for treating mental illness or disease of the central nervous system in a subject and therapeutic compositions for the same.
  • the method can comprise administering to the subject a bacterium and/or multiple bacteria capable of producing endogenous GABA in the subject's gut at a physiologically relevant pH.
  • the present technology can have the advantage of alleviating the symptoms of a mental illness or disease of the central nervous system without the aid of synthetic medications (e.g., antidepressants), which can have unwanted side-effects, or in combination with existing medications. Additionally, the present technology can have the advantage of further improving the digestive health of the subject, such as improving intestinal motility and reducing gastrointestinal pain. Additional features and advantages of the present technology 7 will be apparent to one of skill in the art upon reading the Detailed Description of the Invention, below.
  • Figure 1A shows a co-culture assay to grow and identify previously unculturable bacteria.
  • Figure I B shows the growth of Evtepia gabavorous KLE1738 in the presence of the helper bacteria Bacteroides fragilis KLE.1758.
  • Figure 2A shows the growth of Evtepia gabavorous KLE 1738 in the presence of the supernatant from Bacteroides fragilis.
  • Figure 2B shows a lack of growth of Evtepia gabavorous KLE1738 in the presence of the empty vehicle.
  • Figure 2C shows the growth of Evtepia gabavorous in the presence of the most polar fraction of the supernatant from Bacteroides fragilis LE1758.
  • Figure 2D shows a close-view of the lack of growth of Evtepia gabavorous KLE1738 in the presence of the empty vehicle.
  • Figure 2E shows a close-view of the growth of Evtepia gabavorous KLE1738 in the presence of the supernatant from Bacteroides fragilis KLE1758.
  • Figure 2F shows a close-view of the lack of growth of Evtepia gabavorous KLE1738 in the presence of the empty vehicle (bacterial media).
  • Figure 2G shows a table of potential growth factors for E. gabavorous KLE1738, with green indicating induction of growth.
  • Figure 3 shows a proposed GABA metabolism of E. gabavorous ⁇ . ⁇ 738.
  • Figure 4a shows GABA production of B. fragilis KLE1758 is observed only at a pH of 5.5 and below, highlighting the importance of acidic pH on GABA production for certain strains or species of bacteria.
  • Figure 4B shows an assay for the identification of GABA-producing bacteria, capable of producing GABA at a pH between 4.5 and 7.5, using the GABA-requirement of E. gahavorous KLE1738. The medium was heavily buffered to maintain a pH of the desired range and identify strains of bacteria capable of producing GABA at a pH physiologically relevant to the human gut.
  • Figure 4C shows a phylogenetic tree of GABA producers, capable of producing GABA at a pH of about 4.5 to about 7.5, identified by the methods herein.
  • Figure 5 shows GABA production capabilities of several strains identified using the screen described in Example 7. The ability of organisms to produce GABA at a range of pH conditions is highlighted.
  • Figure 6 A shows the growth of E. gahavorous KLE1738 in the presence of E. coll that has been engineered to express glutamate decarboxylase gadA.
  • Figure 6B shows the growth of E. gahavorous KLE1738 in the presence of E. coli that has been engineered to express glutamate decarboxylase gadB.
  • Figure 6C shows the growth of E. gahavorous KLE1738 in the presence of B. fragilis KLE 1758 that is known to produce GABA.
  • Figure 6D shows the absence of growth of E. gahavorous KLE1738 in the presence of E. coli that has been engineered to express glutamate decarboxylase gadC.
  • Figure 6E shows the absence of growth of E. gahavorous KLE1738 in the presence empty vector.
  • the present disclosure relates to compositions and methods for treating or decreasing a symptom of a disease in a subject.
  • the disease can be a mental illness or a disease of the central nervous system.
  • the method can comprise determining whether the subject would benefit from an increase in endogenous GABA, for instance by measuring the amount of GABA in the subject's stool, blood serum, or other bodily fluids, measuring levels of GABA in different regions of the brain, measuring the GABAergic response in different regions in the brain, measuring activity of GABA producing enzymes in stool, or by measuring the amount of GABA-producing bacteria in the subject's stool.
  • the method can further comprise administering to the subject a GABA-producing bacterium or bacteria that can be capable of producing GABA in the subject's gut, (e.g., at a physiologically relevant pH of the gut).
  • Some bacteria produce GABA from gamma-aminobutyrate to maintain intracellular pH homoeostasis in order to overcome acid stress.
  • microbes e.g., bacteria
  • GABA produced by bacteria in the human gut can act as a neurotransmitter to treat a mental illness, a disease of the central nervous system, or improve gastrointestinal health in a subject.
  • administer and “administration” encompasses embodiments in which one person directs another to consume a bacteria or a bacterial composition in a certain manner and/or for a certain purpose, and also situations in which a user uses bacteria or a bacterial composition in a certain manner and/or for a certain purpose independently of or in variance to any instmctions received from a second person.
  • Non-limiting examples of embodiments in which one person directs another to consume a bacteria or bacterial composition in a certain manner and/or for a certain purpose include when a physician prescribes a course of conduct and/or treatment to a patient, when a parent commands a minor user (such as a child) to consume bacteria or a bacterial composition, when a trainer advises a user (such as an athlete) to follow a particular course of conduct and/or treatment, and when a manufacturer, distributer, or marketer recommends conditions of use to an end user, for example through advertisements or labeling on packaging or on other materials provided in association with the sale or marketing of a product.
  • isolated' encompasses a bacterium or other entity or substance that has been (1) separated from at least some of the components with which it was associated when initially produced (whether in nature, such as human stool, or in an experimental setting, such as a Petri plate consisting of artificial growth medium), and/or (2) produced, prepared, purified, and/or manufactured by the hand of man.
  • Isolated bacteria may be separated from at least about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, or more of the other components with which they were initially associated.
  • isolated bacteria are more than about 80%, about 85%, about 90%, about 91 %, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or more than about 99% pure.
  • a substance is "pure' " if it is substantially free of other components (such as other bacterial species).
  • the terms "purify,” “purifying” and “purified” refer to a bacterium or other material that has been separated from at least some of the components with which it was associated either when initially produced or generated (e.g., whether in nature or in an experimental setting), or during any time after its initial production, as recognized by those skilled in the art of bacterial cultivation.
  • a bacterium or a bacterial population may be considered purified if it is isolated at or after production, such as from a material or environment containing the bacterium or bacterial population, and a purified bacterium or bacterial population may contain other materials up to about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, or above about 90% and still be considered "isolated.”
  • purified bacteria and bacterial populations are more than about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%», about 97%, about 98%, about 99%, or more than about 99% pure.
  • the one or more bacterial types present in the composition can be independently purified from one or more other bacteria produced and/or present in the material or environment containing the bacterial type.
  • Bacterial compositions and the bacterial components thereof are generally purified from residual habitat products.
  • probiotic is understood to mean “Live microorganisms which when administered in adequate amounts confer a health benefit on the host", as currently defined by the World Health Organization.
  • prebiotic is understood to mean an ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microbiota that may (or may not) confer benefits upon the host.
  • medical food is understood to mean “a food which is formulated to he consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation", as defined by 5(b) of the Orphan Drug Act (21 U.S.C. 360ee (b) (3)).
  • initial amount is understood to mean the amount of a substance, e.g., GAB A in an aliquot of sample prior to administration of GABA-producing bacteria to the subject.
  • Initial amount can be measured in terms of concentration. For instance, an initial amount can be measured in terms of micrograms of substance per milliliter of sample, e.g., micrograms of GABA per milliliter of blood or serum ⁇ g GABA/mL blood or serum).
  • the initial amount of can also be measured, for instance, as the amount of GABA in regions of the brain, such as the prefrontal cortex prior to administration of the GABA-producing bacteria.
  • the amount of GABA can be represented in terms of millimoles of GABA per kg tissue (mmol GABA per kg of brain tissue).
  • the initial amount can also be measured, for instance, as the amount of GABA in a subject's stool sample prior to administration of GABA-producing bacteria to the subject.
  • the amount of GABA can be represented in terms of micrograms of GABA per gram of stool (,ug GABA/g stool).
  • the initial amount can also be the level of expression of GABA producing enzymes in the stool (log change of reads), as measured by qPCR or other appropriate method.
  • stool is weighed when wet or dry, i.e. , without active drying, and within one hour of production of the stool. For instance, the stool can be weighed within 45 minutes, 30 minutes, 15 minutes, 10 minutes, or within 5 minutes of production of the stool.
  • GABAergic response means the response of a given organ (e.g., the brain or vagus nerve) to differences in the concentrations of GABA, GABA producing bacteria, or prebiotics to which it is exposed.
  • a GABAergic response can include a change in concentrations of GABA as well as expression levels and/or activity of different GABAA, GABAB, and/or GAB Ac receptors.
  • GABA-producing bacteria is understood to mean bacteria that can produce measurable quantities of GABA, as detected by LC/MS, ELTSA, or other appropriate analytical assays.
  • GABA-producing bacteria ca produce GABA under the physiological conditions in a human, e.g., under the pH, and temperature of the human gut.
  • Physiologically relevant pH of the human intestinal tract is understood to mean a pH range that exists in the body.
  • a pH range that is physiologically relevant to the human gut can be in the range of about 4.5 to about 7.5.
  • gut is understood to refer to the human gastrointestinal tract, also known as the alimentary canal.
  • the gut includes the mouth, pharynx, oesophagus, stomach, small intestine (duodenum, jejunum, ileum), large intestines (cecum and colon) and rectum.
  • bacteria or "bacterial strain” is understood to mean a species of bacteria.
  • a “bacterium” is understood as a single bacterial cell of a given species.
  • treating refers to improving at least one symptom of the subject's disorder. Treating includes curing, improving, or at least partially ameliorating the disorder.
  • EMBL/GenBank/DDBJ ID refers to an accession number, which when used as in input for databases such as the European Molecular Biology Laboratory (EMBL), GenBank, or DNA Data Bank of Japan (DDBJ), via their respective internet websites, enables access to information, such as nucleotide sequence of a gene, and the bacterium encoding that sequence in its genome.
  • EMBL/GenBank/DDBJ ID is used in this application as a conveninent means to access sequence information.
  • GABA garawa-arninobutyric acid ( ⁇ - aminobutyric acid).
  • GABA has the chemical structure: [ ⁇ 84] GABA is a major inhibitory neurotransmitter in the mammalian central nervous system. It plays a principal role in reducing neuronal excitability throughout the nervous system. GABA can be a difficult compound to deliver therapeutically due to efflux and half-life limitations. For example, in rodents, the brain efflux rate of GABA was found to be 17 times higher than the influx rate. Additionally, GABA only has a half-life of only 17 minutes in mice. Accordingly, because of the short half-life of GABA in vivo, oral GABA supplementation can be ineffective, as it may require frequent dosing, even with slow release capsules.
  • the present disclosure provides for delivering a therapeutic composition of one or more bacteria that can produce GABA within the intestinal tract, in order to consistently deliver GABA into systemic circulation (e.g., into the nervous system).
  • the endogenous! ⁇ ' produced GABA can also activate vagal nerve receptors directly. This can mitigate the inherent half-life of GABA.
  • the microbiome can influence GABA levels and the GABAergic response in the brain.
  • germ-free animals can have substantially reduced luminal and serum levels of GABA.
  • GABAergic modulation by microbiome intervention e.g., using methods and compositions described herein
  • GABA can play a role in mental illness or disease of the central nervous system.
  • low levels of GABA can be associated with depression, bipolar disorder, schizophrenia, anxiety, anxiety disorders, addiction, social phobia, treatment-resistant major depressive disorder (TR-MDD), major depressive disorder and its subtypes (melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder), Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic tremor, Lafora disease, restless leg syndrome, neuropathic pain, pain disorders, dementia, epilepsy, stiff-person syndrome, premenstrual dysphoric disorder, autism spectrum disorder, sleep disorders, and attention deficit hyperactivity disorder (ADHD).
  • the present disclosure provides increasing the amount of endogenous GABA in a subject can decrease levels of mental illness or disease of the central nervous system in the subject.
  • GABA produced by gut bacteria can play a role in mental illness or disease of the central nervous system via the vagus nerve, connecting the intestinal tract to the peripheral and central nervous systems.
  • GABA produced by gut bacteria can play a role in mental illness or disease of the central nervous system via affecting circulating levels of systemic GABA in the host, which can influence the peripheral and central nervous systems.
  • Bacteria can produce GABA using a variety of different pathways. Set forth below are exemplary pathways that bacteria and other microbes can use to produce GABA (e.g., in vivo). As set forth below, any of the GABA production pathways described herein can be naturally occurring in a given bacterium. Alternatively, a necessary enzyme or grouping of enzymes can be added to the DNA sequence of a bacteria to enable the bacteria to produce GABA.
  • microbes can produce GABA using the glutamate decarboxylase enzyme (e.g., glutamate decarboxylase EC 4.1.1.15).
  • glutamate decarboxylase is capable of directly converting glutamate to GABA.
  • microbes can produce GABA using the putrescine to 4- aminobutanal pathway. The microbes can then convert 4-aminobutanal to GABA.
  • putrescine aminotransferase for instance, putrescine aminotransferase EC 2.6.1.82
  • putrescine aminotransferase can be used to convert putrescine to 4-aminobutanal.
  • the 4-aminobutanal can then be converted in the presence of garama-aminobutyraldehyde dehydrogenase (e.g., gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19)) to GABA.
  • garama-aminobutyraldehyde dehydrogenase e.g., gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19)
  • microbes can produce GABA using the arginine to agmatine to putrescine Pathway. Once the putrescine is produced, it can be converted as described above (e.g., using the putrescine to 4-aminobutanal pathway) to GABA.
  • arginine decarboxylase e.g., arginine decarboxylase (EC 4.1.1 .19)
  • Agmatine can then be converted to putrescine using agmatinase (e.g., agmatinase (EC 3.5.3.11)).
  • ornithine decarboxylase e.g., ornithine decarboxylase (EC)
  • 4.1.1.17 can be used to convert ornithine to putrescine. Once the putrescine is produced, it can be converted as described above (e.g., using the putrescine to 4-aminobutanal pathway) to GABA.
  • the present disclosure provides bacterial strains (e.g., purified strains) and therapeutic compositions comprising the same for administration to a subject in need thereof.
  • the bacteria can be naturally occurring, or can be engineered (e.g., through strain engineering or selection) to produce GABA.
  • one strain of GABA- producmg bacteria can be administered to a subject.
  • multiple strains of GABA-producing bacteria can be administered to a subject in need thereof.
  • the one or more bacteria e.g., purified bacteria
  • the one or more bacteria can act synergistically.
  • the multiple bacteria can act synergistically to produce high levels of GABA.
  • the one or more bacteria can also help to reduce the number of GABA- consuming bacteria in a human gut. Accordingly, any one, or any combination of the GABA-producing bacteria taught herein can be administered to a subject in need thereof.
  • the bacteria taught herein can produce GABA at physiologically relevant conditions, such as under the conditions of the human gut.
  • the GABA-producing bacteria taught herein can produce GABA a pH relevant to the human gut is between about 4.5 and about 7.5.
  • the pH can be about 4.5, 5.0, 5.5., 6.0, 6.5, 7.0 7.5, or any value between about 4.5 and 7.5.
  • the ability to produce GABA at physiologically relevant pH is important in view of the pH restrictions of GABA production in many bacteria.
  • E. coii is unable to produce GABA above a pH of 4.5.
  • it can use conversion of glutamate to GABA coupled with GABA export, for example, as a means to neutralize the intracellular environment.
  • the present disclosure bacteria capable of producing GABA at a pH relevant to the host environment such as the more neutral large mtestmes (e.g., between about pH 4.5 and about pH 7.5).
  • the bacteria taught herein can also produce GABA under other relevant conditions that exist within the human gut. That is, the GABA-producing bacteria taught herein can produce GABA in the absence of oxygen, in a nutrient-competitive and fluctuating environment, and in the absence of light.
  • the GABA-producing bacteria can be identified by having a 16S nucleic acid sequence substantially similar to the 16S sequences of reference bacteria listed in Table 1 , with a Seq. ID. No. of 1-31.
  • the G ABA-producing bacteria can have at least 90% 16S sequence similarity to the 1 6S sequences given in Table 1 (e.g. , at least 91 % similarity, at least 92% similarity, at least 93% similarity, at least 94% similarity, at least 95% similarity, at least 96% similarity, at least 97%> similarity, at least 98%* similarity, at least 99% similarity, at least 99.5% similarity, at least 99.9% similarity, or 1 00% similarity).
  • the GABA-producing bacteria can be identified by NCBI Taxon ID of the organism they are most related to by 16S sequence. These bacteria include those belonging to the same NCBI Taxon assignment as Barter aides caccae KLE1911; Bacteroides clarus KLE1930; Bacteroides dorei KLE 1912;
  • KLE1862 Clostridium sp. KLE1918; Coprobacillus sp. KLE1779; Coprococcus sp.
  • KLE1880 Dorea longicatena KLE1917; Eggerthelia lenta KLE1926; Eubacterium rectale LE1922; Gordonibacter pamelaeae KLE1915; Osciilibacter sp. KLE 1928; Parahacteroides distasonis LE2020; Parahacteroides merdae KLE 1863; Ruminococcus gnavus KLE1940; Turicibacter sanguinis KLE1941, and combinations thereof.
  • bacteria that are predicted to be capable of producing GABA are identified as being candidate GABA producing bacteria if they have encoded in their genome enzymes involved in GABA biosynthesis.
  • the bacteria that are predicted to be capable of producing GABA can be identified by having a 16S nucleic acid sequence substantially similar to the 16S sequences of reference bacteria listed in Table 2, with a Seq. ID. No. of 32-274.
  • the predicted GABA-producing bacteria can have at least 90% 16S sequence similarity to the 16S sequences given in Table 2, with a Seq. ID. No.
  • 32-274 e.g., at least 91 % similarity, at least 92% similarity, at least 93% similarity, at least 94% similarity, at least 95% similarity, at least 96% similarity, at least 97% similarity, at least 98% similarity, at least 99% similarity, at least 99.5% similarity, at least 99.9% similarity, or 100% similarity).
  • Parabacteroides golds teinii 191
  • bacteria can be engineered to produce GABA (e.g., under the conditions of the human gut).
  • the bacteria ca be engineered using techniques of molecular biology, or can be evolved using the process of selection to produce GABA in the human gut.
  • GABA can be produced by multiple pathways within a microbial cell.
  • GABA can be produced by the glutamate pathway, the putrescine to 4-aminobutanal pathway, the arginiiie to agmatine to putrescine pathway, the L-ornithine to putrescine pathway, or by a combination of pathways.
  • bacteria can be engineered to contain one or more enzymes in any one of the above pathways that can enable the bacteria to produce GABA or a necessary precursor to GABA.
  • Echerichia coli Nissle 1917 can be genetically modified or selected through evolution to produce GABA.
  • the bacteria e.g. , Escherichia coli Nissle 1917
  • the bacteria can also be made to produce GABA by one or more of the other pathways described herein.
  • an engineered GABA-producing strain can be identified as having a specific enzyme encoded in its genomes.
  • the enzyme can be glutamate decarboxylase (EC 4.1 , 1.15); putrescine aminotransferase (EC 2.6.1.82); gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19); arginine decarboxylase (EC 4.1.1.19); agmatinase (EC 3.5.3.11); ornithine decarboxylase (EC 4.1.1.17); or a combination thereof
  • the GABA-producing strain can be engineered to contain an enzyme that has at least 50% similarity with with the representative sequences listed in Table 3 (e.g., at least 60%) similarity, at least 70% similarity, at least 80% similarity, at least 90% similarity, at least 91% similarity, at least 92% similarity, at least 93% similarity, at least 94% similarity, at least 95% similarity, at least 96% similarity, at least 97% similarity, at least 98% similarity, at least 99% similarity, at least
  • glutamate decarboxylase (EC 4.1.1.15) are given below in Table 4 and identified by their EMBL/GENBANK/DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the glutamate decarboxylase set forth in Table 3 or Table 4.
  • the bacteria can be engineered with a version of the glutamate decarboxylase enzyme that has at least 50% nucleotide similarity with any of the versions of glutamate decarboxylase given in Table 4 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90%) nucleotide similarity, at least 91 % nucleotide similarity, at least 92% nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucleotide similarity, at least 95% nucleotide similarity, at least 96% nucleotide similarity, at least 97% nucleotide similarity, at least 98% nucleotide similarity, at least 99% nucleotide similarity, at least 99,5% nucleotide similarity, at least 99.9% nucleotide similarity, or 100% nucleotide similarity).
  • Table 4
  • CDM06669.1 CNH63762.1 CTT19248.1 EDS80418. 1
  • EKJ88854 1 ELS48492. 1 EMX21 187.1 EOD79253.1
  • ETD61 1 17. 1 EWM60131.1 EZE53483.1 GAC19112.1
  • KIP53570 1 KJY39390.1 KLV28432.1 KNF82369.1
  • putrescine aminotransferase EC 2,6.1.82
  • Table 5 Representative examples of putrescine aminotransferase (EC 2,6.1.82) are given below in Table 5 and identified by their EMBL/GenBank/DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the putrescine aminotransferase (EC 2.6.1.82) set forth in Table 3 and Table 5.
  • the bacteria can be engineered with a version of the putrescine aminotransferase enzyme that has at least 50% nucleotide similarity with any of the versions of putrescine aminotransferase given in Table 5 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90% nucleotide similarity, at least 91% nucleotide similarity, at least 92% nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucleotide similarity, at least 95% nucleotide similarity, at least 96%> nucleotide similarity, at least 97% nucleotide similarity, at least 98% nucleotide similarity, at least 99% nucleotide similarity, at least 99.5%o nucleotide similarity, at least 99.9% nucleotide similarity, or 100% nucleotide similarity).
  • EEL07176.1 EFP71978. 1 EHC61797, 1 EIH10970.1

Abstract

The present disclosure relates to methods of treating at least one symptom of a mental disorder or disease of the central nervous system in a subject by modulating the amount of GABA produced in the subject's gut. The present disclosure also relates to methods of culturing the bacterial strain new bacterial strains. Also disclosed are methods of identifying bacterial strains capable of producing GABA, and engineering strains to produce GABA.

Description

MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM
Cross Reference to Related Applications
[0001 ] This application claims priority to, and benefit of, US Provisional Application No. 62/307,991, filed March 14, 2016, the contents of which is incorporated by reference in its entirety.
Incorporation of Seqnence Listing
[0002] The contents of the text file named ΉΟΒΕ001001 WOSeqList.ixt," which was created on March 13, 2017 and is 7.6 MB in size, are hereby incorporated by reference in their entirety.
Figure imgf000002_0001
[0003] This invention was made with government support under 3R01 HG005824-02S 1 awarded by the National Institute of Health. The government has certain rights in the invention.
Field of the Disclosure
[0004] The present disclosure relates to compositions and methods for treating at least one symptom of a disease in a subject. In some cases, the disease is a mental disorder or a disease of the central nervous system. The present disclosure teaches treatment of the disease by modulating (e.g., increasing) the amount of endogenous GABA in a subject's body. In some embodiments, the present disclosure teaches modulating (e.g., increasing) the amount of GABA produced in the subject's gut by bacteria in the gut. For example, the present disclosure teaches administration to a subject in need thereof bacteria that are capable of producing GABA (e.g., inside a human gut).
[0005] The present disclosure also relates to methods of culturing previously uncultured bacterial strains. For instance, the present disclosure teaches the previously uncultured bacterial strain Evtepia gahavorous KLE1738. As set forth herein, newly uncultured bacterial strains such as Evtepia gahavorous KLE1738 can be cultured by providing growth factors necessary for the bacteria's growth and reproduction. Also disclosed are methods of identifying bacterial strains capable of producing certain growth factors. For instance, described herein are methods of identifying bacterial strains capable of producing GABA, for instance under physiologically relevant conditions such as at a physiologically relevant pH.
|0007] The gut microbiome affects certain gastrointestinal and metabolic disorders, such as irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis, celiac disease, obesity, heart disease, type 1 and II diabetes, and colon cancer.
Microbiological studies have so far been limited, by necessity, to cultivable microorganisms. By some estimates, in external environments, 99% of bacteria are thought to be uncultured. The development of new techniques for culturing previously uncultured or uneuiturable bacteria can thus help to expand the scope of microbiology research.
The present disclosure provides compositions and methods for treating diseases such as mental illness or diseases of the central nervous system. In some embodiments, the present disclosure teaches therapeutic compositions comprising one or more bacteria (e.g. , purified bacteria) that are capable of producing GABA. The bacteria can be capable of producing GABA under physiologically relevant conditions, including within a human gut. The present disclosure also provides methods of treating a subject in need thereof comprising administering to a subject a therapeutic composition comprising GABA- producing bacteria. As set forth herein, the GABA-producmg bacteria can produce GABA in the subject's gut. The GABA can diffuse into other systems of the subject's body (e.g., the circulatory and nervous systems). There, the endogenous GABA can act as a neurotransmitter. In some embodiments, increased levels of GABA (e.g., in the nervous sy stem) can improve the symptoms of the mental illness or disease of the central nervous system.
[0010] In some embodiments, the present disclosure also provides methods for identifying bacteria that produce GABA in humans at a physiologically relevant pH range and uses for these bacteria to modulate GABA levels in humans to treat mental illness. [0011] The present disclosure also relates to a method of culturing previously uncultivated bacterial species. For instance the present disclosure teaches the isolation and characterization of a bacterial species KLE1738, provisionally named Evtepia gabavorous. Growth of E. gabavorous requires the presence of the growth factor GABA, which can be supplied by GABA-producing bacteria such as Bacteroides fragilis KLE1758.
[0012] In one aspect, the present disclosure provides a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in a subject in need thereof.
[0013] In some embodiments, the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. 1-31 set forth in Table 1. In some embodiments, the at least one purified bacterial population consists of bacteria selected from the group consisting of: Bacteroides caccae KLE1911; Bacteroides darns KLE1930; Bacteroides dorei KLE1912; Bacteroides finegoldii KLE1931; Bacteroides fragilis LE1958; Bacteroides massi!iensis KLE1932; Bacteroides ovatus KLE1770; Bacteroides stercoris KLE1933; Bacteroides thetaiotaomicron KLE1934; Bacteroides uniformis KLE1913; Bacteroides vulgatus KLE1910; Bacteroides xylanisolvens KLE1935; Bifidobacterium adoiescentis KLE 1879; Blautia obeum KLE1914; Blautia wexlerae LE1916; Butyricimonas virosa KLE1938; Clostridium perfringens KLE1937; Clostridium sordellii KLE1939; Clostridium sp. KLE 1862; Clostridium sp. KLE1918; Coprobacillus sp. KLE1779; Coprococcus sp, KLE1880; Dorea longicatena KI.E1917; Eggerthella lenta KLE 1926; Eubacterium rectale KLE1922; Gordonihacter pamelaeae KLE1915; Oscillibacler sp, KLE 1928; Parabacteroides distasonis KLE2020; Parabacteroides merdae KLE1863; Ruminococcus gnavus KLE1940; Turicibacter sanguinis KLE1941, and combinations thereof.
[0014] In some embodiments, the at least one purified bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. 32-274 set forth in Table 2. In some embodiments, the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to the 16S rDNA sequence selected from one of Seq. ID. Nos. 305-221 7 set forth in Table 10. In some embodiments, the at least one purified bacterial population consists of bacteria comprising a DNA sequence which encodes an enzyme selected from: glutamate decarboxylase; putrescine aminotransferase; garnma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof. In some embodiments, the glutamate decarboxylase; putrescine aminotransferase; gamma- aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof, is encoded by a DNA sequence at least 70% similar in DNA sequence to any one of Seq. ID. Nos. 275-304 set forth in Table 3.
[0015] In some embodiments, the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 4. In some embodiments, the putrescine aminotransferase is encoded by a DN A sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 5. In some embodiments, the garnma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 6. In some embodiments, the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 7. In some embodiments, the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 8. In some embodiments, the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 9.
[0016] In some embodiments, the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to a reference bacterium selected from the group consisting of: Escherichia coli MG1655; Escherichia coli Nissle 1917; or a combination thereof.
[0017] In some embodiments, the bacterial population consists of bacteria capable of producing GABA at a physiologically relevant pH. In some embodiments, the bacterial population consists of bacteria capable of producing GABA at a pH range between about 4.5 and about 7,5. In some embodiments, the bacterial population consists of bacteria capable of producing GABA inside the human gut.
[0018] In some embodiments, the composition is in the form of a probiotic, prebiotic, a capsule, a tablet, a caplet, a pill, a troche, a lozenge, a powders, a granule, a medical food, or a combination thereof. In some embodiments, the composition is administered as a fecal transplant.
[0019] In some embodiments, the bacteria are capable of producing GABA via expression of any combination of glutamate decarboxylase, putrescine aminotransferase, gamma-aminobut raldehyde dehydrogenase, arginine decarboxylase, agmatinase, and/or ornithine decarboxylase.
[0020] In some embodiments, the therapeutic composition further comprises a purified bacterial strain that is cytotoxic or cytostatic to a GABA-consuming bacteria. In some embodiments, the GABA-consuming bacteria is Evtepia gabavorous or Firmicutes bacterium MGS: 114.
[0021] In some embodiments, the therapeutic composition further comprises a prebiotic capable of stimulating the growth or GABA-production levels of a GABA- producing bacteria.
[0022] In one aspect, the present di sclosure provides a m ethod of treati ng a disease or disorder in a subject in need thereof, the method comprising administering to the subject a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in a subject in need thereof.
[0023] In one aspect, the present disclosure provides the use of a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in the manufacture of a medicament for the treatment of a disease.
[0024] In one aspect, the present disclosure provides the use of a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA for the treatment of a disease. [0025] In some embodiments, the disease or disorder is a mental disease or disorder. In some embodiments, the mental disease or disorder is selected from the group consisting of depression, bipolar disorder, schizophrenia, anxiety, anxiety disorders, addiction, social phobia, treatment-resistant major depressive disorder (TR-MDD), major depressive disorder and its subtypes (melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder), Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic tremor, Lafora disease, restless leg syndrome, neuropathic pain, pain disorders, dementia, epilepsy, stiff-person syndrome, premenstrual dysphoric disorder, autism spectrum disorder, sleep disorders, and attention deficit hyperactivity disorder (ADHD), and combinations thereof. In some embodiments, treating a disease or disorder comprises decreasing at least one symptom of the disease or disorder, such as fatigue, insomnia, motor dysfunction, stress, persistent anxiety, persistent sadness, social withdrawal, substance withdrawal, irritability, thoughts of suicide, thoughts of self-harm, restlessness, lo " sex drive, lack of focus, seizures, memory loss, anger, bouts of emotional reactivity, confusion, pain, and muscle spasms, loss of appetite, altered intestine motility, and combinations thereof.
[0026] In some embodiments, the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. of 1 -31 set forth in Table 1 . In some embodiments, the at least one purified bacterial population consists of bacteria selected from the group consisting of: Bacteroides caccae KLE1911; Bacteroides darns KLE1930; Bacteroides dorei KLE1912; Bacteroides finegoldii KLE1931; Bacteroides jragilis KLE1958; Bacteroides massiiiensis KLE1932; Bacteroides ovatus KLE1770; Bacteroides stercoris KLE1933: Bacteroides thetaiotaomicron KLE1934; Bacteroides uniformis KLE1913; Bacteroides vulgatus KLE1910; Bacteroides xylanisolvens KLE1935; Bifidobacterium aaoleseentis KLE 1879; Blautia obeum KLE1914; Blautia wexlerae KLE1916; Butyricimonas virosa KLE1938; Clostridium perfringens KLE1937; Clostridium sordellii KLE1939; Clostridium sp. KLE1862; Clostridium sp. KLE1918; CoprobaciHus sp. KLE1779; Coprococcus sp. KLE1880; Dorea longicatena KLE1917; Eggerthella lenta KLE1926; Eubacterium rectale KLE 1922; Gordonihacter pamelaeae KLE1915; Oscillibacter sp. KLE1928; Parabacteroides distasonis KLE2020; Parahacteroid.es merdae KLE1863; Ruminococcus gnavus LE1940; Tiiricihacter sanguinis KLE1941, and combinations thereof.
[0027] In some embodiments, the at least one purified bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID, Nos. of 32-274 set forth in Table 2,
[0028] In some embodiments, the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to any one of Seq ID Nos. 305-2217 set forth in Table 10.
[0029] In some embodiments, the at least one purified bacterial population consists of bacteria comprising a DNA sequence which encodes an enzyme selected from: glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
[0030] In some embodiments, the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof, is encoded by a DNA sequence at least 70% similar to a DNA sequence selected from one of Seq. ID. Nos. 275- 304 set forth in Table 3,
[0031] In some embodiments, the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 4. In some embodiments, the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 5. In some embodiments, the gamma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 6. In some embodiments, the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 7. In some embodiments, the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 8. In some embodiments, the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 9.
[0032] In some embodiments, the bacteria is genetically engineered to produce GABA. In some embodiments, the bacteria is engineered to produce GABA via expression of glutamate decarboxylase; putrescine aminotransferase; gamma- aminobutyraidehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
[0033] In some embodiments, wherein the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldeh de dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof, is encoded by a DNA sequence at least 70% similar in DNA sequence selected from one of Seq, ID. Nos. of 275- 304 set forth in Table 3.
[0034] In some embodiments, the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 4. In some embodiments, the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 5. In some embodiments, the gamma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK DDB J ID found in Table 6. In some embodiments, the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 7. In some embodiments, the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 8. In some embodiments, the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 9.
[0035] In some embodiments, the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to a reference bacterium selected from the group consisting of: Escherichia coli MG1655; Escherichia coli Nissle 1917; or a combination thereof. [0036] In some embodiments, the bacterial population consists of bacteria capable of producing GABA at a physiologically relevant pH. In some embodiments, the bacterial population consists of bacteria capable of producing GABA at a pH range between about 4.5 and about 7.5. In some embodiments, bacterial population consists of bacteria capable of producing GABA inside the human gut. In some embodiments, the composition is administered as a fecal transplant. In some embodiments, the composition is administered as a probiotic. In some embodiments, the bacteria are capable of producing GABA via expression any combination of glutamate decarboxylase, putrescine aminotransferase, gamma-aminobutyraldehyde dehydrogenase, arginine decarboxylase, agmatinase, ornithine decarboxylase, and combinations thereof.
[0037] In some embodiments, the at least one bacterial strain is cytotoxic or cytostatic to a GABA-consuming bacteria. In some embodiments, the GABA-consummg bacteria is Evlepia gabavorous or Firmicuies bacterium MGS: 1 14.
[0038] In some embodiments, the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA in the subject's stool. In some embodiments, the initial amount of GABA in the subject's stool is below about 8 ^ig per gram of wet or dry stool. In some embodiments, the amount of GABA in the subject's stool is increased relative to the initial amount after administering the therapeutic composition.
[0039] In some embodiments, the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA- producing bacteria in the subject's stool. In some embodiments, the initial amount of GABA-producing bacteria in the subject's stool is less than about 10% of total bacteria as measured by 16S sequence mapping. In some embodiments, at least one GABA- producing bacteria is increased in the subject's stool relative to the initial amount of GABA-producing bacteria in the subject's stool after administering the therapeutic composition. [0040] In some embodiments, the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA in the subject's blood or serum. In some embodiments, the amount of GABA in the subject's blood or serum is below about 10 g per liter of blood. In some embodiments, the amount of GABA in the subject's blood or serum is increased relative to the initial amount after administering the therapeutic composition.
[0041] In some embodiments, the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an amount of GABA in the subject's brain. In some embodiments, the amount of GABA in the subject's brain is below about 1.0 mM/kg. In some embodiments, the amount of GABA in the subject's brain is increased relative to the initial amount after administering the therapeutic composition.
[0042] In some embodiments, the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of expression of GABA-producing enzymes in the subject's stool. In some embodiments, the GABA-producing enzymes are selected from glutamate decarboxylase, putrescine aminotransferase, gamma-aminobutyraldehyde dehydrogenase, argmine decarboxylase, agmatinase, ornithine decarboxylase, and combinations thereof. In some embodiments, the initial amount of enzyme expression is measured by qPCR. In some embodiments, the expression of enzymes is increased relative to the initial amount of enzyme expression after administering the therapeutic composition.
[0043] In some embodiments, the method of treating a subject further comprises identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABAergic response in the subject's brain. In some embodiments, the amount of the GABAergic response in the subject's brain is increased relative to the initial amount after administering the therapeutic composition. In some embodiments, the therapeutic composition comprises a prebiotic capable of stimulating the growth or GABA production of GABA-producing bacteria.
[0044] In one aspect, the present disclosure provides a method of culturing a GABA- dependent bacteria, comprising disposing at least one live GABA-dependent bacterial cell on a suitable substrate, and providing a source of GABA.
|0045] In some embodiments, the suitable substrate is agar. In some embodiments, providing a source of GABA comprises co-culturing with another bacterial strain, said strain is capable of producing GABA. In some embodiments, GABA is added to the substrate. In some embodiments, the GABA-dependent bacteria is E. gabavorous.
[0046] In one aspect, the present disclosure provides a method of identifying a bacterial strain or strains capable of producing GABA at a physiologically relevant pH of the human intestinal tract, comprising:
(a) dispersing a sample believed to contain GABA-producing bacteria within a substrate, the substrate being at least partially permeable to GABA,
(b) contacting the substrate loaded with potential GABA-producing bacteria with a GABA- dependent bacterium; and
(c) identifying a GABA-producing bacteria by observing the formation of a colonies of the GABA-dependent bacteria around potential GABA-producing bacteria in the substrate.
[0047] In some embodiments, the substrate is being buffered to maintain the pH at a physiologically range found in the human gastrointestinal tract, in some embodiments, the GABA-dependent bacteria is E.gabavorous. In some embodiments, the pH range is between about 4.5 and about 7.5.
[0048] The present disclosure provides compositions and methods for treating mental illness or disease of the central nervous system in a subject and therapeutic compositions for the same. The method can comprise administering to the subject a bacterium and/or multiple bacteria capable of producing endogenous GABA in the subject's gut at a physiologically relevant pH. The present technology can have the advantage of alleviating the symptoms of a mental illness or disease of the central nervous system without the aid of synthetic medications (e.g., antidepressants), which can have unwanted side-effects, or in combination with existing medications. Additionally, the present technology can have the advantage of further improving the digestive health of the subject, such as improving intestinal motility and reducing gastrointestinal pain. Additional features and advantages of the present technology7 will be apparent to one of skill in the art upon reading the Detailed Description of the Invention, below.
Brief Description of the Figures
[0049] Figure 1A shows a co-culture assay to grow and identify previously unculturable bacteria.
[0050] Figure I B shows the growth of Evtepia gabavorous KLE1738 in the presence of the helper bacteria Bacteroides fragilis KLE.1758.
[0051] Figure 2A shows the growth of Evtepia gabavorous KLE 1738 in the presence of the supernatant from Bacteroides fragilis.
[0052] Figure 2B shows a lack of growth of Evtepia gabavorous KLE1738 in the presence of the empty vehicle.
[0053] Figure 2C shows the growth of Evtepia gabavorous in the presence of the most polar fraction of the supernatant from Bacteroides fragilis LE1758.
[0054] Figure 2D shows a close-view of the lack of growth of Evtepia gabavorous KLE1738 in the presence of the empty vehicle.
[0055] Figure 2E shows a close-view of the growth of Evtepia gabavorous KLE1738 in the presence of the supernatant from Bacteroides fragilis KLE1758.
[0056] Figure 2F shows a close-view of the lack of growth of Evtepia gabavorous KLE1738 in the presence of the empty vehicle (bacterial media).
[0057] Figure 2G shows a table of potential growth factors for E. gabavorous KLE1738, with green indicating induction of growth.
[0058] Figure 3 shows a proposed GABA metabolism of E. gabavorous ΚΙ.ΕΓ738.
[0059] Figure 4a shows GABA production of B. fragilis KLE1758 is observed only at a pH of 5.5 and below, highlighting the importance of acidic pH on GABA production for certain strains or species of bacteria. [0060] Figure 4B shows an assay for the identification of GABA-producing bacteria, capable of producing GABA at a pH between 4.5 and 7.5, using the GABA-requirement of E. gahavorous KLE1738. The medium was heavily buffered to maintain a pH of the desired range and identify strains of bacteria capable of producing GABA at a pH physiologically relevant to the human gut.
[0061] Figure 4C shows a phylogenetic tree of GABA producers, capable of producing GABA at a pH of about 4.5 to about 7.5, identified by the methods herein.
[0062] Figure 5 shows GABA production capabilities of several strains identified using the screen described in Example 7. The ability of organisms to produce GABA at a range of pH conditions is highlighted.
[0063] Figure 6 A shows the growth of E. gahavorous KLE1738 in the presence of E. coll that has been engineered to express glutamate decarboxylase gadA.
[0064] Figure 6B shows the growth of E. gahavorous KLE1738 in the presence of E. coli that has been engineered to express glutamate decarboxylase gadB.
[0065] Figure 6C shows the growth of E. gahavorous KLE1738 in the presence of B. fragilis KLE 1758 that is known to produce GABA.
[0066] Figure 6D shows the absence of growth of E. gahavorous KLE1738 in the presence of E. coli that has been engineered to express glutamate decarboxylase gadC.
[0067] Figure 6E shows the absence of growth of E. gahavorous KLE1738 in the presence empty vector.
Detailed Description of the Invention
[0068] The present disclosure relates to compositions and methods for treating or decreasing a symptom of a disease in a subject. The disease can be a mental illness or a disease of the central nervous system. After identifying a subject with a mental illness or disease of the central nervous system, the method can comprise determining whether the subject would benefit from an increase in endogenous GABA, for instance by measuring the amount of GABA in the subject's stool, blood serum, or other bodily fluids, measuring levels of GABA in different regions of the brain, measuring the GABAergic response in different regions in the brain, measuring activity of GABA producing enzymes in stool, or by measuring the amount of GABA-producing bacteria in the subject's stool. The method can further comprise administering to the subject a GABA-producing bacterium or bacteria that can be capable of producing GABA in the subject's gut, (e.g., at a physiologically relevant pH of the gut).
[0069] Some bacteria produce GABA from gamma-aminobutyrate to maintain intracellular pH homoeostasis in order to overcome acid stress. As set forth herein, the production of GABA by microbes (e.g., bacteria) in the human gut can impact the health of a subject. For instance, GABA produced by bacteria in the human gut can act as a neurotransmitter to treat a mental illness, a disease of the central nervous system, or improve gastrointestinal health in a subject.
Definitions
[0070] As used herein "administer" and "administration" encompasses embodiments in which one person directs another to consume a bacteria or a bacterial composition in a certain manner and/or for a certain purpose, and also situations in which a user uses bacteria or a bacterial composition in a certain manner and/or for a certain purpose independently of or in variance to any instmctions received from a second person. Non-limiting examples of embodiments in which one person directs another to consume a bacteria or bacterial composition in a certain manner and/or for a certain purpose include when a physician prescribes a course of conduct and/or treatment to a patient, when a parent commands a minor user (such as a child) to consume bacteria or a bacterial composition, when a trainer advises a user (such as an athlete) to follow a particular course of conduct and/or treatment, and when a manufacturer, distributer, or marketer recommends conditions of use to an end user, for example through advertisements or labeling on packaging or on other materials provided in association with the sale or marketing of a product.
[0071] The term "'isolated'" encompasses a bacterium or other entity or substance that has been (1) separated from at least some of the components with which it was associated when initially produced (whether in nature, such as human stool, or in an experimental setting, such as a Petri plate consisting of artificial growth medium), and/or (2) produced, prepared, purified, and/or manufactured by the hand of man. Isolated bacteria may be separated from at least about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, or more of the other components with which they were initially associated. In some embodiments, isolated bacteria are more than about 80%, about 85%, about 90%, about 91 %, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or more than about 99% pure. As used herein, a substance is "pure'" if it is substantially free of other components (such as other bacterial species). The terms "purify," "purifying" and "purified" refer to a bacterium or other material that has been separated from at least some of the components with which it was associated either when initially produced or generated (e.g., whether in nature or in an experimental setting), or during any time after its initial production, as recognized by those skilled in the art of bacterial cultivation. A bacterium or a bacterial population may be considered purified if it is isolated at or after production, such as from a material or environment containing the bacterium or bacterial population, and a purified bacterium or bacterial population may contain other materials up to about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, or above about 90% and still be considered "isolated." In some embodiments, purified bacteria and bacterial populations are more than about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%», about 97%, about 98%, about 99%, or more than about 99% pure. In the instance of bacterial compositions provided herein, the one or more bacterial types present in the composition can be independently purified from one or more other bacteria produced and/or present in the material or environment containing the bacterial type. Bacterial compositions and the bacterial components thereof are generally purified from residual habitat products.
[0072] As used herein, "probiotic" is understood to mean "Live microorganisms which when administered in adequate amounts confer a health benefit on the host", as currently defined by the World Health Organization.
[0073] As used herein, "prebiotic" is understood to mean an ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microbiota that may (or may not) confer benefits upon the host. [0074] As used herein, "medical food" is understood to mean "a food which is formulated to he consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation", as defined by 5(b) of the Orphan Drug Act (21 U.S.C. 360ee (b) (3)).
[0075] As used herein "initial amount" is understood to mean the amount of a substance, e.g., GAB A in an aliquot of sample prior to administration of GABA-producing bacteria to the subject. Initial amount can be measured in terms of concentration. For instance, an initial amount can be measured in terms of micrograms of substance per milliliter of sample, e.g., micrograms of GABA per milliliter of blood or serum ^g GABA/mL blood or serum). The initial amount of can also be measured, for instance, as the amount of GABA in regions of the brain, such as the prefrontal cortex prior to administration of the GABA-producing bacteria. The amount of GABA can be represented in terms of millimoles of GABA per kg tissue (mmol GABA per kg of brain tissue). The initial amount can also be measured, for instance, as the amount of GABA in a subject's stool sample prior to administration of GABA-producing bacteria to the subject. The amount of GABA can be represented in terms of micrograms of GABA per gram of stool (,ug GABA/g stool). The initial amount can also be the level of expression of GABA producing enzymes in the stool (log change of reads), as measured by qPCR or other appropriate method. Unless otherwise defined herein, stool is weighed when wet or dry, i.e. , without active drying, and within one hour of production of the stool. For instance, the stool can be weighed within 45 minutes, 30 minutes, 15 minutes, 10 minutes, or within 5 minutes of production of the stool.
[0076] As used herein, a "GABAergic response" means the response of a given organ (e.g., the brain or vagus nerve) to differences in the concentrations of GABA, GABA producing bacteria, or prebiotics to which it is exposed. A GABAergic response can include a change in concentrations of GABA as well as expression levels and/or activity of different GABAA, GABAB, and/or GAB Ac receptors. [0077] "GABA-producing bacteria" is understood to mean bacteria that can produce measurable quantities of GABA, as detected by LC/MS, ELTSA, or other appropriate analytical assays. In some embodiments, GABA-producing bacteria ca produce GABA under the physiological conditions in a human, e.g., under the pH, and temperature of the human gut.
[0078] "Physiologically relevant pH" of the human intestinal tract is understood to mean a pH range that exists in the body. For instance, a pH range that is physiologically relevant to the human gut can be in the range of about 4.5 to about 7.5.
[0079] The term "gut" is understood to refer to the human gastrointestinal tract, also known as the alimentary canal. The gut includes the mouth, pharynx, oesophagus, stomach, small intestine (duodenum, jejunum, ileum), large intestines (cecum and colon) and rectum.
[0080] As used herein, "bacteria" or "bacterial strain" is understood to mean a species of bacteria. A "bacterium" is understood as a single bacterial cell of a given species.
[0081] The term "treating" with regard to a subject, refers to improving at least one symptom of the subject's disorder. Treating includes curing, improving, or at least partially ameliorating the disorder.
[0082] The term "EMBL/GenBank/DDBJ ID" refers to an accession number, which when used as in input for databases such as the European Molecular Biology Laboratory (EMBL), GenBank, or DNA Data Bank of Japan (DDBJ), via their respective internet websites, enables access to information, such as nucleotide sequence of a gene, and the bacterium encoding that sequence in its genome. The EMBL/GenBank/DDBJ ID is used in this application as a conveninent means to access sequence information.
Gamma-Aminobutyric Add (GABA)
[0083] The term "GABA" is understood to mean garawa-arninobutyric acid (γ- aminobutyric acid). GABA has the chemical structure:
Figure imgf000018_0001
[ΘΘ84] GABA is a major inhibitory neurotransmitter in the mammalian central nervous system. It plays a principal role in reducing neuronal excitability throughout the nervous system. GABA can be a difficult compound to deliver therapeutically due to efflux and half-life limitations. For example, in rodents, the brain efflux rate of GABA was found to be 17 times higher than the influx rate. Additionally, GABA only has a half-life of only 17 minutes in mice. Accordingly, because of the short half-life of GABA in vivo, oral GABA supplementation can be ineffective, as it may require frequent dosing, even with slow release capsules.
[ΘΘ85] The present disclosure provides for delivering a therapeutic composition of one or more bacteria that can produce GABA within the intestinal tract, in order to consistently deliver GABA into systemic circulation (e.g., into the nervous system). The endogenous!}' produced GABA can also activate vagal nerve receptors directly. This can mitigate the inherent half-life of GABA.
[0086] In some embodiments, the microbiome can influence GABA levels and the GABAergic response in the brain. For instance, germ-free animals can have substantially reduced luminal and serum levels of GABA. Without wishing to be bound by theory, this suggests the microbiome is important in regulating levels of this important neurotransmitter. As set forth herein, GABAergic modulation by microbiome intervention (e.g., using methods and compositions described herein) can have therapeutic potential.
[0087] In some embodiments, GABA can play a role in mental illness or disease of the central nervous system. For instance, in some embodiments, low levels of GABA can be associated with depression, bipolar disorder, schizophrenia, anxiety, anxiety disorders, addiction, social phobia, treatment-resistant major depressive disorder (TR-MDD), major depressive disorder and its subtypes (melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder), Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic tremor, Lafora disease, restless leg syndrome, neuropathic pain, pain disorders, dementia, epilepsy, stiff-person syndrome, premenstrual dysphoric disorder, autism spectrum disorder, sleep disorders, and attention deficit hyperactivity disorder (ADHD). As set forth herein, the present disclosure provides increasing the amount of endogenous GABA in a subject can decrease levels of mental illness or disease of the central nervous system in the subject.
[0088] In some embodiments, GABA produced by gut bacteria can play a role in mental illness or disease of the central nervous system via the vagus nerve, connecting the intestinal tract to the peripheral and central nervous systems.
|0089] In some embodiments, GABA produced by gut bacteria can play a role in mental illness or disease of the central nervous system via affecting circulating levels of systemic GABA in the host, which can influence the peripheral and central nervous systems.
Means of GABA Production by Microbes
[0090] Bacteria can produce GABA using a variety of different pathways. Set forth below are exemplary pathways that bacteria and other microbes can use to produce GABA (e.g., in vivo). As set forth below, any of the GABA production pathways described herein can be naturally occurring in a given bacterium. Alternatively, a necessary enzyme or grouping of enzymes can be added to the DNA sequence of a bacteria to enable the bacteria to produce GABA.
Giutaniate Pathway
[0091 ] In some embodiments, microbes can produce GABA using the glutamate decarboxylase enzyme (e.g., glutamate decarboxylase EC 4.1.1.15). In some embodiments, glutamate decarboxylase is capable of directly converting glutamate to GABA.
Putrescine to 4-Ammobutanal Pathway
[0092] In some embodiments, microbes can produce GABA using the putrescine to 4- aminobutanal pathway. The microbes can then convert 4-aminobutanal to GABA. In some embodiments, putrescine aminotransferase (for instance, putrescine aminotransferase EC 2.6.1.82) can be used to convert putrescine to 4-aminobutanal. The 4-aminobutanal can then be converted in the presence of garama-aminobutyraldehyde dehydrogenase (e.g., gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19)) to GABA.
Arginine to Agmatine to Putrescine Pathway
[0093] In some embodiments, microbes can produce GABA using the arginine to agmatine to putrescine Pathway. Once the putrescine is produced, it can be converted as described above (e.g., using the putrescine to 4-aminobutanal pathway) to GABA. In some embodiments, arginine decarboxylase (e.g., arginine decarboxylase (EC 4.1.1 .19)) can convert arginine to agmatine. Agmatine can then be converted to putrescine using agmatinase (e.g., agmatinase (EC 3.5.3.11)).
L-omithine to Putrescine pathway
In some embodiments, ornithine decarboxylase (e.g., ornithine decarboxylase (EC
4.1.1.17)) can be used to convert ornithine to putrescine. Once the putrescine is produced, it can be converted as described above (e.g., using the putrescine to 4-aminobutanal pathway) to GABA.
Bacterial Strains
[0094] The present disclosure provides bacterial strains (e.g., purified strains) and therapeutic compositions comprising the same for administration to a subject in need thereof. The bacteria can be naturally occurring, or can be engineered (e.g., through strain engineering or selection) to produce GABA. In some embodiments, one strain of GABA- producmg bacteria can be administered to a subject. In some embodiments, multiple strains of GABA-producing bacteria can be administered to a subject in need thereof. In some embodiments, the one or more bacteria (e.g., purified bacteria) can act synergistically. For instance, the multiple bacteria can act synergistically to produce high levels of GABA. In some embodiments, the one or more bacteria can also help to reduce the number of GABA- consuming bacteria in a human gut. Accordingly, any one, or any combination of the GABA-producing bacteria taught herein can be administered to a subject in need thereof.
[0095] In some embodiments, the bacteria taught herein can produce GABA at physiologically relevant conditions, such as under the conditions of the human gut. In some embodiments, the GABA-producing bacteria taught herein can produce GABA a pH relevant to the human gut is between about 4.5 and about 7.5. For instance, the pH can be about 4.5, 5.0, 5.5., 6.0, 6.5, 7.0 7.5, or any value between about 4.5 and 7.5.
[0096] The ability to produce GABA at physiologically relevant pH is important in view of the pH restrictions of GABA production in many bacteria. For example, E. coii is unable to produce GABA above a pH of 4.5. Instead, without wishing to be bound by theory, it can use conversion of glutamate to GABA coupled with GABA export, for example, as a means to neutralize the intracellular environment. Accordingly the present disclosure bacteria capable of producing GABA at a pH relevant to the host environment, such as the more neutral large mtestmes (e.g., between about pH 4.5 and about pH 7.5). In some embodiments, the bacteria taught herein can also produce GABA under other relevant conditions that exist within the human gut. That is, the GABA-producing bacteria taught herein can produce GABA in the absence of oxygen, in a nutrient-competitive and fluctuating environment, and in the absence of light.
Natural Strains
[0097] In some embodiments, the GABA-producing bacteria can be identified by having a 16S nucleic acid sequence substantially similar to the 16S sequences of reference bacteria listed in Table 1 , with a Seq. ID. No. of 1-31. In some embodiments, the G ABA-producing bacteria can have at least 90% 16S sequence similarity to the 1 6S sequences given in Table 1 (e.g. , at least 91 % similarity, at least 92% similarity, at least 93% similarity, at least 94% similarity, at least 95% similarity, at least 96% similarity, at least 97%> similarity, at least 98%* similarity, at least 99% similarity, at least 99.5% similarity, at least 99.9% similarity, or 1 00% similarity).
[0098] In some embodiments, the GABA-producing bacteria can be identified by NCBI Taxon ID of the organism they are most related to by 16S sequence. These bacteria include those belonging to the same NCBI Taxon assignment as Barter aides caccae KLE1911; Bacteroides clarus KLE1930; Bacteroides dorei KLE 1912;
Bacteroides finegoldii KLE1931; Bacteroides fragilis KLE1958; Bacteroides massiliensis LE1932; Bacteroides ovatiis KLE1770; Bacteroides stercoris KLE1933; Bacteroides theiaioiaomicron KLE1934; Bacteroides uniformis KLE1913; Bacteroides vulgatus KLE1910; Bacteroides x lanisolvens KLE1935; Bifidobacterium, adolescentis KLE 1879; Blautia obeum KLE1914; Blautia wexlerae KLE1916; Butyricimonas virosa KLE 1938; Clostridium perfrmgens KLE1937; Clostridium sordelhi KLE1939; Clostridium sp.
KLE1862; Clostridium sp. KLE1918; Coprobacillus sp. KLE1779; Coprococcus sp.
KLE1880; Dorea longicatena KLE1917; Eggerthelia lenta KLE1926; Eubacterium rectale LE1922; Gordonibacter pamelaeae KLE1915; Osciilibacter sp. KLE 1928; Parahacteroides distasonis LE2020; Parahacteroides merdae KLE 1863; Ruminococcus gnavus KLE1940; Turicibacter sanguinis KLE1941, and combinations thereof.
Table ί . Strain name of GABA producing bacteria, and their cooresponding Seq. ID No.
Figure imgf000023_0001
[0099] Also disclosed herein are bacteria that are predicted to be capable of producing GABA (e.g., under physiologically relevant conditions and/or in the human gut). Bacteria are identified as being candidate GABA producing bacteria if they have encoded in their genome enzymes involved in GABA biosynthesis. In some embodiments, the bacteria that are predicted to be capable of producing GABA can be identified by having a 16S nucleic acid sequence substantially similar to the 16S sequences of reference bacteria listed in Table 2, with a Seq. ID. No. of 32-274. In some embodiments, the predicted GABA-producing bacteria can have at least 90% 16S sequence similarity to the 16S sequences given in Table 2, with a Seq. ID. No. of 32-274 (e.g., at least 91 % similarity, at least 92% similarity, at least 93% similarity, at least 94% similarity, at least 95% similarity, at least 96% similarity, at least 97% similarity, at least 98% similarity, at least 99% similarity, at least 99.5% similarity, at least 99.9% similarity, or 100% similarity).
Table 2. Predicted GABA producing bacteria and their corresponding Seq. ID No..
Figure imgf000024_0001
Ali stipes shahii
Aquamicrobium defluvii 58
Arenimonas donghaensis 59
Arthrobacter sp. 60
Azospirillum sp. 61
Bacillus bataviensis 62
Bacillus cereus 63
Bacillus cereus 64
Bacillus endophyticus 65
Bacillus weihens tephanensis 66
Bacferoidaceae bacterium 67
Bacteroides acidifaciens 68
Bacteroides caccae 69
Bacteroides ceUulosilvticus 70
Bacteroides dorei 71
Bacteroides eggerthii 72
Bacteroides flnegoldii 73
Bacteroides fragilis 74
Bacteroides gallinarum 75
Bacteroides intestinalis 76
Bacteroides massiliensis 77
Bacteroides oleiciplenus 78
Bacteroides ovatus 79
Bacteroides rodentium 80
Bacteroides sal rv_ e iae 81
Bacteroides sartorii 82
Bacteroides sp. 83
Bacteroides sp. 84
Bacteroides sp. 85
Bacteroides sp. 86
Bacteroides siercoris 87
Bacteroides thetaiotaomicron 88
Bacteroides uniformis 89
Bacteroides vulgatus 90
Bacteroides xylanisolvens 91
Barnesiella intesiinihominis 92
Bhargavaea cecembensis 93
Bifidobacterium adoiescentis 94
Bifidobacterium, angulatum 95
Bifidobacterium dentium 96
Bifidobacterium ruminantium 97 Bias tococcus sp. 98
Bordetella bronchiseptica 99
Borde tella trematum 100
Bosea sp. 101
Bradyrhizobium sp. 102
Brevibacillus borstelensis 103
Brevundimonas diminuta 104
Brevundimonas naejangsanensis 105
Brucella abortus 106
Brucella melitensis 107
Brucella neotomae 108
Burkholderia mallei 109
Burkholderia multivorans 110
Carnobacterium gallinarum 111
Caulobacter crescentus 1 12
Caulobacier sp. 113
Cellulomonas flavigena 114
Cellulomonas sp. 115
Cellulosimicrobium cellulans 116
Cetobacterium somerae 1 17
Citrobacier amalonaticus 1 18
Cloacibacillus evrvensis 119
Clostridium acetobutylicum 120
Clostridium, perfrmgens 121
Comamonas granu!i 122
Corynebacierium variabile 123
Cupriavidus basilensis 124
Cupriavidus sp. 125
Dechloromonas agitata 126
Demococcus geothermaiis 127
Delflia isuru aiensis 128
Desulfovibrio desulfuricans 129
Desulfovibrio sp. 130
Devosia riboflavina 131
Eggertheila sp. 132
Ensifer aahaerens 133
Enterococcus casselifla vus 134
Enterococcus flavescens 135
Escherichia coli 136
Eubacterium limosum. 137
Eubacterium nodatum 138 Eubacterium saphenum 139
Fusobacterium periodonticum 140
Gordonia sputi 141
Gordonia terrae 142
Gordon ibacter pamelaeae 143
Halomonas stevensii 144
Halomonas titanicae 145
Hoeflea sp. 146
Intrasporangium calvum 147
Janibacler hoylei 148
Kms tin granuli 149
Kineococcus radiotolerans 150
Lactobacillus coleohominis 151
Lactobacillus plan tarum 152
Lactobacillus reuteri 153
Lactococcus garvieae 154
Lactococcus lactis 155
Lautropia mirabilis 156
Le ucobacter salsici us 157
Luteimonas huabeiensis 158
Magnetos pir ilium rnagnetotaciicum 159
Marinobacter lipolyticus 160
Marmoricola sp. 161
Megasphaera micronuciformis 162
Megasphaera sp. 163
Mesorhizobium sp. 164
Methanobrevibacter arboriphilus 165
Methylobacterium radiotolerans 166
Methylobacterium sp. 167
Microbacterium sp. 168
Micromonospora aurantiaca 169
Mogibacterium Mogibacferium 170
Morganella morganii 171
Mycobacterium smegmatis 172
Mycobacterium sp. 173
Mycobacterium sp. 174
Mycobacterium vanhaalenii 175
Neisseria sicca 176
Neorhizobium galegae 177
Nocardia rhamnosiphila 178
Nocardiopsis aikaliphUa 179 Nocardiopsis ganjiahuensis 180
Nocardiopsis synnemataformans 181
Nocardiopsis valliformis 182
Novosphingobium nitrogeniflgens 183
Ochrobactrum intermedium 1 84
Odoribacter laneus 185
Odoribacter splanchnicus 186
Oerskovia turbata 187
Pannonibacter phragmitetus 188
Pantoea vagans 1 89
Parabacteroides distasonis 190
Parabacteroides golds teinii 191
Parabacteroides Johns onii 192
Parabacteroides merdae 193
Parabacteroides sp. 194
Parabacteroides sp. 195
Paracoccus denitrificans 196
Paracoccus sp. 197
Paracoccus yeei 198
Parvimonas Parvimonas 199
Pectobacterium caroto vorum 200
Phyllobacterium sp. 201
Polaromonas sp. 202
Porphyromonas bennonis 203
Proteus mirabilis 204
Providencia alcalifaciens 205
Providencia burhodogranariea 206
Providencia rettgeri 207
Pseudacidovorax intermeaius 208
Pseudoalteromonas sp. 209
Pseudochrobactrum sp. 210
Pseudomonas aeruginosa 211
Pseudomonas alcaligenes 212
Pseudomonas chloritidismutans 213
Pseudomonas chlororaphis 214
Pseudomonas japonica 215
Pseudomonas knackmussii 216
Pseudomonas mendocina 217
Pseudomonas monteilii 218
Pseudomonas oleovorans 219
Pseudomonas putida 220 Pseudomonas savastanoi 221
Pse.udom.onas sp. 222
Pseudomonas sp.
Pseudomonas sp. 224
Pseudomonas sp. 225
Pseudomonas sp. 226
Pseudomonas sp. 227
Pseudomonas sp. no
Pseudomonas sp. 229
Pseudomonas sp. 230
Pseudomonas stutzeri 231
Pseudomonas synxantha 232
Pseudomonas syringae 233
Pseudonocardia sp. 234
Ralstonia solanacearum 235
RaouUeila plant icola 236
Rhizobium leguminosarum 237
Rhizobium sp. 238
Rhodococcus defluvii 239
Rhodococcus pyridimvorans 240
Rikenella rnicrofusus 241
Robinsoniella sp. 242
Roseomonas cervicalis 243
Roseomonas sp. 244
Salmonella enter ica 245
Sanguibacter keddieii 246
Shewanella baltica 247
Shewanella sp. 248
Shinella zoogloeoid.es 249
Sphmgopyxis aiaskensis 250
Siarkeya novella 251
Stenotrophomonas maltophilia 252
Stenotrophom.on.as rhizophila 253
Streptococcus thermophilus 254
Streptomyces atrooUvaceus 255
Streptomyces coelicoflavus 256
Streptomyces olindensis 257
Streptomyces rimosus 258
Streptomyces roseoverticillatus 259
Streptomyces sp. 260
Streptomyces sp. 261 Streptomyces sp. 262
Streptomyces sp. 263
Streptomyces sp. 264
Streptomyces sp. 265
Streptomyces sp. 266
Streptomyces toyocaensis 267
Streptomyces turgidiscabies 268
Synergistes sp. 269
TannereUa sp. 270
Thauera ierpenica 271
Variovorax paradoxus 272
Variovorax sp. 273
Xanthomonas axonopodis 274
Engineered Strains
[00100] In some embodiments, bacteria can be engineered to produce GABA (e.g., under the conditions of the human gut). The bacteria ca be engineered using techniques of molecular biology, or can be evolved using the process of selection to produce GABA in the human gut.
[00101] As set forth above, GABA can be produced by multiple pathways within a microbial cell. For example, GABA can be produced by the glutamate pathway, the putrescine to 4-aminobutanal pathway, the arginiiie to agmatine to putrescine pathway, the L-ornithine to putrescine pathway, or by a combination of pathways. In some embodiments, bacteria can be engineered to contain one or more enzymes in any one of the above pathways that can enable the bacteria to produce GABA or a necessary precursor to GABA.
[00102] A variety of different host bacteria can be engineered to produce GABA. For instance, in some embodiments, Escherichia coli Nissle 1917, can be genetically modified or selected through evolution to produce GABA. In some embodiments, the bacteria (e.g. , Escherichia coli Nissle 1917) can be modified to express or overexpress glutamate decarboxylase A or glutamate decarboxylase B. The bacteria can also be made to produce GABA by one or more of the other pathways described herein. [00103] Accordingly, in some embodiments, an engineered GABA-producing strain can be identified as having a specific enzyme encoded in its genomes. For example, the enzyme can be glutamate decarboxylase (EC 4.1 , 1.15); putrescine aminotransferase (EC 2.6.1.82); gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19); arginine decarboxylase (EC 4.1.1.19); agmatinase (EC 3.5.3.11); ornithine decarboxylase (EC 4.1.1.17); or a combination thereof In some embodiments, the GABA-producing strain can be engineered to contain an enzyme that has at least 50% similarity with with the representative sequences listed in Table 3 (e.g., at least 60%) similarity, at least 70% similarity, at least 80% similarity, at least 90% similarity, at least 91% similarity, at least 92% similarity, at least 93% similarity, at least 94% similarity, at least 95% similarity, at least 96% similarity, at least 97% similarity, at least 98% similarity, at least 99% similarity, at least 99.5% similarity, at least 99.9% similarity, or 100% similarity). The enzyme classes, as identified by their Enzyme Commission (EC) numbers, are listed in Table 3.
Table 3. Enzymes involved in GABA-Production Pathways, and Seq. ID No. for representative sequences for each enzyme class
Figure imgf000031_0001
[00104] Representative examples of glutamate decarboxylase (EC 4.1.1.15) are given below in Table 4 and identified by their EMBL/GENBANK/DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the glutamate decarboxylase set forth in Table 3 or Table 4. For instance, the bacteria can be engineered with a version of the glutamate decarboxylase enzyme that has at least 50% nucleotide similarity with any of the versions of glutamate decarboxylase given in Table 4 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90%) nucleotide similarity, at least 91 % nucleotide similarity, at least 92% nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucleotide similarity, at least 95% nucleotide similarity, at least 96% nucleotide similarity, at least 97% nucleotide similarity, at least 98% nucleotide similarity, at least 99% nucleotide similarity, at least 99,5% nucleotide similarity, at least 99.9% nucleotide similarity, or 100% nucleotide similarity).
Table 4. Representative Examples of Glutamate Decarboxylase by
EMBL/GENBANK/DDBJ ID Number
AAA23833.1 ABF03896.1 ABV88270.1 ADI09031.1
AAA23834.1 ABF05994.1 ABV98199.1 ADJ50560.1
AAB 18493.1 ABF08645.1 ABW 16238.1 ADM42706.1
AAC46188.1 ABG57877.1 ABY23810.1 ADN37174.1
AAC74566.1 ABG82826.1 ABY39350.1 AD035975.1
AAC76542.1 ABG85385.1 ABZ77591.1 ADP83065.1
AAG22560.1 ABG97793.1 ABZ87126.1 ADR26899.1
AAG22562.1 ABI47454.1 ACA46668.1 ADR28903.1
AAG56275.1 ABJ00921.1 ACA53668.1 ADT6774 I . I
A AGS 8658.1 ABJ02999.1 ACA88989.1 ADT75096.1
AAK05388.1 ABJ63253.1 ACB 15780.1 ADT77123 , 1
AAK 17187.1 ABJ64910.1 ACB15938.1 ADU00909. 1
AAK47878.1 ABK67541.1 ACC39574.1 ADU26301. 1
AAL54152.1 ABK75920.1 ACD04211.1 ADW04875.1
AAL54153.1 ABK90558.1 ACD07724.1 ADY32347.1
AAN43309.2 ABL03510.1 ACD82162.1 ADY58934.1
AAN45045.2 ABL90375.1 ACH65664.1 ADY59978.1
AAN54823.2 ABM09145. 1 ACJ29997.1 ADZ09662.1
AAN80380.1 ABM12315. 1 ACL47965.1 ADZ09880.1
AAN82764.1 ABM78546.1 ACN1681 1.1 AEA24253.1
AA077677.1 ABP 7401.1 ACO85906.1 AEA24271.1
AAP17196.1 ABP56802.1 ACR68120.1 Αί· Β7239 Ι . |
AAP19142.1 ABQ62050.1 ACS81597.1 AEE27076.1
AAS06807.1 ABQ75258.1 ACU49468.1 AEE56495.1
AAS41604.1 ABQ85037.1 ACU54556.1 AEE58814.1
AAT42735.1 ABQ85038.1 ACU77475.1 AEF37245, 1
AAW85387.1 ABQ85039.1 AC V54143.1 AEF40931.1
AAW85559.1 ABQ85040.1 AC V81603.1 AEG17214.1
AAZ71647.1 ABQ85043.1 AC Y51919.1 AEH47920.1
AAZ88326.1 ABQ85046.1 ACY85701.1 Ah! 193400. ]
AAZ90121 .1 ABQ85049.1 ADA65034.1 AEH93479.1
ABB61740. 1 ABQ85050.1 ADA74124.1 AEI35432.1
ABB63509. 1 ABQ85051.1 ADA75905.1 AEJ56545.1
ABB66175.1 ABQ85053.1 ADB 10338.1 AEJ58918.1
ABB68000.1 ABQ85058.1 ADB51885.1 AEK38321.1
ABC77952.1 ABR41498.1 ADD56429.1 Αί· Κ47566. Ι
ABD09573.1 ABR42591.1 ADD58723.1 Αί· Κ58322. Ι
ABE07185.1 ABS42061.1 ADE69489.1 AEM48695.1
ABE09478.1 ABU72013.1 ADF39290, 1 AEM88213.1
ABE29172.1 ABV20447.1 ADG78237.1 AEN 10737, 1
ABE36450.1 ABV20705.1 ADG96760.1 AEN89628.1 AEO05457.1 AGC43105.1 AHY70401.1 AJD30517.1
AEO07341.1 AGC61247.1 AHY72977.1 AJE06383.1
AEO07410.1 AGE37597.1 AHZ23367.1 AJE12001.1
AEQ12485.1 AGF77926.1 AI AO 1950.1 AJE41795.1
AEQ14770.1 AGG29530.1 AIA05032.1 AJE55882.1
AET90796.1 AGJ55746.1 AIA30132.1 AJE58075.1
AEU40604.1 AGK78014.1 AIA55291.1 AJE83295.1
AEU40605.1 AGK95653.1 ALA73764.1 AJE87567.1
AEV39535.1 AGL28896.1 AIC75915.1 AJF56325.1
AEV71230.1 AGL89003.1 AIE75400.1 AJF58318.1
AEV85044.1 AGM 10224.1 AIE79640.1 AJF66001.1
AEW99357.1 AGM23454.1 AIG80748.1 AJG19558.1
AEY90789.1 AGM30354.1 ΑΠ05027.1 AJG22402.1
AFA40032.1 AGN85370.1 ΑΠ76842.1 AJG22403.1
AFA47141.1 AGO09336.1 AU07554.1 AJG93936.1
AFA74414.1 AGP31884.1 Af .11508!.! AJH 17760.1
AFC23797.1 AGP56881.1 A [.126745.1 AJI06057.1
AFC45457.1 AGP65818.1 AIRl 6227.1 Λ.1125468.1
AFG40494.1 AGR65020.1 AIS03708.1 AJI52230.1
AFG42464.1 AGS70940.1 AIS31569.1 AJI53611.1
AFJ28998.1 AGV73208.1 AIS60683.1 AJI57942.1
AFJ31191.1 AGY44310.1 AIS60750.1 AJI68933.1
AFJ37206.1 AGZ52354.1 ΑΓΓ09528.1 AJI74183.1
AFK19988.1 AHA 64741.1 AIU74973.1 AJI88044.1
AFK57885.1 AHA 64994.1 AIX63299.1 AJJ46763.1
Al l.79172.1 AHA67486.1 AIX65458.1 AJK40118.1
AFM 15894.1 AHA67487.1 AIY00711.1 AJK45246.1
AFN45150.1 Λ111)20397.1 AIY45527.1 AJ083482.1
AFP38009.1 Λ111:48317.1 AIY83613.1 AJ085575.1
AFR07193.1 AHE57937.1 ΑΓΥ84119.1 AJQ91926.1
AFR30984.1 AHE60304.1 A 1/82546.1 AJT65391.1
AFR47006.1 AHF05109,1 AIZ84546.1 AJW41655.1
AF SI 6303.1 AHF 13271,1 AJA 19876.1 AJY44977.1
AFS52965.1 AHG20573.1 AJA25926.1 AKB 18082.1
AFS74495.1 AHH15398.1 AJA28548.1 AKB18368.1
AFT98587.1 AHH98082.1 AJA57089.1 A B214I4.1
AFV89643.1 AHJ76938.1 AJA79136.1 AKB22089.1
AFY29504.1 AHK29878.1 AJA80033.1 A B28570.1
AEZ52375.1 AHM72117.1 AJC56876.1 AKB32481.1
AGA90199.1 AHW62584.1 AJC60332.1 AKB36808.1
AGB21530.1 Λ11X21760.1 AJD29942.1 AKB44521.1 AKB48030.1 ANP2Q338.1 BAN07465.1 CBG71067.1
AKB51234.1 AOM43274.1 BAN32855.1 CBH50652.1
AKB54327.1 AOM46217.1 BA088345.1 CBJO 1067.1
AKB57594.1 AOM69863.1 CAA44834.1 CBJ03264.1
AKB 78420, 1 AOM72020.1 CAA50736.1 CBJ 13441.1
AKB81570, 1 AOT30761.1 CAB42769.1 CBK63002.1
AKC401 19.1 AOT32983.1 CAC97690.1 CBK66783.1
AKD98129.1 APA40105.1 CAC97755.1 CBL04696.1
AKF85158.1 APA42487.1 CAC98526.1 CBL57837.1
AKG70083.1 APA95425.1 CAD00441.1 CBW21055.1
AKG72082.1 BAA15163.1 CAD00512.1 CBW86770.1
AKH24178.1 BAA! 7064.1 CAE20649.1 CBW86835.1
AKH26551.1 BAA24585.1 CAE33151.1 CBY25615.1
AKH83393.1 BAA30034.1 CAG35114.1 CBY25616.1
AKJ11706.1 BAB35521.1 CAG46355.1 CBY83732.1
AKK26454.1 BAB37820.1 CAH06161.1 CCA56552.1
AKK48189.1 BAB8 764.1 CAJ13031.1 CCB79422.1
AKK50365.1 BAC71313.1 CAJ13032.1 CCB79423.1
AKL69083.1 BAC72367.1 CAJ50408.1 CCC28516.1
AKM35002.1 BAD47203.1 CAK21799.1 CCC45780.1
AKM37064.1 BAD58388.1 CAK28447.1 CCC80401.1
AKN61935.1 BAE77777.1 CAL13720.1 CCF80014. 1
AKN70627.1 BAG20906.1 CAL73487.1 CCF80015. 1
AKP77446.1 BAG77107.1 CAL97772.1 CCG87871.1
AKQ55619.1 BAG79310.1 CAM63814.1 CCG91229, 1
AKR03347.1 BAH34246.1 CAQ78882.1 CCG98062.1
AKS23002.1 BAH54322.1 CAQ89093.1 CCH30995.1
ALD25331.1 BAI25363.1 CAQ90311.1 CCH77936.1
Ai.1.88386. 1 BAI27772.1 CAR02896. 1 CCH93070.1
ALL90542.1 BAD 0441.1 CAR05140.1 CCH98079.1
ALZ68108.1 BAI32950.1 CAR07836.2 CCI01250.1
AMC47930.1 BAD 5784.1 CAR10182.1 CCI09506.1
AMW41208.1 BAD 8094.1 CAR 12949 I CCIl 8860.1
AMW43303.1 BAJ28326.1 CAR15161.1 CCI27064.1
AMX13814.1 BAJ74886.1 CAR17889.1 CCJ46136.1
AMX 5691.1 BAK43421 . 1 CAR20131.1 CCJ52392.1
ANK32168.1 BAL67532.1 CAR42970.1 CCK 19015.1
ANM8225 .1 BAL89884.1 CAS09168. 1 CCK 19016, 1
Λ NX 184279 ! BAM06654.1 CAS1 1307. 1 CCK28448.1
A 091466.1 BAM50779.1 CAU97478.1 CCK46704.1
ANP 18008.1 BAN05709.1 CAV00414.1 CCK48823.1 CCK79225.1 CEJ51402.1 CRG01912.1 EAR53494.1
CCO09825.2 CEK27848.1 CRHl 6097.1 EAS62995.1
CCO 10173. 1 CE 31257.1 CRH 16918.1 EAU72855.1
CCO13002.2 CEK34473.1 CRHl 6922.1 EAV43522.1
CCO24580. 1 CEK36954.1 CRI32384.1 EDK88619.1
CCO64903. 1 CEL25420.1 CRI34932.1 EDL53816.1
CCO64970.1 CEOS 8246.1 CRK49247.1 EDL54868.1
CCP46254.1 CEP25754.1 CR 49766.1 EDL56435.1
CCQ12644.1 CEP41466.1 CRY53884.1 EDL68777.1
CCQ14157.1 CEQ04848.1 CRY55938.1 EDM21919.1
CC 09328.1 CEQ04850.1 CRY74150.1 EDM65095.1
CCW10939.1 CFE36737.1 CRZ 15952. 1 EDN56728.1
CDG05069.1 CFE50785.1 CSK83327. 1 EDN71351.1
CDG65008.1 CFQ66985.1 CSK89516.1 EDN82399.1
CDI46519.1 CFT98680.1 CSN37587.1 EDN85024.1
CDK01888.1 CFT98693.1 CSN43893.1 ED014168.1
CDK72542.1 CKO74072.1 CSP86321.1 ED051732.1
CDK77522.1 CKR41672.1 CSS74791.1 EDP24277.1
CDL24770.1 CKR63720.1 CTQ53252.1 EDP59239.1
CDL26737.1 CKR87162.1 CTQ71526.1 EDS02296.1
CDL29747.1 CKV41513.1 CTT09685.1 EDS16532.1
CDM06669.1 CNH63762.1 CTT19248.1 EDS80418. 1
CDM06670.1 CNN53125.1 CTT51717.1 EDS92014. 1
CDN82039.1 CNZ28847.1 CTT83594.1 EDS93501.1
CDN84269.1 COF'20080, 1 CTU03723 , 1 EDT 12835.1
CDO09876.1 COQ21776.1 CTU48438.1 EDT15330.1
CDO20324.1 COR80523.1 CTU63923.1 EDT25330.1
CD027974.1 COV15812.1 CTV28671.1 EDT73179.1
CD044733.1 COV67826.1 CTV69168.1 EDU36907.1
CD087126.1 COV88060.1 CTW64116.1 EDU39421.1
CDP84850.1 COW22072.1 CTX 10177.1 EDU64919.1
CDQ46433.1 COW50746.1 CTZ 19187, 1 EDU66726.1
CDR08766. 1 COW69018.1 CTZ24614.1 EDU90194.1
CDU38691.1 CPR27659.1 CTZ73544.1 EDU92849.1
CDY74306.1 CPR27660.1 CTZ73631.1 EDV04249.1
CDZ89912.1 CQD07112.1 CUJ14933.1 EDX35836. 1
CEA13064.1 CRF40589.1 CUK00697.1 EDX36856. 1
CED70967.1 CRF42243.1 CU021357.1 EDX42043.1
CEF51573.1 CRF44683.1 EA055448.1 ED Y39693 , 1
CEG58623.1 CRF48464.1 EAQ75094.1 EDY48172, 1
CEI23431.1 CRF50704.1 EAQ80748.1 EDY57831.1 EDY66556.1 EEV56374.1 EFH84743.1 EFK90538.1
EDZ49153.1 EEW54005.1 EFI02264.1 EFLO 1709.1
EEA85567.1 EEW82128.1 EFI09603.1 EFL1 1602.1
EEA92251.1 EEX25513.1 EFI13088.1 EFL25055.1
EEB26629.1 EEX36940.1 EFI38206.1 EFL33863.1
EEB44239.1 EEX43978.1 EFI84887.1 EFL40837.1
EEC53338.1 EEY24480.1 EFI86925.1 EFL51206.1
EEC97976.1 EEY27756.1 EFI90012.1 EFM42529.1
EEE44061.1 EEY43805.1 EFJ64163.1 EFM60472.1
EEF92068.1 EEY85097.1 EFJ67574.1 EF055353.1
EEH13682.1 EEZ00407.1 EFJ67825.1 EF056156.1
EEI48912.1 EEZO 1978.1 EFJ70740.1 EF057476.1
EEK47458.1 EEZ22076.1 EFJ74790.1 EFP68935.1
EEK58881.1 EEZ25940.1 EFJ79351.1 EFP72276.1
EEK67538.1 EEZ29262.1 EF.) 83178.1 EFP94638.1
EEK74538.1 EEZ34469.1 EFJ84244.1 EFQ03510.1
EEL55986.1 EEZ40302.1 EFJ97064.1 EFQ52308.1
EEL62126.1 EEZ87328.1 EFJ99289.1 EFR14005.1
EEL64999.1 EFA19754.1 EFK00002.1 EFR14897.1
EEL67614.1 EFB70565.1 EFK01991.1 EFR53885.1
EEM80145.1 EFC83076.1 EFK04591.1 EFR56886.1
EEN88413.1 EFD80779.2 EFK05907.1 EFR83644.1
EEO04360.1 EFE24383.1 EFK13346.1 EFR86795.1
EEC) 15980.1 EFE51558.1 EFK 13449.1 EFR86868.1
EEO27017.1 EFE61 154,2 EFK 18567.1 EFR99235.1
EE029218.1 EFE67958.2 EFK21645.1 EFS34161.1
EEO44870.1 EFE75545.2 EFK25237.1 EFU32132.1
EE051903.1 EFE80893.2 EFK26359.1 EFU32541.1
EEO53210.1 EFE85357.2 EFK27490.1 EFU33441.1
EE059155.1 EFF04255.2 EFK28268.1 EFU33881.1
EEP21 189, 1 EFF 12025.2 EFK45013.1 EFV 13462.1
EEP92210.1 EFF50165.1 EFK46521.1 EFV25334.1
EEQ 1 1471.1 EFF76031.1 EFK48488.1 EFV31 182.1
EES66073.1 EFF93925.2 EFK53224.1 EFV39052.1
EET14820.1 EFG07494.1 EFK62734.1 EFV65675.1
EEU03858.1 EFG18425.1 EFK6570 .1 EFW48115.1
EEU29590.1 EFG35990.2 EFK67634.1 EFW51528.1
EEU51973.1 EFG64869.2 EFK74425.1 EFW54250.1
EEV32935.1 EFG76193.1 EFK74957.1 EFW54681.1
EEV37488.1 Ft ! 179810 ! EFK75509.1 EFW58324.1
EEV50802.1 EFH81299.1 EFK90487.1 EFW59607.1 EGB59643.1 EGN06817.1 EHU11189.1 ΕΠ44135.1
EGB61475.1 EGN63303.1 EHU13384.1 EII46969.1
EGB64139.1 EGP 19624.1 EHU15660.1 [:[(.45389.1
EGB66614.1 EGQ80440.1 EHU18453.1 EIQ03265.1
EGB70190.1 EGU29737.1 EHU18784,1 EIQ09746.1
EGB73425.1 EGU35278.1 EHU21355,1 EIQ 16517.1
EGB88811.1 EGU39626.1 EHU24375.1 EIQ21777.1
EGB89514.1 EGU97184.1 EHU24577.1 EIQ23262.1
EGB90401.1 EGU98834.1 EHU31058.1 EIQ25087.1
EGB91657.1 EGV18719.1 EHU32272.1 EIQ31493.1
EGC70448.1 EGV27688.1 EHU34561.1 EIQ33054.1
EGC88487.1 EGX55742.1 EHU41140.1 EIQ41164.1
EGC95220.1 EHA59342.1 EHU45989.1 EIQ56419.1
EGC96302.1 EHB58351.1 EHU51025.1 EIQ60911.1
EGD21507.1 EHB91964.1 EHU59824.1 EIQ65585.1
EGD55026.1 ! 11)14624.1 EHV53301.1 EIQ73835.1
EGE43685.1 EHE93619.1 EHV59537.1 EIV94746.1
EGF51021.1 EHE94113.1 EHY69914.1 EI Y 16248.1
EGF52343.1 EHE94521.1 EIC22952.1 EIY32949.1
EGG47377.1 EHG27891.1 EH) 17062.1 EIY34626.1
EGI12229.1 EHI10396.1 EID62180.1 EIY38162.1
EGI13717.1 EHI78992.1 EID64225.1 EIY53226.1
EGI 13978.1 EHJ93424.1 EID65429.1 EIY53668.1
EGI17642.1 EHK60317.1 EID81668.1 EIY56384.1
EGI19234.1 HI I 80663 ! EIF28258.1 EIY56765.1
EGI21026.1 EHL31595,1 EIF91592,1 EIY68174.1
EGI39093.1 EHL69790.1 EIG81214.1 EIY77090.1
EGI43841.1 EHL73453.1 EIG83636.1 [·ίΥ 82381.1
EGI50973.1 EHL81956.1 EIG91092.1 EIY84200.1
EGI90408.1 EHM02181.1 EIG94667.1 EIY99194.1
EGI96641.1 EHM25499.1 E1H12190.1 EIZO 1495.1
EGI99727.1 Γ.Ι IN 10689.1 ΕΓΗ 14542.1 EJC61553.1
EGJ08652.1 EHN62296.1 !·!! 123819.1 EIE70343.1
EGJ75615.1 EHN62769.1 EIH24646.1 EJE81777.1
EGK16006.1 EHN72080.1 Ell 144138.1 EJF49319.1
EGK24662.1 Hi 1078886.1 [ ll 144293.1 EJF70133.1
EGK37777.1 EHP50963.1 EIH77187.1 [-..1194816.1
EGL35452.1 EHP65728.1 EIH78539.1 EJJ06689.1
EGM70497.1 EHQ35549.1 EII21895.1 EJL12446.1
EGM97167.1 EHS85882.1 EII32183.1 EJL 17356.1
EGM98872.1 EHU04987.1 EII37008.1 EJ088499.1 EJQ45735.1 EKT59853.1 EME 15609.1 ENA07939.1
EJQ50924.1 EKT60979.1 EME20496.1 ENA37276.1
EJQ75845.1 EKT61230.1 EME52937.1 [:\ A37661 . 1
EJR29226.1 EKT84064.1 EME64490.1 ENA40409.1
EJR29527.1 EKU27305.1 EMF01384.1 ENA42821 .1
EJR54172.1 EKU87970.1 EMF28280.1 ENA44156.1
EJR721 19.1 EKZ99806. 1 EMF57186.1 ENA45677.1
EJS5 1 805.1 ELB02396.1 EMI07274. 1 ENA45982.1
EJS69263.1 ELB85708.1 EMI44202.1 ENC88982.1
EJS76732.1 ELC09056.1 EMI57857.1 ENC89168. 1
! ί .'20276. 1 ELC 13735.1 EMP52368.1 ENC92105. 1
EJV56692.1 ELC 15832.1 EMQ97025.1 END50208.1
EJV88830.1 ELC 19797.1 EMS71451.1 END53674.1
EJZ 1 1766.1 ELC36081.1 EMS81015.1 END88206.1
EJZ58218.1 ELC41591.1 EMT34264.1 END92583.1
EJZ61626.1 ELC88436.1 EMU58101.1 END93094.1
EJZ66136.1 ELC95019.1 EMU62217.1 ENG 1208.1
EJZ66990.1 ELD95713.1 EMU62585.1 ENG94444.1
EKA79028. 1 ELE00848.1 EMU62751.1 ENG94576.1
EKA86551.1 ELE39573.1 EMU66940.1 ENG97999.1
EKA88098.1 ELE43669.1 EMU67068.1 ENG99381.1
EKA94470.1 ELE52314.1 EMU70180.1 ENG99667.1
EKC9161 1.1 ELE55503.1 EMV 16365.1 ENH03300. 1
EKC92880.1 ELE57206.1 EMV 16410.1 ENH06479.1
EKF24812.1 ELE60967.1 EMV21034.1 ENH06612.1
EKI49243.1 ELG85654.1 EMV21 148.1 ENH09530.1
EKI49295.1 ELG89467.1 EMW92532.1 ENT93039. 1
EKI49297.1 ELP68892.1 EMW92626.1 ENZ87560.1
EKI53609.1 ELQ79669.1 EMX05363. 1 EOA56991 .1
EKI53635.1 ELQ90802.1 EMX05478. 1 EOA59672.1
EKI53661.1 ELS31036.1 EMX17914.1 EOD68466.1
EKJ88854. 1 ELS48492. 1 EMX21 187.1 EOD79253.1
EKM22885. 1 ELS55266. 1 EMX28781.1 HO! 172070. 1
EKN10373.1 ELU51445. 1 EMX32419.1 EOH74810.1
EKN12672.1 ELV08451. 1 EMX35642.1 EOH75851.1
EKN18388.1 ELW26442.1 EMX40966.1 HOI 176700. 1
EKN22714.1 ELW30245.1 EMX45867.1 EOH78743. 1
EKN32408.1 ELW35612.1 EMX49551 .1 EOH82280.1
EKN33078.1 ELW38629.1 EMX82482.1 EOH83172.1
EKN71286.1 ELZ99535.1 EMX88290.1 EOH97586.1
EKT54086.1 EMD22949.1 ENA02373.1 EOI53551.1 EOI58405.1 EOU96296.1 EQK38916.1 ERL43390.1
EOI58566.1 EOV01967.1 EQK38918.1 ERM89976.1
EOM77145. 1 EOV09633.1 EQK41 183, 1 ERN40441.1
EON30602.1 EOV50262.1 EQK41 185, 1 ERP96019.1
E0014854.1 EOV53815.1 EQK41 187.1 ERT35460.1
E0021616.1 EOV63027.1 EQK44497.1 ERT41208.1
E0025486.1 EOV75Q70.1 EQK44499.1 ERT49556.1
E0035817.1 EOV79548.1 EQ 30718.1 ERT62990.1
EOO41016.1 EOV87732.1 EQM34161.1 ESA62393. 1
EOO43604.1 EOV92823.1 EQM76570.1 ESA65687.1
E0045684.1 EOW02331.1 EQN22922.1 ESA66394.1
E0062333.1 EOW07796.1 EQN27974.1 ESA93675, 1
EOO80321.1 EOW 18421.1 EQN90009.1 ESC98980.1
EOP01042.1 EOW20754.1 EQN99753.1 ESD24585.1
EOP10173.1 EOW24078.1 EQ057355.1 ESD76492.1
EOP26670.1 EOW28567.1 EQ068196.1 ESE01639.1
EOP64330.1 EOW59950. 1 EQP45261.1 ESE85174.1
EOP73916.1 EOW65871 . 1 EQP56441.1 ES 09396.1
EOQ08142.1 EOW93464. 1 EQQ01715.1 ESK 17280.1
EOQ12252.1 EOW98321.1 EQQ13272.1 ESK32677.1
EOQ46471.1 EPD56434.1 EQV93401.1 ESK371 18.1
EOQ66882.1 HP! 107228. 1 EQV95026.1 ESL01761.1
EOR96931.1 EPH19749.1 EQX25160.1 ES 63984.1
EOS04353.1 HP! 146070 1 EQX28194.1 ESQO. 366, 1
EOS05800.1 HP! 162839 I EQX84913.1 ESS01667, 1
EOS 12272.1 HP! 166025 ! EQX88348.1 EST27229.1
EOS 15404.1 EPH93813.1 EQY14917.1 EST29520.1
EOS50628.1 EPI24085.1 EQY25002.1 EST30199.1
EOT40719.1 EPJ40403.1 EQY56854.1 EST38278.1
EOT40879.1 EPJ94947.1 EQY62408.1 ESU48041.1
EOT47239.1 EPZ46100.1 EiQZ97993.1 ESW58026.1
EOT48800.1 EPZ53654.1 ERA02674.1 ETA03730.1
EOT84227.1 EPZ62416.1 ERB52265.1 ETA07612.1
EOT87490.1 EPZ62425.1 ERB551 18.1 ETA90193.1
EOU43828.1 EPZ62435.1 ERI40669.1 ETB03602.1
EOU46128.1 HP/62442. 1 ERK10135.1 ETB08300. 1
EOU63366.1 HP/62447. 1 ERK 12938.1 ETB 10179.1
EOU68068.1 EQC78775.1 ERK136 4, 1 ETB 16733.1
EOU81074.1 EQC92431.1 ERK41051.1 ETB35297.1
EOU84041.1 EQI 12458.1 ER 66628.1 ETB47280.1
EOU87778.1 EQK38915.1 ERK71783.1 ETD05566.1 ETD33178.1 EWM15117.1 EZD95411.1 GAC 16640.1
ETD61 1 17. 1 EWM60131.1 EZE53483.1 GAC19112.1
ΕΪΕ20971.1 EWS92576.1 EZE53678.1 GAC24811.1
ETE21708.1 EWT00088.1 EZJ35629.1 GAC28020.1
ETE42297.1 EXG78068.1 EZJ35909.1 GAC32436.1
ETI67406.1 EXJ13320.1 EZJ42565.1 GAC47684.1
ET095552.1 EXU65898.1 EZJ48607.1 GAC52174.1
ETT01291.1 EXU86004.1 EZJ48835.1 GAC57015.1
ETT07691.1 EXU92348.1 EZJ52 18.1 GAC62570.1
ETT26644.1 EXY29077.1 EZJ52194.1 GAC65427.1
ETW26102.1 EXY29706.1 EZJ63265.1 GAC68386.1
ETY41349.1 EXY30556.1 EZJ68808.1 GAC80779.1
ETY48295.1 EXY42580.1 EZJ76944.1 GAC84962.1
ETY71896.1 EXY67115.1 EZJ82498.1 GAD02073.1
ETZ28153.1 EXY71894.1 EZJ83430.1 GAD32959.1
ETZ53554.1 EXY75839.1 EZJ85518.1 GAD 74177.1
ETZ64519.1 EXY86423.1 EZJ86304.1 GAD82821.1
EUA 15396.1 EXY92402.1 EZJ86635.1 GAF38011.1
EUA21463.1 EXZ07152.1 EZJ86695.1 GAF50854.1
EUA28413.1 EXZ21 187.1 EZK23505.1 GAJ68231.1
EUA53026.1 EXZ30272.1 GAA03253.1 GAJ81697.1
EUA67104.1 EXZ46400.1 GAA12812.1 GAK24408.1
EUA75069.1 EXZ75157.1 GAA58630.1 GAK28408.1
EUA92002.1 EXZ80321.1 GAA65880.1 GAK83740. 1
EUB26488.1 EX/85038. ! GAA68572.1 GAK 86157. 1
EUB31643.1 EXZ9666L 1 GAA78749.1 GAK86158. 1
EUB36799.1 EYA21095.1 GAA78750.1 GAK86159.1
EUC52448.1 EYA40854.1 GAB03735.1 GAK86194.1
EUC78743.1 EYB 10940.1 GAB 11197.1 GA 86 ! 95. i
EUD07003.1 EYD86105.1 GAB 17583.1 GAL07170.1
EUJ23680.1 EYE48014.1 GAB22060.1 GAL07171 .1
EUJ28388.1 EYE57289.1 GAB34314.1 GAL12019.1
EUJ30749.1 EYT59609.1 GAB40201.1 GAL12020.1
EUJ31401.1 EYT64496.1 GAB42886.1 GAL12022.1
EUJ40784.1 EYT82998.1 GAB44706.1 GAL20988.1
EUJ40792.1 EYU71 182.1 GAB56771.1 GAL20989. 1
EUJ41071.1 EYV06431.1 GAB57270.1 GAL29483.1
EUJ42403.1 EYZ98625.1 GAB87450.1 GAL29484.1
EUJ43336.1 EZAOO.512, GAB93700.1 GAL31575.1
EUJ51856.1 EZA34652.1 GAC00312.1 GAL31576, 1
EWC60294.1 EZA36855.1 GAC07309.1 GAL34169.1 GAL35839.1 KDP04362.1 KEN52247.1 KFZ83979.1
GAL35840.1 KDQOO 107.1 KEN57490.1 KGA45423.1
GAL35841 .1 KDQ03697.1 EN61954.1 KGA59562.1
GAL87714.1 KDQ68019.1 E 64216.1 KGA94282.1
GAL92165.1 KDR43957.1 KEN69872.1 KGE6231 1.1
GAMS 1354.1 KDS 10818.1 KEN70466.1 KGI67105.1
GAM53981.1 KDS 15451.1 KEN96761.1 KGI75049.1
GAM59058.1 KDS30703.1 KEN96869.1 KGJ48506.1
GAM59059.1 KDS50373.1 KEOO 1826.1 KGJ48508.1
GAM60805.1 KDS51190.1 KEO06704.1 KGL37357.1
GAM66966.1 KDS54295.1 KEO 12265.1 KGL37365.1
GAM66967.1 KDS68998.1 KEG 12361.1 KGL42766.1
GAM71689.1 KDU28500.1 KE027842.1 KGL45419.1
GAM71690.1 KDV27639.1 KEO34740.1 KGL45426.1
GAM71691.1 KDV35035.1 KE053821.1 KGM61473.1
GAM74761.1 KDV65274.1 KEQ 19823.1 KGM61755.1
GAM76677.1 KDW28640.1 KER 51036.1 KGM69566.1
GAM76678.1 KDW31269.1 ER76820.1 KGM78904.1
GAM76679.1 KDX 16969, 1 KES06427.1 KGM81894.1
GAM80335.1 KDX 18273.1 KEY62213.1 KGM84341.1
GAM80336.1 KDX 19058.1 KEZ81504.1 KGM85121.1
GAM95569.1 KDX19100.1 KFA95398.1 KGP43353.1
GAO06850.1 KDX37004.1 KFA95888.1 KGQ70005.1
GAP74509.1 KEF97907.1 KFC84707. 1 KGR34277.1
KBR62640.1 KEG40867.1 KFC90678. 1 KHE42794.1
KBZ68706.1 KEI69530.1 KFD42951.1 KHI28202.1
KCV62158.1 KEI99750.1 KFD43242.1 KHJ22054.1
KDA43821.1 KEJ44146.1 KFD74162.1 KHJ71931.1
KDA56308.1 KEJ48094.1 KFD78258.1 KHJ73332.1
KDA58506.1 KEJ57806.1 KFE40611.1 KHK01750.1
KDD64269.1 KEJ63339.1 FF59575.1 KHK96657.1
KDE1 1380.1 KEJ72299.1 KFF94854.1 KF1K97208.1
KDE98800.1 KEJ77438.1 KFF96973.1 Κ Π 1.05645. 1
KDG91983.1 KEJ77524.1 KFI71515.1 KHM48596.1
KDG95757.1 KEJ87021.1 KFI90825.1 KH023213.1
KDN16332.1 KEK13730.1 KFI97074.1 KHO27057.1
KDN21808.1 KEK28691.1 KFJ42086. 1 KHS42788.1
KDN77775.1 KEL662 5.1 KFJ73865.1 KIA60405.1
KDN85633.1 KEL67246.1 KFK85587.1 KIA71170.1
K 1)093455 ! KEL68023.1 KFK95245.1 KIC39052.1
KDP03104.1 KEL70025.1 KFX75687.1 KIC69438.1 KIC99691.2 KJF96745.1 K 1.1)60995. i KMQ76627.1
KID43237. 1 KJG19354.1 KLE26826.1 KM:S68506.1
KID43894.1 KJG35319.1 KLI09651 .1 KMS83576.1
KIE05689.1 KJG55556.1 KLI91468.1 KMT54476.1
KIE57897.1 KJK37053, 1 KLI981 12.1 KMV17260.1
KIF05904.1 KJK56361.1 KLJ05152.1 KMV23624.1
KIF45347.1 KJLl 8343.1 KLN34163.1 KMW38818.1
KIF54655.1 .) 1.32904. 1 KLN95712.1 KMW82598.1
KIF68652.1 .) 1.3800 I . I KL025668.1 KNA39120.1
KIG96197.1 .j 1.44323. 1 KL035668.1 KNA42305. 1
KII76501.1 KJS62465.1 KL043396.1 KNA42530. 1
ΚίΜΟ 1026.1 KJU70415.1 KLO51710.1 KNB52133.1
KIM15962.1 KJW 12820.1 KLR49798.1 KNC .11996.1
KIO34904.1 KJW22772.1 KLR60461.1 KND28891.1
KI044976.1 KJW44373.1 KLU05222.1 KND38179.1
KI094387.1 KJYl 8848.1 KLU19162.1 KND38376.1
KI096271.1 KJY30329.1 KL.U58975, 1 KND61615.1
KIP30337.1 KJY38629, 1 KL.U69060, 1 KNF63080.1
KIP53570, 1 KJY39390.1 KLV28432.1 KNF82369.1
KIP7361 1.1 KJY40940.1 KLX53926.1 KNH21214.1
KIQ 19345, 1 KJY43460.1 KLX61120, 1 KNZ42189.1
KIQ45943.1 KKA40192.1 KLX94454.1 KOA33258.1
KIQ62037.1 KKB46833.1 KLX97537.1 KOA34702.1
KIQ77066.1 KKB57083.1 KME63659.1 K0G31486. 1
KIQ77348.1 KKB58027.1 KME67053.1 KOG36523. 1
KIS21947.1 KKC03154.1 KM! ·68735. 1 K0G41666. 1
KIS23847.1 KKD05819.1 KMM25249.1 KOG45278.1
KIU16352.1 KKD45841.1 KMM34481.1 KOG56200.1
KIV731 77.1 KKD49597.1 KMM81854.1 KOG63866.1
KIX49302. 1 KKD62061.1 KMMSS 123.1 KOG67868.1
KIZ 19716.1 KKE98190.1 KMM89123. 1 KOG82155.1 1/46656. 1 KKI22291.1 KMN03094.1 K0N11130.1
KJE22572.1 KKI421 13.1 KMNl 0907.1 K OX 74404. 1
KJE77520.1 KKI50839.1 KMNl 5408.1 KON83792.1
KJF 18813.1 KKW62398.1 KMNl 8102.1 KOP74641.1
KJF 19781.1 KKX97583.1 KMN42082.1 KOR26641.1
KJF 19871.1 KKYOl 177.1 KMN99021.1 KOS58051.1
KJF23624. 1 KKYO 1179.1 KM068962.1 KOT30645.1
KJF79218. 1 KKY69347.1 KM071467.1 KOT53033.1
KJF79887. 1 KLA29488.1 KM077249.1 KOT88922.1
KJF93058.1 KLA31120.1 KM096783.1 KOT94882.1 KOU20397.1 KOY49525.1 KPN18694.1 KQJ27665.1
KOU22686.1 KOY53494.1 KPN43081.1 KST35322.1
KOU33149.1 KOY54178.1 PN48420.1 KST82806.1
KOU50755.1 KPA51275.1 P013719.1 KST89062.1
KOU54733.1 KPC66018.1 PO 16265. 1 KSU1 406.1
KOU56607.1 KPC77424.1 KPO 16391.1 KSU16536.1
KOV13964.1 KPC82004.1 KPO 17089.1 KXL66213.1
KOV45494.1 KPD04524.1 KPO34510.1 KYR53955.1
KOV48801.1 KPG33268.1 KP035845.1 KYV67232.1
KOV52774.1 PI 196934. 1 KP037368.1 KYV71371 . 1
KOV57805.1 KP 104468, 1 KP041 178.1 OAJ87252.1
KOV68117.1 KPI10516.1 KP044233.1 OAJ89593.1
KOV68430.1 KPI 15295.1 KP051751.1 OA063316. 1
KOV76057.1 KPI19262.1 KP052539.1 OCL 17438.1
KOV97628.1 KPI20012.1 KP058193.1 OEI61147.1
KOX01174.1 ΚΡΓ26485.1 KPQ02829.1 OEN35083.1
KOX37867.1 KPL33203.1 KPV45380.1 OEN35408.1
KOX47623.1 KPM51038.1 KOB54807.1 01X26336, 1
[00105] Representative examples of putrescine aminotransferase (EC 2,6.1.82) are given below in Table 5 and identified by their EMBL/GenBank/DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the putrescine aminotransferase (EC 2.6.1.82) set forth in Table 3 and Table 5. For instance, the bacteria can be engineered with a version of the putrescine aminotransferase enzyme that has at least 50% nucleotide similarity with any of the versions of putrescine aminotransferase given in Table 5 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90% nucleotide similarity, at least 91% nucleotide similarity, at least 92% nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucleotide similarity, at least 95% nucleotide similarity, at least 96%> nucleotide similarity, at least 97% nucleotide similarity, at least 98% nucleotide similarity, at least 99% nucleotide similarity, at least 99.5%o nucleotide similarity, at least 99.9% nucleotide similarity, or 100% nucleotide similarity).
Table 5. Representative Examples of Putrescine Aminotransferase by EMBL/GenBank/DDBJ ID Number
AAA57874.1 AAC36832.1 AAC74384.1 AAC76108.3
AAA89152.1 AAC45301.1 AAC75709.1 AAF 10980.1 AAG03522.1 ACI36066.1 AFG42020.1 AIT00514.1
AAG03688.1 ACI77901.1 AFH65907.1 AIU72158.1
AAG58206.1 ACI77902.1 AFI89823.1 AIW78685.1
AAK 15486.1 ACI77903.1 AFJ30752.1 AIW86257.1
AAL22091.1 ACI77904.1 AFJ45596.1 Λ 1 X66695 }
AA 44587.2 ACI77905.1 AFJ57021.1 AIZ84136.1
AAN82273.1 ACN47379.1 AFM41617.1 AJA28077.1
AAO70680.1 ACO02631.1 AFM61662.1 AJB64485.1
AAP18399.1 ACO80985.1 AFN34266.1 AJC52685.1
AAV78920.1 ACR65342.1 AFR02837. 1 AJC61854.1
AAX67071.1 ACS85106, 1 AFS72647.1 AJC65876.1
AAZ89792.1 ACT07527.1 AFT85698.1 AJE 19840.1
ABA89323.1 ACT 12462.1 AFU 12013.1 AJE57644.1
ABB67447.1 ACT27738.1 AGB 76663.1 AJE82594.1
ABE08957.1 ACX87602.1 AGF56701.1 AJF57894.1
ABF05173.1 ACY90298.1 AGH86154.1 AJF75010.1
ABG71 145.1 ACZ77451.1 AGM28805.1 Ai l s 1 7424. 1
ABJ02583.1 ADA75444.1 AGN85841 .1 AJK49269.1
AB J 15261.1 ADD58285.1 AGQ74484.1 AJ086687.1
AB088369.1 ADF63987.1 AGR60480.1 AJQ98395.1
ABP62186.1 ADM97796.1 AHA09869.1 AJY76773.1
ABR78896.1 AD046913.1 AHA67171.1 AJZ91824.1
ABU78707.1 ADO70560.1 AHA67172.1 A h62036. I
ABV07484.1 ADR28470.1 AHB72039.1 AKE93437.1
AB VI 5541 .1 ADT76707.1 AHE60723.1 A i 108854. 1
ABV20592.1 ADX 19008.1 AHE69148.1 AKH23767. 1
ABX24187.1 AEA71912.1 AHF76631.1 AKK34697.1
ABX64022.1 AEE58362.1 AHJ76496.2 AKK40619.1
ABX69344.1 AEE97629.1 AHM77480.1 A K49917.1
ABX75605.1 AEG95705.1 AHM83064.1 AKL 15453.1
ABY42524.1 AEI06121.1 AHN81979.1 AKL34316.1
ACA76303.1 AEI45944.1 AHY 10460.1 ΛΚ 1.96946. 1
ACB04157. 1 AEJ41147.1 AHY72510.1 AKMl 8742.1
ACB 17060.1 AEJ58471.1 AID92376.1 AKM36624.1
ACF64513.1 AEN66465.1 AII63595.1 AKP48388.1
ACF70070.1 AEQ14325.1 AIP96878.1 .AKP75846.1
ACF88918.1 AEW04404.1 AIR04884.1 .AKZ54414.1
ACH48710.1 AEW63332.1 AIR60611.1 ALA75381.1
ACH77510.1 AEW75317.1 AIR68505.1 ALB43935. 1
ACI09453.1 AEX02383.1 AIS03494.1 ALB53581. 1
ACI18235.1 AFC33584.1 AIS53235.1 ALB68770.1 ALB72871.1 BAS27610.1 CCK00585.1 CFW77176.1
ALC72125.1 BAS27927.1 CCK05055.1 CJF89882.1
ALD27706.1 BAT36548.1 CCK09612.1 CKG89699.1
ALK33515.1 BAT40862.1 CCK2597 .1 CNQ38822, 1
ALL90941.1 BAT45090.1 CCK48380.1 CNT85510.1
ALO12800.1 BAU25986.1 CCO07408.1 CNU205 1.1
ALO 15071.1 BAU53092.1 CCO08483.1 CMJ75336.1
ALR25918.1 CAB99164.1 CCY61522.1 CPR21341.1
ALR78149.1 CAD07742.1 CDB46597.1 CPR52929.1
ALX80070.1 CAD55516.1 CDC39173.1 CPR70581.1
ALY14616.1 CAG74449.1 CDD12313.1 CPS20475.1
ALZ69902.1 CAJ90253.1 CDK69254.1 CPU47210.1
AMA74351.1 CAQ90518.1 CDK78180.1 CPU50448.1
AMJ41057.1 CAR00034.1 CDL09266.1 CPU63604.1
AMJ69166.1 CAR04699.1 CDL 16320.1 CPV69500.1
AMK11196.1 CAR09890.2 CDL21785.1 CPW 19061.1
AMW45996.1 CAR 14711.1 CDL24460.1 CPW 19086.1
AMX 16618.1 CAR19687.1 CDL41008.1 CPW42553.1
ANK35521.1 CAR34636.1 CDL43466.1 CQAO 1 107, 1
A M83865.1 CAR38915.1 CDL49947.1 CQA05377.1
AN02 137.1 CAR61129.1 CDL54548.1 CQR59780.1
AN091000.1 CAS10914.1 CDL60105.1 CQR65737.1
ANP 19910.1 CAU99632.1 CDN08464.1 CQR76108.1
ANZ85526.1 CBA27530.1 CDN83823.1 CRF31866.1
AOM43730.1 CBG36194.1 CDOl 2367.1 CRK82822.1
APA44613.1 CBG91495.1 CDQ16366.1 CRL90015.1
BAA14871.1 CBH75900.1 CDQ55161.1 CSL03976.1
BAA16525.1 CBI02339.1 CDS92449.1 CSN57331.1
BAA94599.1 CBI02439.1 CDU33631.1 CSP97983.1
BAA94600.1 CBJ02843.1 CDU41038.1 CSS48268.1
BAB37378. 1 CBL20779.1 CDW60669.1 CST07703.1
BAD88710.1 CBW19289. 1 CDZ85955.1 CTQ00194.1
BAE77123.1 CCC31907, 1 CDZ90589.1 CTQ01408.1
BAG78878.1 CCF65898.1 CEG33484.1 CTQ06965.1
BAI27353.1 CCI78933.1 CEH27897.1 CTQ 10470.1
BAI32529.1 CCJ45694.1 CEH28958.1 CTQ20562.1
BAI37675.1 CCJ72687.1 CEJ63776.1 CTQ78696.1
BA 33480.1 CCJ77939. 1 CEK06962.1 CTR79713.1
BAM00748.1 CCJ80840. 1 CEL88139.1 CTR96904.1
BAN45963.1 CCJ87365. 1 CE089736.1 CTS73379.1
BAN57107.1 CCJ91 133.1 CEP33002.1 CTS73419.1 CTT28505.1 EEL41357.1 EFR14711.1 EHC67259.1
CTT56172.1 EEL47872.1 EFU36955.1 EHC75056.1
CTT69475.1 EEL58542.1 EFV42072.1 EHC75092.1
CTU79150.1 EEL71807.1 EFW49740.1 EHC81432.1
CTU88023.1 EEL84498.1 EFW54280.1 EHC81436.1
CTU94690.1 EEM06318.1 EFW57755.1 EHC81453.1
CTV09894.1 EEM17585.1 EGB 14251.1 EHC82194.1
CTV11053.1 EEP53384.1 EGB62034.1 EHC82200.1
CTX207G2.1 EEP61904.1 EGB65436.1 EHC87537.1
CTZ29307.1 EEQ93121.1 EGB73934.1 EHC87548. 1
CTZ49322.1 EEW41109.1 EGB87427.1 EHC99340. 1
CUI62304.1 EFC54109.1 EGC96496.1 EHC99346. 1
CUJ87125.1 EFE05843.1 EGE35595. 1 EHC99347. 1
CUK19452.1 EFE61929.2 EGH58156.1 EHC99662.1
CUV19889.1 EFF04850.2 EGI09466.1 EHC99665.1
CUV29759.1 EFF11713.2 EGI 14765.1 EHC99666.1
CUV44247.1 EFI88372.1 EGI20132.1 EHD22256.1
CUW27398.1 EFJ64643.1 EGI39453.1 EHJ00584.1
CUX83295.1 EFJ70989.1 EGI44536.1 EHJ80884.1
CVK16600.1 EFJ81337.1 EGI49547.1 h! 1.180892. 1
EAU62914.1 EFJ85921.1 EGI91691.1 EHM38093.1
EDL55484.1 EFJ98691.1 EGI91882.1 EHM49393.1
ED056632.1 EFK04657.1 EGI91908.1 EHP66038. 1
EDQ32965.1 EFK09659.1 EGJ05807.1 EHT 11055.1
EDS93910.1 EFK 13604.1 EGK 18274.1 EHU06080.1
EDU66756.1 EFK21010.1 EGK35042.1 EHU06383.1
EDU92373.1 EFK23876.1 EGK57964.1 EHU09521.1
EDX36107.1 EFK46876.1 EGU98422.1 EHU19477.1
EDX43683.1 EFK49689.1 EHB43515.1 EHU22647.1
EDX70173.1 EFK57463.1 EHC32088.1 EHU26084.1
EDY23644.1 EFK70624.1 EHC32777.1 EHU36390.1
EDY55948.1 EFK75383.1 EHC32780.1 EHU39097.1
EDY58150.2 EFK91732.1 EHC32793.1 EHU51516.1
EDY59830.2 EFL03670.1 EHC45475.1 EHV54826.1
EEH12859.1 EFL18682.1 EHC 5503.1 EHY68818.1
EEI19352.1 EFL30368.1 EHC52082.1 EID63416.1
EEI70764.1 EFL33839.1 EHC52087.1 EID68002.1
EEI93920, 1 EFL36249, 1 EHC52088.1 EIG80589.1
EEK74306.1 EF059858.1 EHC61796, 1 EIG93735.1
EEL07176.1 EFP71978. 1 EHC61797, 1 EIH10970.1
EEL35424.1 EFP71979.1 EHC67244.1 I Ji 12 1433. 1 EIH45756.1 EKI50350.1 ENZ36084.1 EPJ05539.1
Effl76113.1 EKN69369.1 [.N/85363, i EPJ 10674.1
EII21076.1 EKY 1.5805.1 EOB13036.1 EQD48086.1
EII37121.1 ELC 14392.1 EOO 15443.1 EQN24196.1
EII44330.1 ELC 16479.1 E0021808.1 EQN91238.1
EIK73551.1 ELC36432.1 EOO40793.1 EQ058637.1
EIL52772.1 ELC95414.1 E0075774.1 EQP45856.1
EIQ05705.1 ELD97045.1 E0078537.1 EQQ02030. 1
EIQ18685.1 ELE40056.1 EOP16122.1 EQV89459. 1
EIQ33923.1 ELE53047.1 EOP27458.1 EQX26002.1
EIQ57498.1 ELE57708.1 EOP41686.1 EQX85393.1
EIQ69925.1 ELG86056.1 EOP56689.1 EQY15934, 1
EIQ70386.1 I 1 ,122530 1 EOP57538.1 EQY57475, 1
EJE66457.1 ELJ68100.1 EOP72097.1 EQZ98152.1
EJE84374.1 ELK42117.1 EOP74673.1 ERI03907.1
EJF29639.1 ELS58123.1 EOQ 14051.1 EiU09683, l
EJ 89144.1 ELV07387.1 EOQ45898.1 ERI93353.1
EJL 13039, 1 ELW30847.1 EOQ51737.1 ERK29115.1
EJL42219.1 EMD08043.1 EOU48296.1 ER058336.1
EJP95200.1 EMR53712.1 EOU64078.1 ER059766.1
EJQ09156.1 EMT38915.1 EOU77605.1 ERP00368.1
EJQ42479.1 EMT53291.1 EOU89114.1 ESA64895. 1
EJQ53619.1 EMU59120.1 EOV03214.1 ESA65448.1
EJQ73265.1 EMU68070.1 EOV47394.1 ESA65917.1
EJQ762 5.1 EMV17890.1 EOV55537.1 ESA75128, 1
EJR03070.1 EMW94343.1 EOV76073.1 ESA87456.1
EJR30137.1 EMX18799.1 EOV93686.1 ESA87933.1
EJR37137.1 EMX29635.1 EOW03648.1 ESB01012.1
EJR56655.1 EMX36855.1 EOW19479.1 ESC94775.1
EJR60363.1 EMX47016.1 EOW29746.1 ESDI 1433.1
EJS01188.1 EMX83385.1 EOW62005.1 ESDI 9507.1
EJS 10133.1 EMZ13604.1 EOW94128.1 ESD37227.1
EJS 12547.1 ENA04805.1 EPF20607.1 ESD63043.1
EJS52655.1 ENA37997.1 EPF23810.1 ESD69311.1
EJS66726.1 ENA43345.1 EPF68941.1 ESD77797.1
EJS74470.1 ENC89529.1 EPH43618.1 ESE00825.1
EJU35674.1 ENDS 1354.1 EPI71 152.1 ESE81665.1
EJV59704.1 END88908.1 EP 171726.1 ESE84032.1
EJV88337.1 ENG94980.1 EPI91450, 1 ESF53913.1
EJZ63610.1 FN! 100344 ! EPI98428.1 ESG67336.1
EKB48854.1 ENH06977.1 EPI99620.1 ESJ20736.1 ESK15909.1 EZP34120.1 KE029548.1 KGM83624.1
ES 33462.1 EZP69273.1 KE037679.1 KGM85554.1
ESL70275.1 GAB53792.1 KER50700.1 KGT96644.1
ESM13806. 1 GAD66768.1 ER78502.1 KHD 16675.1
ESN17365.1 GAF37976.1 KEY61249.1 KHG 17857.1
ESN64633.1 GAK71556, 1 KEY61542.1 KHG23880.1
ESS57289.1 GAL45775.1 KEY¾ 1632.1 KHG24026.1
ESS68083.1 GALS 1546.1 KEY61720.1 HG25621 .1
EST52466.1 GAL57703.1 KEY62070.1 HI36730.1
ESU79725.1 GAM01523.1 KEY6221 1.1 KHJ 14566.1
ESU79726.1 GAP71067.1 KEY62248.1 KHN51965. 1
ETA87938.1 GAQ24599.1 KEY62600.1 KHN62432. 1
ETC31011.1 GAQ52594.1 KEY62750.1 KHN91314. 1
ETD63590.1 GAQ62824.1 KEY62777.1 KH061939.1
ETE17194.1 GAR76344.1 KEY63154.1 KHS46174.1
ETE48332.1 GAS78753.1 KEY63197.1 KHS75073.1
ETI91426.1 KCZ71 192.1 EY63491.1 KHT32808.1
ETJ22905.1 KDA56524.1 EY63621.1 ΚΗΪ39972.1
ETJ36492.1 KDE35397.1 EY63666.1 KID02664.2
ETT76699.1 KDF 12097.1 KEZ84112.1 KIH05031.1
ETY41938.1 KDF 12267.1 KEZ91498.1 KIL36988.1
EUA69680.1 KDG92710.1 KFB98795.1 IL37280.1
EUA84046.1 KDM54636.1 KFC77618.1 IL75881 .1
EWG73522.1 KDN97932.1 KFC87779. 1 KIL78121 .1
EWG77224.1 KDU32581.1 KFC92200. 1 KIQ46533.1
EWS95005.1 KDV36696.1 KFC94055. 1 KIQ55575.1
EWS95811.1 KDV41290.1 KFD40864.1 KIS45828.1
EYD83647.1 KDV63554.1 KFD77810.1 KIU31395.1
EYE21343.1 KDW29512.1 KFF72766.1 KIV76534.1
EYV13884.1 KDX22072.1 KFI56278.1 KJC02074.1
EYV14671 .1 KDX46941.1 FI63760.1 KJC05752.1
EYZ94185.1 KEA53701.1 KFI64199.1 KJC 10953.1
EZA39087.1 KEF36300.1 KFI81170.1 KJF38320, 1
EZD30976.1 KEJ44729.1 KFX06880.1 KJH07563.1
EZE08113.1 KEJ58710.1 KFX14235.1 KJM39013.1
EZE58040.1 KEJ72834.1 KFX74939.1 JM95208.1
EZJ36257.1 KEL69605.1 KGA35360.1 JN23016.1
EZJ49055.1 KENS 2983.1 KGA42964.1 KJS00574.1
EZJ70721.1 KEN6525 .1 KGF09343.1 KJS 1 1246.1
EZJ83281.1 KEN97872.1 KGM62239.1 KIS 12052.1
EZK20097.1 KEO07702.1 KGM72003.1 KJS23079.1 KJS48202.1 KM073567.1 KPQ48969.1 KSX94554.1
KJW31626.1 KM079473.1 KPR56433.1 KSY24943.1
KJW48653.1 KMV34687.1 KPU43824.1 KSZ 14257.1 .IX 12962.1 KM V71410.1 KPW09941.1 KTH73029.1
KJX35546.1 KMY52755.1 KPW 15746.1 KTI23444.1
KJZ82908.1 KMY52867.1 KPW54438.1 KTK26313.1
KJZ83822.1 KNA43034.1 KPW91211.1 KTK78251.1
KKA53732.1 KNB70753.1 KPX42861.1 KTM84786.1
KKB33451.1 \B70790.1 KPX63485.1 KT049964.1
KKB37484.1 KNC12151.1 KPY30896,1 K i'()7 18i .l
K.KC61647.1 K C91419.1 KPY55802.1 KTP65662.1
KKI48768.1 KM 71262.1 KPY81707,1 KTZ06525.1
KKI89815.1 KNF81324.1 KPY97724.1 KUB34136.1
KKJ26361.1 K H23702.1 KQB 77808.1 KUE74614.1
KKK45477.1 KNN86024.1 KQC84343.1 Kt;i 145954.1
KKM10135.1 K W78813.1 KQJ43040.1 KUI 157572.1
KKY41353.1 K NY 77855 1 KQL34770.1 KU048919.1
KKY86484.1 N/99940.1 KQL45807.1 KUQ85390.1
KLQ22117.1 KOA27411.1 KQL49683.1 KWU61736.1
KLT72735.1 KON69897.1 KQU20541.1 KWU68561.1
KLU65949.1 KON90844.1 KQU25399.1 KWW11355.1
KLV42517.1 KON96751.1 KRD84748.1 KXG99471.1
KLV56190.1 KOP04345.1 KRE10236.1 KXH99505.1
KLV64988.1 KOP73204.1 KRF52830.1 KXL57621.1
KLV65484.1 KOP92853.1 KRF58868.1 KXQ38659.1
KLV74220.1 KOR79514.1 KRF60614.1 KYR51641.1
KLW86671.1 KOR86809.1 KRF63503.1 KYS98061.1
KLX58084.1 KPA87633.1 KRK41016.1 KYV66420.1
KLX94977.1 KPA87634.1 KRM06091.1 KZJ62467.1
KLY12232.1 KPB72987.1 KRM11195.1 OAC42867.1
KLY33021.1 KPL77404.1 KRQ86107.1 OAJ90061.1
KME67644.1 KPO05706.1 KRT40898.1 OA074321.1
KMI32966.1 KPO33063.1 KSB12379.1 OCL20194.1
KMK12937.1 KP054643.1 KSB60709.1 OCS62224.1
KML66598.1 KPP86588.1 KSB77569.1 OCV69030.1
KMM34304.1 KPP90487.1 KST26609.1 ODH23946.1
KMM41841.1 KPQ06635.1 KST80109.1 OEH16092.1
KMN46751.1 KPQ07802.1 K Si .03228.1 OEN36946,1
KMN64361.1 KPQ17574.1 KSU 11825,1 OFD09909.1
KMX 3720 ! KPQ 18521.1 KSU28121.1 SAE79353.1
KMO70017.1 KPQ21853.1 KSX62841.1 SBL80466.1 SBZ09436.1
[00106] Representative examples of gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19) are given below in Table 6 and identified by their EMBL/GENBAN /DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19) set forth in Table 3 and Table 6. For instance, the bacteria can be engineered with a version of the gamma-aminobutyraldehyde dehydrogenase enzyme that has at least 50% nucleotide similarity with any of the versions of gamma-aminobutyraldehyde dehydrogenase given in Table 6 (e.g., at least nucleotide 60% similarity, at least 70% nucieotide similarity, at least 80% nucleotide similarity, at least 90% nucleotide similarity, at least 91% nucleotide similarity, at least 92%o nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucieotide similarity, at least 95% nucleotide similarity, at least 96% nucleotide similarity, at least 97% nucleotide similarity, at least 98%o nucieotide similarity, at least 99% nucleotide similarity, at least 99.5% nucieotide similarity, at least 99.9% nucleotide similarity, or 100% nucleotide similarity).
Table 6. Representative Examples of Gamma- Ami nobutyraldehyde Dehydrogenase by EMBL/GENBANK/DDBJ ID Number
AAA23428.1 ABA73866.1 ABG69453.1 ABV19711.1
AAC74382.1 ABA76670.1 ABI88593.1 ABV42738.1
AAC74526.1 ABA77271.1 ABI91617, 1 ABV94754.1
AAG56331.1 ABAS 1 134.1 ABJ00886.1 ABX21278.1
AAL20515.1 ABB06719.1 ABO56067.1 ABX67082.1
AAN43345.1 ABB09933.1 ABP60799.1 ACA77853.1
AAN54343.1 ABB61850.1 ABP83011.1 ACB02660.1
AAN68409.1 ABC35115.1 ABQ62162.1 ACB 16069.1
AAN80331.1 ABE07141 .1 ABQ79255.1 ACB 17411.1
AA069141.1 ABE33447.1 ABQ81306.1 ACD08717.1
AAP 17225.1 ABE35009.1 ABR77355.1 ACF65188.1
AAV77220.1 ABES 8543.1 ABR80823.1 ACH48735.1
AAX65500.1 ABF03934.1 ABU77182.1 ACI07089.1
AAY35300.1 ABF07563.1 ABV05856.1 ACI11169.1
AAY91615.1 ABF08506. 1 ABV1261 1.1 ACI 11654.1
AAZ88386.1 ABF77276. 1 ABV19407.1 ACB 8546.1 ACI83776.1 AEG95612.1 AFR27692.1 AHA65444.1
ACI83777.1 AEG98095.1 AFR30100.1 AHA65445.1
ACI83778.1 AEG98933.1 AFR31023.1 AHB59062.1
ACI83779.1 AEH78268.1 AFS74542.1 AHB70534.1
AC Ί 83780. ! AEH79912.1 AFS74651 .1 AHB70670.1
ACI84176. 1 AEI77057.1 AFT90302.1 AHC33991.1
ACI84177. 1 AEI81569, 1 AFT90471.1 AHC33996.1
ACI84178.1 AEJ11708.1 AFY18239.1 AHC38640.1
ACI84179.1 AEJ41144.1 AFY18244.1 AHC86568.1
ACI84180.1 AEJ56308.1 AGB72506.1 AHC90526.1
ACI98856.1 AE.) 56491.1 AGB72704.1 AHC99932.1
ACL96708.1 AEK44843.1 AGB74580.1 AHD03574.1
ACN46267.1 AE 65037.1 AGB75454.1 AUDI 3184.1
ACR63729.1 AEQ 12441.1 AGB78252.1 AUDI 7058.1
ACS85105.1 AEV61105.1 AGE94564.1 AHE51105.1
ACT07528.1 AEW60590.1 AGG75097.1 AHE57975.1
ACT 12461.1 AEW61596.1 AGI23954.1 AHE58040.1
ACX87601.1 AEW61597.1 AGI25578.1 AHE70444.1
ACY88405.1 AEW73833.1 AGK03386. 1 AF1F76632.1
ACZ77452.1 AEW96833.1 AGM29868.1 AHF85737.1
ACZ84797.1 AEX05106.1 AGN78797. 1 AHG19057.1
ACZ84868.1 AEX05672.1 AGN78800.1 AHG19062.1
ADA74159.1 AEX21381.1 AGN79081.1 AHG38795.1
ADD56229.1 AEY02655.1 AGN81120.1 ΛΙ 11 195453. 1
ADD56381.1 AFG40539.1 AGN84096.1 Ai l! 1961 34. 1
ADF61409.1 AFG40645.1 AG056529.1 AHI31496.1
ADF61777, 1 AFI68614.1 AG056534.1 AHJ73863.1
ADI 12862.1 AFI89822.1 AGP45636.1 AHK28152.1
ADJ47943.1 AFJ28854.1 AGP48796.1 AHK28260.1
ADM97795.1 AFJ28952.1 AGP52381.1 AHK29047.1
ADN75355.1 AFJ47105. 1 AGP54692.1 AHK29048.1
AD048635.1 AFK56420.1 AGP54697.1 AHK29235.1
ADP 16410.1 AFK67163.1 AGP60625.1 AHK29423.1
ADR26852.1 AFL53103.1 AGQ73200. 1 AHK34315.1
ADT74882.1 AFM59735.1 AGR58814.1 Al l! . 2427.1
ADT75049.1 AFM60144.1 AGS23468.1 AHM79287.1
AD V53576.1 AFN32345.1 AGS72121.1 AHM80280.1
ADX17297.1 AF048697.1 AGZ34904.1 AHM84957.1
AEC 17673.1 AFO86070.1 AGZ34909.1 ΑΠΜ8591 7 !
AEE56233.1 AF092872.1 AGZ36730.1 1 IN 804 1 !
AEE56444.1 AFR02836.1 AHA65135.1 AHW62955.1 AHX59431.1 AJA25872.1 AKK26535.1 B AI30293 , 1
AHY13380.1 AJC55682.1 AKK48033.1 BAD 0398.1
AHY70456.1 AJC65875.1 AK. 48 1 -I. 1 BAI35600.1
AHZ69437.1 AJC81199.1 AKI. 12092. 1 BAI35738.1
AHZ75601.1 AJD42887.1 AKL36390.1 BAL95971.1
AHZ75934.1 AJE42771.1 AKM34859.1 B.A 47691.1
AIA06216.1 AJE55657.1 AKM34956.1 BAN47978.1
AICl 8252.1 AJE55826.1 AKM45294.1 BAN50325.1
AICl 8257.1 AJE81228.1 AKN71659.1 BAN50330.1
AIC29053.1 AJF56173.1 A R56664.1 BAN56084.1
AID34200.1 AJF56280.1 A R58199.1 CAC47084.1
AID901 10.1 AJF67554.1 AKS06052.1 CADO 1728.1
AIG78005.1 AJF67987.1 AKS06057.1 CAG74448.1
AIG79529.1 AJF73013.1 ALD25372.1 CAQ89037.1
AII0330Q.1 AJG15382.1 AL 1.90586. 1 CAQ98298.1
AII05641.1 AJK47164.1 ALQ29888.1 CAR02855.1
A 1100622. ! AJ083449.1 Al. .27562. 1 CAR07796.2
ΑΠ07903.1 AJP04064.1 ALY13061.1 CAR12812.1
AII88152.1 AJQ48790.1 ALY13176.1 CAR12894.1
AIJ13059, 1 AJQ89920.1 ALZ65876.1 CAR! 7782.1
AIJ13068.1 AJT64083.1 AI .766856. 1 CAR37392.1
AIL63307.1 AJX74179.1 AMW41259.1 CAR50912.1
AIN56881.1 AJY44820.1 AMW41352.1 CAS09132.1
AIN58220.1 AJZ89630.1 AMX15658.1 CAU97432.1
AIO70590.1 AKA21608.1 A K32128.1 CAZ86962.1
AI083941 .1 AKA25271 .1 A M82203.1 CB A30725.1
AIP25746.1 AKA26423.1 ANP 17955.1 CBG87141.1
AIP94956.1 AKA26428.1 ANZ87342.1 CBG88353.1
AIR032Q0.1 AKA26652.1 AOM46387.1 CBJ00907.1
AIR62232.1 AKC39739.1 AOM69814.1 CBJ01019.1
AIR68506.1 AKE96156.1 AOT33034.1 CBW17622.1
AIS00809.1 A F49081.1 APA42536.1 CCB65972.1
AIS00819.1 A G67805.1 APA42696.1 CCB67003.1
AIT03707.1 AKG67810.1 BAA 14869. 1 CCB67169.1
AIU71844.1 AKH07208.1 BAA 15073.1 CCC30509.1
AIU71849.1 AKH08765.1 BAB35471.1 CCE10783.1
AIW48087.1 AKH26598.1 BAD88708.1 CCF61531.1
AIW76907.1 AKI 120766. 1 BAG42223.1 {'CI 128399. 1
AIX63251 .1 A I 185 122. 1 BAG77050.1 { 'CI 13 1 748. 1
AIZ82499.1 AK J 10458.1 BAI25150.1 CCH72874.1
AJ A 14625, 1 AKJ98810.1 BAI25318.1 CCH76962.1 CCH77412.1 CDP84626.1 CEL27771.1 CTT92436.1
CCH79600.1 CDQ13701.1 CEL84834.1 CTT92613.1
CCI52108.1 CDQ14695.1 CEL86039.1 CTT97100.1
CCI77183.1 CDR01601.1 CEP29887.1 CTU01835.1
CCJ43834. 1 CDR17539.1 CFU00610.1 CTU36153.1
CCJ43945. 1 CDU36030.1 CPR21343.1 CTU72845.1
CCJ80233. 1 CDU38743.1 CQD06815.1 CTV40159.1
CCK02487.1 CDW92927.1 CQR61483.1 CTV56108.1
CCK27139.1 CDX1 1539.1 CRI57441.1 CTV74457.1
CCK27147.1 CDX11561.1 CRI58732.1 CTW04360.1
CCK46650.1 CDX14815.1 CRL88003.1 CTW29476.1
CCM79078.1 CDX 15464.1 CRP27791.1 CTW61879.1
CCM79926.1 CDX15608.1 CRQ48403.1 CTW77542.1
CCN44439.1 CDX15708.1 CRZ 15796.1 CTX33307.1
CCQ17877.1 CDX18128.1 CSK40308.1 CTY24484.1
CCT59175.1 CDX23952.1 CSK40325.1 CTZ61796.1
CCV08313.1 CDX24321.1 CSL03164.1 CTZ76546.1
CC VI 0163.1 CDX24344.1 CSM54609.1 CTZ79234.1
CCV14388.1 CDX24795.1 CSM54649.1 CTZ96800.1
CCV15291.1 CDX26102.1 CSN55245.1 CUI28728.1
CCW32353.1 CDX30033.1 CSP80178.1 CUJ66815.1
CDF82476.1 CDX30137.1 CSP84594.1 CUJ82879.1
CDF82481.1 CDX32833.1 CSP99410.1 CUZ08279.1
CDF83258.1 CDX33250.1 CSS89574.1 EDM61330.1
CDG13595.1 CDX33780.1 CTP99211.1 EDS91265.1
CDG 17619.1 CDX35494.1 CTQ00586.1 EDS92029.1
CDH77402.1 CDX39763.1 CTQ03890.1 EDU65292.1
CDK71 151.1 CDX50647.1 CTQ 10217.1 EDU90202.1
CDK74582.1 CDX52898.1 CTQ 15467.1 EDU90317.1
CDL26553.1 CDX53624.1 CTQ16305.1 EDX34020.1
CDL56081.1 CDX58882.1 CTQ 16977.1 EDX35915.1
CDL.81552.1 CDX59913.1 CTQ 17997.1 EDX46872.1
CDL.81886.1 CDX61300.1 CTQ25284.1 EDY24930.1
CDM87455.1 CDX61327.1 CTR39889.1 EDY65642.1
CDN05905.1 CDX61366.1 CTS37133.1 EED35505.1
CDN06835.1 CDX62732.1 CTS49511.1 EED97074.1
CDN820Q2.1 CDZ83389.1 CTS54984.1 EEE03881.1
CDO06723.1 CEG54345.1 CTT37563.1 EEE05415.1
CDOl 1 198.1 CEI20766.1 CTT55391.1 EEP49475.1
CDO20175.1 CEJ64257.1 CTT62054.1 EEP84228.1
CD027859.1 CEL27766.1 CTT65179.1 EET48351.1 EET48956.1 EGB72004.1 EHH11988.1 EII44042.1
EEW39317.1 EGB90260.1 EHJ94704.1 EIK70381.1
EEW60473.1 EGB98679.1 EHJ94844. 1 E1K70690.1
EEX16532.1 EGC95168.1 EHK52408. 1 E1K97767.1
EFC56792.1 EGD06231.1 EHK54788.1 EI 97772.1
EFE08792.1 EGE34132. 1 EHK66824.1 EIL50217.1
EFE63903.2 EGE48689. 1 EH 74830.1 Ett.50351.1
EFE64066.2 EGE61394.1 EHM27681.1 EIM73619.1
EFF07668.2 EGF89341.1 EHM47677.1 EIQ09709.1
EFF07812.2 EGG47793.1 EHN75593.1 EIQ75858.1
EFF12655.2 EGI 10883.1 EHP43848.1 EJE59098.1
EFF 12736.2 EGI11039.1 EHP62718.1 EJE61181.1
EFG35656.2 EGI 17601.1 EHP64017.1 EJE85045.1
EFH33353.1 EGI21877.1 EHT05663.1 EJE96318.1
EFI90126.1 EGI22685.1 EHT 13683.1 EJF29138.1
EFJ64881.1 EGI41263.1 EHU11201.1 EJF32265.1
EFJ72274.1 EGI41264.1 EHIJ13340. 1 EJF68495.1
EFJ83495.1 EGI46454.1 EHIJ15614. 1 EJF68500.1
EFJ 89608.1 EGI47073.1 EHU24532.1 EJI90289.1
EFJ98868.1 EGI51604, 1 EHU29232.1 EJI93345.1
EFK05124. 1 EGI51699, 1 EHU31012.1 EJI93407.1
EFKl 5965.1 EGI96778.1 EHU41094.1 EJI95486.1
EFK19444.1 EGI99670.1 EHU45943.1 EJI95544.1
EFK26532.1 EGI99749.1 EHU59778.1 EJI96663.1
EFK45262.1 EGJ03157.1 EHV59483.1 EJI98843.1
EFK52086.1 EGJ05085.1 EIC82100.1 EJJ00315.1
EFK66278.1 EGJ74429.1 EID61817.1 EJJ07858, 1
EFK74995.1 EGK24148.1 !! 1)622 14. 1 EJ 91259.1
EFK91 145.1 EGK24149.1 ED365440.1 EJK91378.1
EFL88470.1 EGK24615.1 ED365521.1 EJL01279.1
EFM58433.1 EGK24616.1 EID73534.1 EJL02848.1
EF059324. 1 EGK37820.1 EIE52002.1 EJL08255.1
EFP69095. 1 EGK60394.1 EIF92872.1 EJL08816.1
EFP69402. 1 EG094631.1 EIG83929.1 EJL08880.1
FI R 14050. i EGU9561 1.1 EIG94831.1 EJL 16742, 1
EFU33457.1 EGW40786.1 EIH12409.1 EJL 17014.1
EFV41685.1 EGX55949.1 EIH21939.1 EJ032261.1
EFV42196.1 EHB41733.1 EIH44123.1 EJT03922.1
EFV44308.1 EHD22257.1 EIH77056.1 EJU29480.1
EGB59482.1 EHH02231.1 EII23324.1 EJZ04156.1
EGB68820.1 ! · ] [] 1095 16 ! EIB2616.1 EJZ05782.1 EJZ07520.1 ELJ74005.1 EOU43864.1 EPL05218.1
EJZ 1 1850.1 ELQ84051.1 EOU68015.1 EPR07720.1
EJZ 13633. 1 ELQ90577.1 EOU70063. 1 EQD81697.1
EJZ 18209.1 ELV07386.1 EOU79907. 1 EQD82324.1
EJZ22729.1 ELW35774.1 E0U81 1 19.1 EQD83794.1
EJZ67420.1 CI . X I 1 . 1 EOU96152.1 EQD87767.1
EJZ67421.1 EMD 12755.1 EOU96255.1 EQL44300.1
EKE69095.1 EMD12954.1 EOV09796.1 EQM34719. 1
EKF44031. 1 EMD13067.1 E0V10270.1 EQM69852. 1
EKF58906.1 EMF25251.1 EOV49578.1 EQM71564.1
E 153765.1 EMP54680.1 EOV63174.1 EQM71569.1
EKI53852.1 EMP54686.1 EOV63548.1 EQM75964.1
EKT77536.1 EMR54447.1 EOV79497.1 EQM77609.1
EKU47209.1 EMU62810.1 EOV79860.1 EQM78485.1
EKU47702.1 EMU70199.1 EOV87779.1 EQM79321. 1
EKX82560.1 EMV21 190.1 EOW08077.1 EQM80144.1
EKX83133.1 EMX05854.1 EOW08486.1 EQN28573.1
EKX83138.1 EMX21 136.1 EOW21036.1 EQN28672.1
EKX85141.1 EMX32353.1 EOW21374.1 EQN99840.1
EKZ96977.1 EMX40913.1 EOW24870.1 EQN99841. 1
EKZ99926.1 EMX51 161.1 EOW26044.1 EQO00250. 1
ELB93420. 1 EMX88242.1 EOW65040.1 EQ068143.1
ELC09512. 1 EMY35234.1 EOW98830.1 EQO71509.1
ELC09701.1 ENA08671.1 EPB97616.1 EQP56400.1
ELC 19003.1 ENA40359.1 EPC03794.1 EQQ 14012.1
ELC41369.1 EiNA45932, l EPE95228.1 EQQ 14796.1
ELC41538.1 ENC92169.1 EPF 16860.1 EQV92076.1
ELC88918.1 END53755.1 HP! 143 1 . 1 EQV93438.1
ELC89051.1 END93044.1 EPH4343 1.1 EQX28154.1
ELE01 126.1 E G98074.1 EPI73506.1 EQX88295.1
ELEO 1606.1 ENH03358.1 EPI73882.1 EQX88882.1
ELE44498.1 C\ ] 1096 1 0. 1 EPI 87463.1 EQY25054.1
ELE44659.1 ENY73407.1 EPJ00727.1 EQY25162.1
ELE56019.1 ENY78290.1 EPJO 1 132, 1 EQY62629. 1
ELE561 14.1 ENZ86937. 1 EPJ03992.1 EQY63 166. 1
ELE60912.1 EOD53374.1 EPJ12747.1 EQZ93705.1
ELE61 186.1 EOQ49232.1 EPJ38971.1 ERA03230.1
ELG8941 1 .1 EOQ49914.1 EPJ38980.1 ERB51269.1
ELG90335.1 E0Q61470.1 EPJ81214.1 ERE03382.1
ELI30197.1 EOQ65631.1 EPJ81219.1 ERF62800.1
ELD 1 157.1 EOU43508.1 EPJ89017.1 ERF79994.1 ERF80025.1 ESK09882.1 ESX43501.1 ESZ28042.1
ERF86678.1 ESK 10485.1 ESX52337.1 ESZ34731.1
ERH52669.1 ESK37171.1 ESX56930.1 ESZ35713.1
ERH54945.1 ESK37414.1 ESX58061.1 ESZ39312.1
K ] 156364. 1 ESL81948.1 ESX60692.1 ESZ47365.1
ERH56369.1 ESL82348.1 ESX73443.1 ESZ49754.1
ERI50841.1 ESM 14498.1 ESX77081.1 ESZ50191.1
ERI52992.1 ESN13440.1 ESX81416.1 ESZ51262.1
ERK06991.1 ESQ05398.1 ESX87236.1 ESZ60420.1
ERK14296.1 ESQ76607.1 ESX88150.1 ESZ6298 .1
ERK98773.1 ESQ77377.1 ESX88342.1 ESZ63558.1
ERK98876.1 ESQ81731.1 ESY00266.1 ESZ67001.1
ERL53130.1 ESQ83104.1 ESY04276.1 ESZ70861.1
ER058335.1 ESQ91911.1 ESY06338.1 ESZ73525.1
ER062836.1 ESQ93897.1 ESY12861.1 ESZ73952.1
ER063658.1 ESQ98710.1 ESY17564.1 ESZ75665.1
ERP07702.1 ESS14987.1 ESY 8933.1 ETA08782. 1
ERP86472.1 ESS59788.1 ESY26034.1 ETA86576. 1
ERS89090.1 EST30101 .1 ESY28484.1 ETC29664.1
ERT55553. 1 EST30107.1 ESY30944.1 ETD30716.1
ESA66810. 1 EST33761.1 ESY33527.1 ETD31 105.1
ESA77122.1 EST33892.1 ESY37324.1 ETD62961.1
ESA78274.1 EST36063.1 ESY52717.1 ETE 19722.1
ESA83620.1 EST39150.1 ESY60955.1 ETE531 15.1
ESA83744.1 ESU49379.1 ESY66683.1 ETF04172.1
ESA95270.1 ] · Si : 76946 ! ESY68060.1 ETF05232.1
ESBO 1449, 1 ESU81649.1 ESY74421.1 ETF07523.1
ESD02695.1 ESU81650.1 ESY80296.1 ETI61741.1
ESD09814.1 ESW36007.1 ESY83492.1 ETK22368.1
ESD21218.1 ESW41503.1 ESY84782.1 ETK22373.1
ESD33644.1 ESW64252.1 ESY90437.1 ETK33993.1
ESD67552. 1 ESW66425.1 ESY93751.1 ET 35735.1
ESD75875. 1 ESW68009.1 ESZ00304.1 ETM65117.1
ESD88637. 1 ESW86999.1 ESZO 1923.1 ETM65275.1
ESD99184. 1 ESW87442.1 ESZ09540.1 ETM67859.1
ESE82501.1 ESW90408.1 ESZ09896.1 ETM67864.1
ESE84822.1 ESW91937.1 ESZ13256.1 ETM68681.1
ESF48176.1 ESX01731.1 ESZ14738.1 ETY48139.1
ESG58184.1 ESX14872.1 ESZ24600.1 ETY48243.1
ESJ13234.1 ESX15364.1 ESZ25961.1 ETZ 1 1507.1
ESJ21013.1 ESX27250.1 ESZ27305.1 EUB 74063.1 EUB83842.1 GAD63079.1 KEC77821.1 KFF99222.1
EWC42375.1 GAD63084.1 KEG39710.1 KFG67154.1
EWG76330.1 GAK29357.1 KEH13576.1 KFG73420.1
EWH00701.1 GAK29362.1 KEJ48744.1 KFG77433.1
EWM 12655.1 GAL43981.1 KEJ63425.1 KFI29656.1
EXF91839. 1 GAL48526.1 KEJ77549.1 KFK85449.1
EXF93299. 1 GALS 8082.1 KEJ95365.1 KFK97286.1
EXF94820.1 GAM50401.1 KEL69022.1 KFK97291.1
EXF94825.1 GAO07729.1 KEN57716.1 KFL25738.1
EXF96398.1 GAP56165.1 KEN70496.1 KFL29966.1
EXJ51305.1 GAP56166.1 KEO01987.1 KFL38046.1
EXL03099.1 GAP56167.1 KE012714.1 KFN19465.1
EXU69106.1 DA58453.1 KE035027.1 KFN41 1 1 1.1
EXU88516.1 KDD67292.1 KE051439.1 KFN46900.1
EYC51688.1 KDD68894.1 KE053693.1 KFN49964.1
EYD86031.1 KDD69165.1 KE057514.1 KFN51535.1
EYR82110.1 KDD69170.1 ER68883.1 KFX06879.1
EYT83596.1 KDE38101.1 ES06595. 1 KFX69867.1
EYU66295.1 KDE98698.1 KES20242.1 KGA35361.1
EYV04090.1 KDF06849.1 KES21942, 1 KGA42963.1
EYV 10968.1 KDF 18076.1 KES22773.1 KGD59263.1
EZA00470.1 KDF20685.1 KES22778.1 KGD94090.1
EZ A36281.1 KDG95704.1 KEX91709.1 KGE65706.1
EZD25558.1 KDG97056.1 KEX92394.1 KGE65711.1
EZD99900.1 KDM67929.1 KEY87097.1 KGF68263.1
EZE53557.1 DN76233.1 KEZ76822.1 KGF72312.1
Γ./1 178629.1 KDN831 14.1 KFB89554.1 KGI67195.1
EZH78632.1 KDN831 17.1 KFB89559.1 KGI94899.1
EZI29263.1 KDO01521.1 KFC10517.1 KGJ03236.1
EZI29268.1 KDQ69796.1 KFC67945.1 KGK24105.1
EZJ43273.1 KDS87067.1 KFC70569.1 KGM32302.1
EZJ52521.1 KDU28283.1 KFC75085.1 KGM44306.1
EZJ77242.1 KDV34603.1 KFC81786.1 KGM58952.1
EZJ87004.1 KDV38010.1 KFC91913.1 KGM69324.1
EZK23644, 1 KDV65222.1 KFC95867.1 KGM78828.1
EZP27312.1 KDW32558.1 KFC99397.1 KGM81944.1
EZP41476.1 KDX18550.1 KFD74218.1 KGP01633.1
EZP45031.1 KDX47161.1 KFE44941.1 KGQ21090.1
EZP62483.1 EA05640.1 KFE53051.1 KGR84694.1
GAB53548.1 EA51004.1 KFF88438.1 K.GT96645.1
GAB56017.1 KEC74664.1 KFF88443.1 KGU84905.1 KGU85044.1 KIQ45546.1 KJK 52206. 1 KKD60858.1
KGW16883.1 KIQ47862.1 KJK58811.1 KKE99588.1
KHA75030.1 KIQ55257.1 KJL20365.1 KKF00080.1
KHA75035.1 KIQ59125.1 KJL23069.1 KKF03311.1
KHD08750.1 KIQ63814.1 KJL30351.1 146974 !
KHD 11829.1 KIU18518.1 KJL31602.1 146979 !
KHI27478.1 KIU34636.1 KJL33666.1 KKJ25486.1
KHJ12630.1 KIU47422.1 KJL48804.1 KKO 14271.1
KHK63949.1 KIU53338.1 KJM37801.1 KKW63834.1
KHK63954.1 KIU53341.1 KJM97308.1 KKX63769.1
KHL04063.1 KIX41539.1 KJN29799.1 KKX64098.1
KHL 17238.1 IX76475.1 KJQ55807.1 K.KY43260.1
KHL 18800.1 KIY37490.1 KJQ55948.1 K.KY88574.1
K l 11.69724. 1 KIY39817.1 KJW23607.1 KKZ 17922.1
KHN51966.1 KIY42118.1 KJW25580.1 KKZ 17927.1 l 1X62433. 1 KIY42676.1 KJW52220.1 KKZ88372.1
KHN91313.1 ΚΪΖ13851. 1 KJX08981 .1 KLI09733.1
KHO23301.1 KIZ24787. 1 KJX38421 .1 KLI88767.1
KH027139.1 KJC00426.1 KJY22909.1 KLI99518.1
KHO65650.1 KJC06180.1 KJY33089.1 KLK91 133.1
KHS48549.1 KJC 1 1238.1 KJY33790.1 KL051629.1
KHS48554.1 KJE36612.1 KJY43331.1 KLQ25311.1
KHS75072.1 KJE78198.1 KJZ 10920.1 KLT72736.1
KHT32807.1 KJF18418.1 KJZ37958.1 KLU27310.1
KHT39971.1 KJF21349.1 KJZ37963.1 KLV08340.1
KIC09090.1 JF69984.1 KJZ40441.1 KLV50364.1
KIC40995.1 KJF70827.1 KJZ40446.1 KLV67254.1
KIC41133.1 KJH08553.1 KJZ45327.1 KLV72352.1
KIC83744.1 KJH75518.1 KJZ45333.1 KLW92152.1
KIC99939.2 KJH75523.1 KJZ66226.1 KLX61073.1
KIC99947.1 KJH76614.1 KJZ66231. 1 KLX97485.1
KID09632.1 KJH78831.1 KKA04889. 1 KLY16841 .1
KIF07001.1 KJH87663.1 KKA04894. 1 KLY40951 .1
KIF26716.1 KJH87668.1 KKA0991 1. 1 KME63607. 1
KIF43517.1 KJKO 1996, 1 KKA37777. 1 KMI305 9.1
KIF59716.1 KJK02001.1 KKA42030.1 KMK11631.1
KIF59721.1 KJK03668.1 KKA53217.1 KML66599.1
KIF67705.1 KJK05212.1 KKB78257.1 KMM42844.1
KIH01614.1 J 08131 .1 KKB82836.1 !< MM 79980 !
KI 89863.1 J 20451 .1 KKC631 15.1 !< M 79984 !
KIK89868.1 KJK37817.1 KKD05136.1 KMM93815.1 KMN 10712.1 KOG30324.1 KPC80506.1 KTH76882.1 MX 1071 5. 1 KOG34758.1 KPC83739.1 KTZ 11478.1
KMN35503.1 KOG38875.1 KPC92801.1 KUN93478.1
KMN66213.1 KOG44119.1 KPF46210.1 KUU42596.1
KMN83689.1 KOG60686.1 KPF61380.1 KWZ91965.1
KM068456.1 KOG65984.1 KPG35216.1 KXG93510.1
KM068855.1 KOG73930.1 KPG89320.1 KXHO 1990.1
KMO70407.1 KOG84617.1 KPG89325.1 KXI02527.1
KM071981.1 KOP04486.1 KPG90595.1 KXL57426.1
KMO77030. 1 KOP81781.1 KPG90600.1 KXL65443.1
KM077166.1 KOT34360.1 KPG95593.1 KXQ40269.1
KM078179.1 OT54726.1 KPG96003.1 KYR44624.1
KMO83081.1 OT89785.1 i 106793. 1 KYR46262.1
KM084977.1 OT93096.1 KPL32866.1 KYS89391.1
KM098166.1 KOU23107.1 KPL68330.1 KYV69812.1
KMQ75593.1 KOU32059.1 KPN71959.1 KYV69919.1
KMS67055.1 K()i. 37064. 1 KPN74360.1 KZJ61423.1
KMS84091.1 KOU48313.1 KPN92591 .1 OAC44376.1
KMV13999.1 KOU68154.1 KPN92596.1 OAJ89643.1
KMV35767.1 KOU76809.1 KPO09259. 1 OAJ89801.1
KNA39386.1 KO VI 0064, 1 KP042565.1 OA073826.1
KNC09274.1 KOV34566.1 KP048511.1 OCB47501.1
KNC93864.1 KOV38826.1 KP053785.1 OCS64471.1
KND34924.1 KOV52198.1 KPP88272.1 OCS99847.1
KND39332.1 KOV66117.1 KPP99458.1 OCV46435.1 N 1)42278 1 OV74373.1 KPQ21464.1 OCV69750.1
KNF62763.1 KOV87450.1 KPQ21534.1 01)1 120373 1
KNF78118.1 KOX03723.1 KPQ21854.1 ODN18141.1
KNF82323.1 KOX05951.1 KPR53957.1 OEG95421.1
KNG95257.1 KOX35809.1 KPW26103.1 OEH12679.1 M l i 8859. ] KOX51055.1 KPW26988.1 OEH17081 .1
KNH37980.1 KOY03131.1 KPW67069.1 OEI60939.1
K\] 143304. 1 KOY03136, 1 KPW74859.1 OEN32142.1
KNN88316.1 KOY58167.1 KPY59757.1 OEN32392.1
K W77292.1 KPA89964.1 KPY87595.1 OIR52348.1
KNY72567.1 KPA90118.1 KQ J 17275.1 OJF09290.1
KNZ31302.1 KPB70152.1 KQJ36447.1 SAD98048.1 N/82970. 1 KPC25344.1 KQJ45372.1 SAZ48890.1 N/97006. 1 PC62377.1 KS! 107068. 1 SBX26203.1
KO A33208.1 PC63412.1 KST34997.1
KOF21370, 1 KPC68317.1 KSY01459.1 [00107] Representative examples of arginine decarboxylase (EC 4.1.1.19) are given below in Table 7 and identified by their EMBL/GENBANK/DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the arginine decarboxylase (EC 4.1.1.19) set forth in Table 3 and Table 7. For instance, the bacteria can be engineered with a version of the arginine decarboxylase enzyme that has at least 50% nucleotide similarity with any of the versions of arginine decarboxylase given in Table 7 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90% nucleotide similarity, at least 91% nucleotide similarity, at least 92% nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucleotide similarity, at least 95% nucleotide similarity, at least 96% nucleotide similarity, at least 97% nucleotide similarity, at least 98% nucleotide similarity, at least 99% nucleotide similarity, at least 99.5% nucleotide similarity, at least 99,9% nucleotide similarity, or 100% nucleotide similarity).
Table 7. Representative Examples of Arginine Decarboxylase by EMBL/GENBANK/DDBJ ID Number
AAA 2348 1 ! AAK65019.2 j AAP 10882.1 AAV82053.1
AAA24646.1 AAL21961.1 j AAP 18235.1 AAV93917.1
AAA62686.1 AAL23120.1 j AAP27896.1 AAW73474. 1
AAA69105.1 AAM38760.1 j AAP77830.1 AAW87910. 1
AAA97017.1 AAM43099.1 j AAP99095. 1 AAW90125. 1
AAC24937.1 AAM86863.1 I AAQ60544. 1 AAX66932.1
AAC75975.1 AAN444I2.1 j AAQ61700. 1 AAY3941 1.1
AAC77078.2 AAN54922.1 j AAR35910.1 AAY50992.1
AAD06541.1 AAN66194.1 j AAS63667.1 AAY96086.1
AAD07486.1 AAN81972.1 j AAS81619.1 AAZ3381 1.1
AAF09826.1 AAN83546.1 j AAS94900.1 AAZ58866.1
AAF40905.1 AAO10730.2 j AAT33294.1 A A/89679. 1
AAF82957.1 AAO28012. 1 j AAT56175.1 ABA21777.1
AAF96713.1 AA058271. 1 j AAU16546.1 ABA23030.1
AAG08224.1 AAO70551.1 j AAU261 14.1 ABA48961.1
AAG58069.1 AA071667.1 j AAU91686.1 ABA57077.1
AAK03466.1 AAO78500.1 j AAV78788. 1 ABA72371.1
AAK65018.1 AAP07133.1 j AAV8161 1 . 1 ABA89337.1 ABB 10893.1 ABI46161.1 ABQ05833.1 ACA99796.1
ABB26344.1 ABI55429.1 ABQ 19043.1 ACB 15562.1
ABB27130.1 ABI60410.1 ABQ25189.1 ACB 16864.1
ABB31 146.1 ABI68665.1 ABQ76774.1 ACB59509.1
ABB35370.1 ABI71549.1 ABQ91208.1 ACB76743.1
ABB36243.1 ABJ02367.1 ABR39026.1 ACB91563.1
ABB37372.1 AB J 14223.1 ABR71752, 1 ACC79266.1
ABB44410.1 ABJ88595.1 ABR78771.1 ACC84558.1
ABB49107.1 ABK 15308.1 ABR85787.1 ACD05477.1
ABB 50154.1 ABK38605.1 ABR886 9.1 ACD08093.1
ABB56739.1 ABK43242.1 ABS07904.1 ACD08437.1
ABB57067.1 ABK47857.1 ABS26167.1 ACD22470.1
ABB63148.1 ABK75092.1 ABS44765.1 ACD56878.1
ABB67557.1 ABK82178.1 ABS51948.1 ACD84161.1
ABB 74343.1 ABK86821.1 ABU58554.1 ACD95391.1
ABC 18380.1 ABL00211.1 ABU74620.1 ACE82746.1
ABC20552.1 ABL82864.1 ABU75700.1 ACF30404.1
ABC33051.1 ABL89457.1 ABV15373.1 ACF53467.1
ABC81667.1 ABMOO 169.1 ABV17227.1 ACF61369.1
ABC98358.1 ABM02703.1 AB VI 7863.1 ACF63192.1
ABD03703.1 ABM 13722.1 ABV37216.1 ACF69056.1
ABD80860.1 ABM 17621.1 ABV43068.1 ACF90655.1
ABE08775.1 ABM25203.1 ABV49674.1 ACG73211.1
ABE10119.1 ABM29533.1 ABV67224.1 ACH39919.1
ABE55560.1 ABM63175.1 ABV87800.1 ΛΠ 1 1462. 1
ABE57906.1 ABM69334.1 ABW26679.1 ACH52106.1
ABF05062.1 ABM71261.1 ABX07146.1 AC! [64501 . 1
ABF09627.1 ABM74623.1 ABX07983.1 AC! 176229. 1
ABF 6066.1 ABM79561.1 ABX24332.1 ACH83424.1
ABF85039.1 ABN07206.1 ABX48976.1 ACI09897.1
ABF88624.1 ABN61275.1 ΛΒΧ6 18 1 . 1 ACI17330.1
ABG12304.1 ABN69317.1 ABX73818.1 ACI27705.1
ABG12881.1 ABO 16671.1 ABY34333.1 ACI37609.1
ABG19102.1 AB023486.1 ABY96523.1 ACI78401.1
ABG19453.1 ABO48608.1 ABZ76368.1 ACI78402.1
ABG42373.1 ABO50340.1 ACA11160.1 ACI78403.1
ABG50504.1 ABO90758.1 ACA16086.1 ACI78404.1
ABG5061 1.1 ABP62006.1 ACA35608.1 ACI78405.1
ABG58847.1 ABP75372.1 ACA67146.1 ACJ08154.1
AB 138635.1 ABP78675.1 ACA75078.1 ACJ29742.1
ABI42627.1 ABP83495.1 ACA86341.1 ACJ78722.1 ACK4701 1.1 ACU90402.1 ADD 5097.1 ADU6191 .1
ACK63941.1 ACU93413.1 ADI63948.1 ADU65890.1
ACK65701.1 ACV26547.1 ADJ27548. ! ADU70509.1
ACK72412.1 ACV27755.1 ADJ649 I . ! ADU80224.1
ACK80041.1 ACV29034.1 ADK 13228. 1 ADU81854.1
ACK89576.1 ACX84176.1 ADK82353. 1 ADU83415.1
ACK93714.1 ACX89634.1 ADK95316. 1 ADU84974.1
ACL08484.1 ACX98134.1 ADL08911.1 ADU91399.1
ACL 10977.1 ACX99534.1 ADL25363.1 ADV04673.1
ACL24678.1 AC Y 12668.1 ADL33935.1 ADV26011.1
ACL46250.1 ACY40093.1 ADM42795.1 ADV42555.1
ACL48808.1 ACY48301.1 ADN00 48.1 ADV46298.1
ACL65409.1 ACY53514.1 ADN01531.1 AD V49133.1
ACL74193.1 ACY85796.1 ADN09145.1 ADV54125.1
ACL75477.1 ACY90136.1 ADN13212.1 ADV64798.1
ACM20036.1 ACZ 12309.1 ADN74820.1 ADV66885.1
ACM64074.1 ACZ78457.1 ADN80145.1 ADW 14248.1
ACM92229.1 ADA75259.1 ADO02588.1 ADW 16260.1
ACM 3264. 1 ADB 16530.1 ADO07215. 1 ADW22931 . 1
ACN47236.1 ADB41493.1 ADO 10713. 1 ADW75122. 1
AGO 16949.1 ADB95292.1 ADO30989. 1 ADXl 8873.1
ACO 18249.1 ADC70718.1 ADO47091.1 ADX68773.1
ACO45270.1 ADDS 8093.1 ADO50285.1 ADY13324.1
ACO74026.1 ADD69353.1 AD071288.1 ADY25759.1
AC074435.1 ADD78376.1 A DP I 1444. 1 ADY29884.1
AC076955.1 ADE 16426.1 ADP85550.1 ADY33564.1
ACP07734.1 ADE54552.1 ADP96036.1 AD Y37564.1
ACQ68147.1 ADE68385.1 ADQ16388.1 AD Y51339.1
ACQ92008.1 ADE82828.1 ADQ41297.1 ADY54539.1
ACQ95950.1 ADF38194.1 ADQ80979.1 AD Y57443.1
ACR12004.2 ADF54509. 1 ADR 18999.1 ADY59760.1
ACR67553.1 ADF63801.1 ADR23218.1 ADZ04173.1
ACR7051 U ADG05247.1 ADR28298.1 ADZ79550.1
ACS84361.1 ADG69601.1 ADR33896.1 ADZ81772.1
ACT05390.1 ADG90777.1 ADT68877.1 ADZ83276.1
ACT 14721.1 ADG93622.1 ADT69825.1 ADZ90751.1
ACT ! 7369. 1 ADH59926.1 ADT76573.1 AEA21246.1
ACT94637.1 AO! 164946. ! ADT88845.1 AEA43924.1
ACU04524.1 ADH85917.1 ADU23228.1 AEA66789.1
ACU08698.1 ADD 3223.1 ADU27690.1 AEA80789.1
ACU63629.1 ADD 1741.1 ADU41306.1 AEA82850.1 AEB00023.2 AEK23616.1 AEX02268.1 AFL79082.1
AEB 11372.1 AEK58300.1 AEX23688.1 AFL80326.1
AEB28348.1 AEK61259.1 AEX24950.1 AFL84801.1
AEB56841.1 AEL05345.1 AEX53406.1 AFL98027.1
AEB69458.1 AEL27626. 1 AEYO 1954, 1 AFM03193.1
AEB99114.1 AEM47745.1 AEY67109, 1 AFM14860.1
AEC00221.1 AEM531 14.1 AFA47332.1 AFM34600.1
AEC17309.1 AEM69221.1 AFA73970.1 AFM61484.1
AEE18245.1 AEN15598.1 AFC23734.1 AFN34158.1
AEE24780.1 AEN17163.1 AFC87564.1 AF049567.1
AEE58171.1 AEN 18717.1 AFD07122.1 AFP36739.1
AEE70651 .1 AE 66325.1 AFD26775.1 AFR05095.1
AEE81155.1 AEN73395.1 AFD56867.1 AFR34769.1
AEE81 156.1 AEO44056.1 AFE10378.1 AFS72870.1
AEE97250.1 AEP12819.1 AFE59771.1 AFS76505.1
AEF05606.1 AEP31437.1 AFF 19873.1 AFS77190.1
AEF16136.1 AEP37160.1 'G36749.1 AFS 77221.1
AEF 16227.1 AEP84802.1 AFG41864.1 AFS78772.1
AEF17164. 1 AEP86444.1 AFFB8314.1 AFT72428.1
AEF23959. 1 AEQ141 10.1 AFH68776.1 AFT76388.1
AEF90677. 1 AEQ98316.1 AFH99689.1 AFT80129.1
AEF92944.1 AER31405.1 AFI02753.1 AFT97219.1
AEF93776.1 AER40829.1 AFI04761.1 AFU69082.1
AEF98646.1 AER54676.1 AFI06437.1 AFU98562.1
AEG11827.1 AET65493.1 AFI07649.1 AF\O6QG9.1
AEG13685.1 AEU09127.1 AFI84424.1 AFV13045.1
AEG34055.1 AE VI 54 1 , 1 AFI921 12.1 AFV75467.1
AEG95551.1 AEV30675.1 AFJ01340.1 AFW94965.1
AEH00504.1 AEV33398.1 AFJ07943.1 AFX90032.1
AEH34628.1 AEV37643.1 AFJ30621.1 AFX91360.1
AEH46105.1 AEV60701.1 AI;J45704. ! AFY00064.1
148741 1 AEV60704.1 AFJ58120.1 AFY17769.1
AEI50098.1 AEV60707.1 AFJ81937.1 AFY19232.1
AEI66195.1 AEV67344.1 AFJ90992.1 AFY20072.1
AEI78192.1 AEV70467.1 AFK03753.1 AFY29829.1
AEI99981.1 AEV98535.1 AFK51272.1 AFY31564.1
AEJ04159.1 AEW03722.1 AFK70099.1 AFY33433.1
AEJ1 1150.1 AEW50294.1 AFL54808.1 AFY36612.1
AEJ 19738.1 AEW63140.1 AFL66748.1 AFY38143.1
AEJ58269.1 AEW75168.1 AFL68607.1 AFY42927.1
AEJ60865.1 AEW84926.1 AFL74612.1 AFY43519.1 AFY49150.1 AGA6491 1.1 AGN85662.1 ΛΙ Η-Ό2503 1
AFY53502.1 AGA71585.1 AG056879.1 AHF 12870.1
AFY58942.1 AGA78721.1 AGP45919.1 AHF 14205.1
AFY60143.1 AGA87856.1 AGP60451.1 AHF64905.1
AFY62113.1 AGA91287.1 AGP79570.1 AHF69813.1
AFY66936.1 AGB27428.1 AGP99328.1 AHF75852.1
AFY67481.1 AGB76810.1 AGQ7501 1. 1 AHF89946.1
AFY68642.1 AGB83896.1 AGQ75715.1 AHG19399.1
AFY69655.1 AGC44465.1 AGQ92959.1 AHG42876.1
AFY74051.1 AGC68230.1 AGR60292.1 AHG91 184.1
AFY79174.1 AGC68780.1 AGR77271.1 ΛΙ 1104766. 1
AFY80035.1 AGC77086.1 AGS39310.1 Al l.! 12914 1
AFY81634.1 AGD97973.1 AGT 10955.1 AI-D98606.1
AFY88446.1 AGE21541.1 AGT74287.1 AHK03030.1
AFY89952.1 AGE28840.1 AGU60604.1 AHK76683.1
AFY96160.1 AGE63314.1 AGW85841.1 AHK78070.1
AFZ00099.1 AGF46648.1 AGX41788.1 AHL31986.1
AFZ00 40.1 AGF47390.1 AGX44838.1 AHL74294.1
AFZ04829. 1 AGF48115.1 AGY58242. 1 AHM04085.1
AFZ05210. 1 AGF48812.1 AGY75546. 1 A1 1M0 146. 1
AFZ13691. 1 AGF58399.1 AGY76455. 1 AHM55552.1
AFZ 14945.1 AGF77157.1 AGY88583.1 AHM55591.1
AFZ 19310.1 AGF98737.1 AGZ37216.1 AHM56089.1
AFZ 19658.1 AGG02742.1 AHA67006.1 AHM57413.1
AFZ23331.1 AGG32139.1 AHA68178.1 AHM72257.1
AFZ25951.1 AGG70048.1 AHA90255.1 A1 1M 77671 1
AFZ28979.1 AGG70049.1 AHB58530.1 ΑΉΜ83263.1 1 /29238. 1 AGG9091 1.1 AHB69077.1 Al 1X36471 1
AFZ34486.1 AGH42699.1 AHB88451.1 AHN42175.1
AFZ35910.1 AGH79375.1 AHC 15721.1 AHN78631.1
AFZ44576.1 AGH84838.1 A1 !C33269. ! AHN81853.1
AFZ45212. 1 AG! 196448. 1 AHC86082.1 AH 76536. 1
AFZ47363. 1 AG! 198733. 1 AHD06174. 1 AHX13501.1
AFZ47406. 1 AGI26195.1 Λ! si) 1 2720. 1 AFIX15381.1
AFZ52083. 1 AGK04961.1 AHE48922.1 Al 1X 1 830. 1
AFZ53867.1 AGK18815.1 AHE59627.1 AHY10273.1
AFZ55178.1 AGL50812.1 AHE60910.1 AHY11503.1
AFZ56231.1 AG1.70280. 1 AHE67762.1 AHY41739.1
AFZ58381.1 AGL71083.1 AHE69334.1 AHY57313.1
AFZ68543.1 AGN36083.1 AHE94171 .1 A1 1Y72294 1
AGA32088.1 AGN77656.1 AHE99491.1 ΑΉΥ7377 .1 AHZ25697.1 AIP98185.1 AJC67765.1 AJK84596.1 i 1/27049. j AIQ93098.1 AJC84641.1 AJ076357.1
AHZ69904.1 AIQ94087.1 AJC86256.1 AJ084926.1
AHZ75105.1 AIQ96154.1 AJC87691.1 AJ086233.1
AIA25262.1 AIR06030.1 AJC89173.1 AJQ25834.1
AIA55267, 1 AIR59441.1 AJC90641.1 AJQ49239.1
AIA73814.1 AIR70547. I AJC94047.1 AJQ86078.1
AIC09292.1 AIR7881 1. I AJDO 1709.1 AJQ92951.1
AICl 3270.1 AIR89334. I AJD06276.1 AJQ96966.1
AICl 7824.1 AIS 1 7530.1 AJD49796.1 AJR02566.1
AID43715.1 AIS 18369.1 AJD72328.1 AJR08104.1
AID92227.1 AIS51300.1 AJD90845.1 AJW64789.1
AIE59498.1 AIS52271.1 AJE04066.1 AJY49487.1
AIE72691.1 AIT00342.1 AJE22826.1 AJY68826.1
AIE73587.1 AIU71685.1 AJE57486.1 AJZ41720.1
AIE80613.1 AIU74296.1 AJE58684.1 AJZ91147.1
AIF46276.1 AIU75005.1 AJF05803.1 AKA26859.1
AIF53874. 1 AIW15710.1 AJF57742.1 AKA35243.1
AIG00462.1 AIW78499.1 AJF57774.1 AKA84246.1
AIG04575.1 Λ 1X49204.1 AJF58959.1 AKA84438.1
AIG24465.1 AIX64799.1 AJF74877.1 AKB 79206.1
AIG27859.1 AIX64838.1 AJG15944.1 AKB84150.1
AIG32739.1 AIX66185.1 AJG20615.1 AKC79848.1
AIG34894.1 AIX72613.1 AJG76397.1 AKC82482.1
AIG39523.1 AIY05985.1 AJG96579.1 AKC86571.1
Ail! 4684, 1 AIY42499.1 AJH06775.1 AKD0361 1.1
AII44730.1 ΑΓΥ444Ι0.1 AJH14965.1 AKD24893.1
AII46407.1 AIY64168.1 AJH21997.1 AKD38345.1
AIMS 194.1 AIY65959.1 AJH79563.1 AKD58010.1
AII5313 I .1 AIZ35463.1 AJI04447.1 AKE51966.1
AIJ07653.1 AIZ41262.1 AJIl 1123.1 AKE61219.1
AIJ37593.1 AIZ46633.1 AJI18133.1 AK.E61764.1
AIK36959.1 Ai 7.64390 1 AJI20378.1 AKE62865.1
A 11.47042. 1 AIZ80755.1 AJI21783.1 AKE94625.1
AIL63848.1 AIZ83995, 1 AJI51649.1 A F03665.1
AIM36252.1 AJA12982.1 AJI68839.1 AKF25158.1
AIN60343.1 AJA27933.1 AJI86574.1 AKF49695.1
AI035913.1 AJA50204.1 AJJ47448.1 AKF81025.1
AIO46079.1 AJA51748.1 AJJ79421.1 AKG68123.1
AI086595.1 AJC46830.1 AJJ80961.1 A i 108725 !
AIP97923.1 AJC63707.1 AJK45428.1 A ! 109890 1 AKH 17278.1 AKQ54037.1 BAA 18683, 1 BAM04828.1
AKH20941.1 AKQ67372.1 BAB06359.1 BAM33479.1
AKH23616.1 AKS06605.1 BAB37237.1 BAM50284.1
A 1 124763. 1 ALD23720.1 BAB75100.1 BAM53453.1
AKH64396.1 ALD23755.1 BAC09359.1 AM 96903. 1
AKH69186.1 ALD27245.1 BAC61513.1 BAM98361.1
AKIOl 113.1 ALL39775. 1 BAC92011.1 BAM99840.1
AKI01416.1 Λ 1.1.89048. 1 BAC94750.1 BAN02878.1
AKJ05268.1 ALR26077.1 BAD46988.1 BAN50817.1
AKJ41 195.1 ALV75857.1 BAD64942.1 BAN52492.1
A J53541.1 ALV77901.1 BAD71463.1 BAN70003.1
AKJ64714.1 ALY14442, 1 BAD78700.1 BA054359.1
AK.) 94106, 1 ALY15746.1 BAE75293.1 BA098678.1
AKJ97406.1 ALZ68230.1 BAE77001.1 BAP18257.1
AKK00568.1 ALZ68795.1 BAE78119.1 BAP32992.1
AKK49722.1 AMC46980.1 BAF69929.1 BAP43154.1
AKK66313.1 AMJ69296.1 BAF 72313.1 BAP57483.1
AKK71642.1 AMW42739.1 BAG04503.1 BAP58680.1
AKL 10485.1 AMX13191.1 BAG78731.1 BAU72598.1
AKL34468.1 AMX14483.1 BAG83373.1 BAU76793.1
AKL93588.1 ANC21029.1 BAH39093.1 CAA41337, 1
AKL93616.1 ANH43655.1 BAH44872.1 CAA65422.1
Λ MO 1921 . 1 ANK33675.1 BAH46155.1 CAB 13336.1
AKM 17405.1 ANK34958.1 BAI27222.1 CAD0291 1.1
AKM18378.1 A M83718.1 BAI32252.1 CAD09281.1
AKM36436.1 A M84924.1 BAI37476.1 CAD 16072.1
A M38713.1 ANO92070.1 BAI80755.1 CAD73363.1
AKM39687, 1 ANP 19758.1 BAI92054.1 CAE08874.1
AKM41511.1 A P20955.1 BAJ02496.1 CAE09688.1
A KM 204 1 . 1 AOE77376.1 BAJ55572.1 CAE 16054.1
AKN25889.1 AOM43879.1 BAJ56452.1 CAE 18504.1
AKN61444.1 AOM48592.1 BAJ57954.1 CAE22324.1
AKN68937.1 AOM71331.1 BAJ60069.1 CAE31349.1
AKO77003.1 AOM71367.1 BAK12516.1 CAE40174.1
AK096332.1 AOM72743.1 BAK33766.1 CAE40569.1
AKP45430.1 AOT31396.1 BAK70627.1 CAE78014.1
AKP46702.1 AOT34840.1 BAK73092.1 CAG45065.1
A P53234.1 AOZ73672.1 BAK76369.1 CAG76815.1
AKP75073.1 AOZ75058.1 BAK98463.1 CAH05973.1
AKP76339.1 APA40674.1 BAL81291.1 CAH 14236.1
AKQ46065.1 BAA16587.1 BAL84001.1 CAH20481.1 CM 122440.1 CAR42872.1 CBL08498.1 CCG93934.1
CAI86150.1 CAR44185.1 CBL11309.1 CCG98515.1
CA 187882.1 CAR54969.1 CBL17760.1 CCH32647.1
CAJ25769.1 CAS10739.1 CBL18279.1 CCH47920.1
CAJ48085.1 CAU99219.1 CBL.18584.1 CCH56597.1
CAJ50298.1 CAVO 1446.1 CBL22837.1 CCH64504.1
CAJ67721.1 CAV18374.1 CBL25542.1 CCH66661.1
CAJ70455.1 CAX29520.1 CBL33751.1 CCH73037.1
CAJ94006.1 CAX61193.1 CBL33969.1 CCH92456.1
CAJ99421.1 CAY46894.1 CBL41416.1 CCH95671.1
CAK 17500.1 CAY75592.1 CBL46386.1 CCH97887.1
CA 24815.1 CAZ96112.1 CBN55346.1 CCH98535.1
CA 29281.1 CBA07513.1 CBV43889.1 CCI02124.1
CAL 13443,1 CB A 14903,1 CBW19161.1 CCI02703.1
CAL 17846.1 CBA19555.1 CBW20794.1 CCI05752.1
CAL 19596.1 CBA33565.1 CBW26940.1 CCI08081.1
CAL34892.1 CBG39474.1 CBW74145.1 CCIl 2608.1
CAL43775.1 CBG91721.1 CBY25861.1 CCIl 3269.1
CAL68563.1 CBH20174.1 CBY83075.1 CCIl 7237.1
CAM09122.1 CB 142666,1 CCA53939.1 CCI21360.1
CAM 10863.1 CB 166029,1 CCA57465,1 CCI26537.1
CAN92612.1 CBJ02631.1 CCB69668.1 CCI26557.1
CA097871.1 CBJ10334.1 CCB80486.1 CCI27928.1
CAP44435.1 CBJ81373.1 CCB85396.1 CCD 1841.1
CAP53422.1 CBJ82759.1 CCB88488.1 CCD 5741.1
CAQ47743.1 CBJ89096.1 CCC31740.1 CCI36837.1
CAQ70346.1 CBJ90126.1 CCC32782.1 CCI78870.1
CAQ81008.1 CBK629 1.1 CCC57896.1 CCJ33001.1
CAQ83180.1 CBK67757.1 CCD40282.1 CCJ37191.1
CAQ83413.1 CBK75517.1 CCE19088.1 CCJ45542.1
CAQ90371.1 CBK76873.1 CCE 19708.1 CCJ46772.1
CAR04456.1 CBK79250.1 CCE25072.1 CCJ48129.1
CAR05775.1 CBK89692.1 { { [69259 ! CCJ54509.1
CAR09410.1 CBK93443.1 CCF81308.1 CCJ71908.1
CAR 10810 ! CBK95550.1 CCG 18048.1 CCJ80969.1
CAR14453.1 CBK97421.1 CCG19863.1 CCJ86077.1
CAR15764.1 CBK98076.1 CCG39483.1 CCJ89761.1
CAR 19475.1 CBK99239.1 CCG45166.1 CCJ99408.1
CAR20645.1 CBL02265.1 CCG53314.1 CCK02016.1
CAR38786.1 CBL06429.1 CCG86051.1 CCK08384.1
CAR39908.1 CBL06632.1 CCG93076.1 CCK48228.1 CCK49456.1 CDF92784.1 CDL78959.1 CDZ24843.1
CCK74876.1 CDF94833.1 CDL81271.1 CDZ77476.1
CCK76603.1 CDF95827.1 CDL85577.1 CDZ85766.1
CCK78280.1 CDG13951.1 CDL87375.1 CDZ95756.1
CCK88893.1 CDG 17974.1 CDL90268.1 CEA06065.1
CCK89714.1 CDG -18838.1 CDL90667.1 CEA15542.1
CCK96041.1 CDG20298.1 CDM04050.1 CED57568.1
CCK96850.1 CDG21576.1 CDM25489.1 CED79730.1
CCK99990.1 CDG29398.1 CDM39225.1 CEEO 1723.1
CCL00838.1 CDG34413.1 CDM40785.1 CEF27490.1
CCL21002.1 CDG41242.1 CDM61201.1 CEF30990.1
CCL24016.1 CDG57553.1 CDM66630.1 CEF31449.1
CCL28925.1 CDG92785.1 CDM69239.1 CEF32542.1
CCL31787.1 CDG93659.1 CDM89651.1 CEF33945.1
CCO04884.1 CDG98742.1 CDM91302.1 CEG51568.1
CCO08560.1 CDG98818.1 CDN08348.1 CEG53321.1
CC012883.1 CDG99561.1 CDN 19844.1 CEG53340.1
CCP 12708.1 CDG99621.1 CDN43705.1 CEG55497.1
CCP13614. 1 CDH04673.1 CDN75234.1 CEG60275.1
CCP17046. 1 CDH05982.1 CDN83562.1 CEI12237.1
CCP18758. 1 CDH 19229.1 CDG 12490.1 CEI20008, 1
CCP24686.1 CDH21449.1 CD059353.1 CEJ65415.1
CCP27538.1 CDH24501.1 CDP53980.1 CEJ67509.1
CCQ09200.1 CDH25327.1 CDQ16188.1 CEJ70957.1
CCQ09658.1 CDH33018.1 CDR28964.1 CEK09860.1
CCQ91054.1 CDH35045.1 CDR33456.1 CEK.22005.1
CCQ92417.1 CD! 179904. 1 CDR89846.1 CEK22994.1
CCQ95938.1 CDK72226.1 CDR91413.1 CEK27007.1
CCU62281.1 CDK72598.1 CDS49197.1 CEK36677.1
CCU62303.1 CDK73473.1 CDS55845.1 CEK37311.1
CCW05309.1 CDL 10509.1 CDS84399.1 CEL27366.1
CCW08807.1 CDL10510.1 CDS84845.1 CEL28884.1
CCW 14223.1 CDL14319.1 CDS89935.1 CEL88254.1
CCW 18613.1 CDL23452.1 CDS90150.1 CEN32690.1
CCW31446.1 CDL25124.1 CDT621 12.1 CEN35796.1
CCW32107.1 CDL25589.1 CDT66706.1 CEN40 72.1
CDF57172.1 CDL37867.1 CDU33290.1 CEN48259.1
CDF5771 1.1 CDL39140.1 CDU33786.1 CEN49444.1
CDF63223.1 CDL46170.1 CDU40272.1 CEN51746.1
CDF80723.1 CDL58441 .1 CDU41 159.1 CEN53336.1
CDF86470.1 CDL62104.1 CDY74095.1 CE037650.1 CEO?) 7783.1 CKQ74340.1 CRF41170.1 CSA60188.1
CE037785.1 CKR21949.1 CRF42208.1 CSB08393.1
CE037787.1 CKS03825.1 CRF43922.1 CSB25865.1
CE037789.1 CKS26945.1 CRF48690.1 CSB40644.1
CEO39707.1 CKU60545.1 CRF51588.1 CSB44143.1
CE041667.1 CNA50506.1 CRF97350.1 CSB49667.1
CEP33357.1 CNG15293.1 CRGO 1188.1 CSB66054.1
CEP41494.1 CNU29954.1 CRG01880.1 CSB75406.1
CEQ02610.1 CNU37560.1 CRGO 1892.1 CSB76184.1
CEV48346.1 CNY76236.1 CRG49571.1 CSB95854.1
CEX91433.1 CNZ37408.1 CRG51097.1 CSB98158.1
CEY68596.1 COB87482.1 CRH09188.1 CSC34871.1
CFB65687.1 COB97035.1 CRH 15043.1 CSC73993.1
CFC48275.1 COC 15604.1 CRH30682.1 CSD22235.1
CFE47017.1 C0C27925.1 CRH35400.1 CSI57174.1
CFQ52871.1 COC38808.1 CRH39703.1 CSK13615.1
CFT90862.1 COC67187.1 CRH76554.1 CSK81683.1
CFT92467.1 COE22069.1 CRH80270.1 CSM45986.1
CFW00234.1 COE68225.1 CRH99218.1 CS 191 17.1
CGF82653.1 COE79226.1 CRB2264.1 CSP73797.1
CI061989. 1 COE80568.1 CRB4231.1 CSR75551.1
CIU00001.1 COE81104.1 CRI55296.1 CSS00410.1
CIX12577.1 COE89634.1 CRL61081.1 CSS26808.1
CIY95083.1 COF 13698.1 CRL62210.1 CSS59054.1
CJA23818.1 COL35053.1 CRL87965.1 CTF84311.1
CJC39705.1 COO42015.1 CRL89510.1 CTO24990.1
CJF41584.1 COP44209.1 CRL90918.1 CTP86128.1
CJF88893.1 COP71525.1 CRL92324.1 CTP91660.1
CJF991 17.1 COQ07912.1 CRN95722.1 CTP92036.1
CJK22396.1 COQ86754.1 CRO14030.1 CTQ00822.1
CJM58301.1 COQ96585.1 CRQ27226.1 CTQ01840.1
CJP89135.1 COS68670. 1 CRQ69552.1 CTQ07393.1
CJU40070.1 COV97320.1 CRQ76426.1 CTQ11016.1
CJV39857.1 COW 18997.1 CRR63643. 1 CTQ21388.1
CJV78922.1 COW22156.1 CRV31623 , 1 CTR60186.1
CJW30609.1 CPR16817.1 CRX68631.1 CTR88293.1
CKB02318.1 CPR28569.1 CRY53197.1 CTS05226.1
CKE35363.1 CPR28570.1 CRY55323.1 CTS30710.1
CKE99011.1 CQH27992.1 CRY79285.1 CTT02231 , 1
CKF04495.1 CQR55269.1 CRY93389.1 CTT12868, 1
CKI15512.1 CQR76248.1 CSA21308.1 CTT68786.1 CTT71981.1 CUB52004.1 EAQ32906.1 EDM24091.1
CTT77614.1 CUB53555.1 EAQ43377.1 EDM28695.1
CTT83391.1 CUB55220.1 EAQ50085.1 EDM34238.1
CTT94455.1 CUB55706.1 EAQ66911.1 EDM43630.1
CTT95016. 1 CI .1 192886 ! EAQ70464.1 EDM47206. 1
CTU31752.1 CUH95441.1 EAQ72344.1 EDM59952, 1
CTU43794.1 CUI26621.1 EAQ76582.1 EDM72867. 1
CTU68580.1 CUI32013.1 EAQ77591.1 EDM78148.1
CTU79219.1 CUI43235.1 EAQ97815.1 EDN58210.1
CTV10378.1 CUI77995.1 EAR09325.1 EDN69139.1
CTV16830.1 CUI82617.1 EAR13003.1 EDN84738.1
CTV23368.1 CUI97214.1 EAR 16281.1 EDOl 2412.1
CTV42489.1 CUJO 1273.1 EAR17315.1 ED055269.1
CTV60594.1 CUJ29137.1 EAR22580.1 EDP57831.1
CTV70893.1 CUJ59072.1 EAR30279.1 EDP96203.1
CTW39538.1 CUJ84510.1 EAR53966.1 EDP99652.1
CTW91358.1 CUJ95389.1 EAS21033.1 EDR32346.1
CTX50053.1 CUK 18245.1 EAS45733.1 EDR33302.1
CTZ18208. 1 CUR47999.1 EAS66651.1 EDS0431 1 .1
CTZ55606. 1 CUS48382. 1 EAT02109.1 EDS 14810. 1
CTZ68780. 1 CUX80760.1 EAT04436.1 EDS90152.1
CTZ88923.1 CVA34089.1 EAT 12991.1 EDS94131.1
CUB 10138.1 CVE90640.1 EAT 16635.1 EDU60243.1
CUB 14550.1 CVQ04108.1 EAT98614.1 EDU61801.1
CUB 17378.1 CVT44067.1 EAU54879.1 EDU64180.1
CUB 19225.1 CW27730.1 EAU62359.1 EDU66731.1
CUB20007.1 CWE46408.1 EAU71335.1 EDU92574.1
CUB20037.1 CWM52080.1 EAU75144.1 EDU93429.1
CUB21150.1 CYJ06643.1 EAW26171.1 EDV02459.1
CUB24943.1 CYL65762.1 EAW26965.1 EDV06321.1
CUB26441.1 CYN07819.1 EAW38293.1 EDW23582.1
CUB28066.1 CY072927.1 EAZ83215.2 EDX35590.1
CUB30863.1 CZQ34128.1 EAZ92702.1 EDX36036.1
CI 2254 ! CZX12172.1 EAZ94470.1 EDX36066.1
CUB38825.1 CZX80218.1 EBA47554.1 EDX46577.1
CUB42267.1 EAL52385.1 EDK22114.1 EDX47180.1
CUB42609.1 EAO 12990.1 EDK27087.1 EDX68999.1
CUB42690.1 EA054355.1 ED 35189.1 EDX75316.1
CUB45694.1 EAP73812.1 ED 35781 .1 EDX86149.1
CUB49762.1 EAP87194.1 EDL55745.1 EDX90404.1
CUB5011 1.1 EAP93054.1 EDM19339.1 EDY20546.1 EDY23711.1 EEO 17497.1 EEZ39280.1 EFri7631.1
EDY26729.1 EE024268.1 EEZ41342.1 EFI38855.1
EDY39883.1 EE026226.1 EEZ42255.1 EFI48237.1
EDY80770.1 EE046786.1 EEZ84 I7.1 EFT71796.1
EDY87242.1 EE048467.1 EEZ88011.1 EFI85175.1
EDY97001.1 EE055967.1 EFA19997,1 EFI87349.1
EDZ51155.1 EEO62202.1 EFA24542.1 EFI90947.1
EDZ64094.1 EEP52908.1 EFA45160.1 EFJ68585.1
EDZ92135.1 EEP83814.1 EFA68566.1 EFJ68633.1
EEA96461.1 EEP91273.1 EFA72660.1 EFJ72102.1
EEB25237.1 EEQ09356.1 EFA9309 .1 EFJ74584.1
EEB32660.1 EEQ47662.1 EFA97054.1 EFJ78630.1
EEB44175.1 EEQ48939.1 EFB31818.1 EFJ81431.1
EEB45162.1 EEQ63558.1 EFB33967.1 EFJ85215.1
EEB65951.1 EES50668.1 EFB71688.1 EFJ85317.1
EEC22705.1 EES65191.1 EFB72852.1 EFJ95126.1
EEC52457.1 EES68952.1 EFC32879.1 EFJ95461.1
EEC95655.1 EES72773.1 EFC53930.1 EF 02094.1
EED08084.1 EES89131.1 EFC68230.1 EF 02694.1
EED09856.1 EET 13958,1 EFC70407.1 EF 07237.1
EED26047.1 EET79835.1 EFC74158.1 EFK 16317.1
EED37169.1 EEV18063.1 EFC76178.1 EFK 16401.1
EED40881.1 EEV88514.1 EFE04794.2 EFKl 7953.1
EEE02695.1 EEW07548.1 EFE06567.1 EFK! 8112.1
EEE38554.1 EEW09243.1 EFE24315.1 EFK25144.1
EEE39911.1 EEW41138.1 EFE28188.2 EFK27352.1
EEF 12870.1 EEX09883.1 EFE52717.1 EFK33114.1
EEF60316.1 EEX12420.1 EFE53196.1 EFK43745.1
EEF76458.1 EEX18739.1 EFE61789.2 EFK47161.1
EEF78531.1 EEX36091.1 EFE96242.1 EFK50509.1
EEF90887.1 EEX44127.1 EFF05372.2 EFK52583.1
EEG08845.1 EEX49425.1 EFF 11562,2 EF 58701.1
EEG09028.1 EEX52952, 1 EFF44939.1 EF 66137.1
EEG41374.1 EEX72486.1 EFF46228.1 EFK66442.1
EEG42545.1 EEX77148.1 EFF52960.1 EFK71309.1
EEG85449.1 EEY45420.1 EFF65456.1 EFK73843.1
EEI48480.1 EEY72539.1 EFF72972.1 EFK91754.1
EEI89760.1 EEY99071.1 EFG19573.1 EFK92718.1
EEJ52636.1 EEZ05434.1 EFG77890.1 EFL44876.1
EE 14623.1 EEZ20306.1 EH 174644.1 EFM01444.1
EEO01851.1 EEZ25742.1 EFI14920,1 EFM05245.1 EFM19909.1 EFZ38208.1 EGI71763.1 EGQ 14735.1
EFM22067.1 EGA66011.1 EGI73765.1 EGQ 16803.1
EFN90887.1 EGA71636.1 EGI74585.1 EGQ61183.1
EFN94455.1 EGB 13397.1 EGI88322.1 EGU34333.1
EFN97184. 1 EGB61889.1 EGI88695.1 EGU40288.1
EF054374. 1 EGB66940.1 EGI89525.1 EGU4401 1 .1
EFO56780. 1 EGB73846.1 EGI92003.1 EGU51392.1
EF059695.1 EGB86369.1 EGI92757.1 EGU98977.1
EF079517.1 EGB86483.1 EGJ06067.1 EGV18080.1
EFP71829.1 EGCO 1298.1 EGJ06595.1 EGV30721.1
EFP73330.1 EGC21337.1 EGJ31789.1 EGV36706.1
EFQ63652.1 EGC85605.1 EGJ32358.1 EGV43418.1
EFQ65858.1 EGC96357.1 EGJ48895.1 EGW22905.1
EFR 17600.1 EGD 13828.1 EGJ70523.1 EGW38512.1
EFR18234.1 EGD20671.1 EGK01810.1 EGW45479.1
EFR54063.1 EGD33620.1 EGK05202.1 EGW47999.1
EFR58692.1 EGD47799.1 EGK08599. 1 EGW49793.1
EFS20507.1 EGD49452.1 EGK19270.1 EGW53900. 1
EFS31465. 1 EGE35466. 1 EGK29801.1 EGY261 17.1
EFS98153. 1 EGE46318. 1 EGK32128.1 EGY52145.1
EFU31591. 1 EGF27184.1 EGK32129.1 EGY52303.1
EFU33766.1 EGF51940.1 EGK34621.1 EGY80801.1
EFU36797.1 EGF55092.1 EGK58218.1 EGZ43857.1
EFU69462.1 EGG29616.1 EGK87545.1 EGZ47008.1
EFU72568.1 EGG38296.1 EGK89608.1 EHA13596.1
EFV04322.1 EGG53968.1 EGL19747.1 EHA29720.1
EFV27725.1 EGG94813.1 EGL54944.1 EFIA61904.1
EFV30929.1 EGH07763.1 EGL86229.1 EHA63133.1
EFV39452.1 EGH20626.1 EGL91485.1 EHB43287.1
EFV43819.1 EGH41959.1 EGM69611.1 EHB92177.1
EFV63706.1 EGH53302.1 EGM77628.1 EHC12856.1
EFV69380. 1 CGI 160244. 1 EGM98072.1 EHC15115.1
EFW49235.1 EGH92632.1 EGN04092.1 EHC32562.1
EFW49274.1 EGH94776.1 EGN06621.1 EHC33284.1
EFW54088.1 EGI01301.1 EGN55947.1 EHC45854.1
EFW57052.1 EGI09326.1 EGN75140.1 EHC52500.1
EFW58445.1 EGI14581.1 EGP08625.1 EHC67678.1
EFW59098.1 EGI 19909.1 EGP18125.1 EHC67688.1
EFX42291.1 EGI39909.1 EGP70309.1 EHC82045.1
EFX56847.1 EGI45082.1 EGP70453.1 EHC8281 U
EFX59483.1 EGI49388.1 EGQ13522.1 EHC84879.1 EHC87972.1 EHU07105.1 EU34481.1 EIY66667. 1
EHC99842.1 EHU07471.1 EU40219.1 EIY70029.1
EHC99945.1 EHU 10272.1 EIJ41403.1 EIY74616.1
EHC99946.1 EHU 19741.1 EI 43927.1 ΕΓΥ79988.1
EHD20027.1 EHU20407.1 EI 45786.1 EIY85347.1
EHG15746.1 EHU20988.1 ΕΪΚ46160.1 ELZOO 158.1
EHG22758.1 EHU23878.1 EI 53544.1 EIZO 1825.1
EHHO 1677.1 Ki ll 27439. 1 EIK63187.1 EJB 14848.1
EHI48137.1 Ki ll 20624. 1 EIK68334.1 EJB16556.1
Hi 1197007. 1 EHU34399.1 EIK69996.1 EJB 19827.1
EHJ01371.1 EHU35766.1 EIK96535.1 EJB23702.1
EHJ04424.1 EHU37211.1 EIL52554.1 EJB23977. 1
□ 1.137076. i EHU40410.1 EIL87847.1 EJB26400. 1
EHJ81032.1 EHU49113.1 EIL89177.1 EJB29229. 1
EHJ81054.1 EHU52686.1 EIL96389.1 EJB29946.1
EHJ930Q9.1 EHV51291.1 EIL96460.1 EJB30033.1
EHK60802.1 EHV55180.1 EIM32597.1 EJB32499.1
EHK70010.1 EHY68649.1 EIP99569.1 EJB35336.1
EHL81981.1 EHY76875.1 EIQ05168.1 EJB37017.1
EHL91407.1 EIA07694.1 EIQ05557.1 EJB37646.1
EHM45586.1 EIA38800, 1 EIQ 17816.1 EJB39924.1
EHM49306.1 EIB51628.1 EIQ18546.1 EJB42939.1
EHM52790.1 EIC22362.1 EIQ26062.1 EJB43406.1
EHO08337.1 EIC28827.1 EIQ30073.1 EJB45027.1
EHOl 1855.1 EIC82504.1 EIQ34463.1 EJB45391 .1
EHO68606.1 EID3291 I .1 EIQ555 9.1 EJB49839. 1
EH071565.1 EID63306.1 EIQ57190.1 EJB50034. 1
EHP31153.1 EID67828.1 EIQ64791.1 EJB51708. 1
EHP45502.1 EJD72224.1 EIQ65835.1 EJB53907.1
EHP66625.1 EIE30102.1 EIQ71328.1 EJB55025.1
EHQ02439.1 EIF06919. I EIQ78421.1 EJB56551.1
EHQ24721.1 EIF52011.1 EIT71762.1 EJB57975.1
EHQ40902.1 EIG78691.1 EIW88565.1 EJB59811.1
EHQ44550.1 EIG93478.1 EIW91670, 1 EJB60409.1
EHQ51868.1 EIH12869.1 EIY 17637.1 EJB63120.1
EHR41063.1 Effl21876.1 EIY32545.1 EJB65622.1
EHT11453.1 EIH45560.1 EIY36788.1 EJB65702.1
EHT99387.1 EIH76673.1 EIY37052.1 EJB68991 .1
EHU03082.1 EII24830.1 EIY53920.1 EJB70910. 1
EHU03351.1 EII34710.1 EIY54279.1 EJB71404. 1
EHU05505.1 ΕΠ46184.1 EIY58813.1 EJB74413. 1 EJB74966.1 EJC43069.1 EJM801 12.1 EKE95013.1
EJB75595.1 EJC44761.1 EJM80845.1 EKF04077.1
EJB 77218.1 EJC46949.1 EJM90007.1 EKF56035.1
EJB80849.1 EJC48994.1 EJM95558.1 EKF75530.1
EJB81088.1 EJC51269.1 EJN26255.1 EKG30394.1
EJB8 799.1 EJC51645.1 EJN28670.1 EKCB5718.1
EJB84950.1 EJC52741.1 EJN35237.1 EKI47752.1
EJB87126.1 EJC55221.1 EJN38607.1 EKI50663.1
EJB88385.1 EJC57220.1 EJP75284.1 EKJ91033.1
EJB90467.1 EJC60490.1 EIP79470.1 EKK03341.1
EJB90548.1 EJE70688.1 EJU30245.1 EKM19532.1
EJB92801.1 EJE72667.1 EJU35714.1 EKM27369.1
EJB94869.1 EJF07261.1 EJU5591 1.1 EKM33123.1
EJB95273.1 EJF 10819.1 EJW20856.1 EKM97272.1
EJB96496.1 EJF28963.1 EJZ56337.1 EKN06246.1
EJB99121.1 EJF35650.1 EJZ62656.1 EKN13589.1
EJC02347.1 EXF67926.1 EJZ62989.1 EKQ59703.1
EJC02425.1 EJF99356.1 EJZ63479.1 EKQ67050.1
EJC04636.1 EJG45313.1 E A78857.1 EKQ70123.1
EJC08570.1 EII86684.1 EKA86757.1 EKQ72452.1
EJC08694.1 EII92286.1 EKA88055.1 EKT55066.1
EJC08709.1 EJK90497.1 EKB08191.1 EKT55968.1
EJC1181 1.1 EJL05765.1 EKB20130.1 EKT57267.1
EJC1 826.1 EJL07513.1 EKB20483.1 EKT60399.1
ETC 14043.1 EJL 10780.1 EKB29486.1 EKT65146.1
EJC 15845.1 EJL13646.1 EKB43813.1 EKU1 1723.1
EJC18371.1 EJL59252.1 EKB47023.1 EKU90730.1
EJC 19409.1 EJL74965.1 EKB50524.1 EKU99609.1
EJC21392.1 EJL86651.1 EKB56886.1 EKV02611.1
EJC22985.1 EJL93876.1 EKB59777.1 EKX85043.1
EJC23357.1 EJMO 1555.1 EKD09436.1 EKX91099.1
EJC26559.1 EJM14551.1 E E75917.1 EKY02026.1
EJC27448.1 ( J M l 6866. 1 E E80497.1 EKY07478.1
EJC29756.1 EJM18376.1 E E80736.1 EKY10219.1
EJC32969.1 EJM29803.1 EKES 1635.1 EKY13803.1
EJC33159.1 EJM31718.1 EKE84692.1 EKY21 196.1
EJC34883.1 EJM47413.1 EKE87132.1 ELC14266.1
EJC37288.1 EJM51011.1 EKE88767.1 ELC16837.1
EJC37890.1 EJM64276.1 EKE92179.1 ELC37938.1
EJC39690.1 EJM73569.1 EKE92371.1 ELC95207.1
EJC42076.1 EJM76313.1 EKE94894.1 ELD97322.1 ELE41731.1 E G92921.1 EMQ99308.1 ENA43837.1
ELE53629.1 EMG95880.1 EMR04830.1 ENC88200.1
ELE58435.1 EMG97280.1 EMR05081 .1 ENC90023.1
ELG86731.1 EMG97371.1 EMR07653.1 END49167.1
ELI22619.1 CM] 101414. 1 EMR12041 . 1 ENDS 1201 .1
ELJ68848.1 EMH01598.1 EMR52882. 1 END87069.1
ELP32817.1 EMH05152.1 EMR55723. 1 END90132.1
ELP53718.1 EMH05692.1 EMR57703.1 ENG93781.1
ELP56620.1 KMi 107062. 1 EMR59166.1 ENG95643.1
ELQ06726.1 EMH07880.1 EMR59894.1 ENG97959.1
ELQ 17703.1 EMH1 1608.1 EMS33700.1 ENHO 1175.1
ELR67226.1 EMH20676.1 EMS70703.1 E H05522.1
ELR68531.1 EMH23184.1 EMS73603.1 ENH07606.1
ELR73634.1 EMH23218.1 EMU56968.1 ENH60192.1
ELR80702.1 EMH24922.1 EMU59687.1 ENN97706.1
ELR96270.1 EMH27240.1 ElViU65357.1 ENN99012.1
ELS03888.1 EMH31442.1 EMIJ68327.1 EN014664.1
ELS26426.1 EMH32228.1 EMV15078.1 ENY70479.1
ELS26899.1 EMH36381.1 EMV1 7996, 1 ENY75181 .1
ELS33992.1 EMH36815.1 EMW91062.1 ENZ85539.1
ELS34647.1 t -All 13701 . 1 EMW96728.1 ENZ95106, 1
ELS45534.1 KXll 140386. 1 EMW97461.1 EOA53659.1
ELT80942.1 EMH40500.1 EMX15494.1 EOA60059.1
ELU52902.1 EMH44660.1 EMX18621.1 EOC 16725.1
ELW29101.1 EMH49506.1 EMX29476.1 EOD01056.1
ELW31523.1 EMH59432.1 EMX33528.1 EOD01708.1
ELX08395.1 EMH69334.1 EMX34251.1 EOD55293.1
ELX67235.1 KM! 171 08 1 EMX3671 1.1 EOD78016.1
ELY20188.1 EMI08652.1 EMX46865.1 EON77899.1
EMB 16639.1 EMI13553.1 EMX56824.1 EON87503.1
EMD05366.1 EMI 19018.1 EMX81299.1 EON89205.1
EMD08744.1 EMI25919.1 EMX83206.1 EON91 172.1
EMD99302.1 EMI45208.1 EMY81020, 1 EOQ46177.1
EMG29941.1 EMI58017.1 EMZ41287.1 EOQ52663.1
EMG36518.1 EMJ41880.1 EMZ50395.1 EOR94186.1
EMG80552.1 EMJ41986.1 ENA01016.1 EOR98455.1
EMG81375.1 EMJ43448.1 ENA04654.1 EOS02472.1
EMG83328.1 EMJ45150.1 ENA32193.1 EOS 1 1079.1
EMG85067.1 EMP51370.1 1Ξ Α35846.1 EOS14650.1
EMG90353.1 EMP54150.1 1Ξ Α38210.1 EOU48069.1
EMG92202.1 EMQ95230.1 ENA41620.1 EOU65288.1 EOU78387.1 EPR32845.1 EQL67045.1 ERI81690.1
EOU89741.1 EPR44697.1 EQL70097.1 ERJ19318.1
EOV04150.1 EPR66995.1 EQL73574.1 ERJ22052.1
EOV47240.1 EPR73837.1 EQL75680.1 ERJ22898.1
EOV55388.1 EPT33373.1 EQL75690.1 ERJ26266.1
EOV76751.1 EPX63361.1 EQL75717.1 ERJ29171.1
EOV94391.1 EPX75972.1 EQM66263.1 ERJ30739.1
EOW04341.1 EPX79893.1 EQM78326.1 ERJ32256.1
EOW 16263.1 EPX85529.1 EQM87861.1 ERJ59126.1
EOW 19942.1 EPZ50793.1 EQN24782.1 ERJ59423.1
EOW61852.1 EPZ68373.1 EQN91650.1 ERJ76012.1
EOW95132.1 EPZ69904.1 EQ059512.1 ERJ 79618. 1
EOZ93556.1 EPZ70096.1 EQP47195.1 ERJ98652. 1
EPA96712.1 EPZ71437.1 EQQ03971.1 ERK00664.1
EPB93485.1 EPZ73670.1 EQV89276.1 ERK06334.1
EPC02883.1 EPZ93539.1 EQX25773.1 ERK1 1302.1
EPD31850.1 EPZ96226.1 EQX86242. 1 ERK12084.1
EPD98827.1 EPZ96901.1 EQY17583.1 ERK40558.1
EPF 13751 . 1 EPZ97559.1 EQY57339.1 ERL00460.1
EPF 17537. 1 EQB40349.1 EQZ99176.1 ERL46829.1
EPF21605. 1 EQB91601.1 ERA59136.1 ERL52081.1
EPF68350.1 EQC00900.1 ERE06409.1 ERL56578.1
EPF68473.1 EQC06150.1 ERF66688.1 ERM21676.1
EPH07536.1 EQC46203.1 ERF'77295.1 ERM81855.1
EPH21580.1 EQC46450.1 ERG07873.1 ERM89954.1
EPI67044.1 EQC51959.1 ERG1 1044.1 ERN40958.1
EPI70349.1 EQC66601.1 ERG 17091.1 ERO57040.1
EPI90403.1 EQD88409.1 ERG24593.1 ER062594.1
EPJ00323.1 EQD91604.1 ERG26262.1 ERP09069.1
EPJ02080.1 EQD92375.1 ERG36314.1 ERP91471.1
EPJ05850.1 EQD93814.1 ERG36846.1 RP 9 ! 42. i
EPJ 12078.1 EQD96580.1 ERG42423.1 ERS04711.1
EPJ79656.1 EQD96886.1 ERG44637.1 ERS86390.1
EPJ90215.1 EQD99945.1 ERG53669.1 ERS87232.1
EPJ93745.1 EQL43170. 1 ERG54725.1 ERS91854.1
EPL04978.1 EQL47661.1 ERH47769.1 ERT06712.1
EPL63254.1 EQL50895.1 ERH53106.1 ERT14070.1
EPN64426.1 EQL54133.1 ERH97657.1 ERT56956.1
EPP23941.1 EQL57441.1 ERI03748.1 ESA33218.1
EPR12129.1 EQL59958.1 ERI53864.1 ESA61592, 1
EPR26288.1 EQL63991.1 ERI61622.1 ESA67358.1 ESA68724.1 ESU27166.1 ETZ 11401.1 EXZ30510.1
ESA72702.1 ESU77439.1 ETZ20997.1 EXZ46466.1
ESA84976.1 ESU78126.1 ETZ22197.1 EXZ75334. 1
ESA92507.1 ESW37563.1 EUB71843.1 EXZ80412.1
ESBO 1863.1 ESW52929.1 EUB87538.1 EXZ80749.1
ESC99189.1 ETA89391 . 1 EUD05822.1 EXZ81010.1
ESD05521. 1 ETB63778.1 EVU13225.1 EXZ81 185.1
ESD21415.1 ETC27700.1 EVU13226.1 EXZ82079.1
ESD37527.1 ETC31 135.1 EWC41146.1 EXZ83185.1
ESD70934.1 ETC85052.1 EWC58917.1 EXZ83435.1
ESD76699.1 ETD 18804.1 EWC60810.1 EXZ84050.1
ESD90268.1 ETD22871.1 EWG73749.1 EXZ84907.1
ESE04816.1 ETD26440.1 EWH03492.1 EXZ85059.1
ESE42704.1 ETD27161.1 EWH03493.1 EXZ85221.1
ESE82023.1 ETD59989.1 EWH04198.1 EXZ85313.1
ESE83037.1 ETD64469.1 EWH06793.1 EXZ85634.1
ESE85318.1 ΕΊΈ22281.1 EWH11550.1 EXZ85863. 1
ESE86258.1 ΕΊΈ27053.1 EWH15068.1 EXZ86207. 1
ESF53718. 1 ETE36278.1 EWS59738.1 EXZ8624 .1
ESF55412. 1 ETE47321.1 EWS77356.1 EXZ86725.1
ESG63282. 1 ETE48159.1 EWS97918.1 EXZ91489, 1
ESG73913.1 ETE50251.1 EWS99002.1 EXZ92090.1
ESJ12988.1 ETF 10350.1 EXF46432.1 EXZ92345.1
ESJ19423.1 ETI62472.1 EXF51063.1 EXZ96372.1
ESK15533.1 ETK18845.1 EXF91547.1 EXZ96517.1
ESK34335.1 ETK24212.1 EXG78764.1 EXZ96775.1
ESL70097.1 ETK27546.1 EXG84733.1 EXZ96947.1
ESM15736.1 ETM65380.1 EXJ09881.1 EXZ97324.1
ESN17180.1 ETN88238.1 EX.) 1 3081 . 1 EYA21384.1
ESN61562.1 ETN95568.1 EXU67280.1 EYA41181.1
ESP91266.1 ETS33246.1 EXIJ74155.1 EYB11611.1
ESQ72659. 1 ETT00960.1 EXY29211.1 EYB68441.1
ESQ98506. 1 ETT02263.1 EX Y33704, 1 EYD71048.1
ESR23196.1 ETT07388.1 EXY43202.1 EYD71269.1
ESR27061.1 ETT28858.1 EXY67304.1 EYD77132.1
ESS57492.1 ETW99192.1 EXY72022.1 EYD83103.1
ESS71276.1 ETX06515.1 EXY75943.1 EYD83144.1
EST40648.1 ETX09877.1 EXY86437.1 EYE47819.1
EST58096.1 ETY41684.1 EXY92714.1 EYE59402.1
ESU18866.1 ETZ09940.1 EXZ07363.1 EYF00414.1
ESU25453.1 ETZ 11400.1 EXZ21227, 1 EYUl 5774.1 EYU15950.1 GAA81294.1 GAL04347.1 K DA 35749 !
EYV07474.1 GABS 1337.1 GAL04804.1 KD A37931.1
EYV09937.1 GAB55910.1 GAL05072.1 KDA55394.1
EYV12182.1 GAB59559.1 GAL 1 1044.1 KDA56762.1
EYV18353.1 GAB61720.1 GAL 16861 , 1 KDA92360.1
EYZ99020.1 GAC05867.1 GAL30713.1 KDC48914.1
EYZ99540.1 GAC 16515.1 GAL36801.1 KDC51679, 1
EZA32955.1 GAC 19153.1 GAL45647.1 KDD67072.1
EZ A36513.1 GAC24840.1 GAL50933.1 KDD69088.1
EZD27285.1 GAC27365.1 GAL56699.1 KDE33950.1
EZD33881.1 GAC31749.1 GAL62431.1 KDE39162.1
EZE09296.1 GAC65340.1 GAL66822.1 KDE41001.1
EZEI 2279.1 GAD 19562.1 GAL70388.1 KDE90314.1
EZE47844.1 GAD32505.1 GAL75241.1 KDF 12960.1
EZE49623.1 GAD63345.1 GAL79181.1 KDF 13307.1
EZH71533.1 GAD68291.1 GAL86673.1 KDG93657.1
EZH79132.1 GAD77234.1 GAL90465.1 KDM49648.1
EZI29906.1 GAE14826.1 GAL93717.1 KDM68718.1
EZJ34131.1 GAE 17566.1 GAM07869.1 KDM68719.1
EZJ36632.1 GAE20934.1 GAM 14623.1 KDN30189.1
EZJ47817.1 GAE50743.1 GAM 16409.1 KDN56291.1
EZJ49365.1 GAE50744.1 GAMS 7915.1 KDN73057.1
EZJ65986.1 GAE54881.1 GAM65554.1 KDN99663.1
EZJ71202.1 GAE64745.1 GAM65555.1 KDR44432.1
EZJ81000.1 GAE82642.1 GAM68525.1 KDR51619.1
EZJ8351 1 .1 GAF02272.1 GAM76288.1 KDR94681 .1
EZK 16071.1 GAJ47652.1 GAO04477.1 KDR94730.1
EZK 19946.1 GAJ68143.1 GA031699.1 KDR96264.1
EZP28490.1 GAJ70028.1 GA033666.1 KDS 17972.1
EZP44002.1 GAJ74711.1 GA045653.1 KDS22344.1
EZP56652.1 GAK15505.1 GA091678.1 KDS33124.1
EZP66078.1 GAK22285.1 GA091679. 1 KDS52278.1
EZQ 19254.1 GAK28095.1 GAP37055.1 KDS56812.1
GAA05804.1 GAK35190.1 GAP61915.1 KDU29239.1
GAA59698.1 GAK75264.1 GAP72423.1 KDU31861.1
GAA61579.1 GAK75265.1 GAP76842.1 KDV26776.1
GAA62825.1 GAK86393.1 GAR75750.1 KDV28114.1
GAA65644.1 GAK92926.1 KAJ56674.1 KDV40156.1
GAA68204.1 GA 92927.1 KCU95650, 1 KDV41543.1
GAA68485.1 GA 97921 .1 KCW98899.1 KDV62400.1
GAA80936.1 GAL04346.1 KDA24159.1 KDV63793.1 KDW27169.1 KER76638.1 KFE29849.1 KFX71524.1
KDW29868.1 KES24091.1 KFE38039.1 KFX75866.1
KDX21121.1 KEX90562.1 KFE40407. 1 KFZ27800.1
KDX22110.1 KEX95184.1 KFE50878. 1 KFZ30182.1
KDX42786.1 KEY 18642.1 KFE51463.1 KFZ38533.1
KDX45707.1 KEY39601.1 KFE51926.1 KGA31718.1
KEA46535.1 KEY59238.1 KFE53529, 1 KGA43478.1
KEA54562.1 KEY84828.1 KFE64790.1 KGA48786.1
KEA61551.1 KEZO 1477.1 KFF00394.1 KGA58341.1
KEA62619.1 KEZ03267.1 KFF03918.1 KGA92942.1
KEF30262.1 KEZ78110.1 KFF04643.1 KGB23003.1
KEF33353.1 KEZ92071.1 KFF 13425.1 KGB92031 .1
KEI67085.1 KFA04678.1 KFF13691.1 KGD52658.1
KEI68609.1 KFA36836.1 KFF 15603.1 KGD62570.1
KEI72809.1 KFA89275.1 KFF24492.1 KGD63593.1
KEJ43225.1 KFA97526.1 KFF24725.1 KGD67727.1
KEJ44938.1 KFBO 1609.1 KFF33206.1 KGD 74930.1
KEJ56396.1 KFB86395.1 KFF49430.1 KGD75028.1
KEJ59126. 1 KFC05463. 1 KFF67537.1 KGE 12918.1
KEJ70817. 1 KFC07098. 1 KFF75398.1 KGE50810.1
KEJ73415. 1 KFC 18775. 1 KFF88090.1 KGE68364.1
KEK28674.1 KFC20875.1 KFG77442.1 KGE71433.1
KEL65109.1 KFC39603.1 KFH26796.1 KGE78509.1
KEL72014.1 KFC59091.1 KFI20485.1 KGF 16727.1
KEN50130.1 KFC78158.1 KFJ74929.1 KGF26636.1
KEN53759.1 KFC79267.1 KFJ92088.1 KGF34522.1
KEN65627.1 KFC83040.1 KFK53898.1 KGF43280.1
KEN81913.1 KFC87306.1 KFK84555.1 KGF45725.1
KEN95683.1 KFC87307.1 KFK92733.1 KGF49777.1
KEN98031.1 KFC88523.1 KFL36101.1 KGF52178.1
KEO05580.1 KFC89970.1 KFL54829. 1 KGF56050.1
KEO08161.1 KFC90672. 1 KFL92212, 1 KGF63655.1
KE024816.1 KFC95288. 1 KFN02659.1 KGF63738.1
KEO30080.1 KFC98497. 1 KFN09730.1 KGF88277.1
KE072498.1 KFD07809.1 KFN20471.1 KGF91126.1
KEQ 1 1859.1 KFD17131.1 KFN41529.1 KGF94746.1
KEQ16618.1 KFD39669.1 KFN43972.1 KGF98813.1
KEQ28307.1 KFD75087.1 KF 46384.1 KGG02043.1
KER03202.1 KFD78853.1 KFN49579.1 KGG06694.1
KER51206.1 KFD81164.1 KFX05 54.1 KGG08515.1
KER72322.1 KFE26842.1 KFXl 0605.1 KGG13342.1 KGG16902, 1 KGM67544.1 KHE71266.1 KHN93577, 1
KGG20690.1 KGM71413.1 KHF26633.1 KH063712.1
KGG25301.1 KGM76900.1 KHF28513.1 KH063713.1
KGI22183.1 KGM78995.1 KHF28514.1 KH064416.1
KGI51761.1 KGM83357.1 KHF29887.1 KHS42892.1
KGI53124.1 KGM85011.1 KHF33712.1 KHS44852.1
KGI59215.1 KGN81341.1 KHF33713.1 KHS51059.1
KGI60343.1 KGO 11905.1 KHF36661.1 KHS53269.1
KGI79227.1 KG035136.1 KHG33418.1 KHS73061.1
KGI87491.1 KG083427.1 KHG41692.1 KHT30841.1
KGI91964.1 KG086156.1 KHG64539.1 KHT42018.1
KGJ93972.1 GO90041 .1 KHI35431.1 KHT50744.1
KG.) 99825, 1 G094762.1 KHI37340, 1 KHT65210.1
KGK02508.1 KGO96620.1 KHJ15087.1 KIA76173.1
KGK02667.1 KG098326.1 KHJ20005.1 KIA79535.1
KGK11102.1 KGP46487.1 KHJ37179.1 KIA84354.1
KGK23554.1 KGP63789.1 KHJ49938.1 KIA86664.1
KGK41898.1 KGQ20140.1 KHJ65217.1 KIA88155.1
KGK59739.1 KGQ21232,2 KHK62458. 1 KIA96246, 1
KGK66000.1 KGQ31157.1 KHL08583.1 KIA97247.1
KGK82506.1 KGQ42404.1 KHL 1 1564, 1 KIC20030.1
KGL06861.1 KGQ44023.1 KHL 18640.1 KIC34193.1
KGL1 1309.1 KGQ45908.1 KHL59754.1 KIC41765.1
KGL 13567.1 KGQ50253.1 Ki If .70867. 1 KIC41860.1
KGL 15463.1 KGQ57330.1 Ki If .78786. 1 KIC47910.1
KGL 17335.1 GQ59395.1 i H.79579. 1 KIC63479.1
KGL29400.1 KGQ63142.1 K i ll .80012. 1 KIC80370.1
KGL30461.1 KGR36637.1 KHL81 128.1 KIC91903 , 1
KGL33804.1 KGR59419.1 KHL83404.1 KIC93749.1
KGL37280.1 KGT92074.1 KHL85844.1 KIC99323.2
KGL61019.1 KGT93839.1 KI 11.86355. 1 KIDO 1690.1
KGL63589.1 KGT99163.1 KHL87974.1 1006608 2
KGM06101 .1 KGU86824.1 KHL89471.1 11)0991 5 !
KGM21402.1 KGY09804.1 KHL90211.1 KID53399.1
KGM27648.1 KG Y 14273 , 1 KHM48729.1 KID55412.1
KGM27861.1 KHA74142.1 KHM49647.1 KIE10977.1
KGM51253.1 KHD07149.1 KHM50824.1 KIE41615.1
KGM53981.1 KHD11120.1 KHM92424.1 KIE47462.1
KGM56140.1 HD26207.1 KHN50316.1 K.IE57848. 1
KGM58508.1 HD65185.1 KHN57161.1 KIF05806.1
KGM62446.1 KHE42876.1 KFI 63730.1 11 1 862. 1 KIF29318.1 KIP86694.1 KJC 1 1070.1 KJL32721.1
KIF31064.1 KIP92292.1 KJD22009.1 KJL47944.1
KIF41875.1 KIP99462.1 KJD31599.1 KJM40294.1 11-4 60. 1 KIQ14588.1 KJD36996.1 KJM94811.1
KIF47532.1 KIQ28277.1 KJE41320.1 KJN20030.1
KIF56410.1 KIQ33154.1 KJE51611.1 KJR24918.1
KIF65759.1 KIQ47084.1 KJF82239.1 KJS62014.1
KIG15607.1 KIQ47216.1 KJF92896.1 KJU76259.1
KIHO 1698.1 KIQ55660.1 KJF94545.1 KJV08099.1
KIH04248.1 KIQ56619.1 KJF95976.1 KJV28421.1
KIH77871.1 KIQ60207.1 KJF96788.1 KJV33512.1
KIH85503.1 KIQ79728.1 KJF97649.1 KJV50178.1
KII76310.1 KIQ93208.1 KJF99814.1 KJW32727.1
KIJ73823.1 KIQ93267.1 KJG 1 3 i 2. 1 KJW37560.1 1.180520. 1 KIQ96608.1 KJG17565.1 KJW52381.1
KIK87497.1 KIR02360.1 KJG26623.1 KJW52975.1 11.06108. 1 KIR20554.1 KJG26708.1 KJX12328.1 l 1. 10730. ! KIR21483.1 KJG34980.1 KJX37016.1
KIL 19543.1 KIR22223.1 KJG38239.1 KJY36082.1
KIL44729.1 KIS42545.1 KJG40540.1 KJY40855.1
KIL47560.1 KIS78068.1 KJG52887.1 KJY40903.1
KIL50316.1 KIT53654.1 KJG53015.1 KJY81951.1
KIM02995.1 KIU32905.1 KJG53489.1 KJY87010.1
KIM08543.1 KIU53521.1 KJG56948.1 KJY91596.1
KIM08702.1 KIV63259.1 KJH06976.1 KJY96966.1
KIM10584.1 KIV65004.1 Ki 1 108954. 1 KJZ05971.1
K IM 1 3067. 1 KIV66814.1 KJH71848.1 KJZ06664.1
KIN 12773.1 KIV70624.1 KJH75936.1 KJZ 14999, 1
KI035234.1 KIV70876.1 KJH77340.1 KJZ 15059.1
KI044426.1 KIX22820.1 KJH83755.1 KJZ 18625.1
KIO52490.1 KIX48438.1 KJH88029.1 KJZ33665.1
KIO64044.1 ΚΪΥΊ4042.1 KJJ39829.1 KJZ36032.1
KI064828.1 KIY14047.1 KJJ74678.1 KJZ46139.1
KIO64880.1 KIY40969.1 KJJ86656.1 KJZ47590.1
KIO74024.1 KIZ 15345, 1 KJJ97023.1 KJZ49128.1
KI075181.1 KIZ36062.1 KJK09157.1 KJZ60809.1
KIP20469.1 KIZ50625.1 KJKl 7930.1 KJZ64968.1
KIP22393.1 KJC02191.1 KJK39268.1 KJZ83739.1
KIP30082.1 KJC03662.1 KJL17379.1 KJZ85288.1
KIP63626.1 KJC05650.1 Ki 1. 19924. 1 KKA06404.1
KIP77624.1 KJC06414.1 KJL32283.1 KKA09841.1 KKA50887.1 KKS72573.1 KLC03447.1 KLI99305. 1
KKA53937.1 KKS83788.1 KLC04907.1 KLJ14455.1
KKB03410.1 ΚΚΊΌ0885.1 KLC 18880.1 KLN47468.1
KKC56343.1 KKT03015.1 KLC 19575.1 KLN96569.1
KKC64605.1 KKT 10692.1 KLC24598.1 KLQ26951 .1
KKC65426.1 KKT 19966.1 KLC34817.1 KLQ27291 .1
KKC79309.1 KKT24904.1 KLC35928.1 KLS52971.1
KKD31624.1 KKU39856.1 KLC38727.1 KLT65350.1
KKD58709.1 KKU48195.1 KLC42228.1 KLT70448.1
KKD62G46. 1 KKU49767.1 KLC42317.1 KLT72986.1
KKE81684.1 KKU75779.1 KLC49000.1 KLU04484.1
KKF37789.1 KU87068.1 KLC54631.1 KLU62082.1
KKI42107.1 KW45691.1 KLC62972.1 KLU63827.1
KKI44372.1 KKW50514.1 KLC63061.1 KLU67158.1
KKI47461.1 KKX49557.1 KLC63907.1 KLU99121.1
KKI52239.1 KKX58062.1 KLC72357.1 KLV00218.1
KKJ26482.1 ΚΚΧ63732.1 KLC80920.1 KLV01109.1
KKJ98306.1 KKX66458.1 KLC81056.1 KLV04650.1
KKK99989.1 K Y43327.1 KLC86009.1 KLV04732.1
KKO 13447.1 ΚΚΥ43878, 1 KLC90423.1 KLV10775.1
KK045109.1 ΚΚΥ65107.1 KLC94053.1 KLV43183.1
KKO48310.1 KKY79845.1 KLC98220.1 KLV47021.1
KK064897.1 ΚΚΖ 13187.1 KLD01509.1 KLV65167.1
KKO88680.1 ΚΚΖ 18899.1 KLD01730.1 KLV65610.1
KKP3Q 1 72.1 KKZ98376.1 KLD13508.1 KLV87502.1
KKP36843.1 KKZ99926.1 KLD20683.1 KLW86530.1
KKP40578.1 KLA23800, 1 KLD2131 1.1 KLX50943.1
KKP72963.1 KLA25117, 1 KLD25825.1 KLX57834.1
KKP75581.1 KLA31027, 1 KLD31524.1 KLX90366.1
KKP88656.1 KLA31452, 1 KLD34072.1 KLX95655.1
KKP98423.1 KLA96304.1 KLD38665.1 KLY 12052.1
KKQ21504.1 KLA99369.1 KLD63515.1 KLY34066.1
KKQ47851.1 KLB01232.1 KLD63554.1 ΚΜΕ68569, 1
KKQ55697.1 KLB 1 1267.1 KLD66193 , 1 KMI32840.1
KKR39473.1 KLB 14716, 1 KLD71246, 1 KMJ44158.1
KKR41999.1 KLB22478.1 KLD80177.1 KMJ45198.1
KKR62922.1 KLB23603.1 KLE01246.1 KMJ53196.1
KKR69783.1 KLB27709.1 KLE03460.1 KMK12312.1
KKS05164.1 KL.B31750.1 KLE09177.1 KMK12388.1
KKS 12144, 1 LB41291 .1 KLE26682.1 KMK65741.1
KKS23019.1 KLC01821.1 KLI68356.1 KML20789.1 KML20912.1 MV32029.1 KNF70644.1 KOO07593.1
KML48083.1 KMV34547.1 K F794 5.1 K0013952.1
KML65003.1 KMV67940.1 KNF81883.1 K0059694.1
KMM17341.1 KMV68973.1 K H02424.1 K0065836.1
KMM40283.1 KMV72040.1 KNH10085.1 KOO83034.1
KMM44209.1 KMW72260.1 KNH14365.1 KOP01917.1
KMM74668.1 KMW73819.1 K -I26156.1 KOP04218.1
KMM79436.1 KMW79566.1 K H46145.1 KOP26957.1
KMM83437.1 KMY85028.1 KNN84556.1 KOP33536.1
KMM87484.1 KMZ 12404.1 KNN85899.1 KOP34817.1
KMM91807.1 KMZ45161.1 KNW70656.1 KOP36989.1
KMM98149,1 MZ45733.1 KNW74427.1 KOP96620.1
KMN11315.1 MZ47283.1 KNX43865.1 KOQ72056.1
KMN13443,1 MZ48992.1 KNX46584.1 KOQ79259.1
KMN18851.1 KMZ49221.1 KNX47560.1 KOR18913.1
KMN35621.1 KNA43180.1 K X49078.1 KOR38747.1
KMN52211.1 KNA60505.1 K X80210.1 KOR43231.1
KMN58862.1 KNB61204.1 KNX94009.1 KOR44320.1
KMN64506.1 KNC06722.1 KNY27166.1 KOR71845,1
KMN81232.1 KNC 12046.1 KNY27231.1 KOS05070.1
KMN92035.1 KNC 16749.1 KNY29154.1 KOS31558.1
KM078898.1 KNC68501.1 KNY73335.1 KOS31918.1
KMO80014.1 KNC94639.1 KNY78421.1 KOS33911.1
KMP 3875.1 KND51979.1 KNZ84104.1 KOU24174.1
KMP92251.1 KND54388.1 KNZ85960.1 KOU67934.1
KMQ23559.1 ND59806.1 KNZ96652.1 KOV81195.1
KMQ62276.1 NE03726.1 KNZ97917.1 KOV90464.1
KMQ65521.1 K E05809.1 KOA18143.1 KOV92694.1
KMQ67933.1 K E07439.1 KOA19093.1 KOX28823.1
KMQ72280.1 K E07808.1 KOA27317.1 KOX89259.1
KMQ73391.1 KNE08827.1 KOA35716.1 KOY02434.1
KMQ80007.1 KNE 10687.1 KOA70224.1 KOY04397.1
KMS77340.1 KNE13318.1 KOB20841.1 KOY33063.1
KMS90246.1 KNE 14112.1 KOC89710.1 KOY42334.1
KMT22151.1 M; 16939.1 KOC93511.1 KOY42343.1
KMT22950.1 KNE17736.1 KOE81619.1 KOY45863.1
KMT55834.1 KNE24464.1 KOE86500.1 KOY50204.1
KMT66157.1 KNE76189.1 KOE98088.1 KOY52585.1
KMT67645.1 NF09795.1 KOF02803.1 KOY61140.1
KMT68464.1 NF09831.1 KOG62614.1 KOY61821.1
KMU66082.1 KNF69262.1 KOFI46400.1 KOY85392.1 KPA10472, 1 KPM81369.1 KPW23692.1 KPY64080.1
KPA52388.1 KPM81389.1 KPW27562.1 KPY70158.1
KPA53393.1 KPM84874.1 KPW34805.1 KPY74009.1
KPA53642.1 KPM96730.1 PW42050.1 KPY80616.1
KPA88888.1 KPN17561.1 KPW48373.1 KPY90395.1
KPA90439.1 KPN64870.1 KPW51442.1 KPY92798.1
KPA92636.1 KPN71852.1 KPW62237.1 KPY99398.1
KPB67773.1 KPN73933.1 KPW62967.1 KPZ05993.1
KPB69211.1 KPN76064.1 KPW66391.1 KPZ14794.1
KPB79158.1 KPN88872.1 KPW77493.1 KPZ 14841.1
KPB81326.1 KPN90573.1 KPW79725.1 KPZ23429.1
KPC07003.1 PN90601 .1 KPW85370.1 KPZ24832.1
KPC 14008.1 P018579.1 KPW97437.1 KPZ304 4.1
KPC35485.1 KP032516.1 KPX00575.1 KPZ42886.1
KPC49975.1 KP036865.1 KPX06301.1 KPZ47275.1
KPC57075.1 KP046576.1 KPX09224.1 KPZ49946.1
KPC99496.1 KP056914.1 PX14980.1 KPZ52051.1
KPD01309.1 KPP89788.1 PX22033.1 KPZ54935.1
KPD0321 1.1 KPP99272.1 KPX30196.1 KPZ63333.1
KPD11155.1 KPQ04554.1 KPX31760.1 KPZ63441.1
KPD20872.1 KPQ 14293 , 1 KPX38634.1 KPZ64594.1
KPD32893.1 KPQ25476.1 KPX43708.1 KPZ67736.1
KPE49813.1 KPQ26228.1 KPX44429.1 KPZ72598.1
KPG83065.1 KPQ27964.1 KPX56237.1 KPZ74870.1
KPG95064.1 KPQ28712.1 KPX65518.1 KQA98214.1
KPG99865.1 PQ35007.1 KPX66339.1 KQB40657.1
KPHO 1642, 1 KPQ40221.1 KPX73444.1 KQB42336.1
KPH13642, 1 KPQ42687.1 KPX75665.1 KQB 52498.1
KPH55638.1 KPR47334.1 KPX84858.1 KQB 89823.1
KPH58606.1 KPR54754.1 KPX85936.1 KQB94067.1
KPH60167.1 KPR57621.1 KPX98179.1 KQJ13933.1
KPI00128.1 KPU43059.1 KPY01 178.1 KQJ 19480.1
KPI21829.1 KPU45374.1 KPY03822.1 KQJ38967.1
KPI28804.1 KPU53302.1 KPY16964.1 KQJ46044.1
KPL49155. 1 KPU59624.1 KPY2091 1.1 KRG50855.1
KPL85176.1 KPV48774.1 KPY29392.1 KRV51537.1
KPL99048.1 KPW00046.1 KPY38577.1 KRV54923.1
KPM32213.1 KPW04292.1 KPY41782.1 KSG98439.1
KPM49141.1 PW13659.1 KPY47144.1 K.ST27457, 1
KPM63679.1 PW 16726.1 KPY54488.1 K.ST30748, 1
KPM65064.1 KPWT7184, 1 KPY56327.1 KSX90037.1 KSX90873.1 KXG97350. 1 OAC39173.1 OCX56897.1
KSZ13905. 1 K XI 100368. 1 OAC431 14.1 ODH24470.1
KTH73164.1 KXH98343.1 OAE941 14.1 ODJ92889.1
KTI23271.1 KXI03206.1 OAS 132 1 2 1 . 1 ODN20234.1
KTM92464.1 KXL66971 .1 OAI64384.1 ODR86790.1
KTP62443. 1 KXQ41321.1 OAJ86653.1 OEB 17588.1
KUG62774.1 KXQ42780.1 OAJ87922. 1 OEC25471.1
KUH45679.1 KXY17951.1 OAN24058. 1 OEH12480.1
KUQ52564.1 KXY86957.1 OA068286. 1 OEH95894.1
KUR40671.1 YR44969.1 OA072924.1 OEI6251 1.1
KUU48152.1 KYR45993.1 OBS 13167.1 OEI65537.1
KWS 16060.1 YS91454.1 OCL 17286.1 OEN36599.1
KWS38521.1 YS97775.1 OCQ74268.1 OFJ25861 . 1
KWS79043.1 KYV67950. 1 OCS74958. 1 ΟΓΝ26436. Ι
KWV37200.1 KYV73707. 1 OCS76529.1 OIN31202.1
KWV39942.1 KZD84079.1 OCS95943.1 SAD71382.1
KWX82425.1 KZD88271.1 OCS96129.1 SAE32738.1
KWZ89005.1 KZE54774.1 OCV53558.1 SAY76613.1
KXA39294.1 KZJ50109.1 OCV69154.1 SBX90614.1
KXG92416.1 KZJ59532.1 OCW73841.1 SBZ90867.1
[00108] Representative examples of agmatinase (EC 3.5.3. 1 1) are given below in Table 8 and identified by their EMBL/GE BANK/DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the agmatinase (EC 3.5.3.1 1) set forth in Table 3 and Table 8. For instance, the bacteria can be engineered with a version of the agmatinase enzyme that has at least 50% nucleotide similarity with any of the versions of agmatinase given in Table 8 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90% nucleotide similarity, at least 91% nucleotide similarity, at least 92% nucleotide similarity, at least 93% nucleotide similarity, at least 94% nucleotide similarity, at least 95% nucleotide similarity, at least 96%> nucleotide similarity, at least 97% nucleotide similarity, at least 98% nucleotide similarity, at l east 99% nucleotide similarity, at least 99.5% nucleotide similarity, at least 99.9%> nucleotide similarity, or 100% nucleotide similarity).
Table 8. Representative Examples of Agmatinase by EMBL/GENBANK/DDBJ ID Number AAA24647.1 1 AAV93914.1 ABC36254.1 ABG87141.1
AAA69104.1 1 AAV95718.1 ABC90370.1 ABI47535.1
AAA83909.1 1 AAV95721.1 ABC90927.1 ABI59683.1
AAB98295.1 1 AAV97369.1 ABC99063.1 ABI60409.1
AAC75974.1 1 AA 87909.1 ABD0270 .1 ABI67996.1
AAF40906.1 1 AAW90124.1 ABD 10232.1 ABI89619.1
AAG58067.1 1 AAX66926.1 ABD53194.1 ABI90194.1
AAK40769.1 1 AAY90871.2 ARD54884.1 ABJ02365.1
AAK42842.1 1 AAZ22133.1 ABD55257.1 ABK02249.1
AAL21953.1 1 AAZ24263.1 ARD68100.1 ABK 16419.1
AAL51292.1 1 AAZ54096.1 ABD68348.1 ABK71425.1
AAL52351.1 1 AAZ58777.1 ABE08773.1 ABK71845.1
AAM30619.1 1 AAZ65050.1 ABE29546.1 ABK73126.1
AAN44408.1 1 AAZ69672.1 ABE35008.1 ABK750 6.1
AAN67809.1 1 AAZ89678.1 ABE43955.1 ABK78003.1
AAN81970.1 1 ABA 19753.1 ABE52778.1 ABK88044.1
AAO70550.1 1 ABA52140.1 ABE55558.1 ABL69259.1
AAO90262.1 1 ABA53789.1 ABE60184.1 ABL73176.1
AAP 12232, 1 1 ABA73200.1 ABE75327.1 ABL77915.1
AAP 18231.1 1 ABA74317.1 ABF05058.1 ABL82726.1
AAP29255.1 1 ABA79070.1 ABF41119.1 ABL82883.1
AAQ00893.1 1 ABAS 1349.1 ABF53436.1 ABL88073.1
AAQ58167.1 1 ABB07975.1 ABF63671.1 ABL91072.1
AAQ87313.1 1 ABB 10482.1 ABF63672. ! ABL91501.1
AAQ87384.1 1 ABB 11261.1 ABF77979.1 ABL91972.1
AAT34764.1 1 ABB 12898.1 ABF78588.1 ABL92277.1
AAT57507.1 1 ABB27188.1 ABG05817.1 ABM02702.1
AAT63474.1 1 ABB37375.1 ABG32253.1 ABM 10897, 1
AAU15214.1 ABB50840.1 ABG32638.1 ABMl 1012, 1
AAU45759.1 1 ABB63153.1 ABG32639.1 ABM11652.1
AAV44785.1 1 ABB67558.1 ABG62558.1 ABM13827.1
AAV46799.1 1 ABC201 15.1 ABG70915.1 ABM29529.1
AAV78787.1 1 ABC35193.1 ABG82607.1 ABM37937.1 ABM56124.1 1 ABQ18665.1 ACE90614.1 ACR70510.1
ABM71 179.1 1 ABQ26532.1 ACE91158.1 ACS32933.1
ABM73084.1 1 ABQ3 960.1 ACE94809.1 ACS41939.1
ABM76715.1 1 ABQ33008.1 ACF30403.1 ACS89313.1
ABM79681.1 1 ABQ60179.1 ACF61915.1 ΑΠ 08695. 1
ABM79929.1 1 ABQ77546.1 ACF67727.1 ACV76715.1
ABM94848.1 1 ABQ79666.1 ACF91868.1 AC V81 107.1
ABM98665.2 1 ABQ87081.1 ACH50852.1 ACY53515.1
ABN06601.1 1 ABQ91371.1 ACH63482.1 ACY85795.1
ABN56898.1 1 ABR78770.1 AC! 177920. i AC Y90127, 1
ABN70230.1 1 ABR81216.1 ACI 10057.1 ACZ87232.1
ABN76664.1 1 ABR81751.1 ACI 11642.1 ADA75255.1
ABN78567.1 1 ABS77512.1 ACI 18698.1 ADB74457.1
ABN87189.1 1 ABU75701.1 ACI35219.1 ADC90860.1
ABN87725.1 1 ABV07331.1 ACI78406.1 ADD45355.1
ABN92921 .1 1 ABV15371.1 ACI78407.1 ADDS 8091.1
ABN92962.1 1 ABV21194.1 ACI78408.1 ADD78375.1
ABO09043.1 1 ABV43067.1 ACI78409.1 ADE04586.1
ABO 18500.1 1 ABV51572.1 AC 1784 10. 1 ADE37357.1
AB023488.1 1 ABV67817.1 ACJ29740.1 ADE39009.1
AB036121.1 1 ABV93477.1 ACK73593.1 ADE40257.1
ABO49035.1 1 ABX09748.1 ACM05018.1 ADE40278.1
AB056523.1 1 ABX69169.1 ACM06157.1 ADE67897.1
AB058149.1 1 ABX74248.1 ACN 13261.1 ADE69284.1
ABP42590.1 1 ABX8191 1.1 ACN47228.1 ADE72169.1
ABP43281.1 1 ABY21971.1 AC074132.1 ADE85469.1
ABP45780.1 1 AC A38569.1 ACP07733.1 ADE86001 .1
ABP51374, 1 1 ACA76446.1 ACP21851.1 ADF37727.1
ABP62005.1 1 ACB04033.1 ACP21922.1 ADF39062.1
ABP70012.1 1 ACB 18855.1 ACP26294.1 ADF41976.1
ABP86798.1 1 ACC84325.1 ACP35785.1 ADF63800.1
ABP94673.1 1 ACD06722.1 ACP36686.1 ADG91 41.1
ABP96350.1 1 ACD24294.1 ACR61943.1 ADG91991.1 A D! 1 4533. 1 ADY72884. 1 AEH00503.1 AEW06905.1
ADJ63231.1 ADZ04172.1 AEH06103.1 AEW63 139.1
ADK07910.1 ADZ08379.1 AEH08712.1 AEW75167.1
ADL0791 1.1 ADZ 10562.1 AEH1 1 147.1 AEX02267.1
ADL 18546.1 ADZ27749.1 Λί · I i22 25. 1 AEX23687.1
ADL44534.1 ADZ83109.1 AEH36766, 1 AFA38334.1
ADM42794.1 ADZ91927.1 AEH48221.1 AFA38752.1
ADN75943. 1 AEA33345.1 AEH49662.1 AFA47334.1
ADO 10712.1 AEA4561 1.1 AEH50623.1 AFC24160.1
ADO30990.1 AEA47221.1 ΑΕΠ4843. 1 AFD00687.1
ADO47092.1 AEA80791.1 AEI94329. 1 AFG41863.1
ADP1 1446.1 AEA80792.1 AEI94330. 1 AFI84427.1
ADP83855.1 AEB08603.1 AEJ58268.1 AFJ01337.1
ADQ6631 1.1 AEB 10992.1 AEK22524.1 AF'J30619.1
ADR28296.1 AEB 12421 .1 AEK23614.1 AF'J45705.1
ADT68876.1 AEC00219.1 AE 61616.1 AFJ59747. 1
ADT70429.1 AEE58170.1 AE 64195.1 AFJ63961 . 1
ADT76571.1 AEE96159.1 AEM40724. 1 AFK 19996.1
ADT96768.1 AEF 17260. 1 AEM58024. 1 AFL51309, 1
ADT97392.1 AEF54342.1 AEM69220. 1 AFL51840.1
ADT99263.1 AEF88522.1 AEN05459.1 AFM19977.1
ADU52417.1 AEF93913.1 AEN05763.1 AFM61483.1
ADU70503.1 AEF93919.1 Λί · Ν06930. 1 AF087859.1
AD V49134.1 AEF95254.1 AEN66324.1 AFO87860.1
ADV64546.1 AEF97223.1 AEP88702.1 AF091682.1
AD V66173.1 AEG03799.1 AEQ14108.1 AF091683.1
ADX 18864.1 AEG05228.1 AER31406.1 AFP37519.1
ADX72077.1 AEG14656.1 AEV37646, 1 AFP39918.1
ADY13321.1 AEG 17355.1 AEV38161.1 AFP40726.1
ADY27253.1 AEG33547.1 AEV61529.1 AFP40804.1
ADY29885.1 AEG44996.1 AEV87262.1 AFQ48622.1
AD Y33548.1 AEG44997.1 AEV97888.1 AFQ49589.1
ADY55312.1 AEG95549.1 AEW04403.1 AFQ50194.1 AFQ51687.1 AGG73823.1 AHD07591.1 AIF84264.1
AFRQ9275.1 AGG75093.1 AHD07965.1 AIF84945.1
AFS72872.1 AGH87553.1 AI !IX)796(). I AIG28743.1
AFS77227.1 AGI26201.1 AHD09199.1 AIG32998.1
AFV11211.1 AGI47257.1 AHD09200.1 AIG35154.1
AFY 19072.1 AGI68304.1 AHE60912.1 AIG39783.1
AFY19668.1 AGI68305.1 AHE69335.1 AIG97525.1
AFY21148.1 AGI72348.1 AHF69002.1 AII87322.1
AFY36898.1 AGI72349.1 AHF73775.1 AII87324.1
AFY39232.1 AGI84982.1 AHF75853.1 AIJ07652.1
AFY4Q247.1 AGJ55062.1 AHG19398.1 AIJ37317.1
AFY66803.1 AGJ58747.1 AHK01 119.1 AIK37348.1
AFY87223.1 AGJ59299.1 AHK03741.1 AIK38502.1
AFZ 10381.1 AGK77294.1 AHM05195.1 AIM26660.1
AFZ31237.1 AGN38302.1 AHM05332.1 AIM28333.1
AFZ34586.1 AG056878.1 AHM57412.1 AIO30916.1
AFZ37423.1 AGP45918.1 AHM77673.1 AI031498.1
AFZ44104.1 AGQ74348.1 AHM83265.1 AJ035681.1
AFZ47238.1 AGQ92958.1 AHN81844.1 AJ035975.1
AFZ54331.1 AGR60291.1 AHW76535.1 AI036489.1
AFZ55267.1 AGR77854.1 A! IY 10272. 1 AI044724.1
AGA67678.1 AGS21412.1 AHYr72292.1 AIO46049.1
AGA7269 .1 AGS21940.1 AHZ23375.1 AI046224.1
AGB21222.1 AGS26045.1 AIA74065.1 AIO49720.1
AGB 76811.1 AGS39313.1 AIC26759.1 AIO70072.1
AGB 83895.1 AGT07309.1 AIC27350.1 AIO701 12.1
AGC68778.1 AGT11108.1 AID41526.1 AIO82805.1
AGC77085.1 AGX41862.1 AID92226.1 AI084618.1
AGD97972.1 AGY56862.1 AIE61595.1 AIP28881.1
AGE22498.1 AGZ34567.1 AIE72946.1 AIP29149.1
AGE23989.1 AHA67015.1 AIE75743.1 AIP96985.1
AGG04209.1 AHB69078.1 AIE81817.1 AIQ96062.1
AGG32138.1 AHC 15724.1 AIF82761.1 AIQ98336.1 AIR06031.1 1 AJG14739.1 AKA85572.1 AKH98312.1
AIRS 94 0.1 1 AJG17918.1 AKB 13293.1 AKH99850.1
AIS52428.1 1 AJG79170.1 AKB 16072.1 AKIO 1044.1
AIU71687.1 1 AJG94738.1 AKB 17277.1 AKJ41197.1
AIW 15709.1 1 AJH06394.1 AKB20676.1 AKJ64711.1
AIW78498.1 1 AJHl 7306.1 AKB23916.1 AKK49720.1
AIX49199,1 1 AJH80029.1 AKB30046.1 AK.L 10486.1
AIX64797.1 1 AJI07021.1 AKB33946.1 AKL34469.1
AIX72614.1 1 AJIll 177.1 AKB38310.1 AKL94121.1
AIY06411.1 1 Alii 8362.1 AKB39394.1 AKM00856.1
AIY17255.1 1 AJI19711.1 AKB45534.1 AKM03663.1
AIY19826.2 1 AJI21563.1 AKB49003.1 AKM20612.1
AIY19931.2 1 AJI23861.1 AKB49561.1 AKM36435.1
AIY44086.1 1 AJI24944.1 AKB56266.1 AKM38930.1
AIY47278.1 1 AJK42294.1 AKB59739.1 AKM44683.1
AIY65960.1 1 AJ 48584.1 AKB60366.1 A KM 92040 !
AIZ56989.1 1 AJ084924.1 AKB63578.1 AKO77002.1
AIZ83993.1 1 AJQ48197.1 AKB66937.1 AK096563.1
AJA15226,1 1 AJW70766.1 AKB 70291.1 AK098269.1
AJA27931.1 1 AJX73400.1 AKB 73823.1 AKP48868.1
AJA92009.1 1 AJX73637.1 AKB 76958.1 AKP80163.1
AJC63708.1 1 AJY10662.1 AKB83790.1 AKV73628.1
AJC78797.1 1 AJY38564.1 AKB 84178.1 AKV75131.1
AJC79353.1 1 AJY39189.1 AKD38344.1 AKV75868.1
,\j 1)40791.1 1 AJY39634.1 AKE61765,1 AKV77369.1
AJD44781.1 1 AJY49045.1 AKE63966,1 AKV78118.1
AJD44817.1 1 AJY49192,1 AKE65066.1 AKV79620.1
AJD52273.1 1 AJY49305.1 AKE94626.1 AKV80363.1
A.! 1)92404.1 1 AJZ58787.1 AKG68119.1 AKV81865.1
AJE47384.1 1 AJZ6I461.1 AKG91930.1 AKV82611.1
AJE57484.1 1 AJZ62973.1 AKH08717.1 AKV84100.1
AJF57741.1 1 AJZ91146.1 AKH23614.1 ALD23757.1
AJF74876.1 1 AKA25996.1 AKH64397.1 ALG82706.1 A i .1. 9774. 1 1 BAG30482.1 CAD 18729.1 CAM05191.1
ALV77276.1 1 BAG45193.1 CAD83324.1 C 409121.1
ALV81 183.1 1 BAG46924.1 CAD85058.1 CAM 10862. 1
ALY14440.1 1 BAG78729.1 CAE07927.1 CAN90200. 1
ALZ68232.1 1 BAH3 284.1 CAE08937.1 CAN99327.1
AMJ69304.1 1 BAH46484.1 CAE16053.1 CA097869.1
AMW42737.1 1 BAi 150 1 ! CAE20145.1 CAP 14282, 1
AMX08364.1 1 ΒΑΪ-Ι51568.1 CAE22388. 1 CAQ83181.1
AMX14485.1 BAI27220.1 CAE33200. 1 CAQ90364.1
ANC 16538.1 1 BAI32251.1 CAE38071. 1 CAQ99884.1
ANC22333.1 1 BAI37474.1 CAE78008.1 CAR04454.1
.WM8 716. 1 1 BAI75018.1 CAE78232.1 CAR09553.2
ANO90761.1 1 BAI75040.1 CAF31 141.1 CAR14451.1
ANP 19756.1 1 BAI75047.1 CAH37930.1 CAR 19473.1
AN/85603 , i 1 BAI80439.1 CAH39062.1 CAR34499.1
AOM43881.1 1 BAJ82447.1 CAI86151 .1 CAR38778.1
AOM71329.1 1 BAK12515.1 CAI89357.1 CAR44182.1
AOT31398.1 1 BAK34589.1 CAJ 10765.1 CAR5 520.1
APA40676.1 1 BAK98432.1 CAJl 1914.1 CAR54274.1
BAA16710.1 1 BAK98465.1 CAJ35086.1 CAR56347.1
BAA 17298.1 1 BAL95958.1 CAJ53446.1 CAR60989.1
BAA80638.2 1 BAN02875.1 CAJ67724.1 CAS 10737.1
BAB07529.1 1 BAN46237.1 CAK07164.1 CAU99217.1
BAB37235.1 1 BAN54991.1 CAK09940.1 CAV18375.1
BAB51449.1 1 BAN90497.1 CAK 10592.1 CAX26528.1
BAB65332.1 1 BAU72144.1 CAK 16253.1 CAX58939.1
BAC 14507.1 1 BAU75360.1 CA K 1 6639. 1 CAX61 192.1
BAD63716.1 1 BAU76701.1 CAK24880.1 CAYS 1214.1
BAD66428.1 1 CAB02517.1 CAK29338.1 CAY75590.1
BAD77689.1 1 CAB 15776.1 CAK29381.1 CAZ86945.1
BAD85071.1 1 CAC45820.1 CAL44270.1 CAZ961 13.1
BAE75292.1 1 CAC47080.1 CAL68562.1 CBA07510.1
BAE77000.1 1 CAD02910.1 CAL80391.1 CBA 19557.1 CBA33563.1 1 CCD03343.1 CCD 3643.1 CCO08237.1
CBG91722.1 1 CCD89954.1 CCI38967.1 CCP10570.1
CBI 120171.1 1 CCD93845.1 CCI52514.1 CCQ09657.1
CBI44700.1 1 CCE01319.1 CCI78869.1 CCQ 10974.1
CBJ02630.1 1 CCE10074.1 CCJ06579.1 CCQ34449.1
CBJ36000.1 1 CCE15097.1 CCJ36819.1 CCQ35689.1
CBJ41226.1 1 CCE17011.1 CC '1455401 CCQ36200.1
CBJ80582.1 1 CCE95457.1 ((.149843 1 CCQ47332.1
CBJ89098.1 1 CCE96893.1 CCJ52441.1 CCQ74550.1
CBK43642.1 1 CCF 18965.1 C( j71 071 CCQ94339.1
CBK64440.1 1 CCF20747.1 CCJ80970.1 CCQ95023.1
CBK76875.1 1 CCG46987.1 CCJ86076.1 CCQ95940.1
CBK99237.1 1 CCG52586.1 CCJ89760.1 CCV06472.1
CBL02267.1 1 CCG86053.1 CCJ99407.1 CC VI 3247.1
CBL06427.1 1 CCH00037.1 CCK02015.1 CCV63725.1
CBI.17762.1 1 CCH71227.1 CC 08383.1 CCV65581.1
CBL18586.1 1 CCH91980.1 CC 48226.1 CCW06091.1
CBL22839.1 1 CCH94031.1 CCK74894.1 CCW 16005.1
CBL25540.1 1 CC! 197873 1 CCK78277.1 CCW31444.1
CBL28295.1 1 CCH98110.1 CCK89717.1 CDF80722.1
CBL41552.1 1 CCH99362.1 CCK96853.1 CDF85323.1
( BY 41181.1 1 CCI04256.1 CCL00841.1 CDF86475.1
CBW19153.1 1 CCI06792.1 CCL21005.1 CDF92525.1
CCB64763.1 1 CCI07869.1 CCL28928.1 CDG13942.1
CCB65171.1 1 CC 114209.1 CCM75184,1 CDG18839.1
CCB70695.1 1 CCI14551.1 CCM77037.1 CDG20299.1
CCB85395.1 1 CCD 8636,1 CCM78508.1 CDG31563.1
CCB88489.1 1 CCI20568.1 CCM79193.1 CDG92784.1
CCC 19821.1 1 CC! 265091 CCM80257.1 CDG98743.1
CCC31739.1 1 CCI27381.1 CCO04886.1 CDG99622.1
CCC41606.1 1 CCI27656.1 CCO05578.1 CDH05986.1
CCC82222.1 1 CCI29463.1 CCO05593.1 CDH21445.1
CCD03081.1 1 CCI33484.1 CCO06200.1 CDH24733.1 CDH33017.1 CDN42601.1 CDX62547.1 CEY70465.1
CDH74672.1 CDN83560.1 CDY73639.1 CFC48269.1
CDH78253.1 CDN91 137.1 CDY74077.1 CFT92190.1
CDI05863.1 CDQ16187.1 CDY75840.1 CFT96567.1
CDI08139.1 CDR93058.1 CDY77024.1 CJA40003.1
CDI40700. 1 CDS53731 . 1 CDY78583.1 CJC36758.1
CDK71508.1 CDS55128. 1 CDZ23447.1 CJF84864.1
CDK72224.1 CDS59015. 1 CDZ85765.1 CJG89416.1
CDK72597.1 CDS84404. 1 CED57567.1 CJI93354.1
CDK98654.1 CDS84851. 1 CEE01721.1 CJI95124.1
CDL10508.1 CDT66748.1 CEF30993.1 CJ 33702.1
CDL11618.1 CDU33788.1 CEF31451.1 CJN67826.1
CDL 16097.1 CDU41160.1 CEH98691.1 COF22522.1
CDL 17208.1 CDW 92944.1 CEI 18991.1 COF38764.1
CDL 19544.1 CDX00216.1 CEI51711.1 COI45864.1
CDL23451.1 CDX 11223.1 CEJ65416.1 COP 15970.1
CDL25123.1 CDX16126.1 CEK22007.1 COP30452.1
(1)1.391 9 ! CDX17209.1 CEK37314.1 COP45895.1
CDL46167, 1 CDX17653.1 CEL88255.1 COQ71690.1
CDL57556.1 CDX18157.1 CEN33873.1 CPR16225.1
CDL57557.1 CDX23096.1 CEN34609.1 CPR16252.1
CDL58440.1 CDX26808.1 CEN35800.1 CPR21886.1
CDL62829.1 CDX28868.1 CEN39832.1 CPR28567.1
CDL63085.1 CDX31490.1 CEN43042.1 CPR28568.1
CDL.79639.1 CDX34075.1 CEN51600.1 CQR76249.1
CDL.85576.1 CDX36972.1 CEN51743.1 CRF98508.1
CDM42435.1 CDX38569.1 CEN53478.1 CRH30681 .1
CDM57288.1 CDX38670.1 CEN53480.1 CRH35397.1
CDM60749.1 CDX49350.1 CEN53702.1 CRH39702.1
CDM60990.1 CDX53768.1 CE041666.1 CRH69483.1
CDM66632.1 CDX56980.1 CEO90406.1 CRI55920.1
CDM91301.1 CDX58275.1 CEP33358.1 CRI56443.1
CDN08347.1 CDX59705.1 CEQ02613.1 CRL 10051.1 CRL61080.1 1 CTT83409.1 EAP72459.1 EDO83906.1
CRL62208.1 1 CTT95037.1 EAP93055.1 EDO88009.1
CRL90920.1 1 CTU43832.1 EAQ63147.1 EDP21555.1
CRL92325.1 1 (TS 68877. 1 EAQ97486. 1 EDP46398.1
CRP39759.1 1 CTV16782.1 EAQ99338.2 EDP57830.1
CRP93373. 1 1 CTV23427.1 EAR30280.1 EDP99239.1
CRQ49718.1 1 CTV60644.1 EAR49722.1 EDQ32183.2
CRQ59532.1 1 CTW91398.1 EAR53967.1 EDQ32422.2
CRV25744.1 1 CTZ55651.1 EAR60303.1 EDQ33985.1
CSB25877. 1 1 CTZ68789.1 EAS45732.1 EDQ34081.2
CSB76203.1 1 CUB 11509.1 EAS66652.1 EDS 19662.1
CSC35023.1 1 CUB 13588.1 EAT13839.1 EDS72096.1
CSI87493.1 1 CUB 16299.1 EAU53062.1 EDS73897.1
CS 81664.1 1 CUB23833.1 EAW26172.1 EDS80988.1
CSN19142.1 1 CUB24713.1 EAW41481.1 EDS83158.1
CSP73809.1 1 CUB31352.1 EAY25698.1 EDS88464 1
CSS26770.1 1 CUB37524.1 EAY29686.1 EDS93649.1
CTQ00826.1 1 CUB38342.1 EAY71091.1 EDT16696.1
CTQO 1842.1 1 CUB41881.1 EBA17342.1 EDT25032.1
CTQ07399.1 1 CUB48656.1 EBA45829.1 EDT72172.1
CTQ 11021.1 1 CUB51818.1 EBA46625.1 EDU60242.1
CTQ21393.1 1 CUB57702.1 EBA46696.1 EDU65565.1
CTQ33005.1 1 CUH40798.1 EBA49948.1 EDU92236.1
CTQ42017.1 1 CUH92888.1 EDK27088.1 EDW21378.1
CTQ47453.1 1 CUJ 17376.1 EDK34419.1 EDX36044.1
CTQ50609.1 1 CUJ29157.1 EDL55746.1 EDX47360.1
CTQ53954.1 1 CUJ95397.1 EDL67758.1 EDX72527.1
CTQ63712.1 1 CVA34134.1 EDM72574.1 ED Y23983.1
CTQ76095.1 1 CVE90668.1 EDM85436.1 EDY34967.1
CTR88335.1 1 CVG47751.1 EDN00141.1 EDY39135.1
CTS05166.1 1 CZX11870.1 EDN58209.1 EDY82527.1
CTS30798.1 1 CZX80257.1 EDN75782.1 EDZ41638.1
C 1177634. ! 1 EAO57065.1 ED061990.1 EDZ41715.1 EDZ42430.1 1 EEE38911.1 EEW41136.1 EFE81272.2
EDZ44891.1 1 EEE39080.1 EEW57117.1 EFE96243.1
EDZ45134.1 1 EEE41906.1 EEW57168.1 EFF05370.2
EDZ47076.1 1 EEE44992.1 EEX09750.1 EFF 11560.2
EDZ51775.1 1 EEE45349.1 EEX09880.1 EFF63745.1
EDZ60731.1 1 EEE45625.1 EEX09889.1 EFF65458.1
EDZ60741.1 1 EEE46631.1 EEX 10564.1 EFF77651 .1
EEA81924, 1 1 EEF78555.1 EEX10565.1 EFG05259.1
EEA96242.1 1 EEG29984. 1 EEX13167.1 EFG07008.1
EEA96590.1 1 EEG55452. 1 EEX13946.1 EFG47867.1
EEA96958.1 1 EEG85448.1 EEX22145.1 EFG79255.1
EEB32402.1 1 EEH25515.1 EEX36090.1 EFG80390.1
EEB44176.1 1 EEH27429.1 EEX49424.1 EFH08237.1
EEB65944.1 1 EEI48479.1 EEX69732.1 EFH16891.1
EEB71277.1 1 EEK 13686.1 EEX74040.1 EFI8735 1 .1
EEB71305.1 1 EEK47650.1 EEX77692.1 EFJ68586.1
EEB77525.1 1 EEN89060.1 EEY45419.1 EFJ72104.1
EEB78979.1 1 EEO01852.1 EEY72540.1 EFJ78632, 1
EEB83949.1 1 EEO 17496.1 EEY99072.1 EFJ85217.1
EEB85264.1 1 EEP49793.1 EEZ40965.1 EFJ95125.1
EEB85629.1 1 EEP50112.1 EFB71687.1 EFK02096.1
EEC31786.1 1 EEP54377.1 EFB74416.1 EFK07239.1
EEC32371.1 1 EEP83565.1 EFB90964.1 EFK 16400.1
EED32136.1 1 EEQ48941 .1 EFC53923.1 EFK22733.1
EED33461.1 1 EES48642.1 EFC82450.1 EF 27354.1
EED96977.1 1 EET02842.1 EFC93346.1 EF 331 16.1
EEE02117.1 1 EET04446.1 EFD51996.1 EF 43743.1
EEE06332.1 1 EET46812.1 EFE04795.2 EFK52585.1
EEE08690.1 1 EET48304.1 EFE06568.1 EF 66135.1
EEE34962.1 1 EET48468.1 EFE11218.1 EFK73841.1
EEE35534.1 1 EEU96709.1 EFE24314.1 EFK92719.1
EEE35828.1 1 EEV88951.1 EFE53195.1 EFK93271.1
EEE38756.1 1 EEW39916.1 EFE61787.2 EFL53944.1 EFL89152.1 1 EGCO 1999.1 EGY261 11.1 EHP82577.1
EFL90564.1 1 EGC96351.1 EGY53448.1 EHQ34219.1
EFM05246.1 1 EGC98049.1 EGY80770.1 EHT1 1452.1
EFM 19908.1 1 EGD34121.1 EGZ47428.1 EHT99386.1
EFM24365.1 1 EGE35458.1 EHA17557. 1 EHU07090.1
EFM59353.1 1 EGG31693.1 EH A32192, 1 EHU07469.1
EFO29280. 1 1 EGI09325.1 EH A61998, 1 i si : 10270. 1
EFO29703. 1 1 EGI14579.1 EHB47773.1 EHU20405.1
EF059693. 1 1 EGO 9907, 1 EHC 12051.1 EHU23876.1
EFP56876. 1 1 EGI45080.1 EHC32561.1 EHU27436.1
EFP71835.1 1 EGI49386.1 EHC45853.1 EHU37208.1
EFQ06576.1 1 EGI74586.1 EHC52512.1 EHU40408.1
EFQ61867.1 1 EGI92001.1 EHC62337.1 EHU52683.1
EFR18236.1 1 EGI92746.1 EHC67687.1 EHV55179.1
EFR40215.1 1 EGJ06069.1 EHC75282.1 EHY68648.1
EFS98037.1 1 EGK08600.1 EHC82043.1 EIC82503.1
EFU36795.1 1 EGK 10342.1 EHC82835.1 EID63302. 1
EFU68774.1 1 EGK 19205, 1 EHC87961.1 EID67830. 1
EFV39454.1 1 EGK34617.1 EHC99966.1 EIE52962.1
EFV63707.1 1 EGK58217.1 EHD 19777.1 EIG78918.1
EFW12879.1 1 EGK59573.1 EHD20169.1 EIG93520.1
EFW30568.1 1 EGK89404.1 EHD22253.1 EIH12673.1
EFW49236.1 1 EGL19982.1 EHE87999.1 E1H22144.1
EFW57058.1 1 EG094614.1 EHH1 1803.1 E1H45204.1
EFW59097.1 1 EGP19949.1 EHJ99584.1 i! 176840. 1
EGA66010.1 1 EGQ26127.1 EHK55408, 1 EII24708.1
EGA71635.1 1 EGQ26450.1 EHK613 8.1 EII34469.1
EGB61887.1 1 EGU34334.1 EHK77285.1 ΕΠ46301.1
EGB66941.1 1 EGU40287.1 EHM45588.1 EU66488.1
EGB73848.1 1 EGU44010.1 EHM49309.1 EIK61760.1
EGB86481.1 1 EGU44343.1 EHN09006.1 EIK70683.1
EGB97943.1 1 EGU51393.1 EHN12391.1 EIK72394.1
EGC01418.1 1 EGU98979.1 EHP66623.1 EIK96204.1 EIL52555.1 1 EJU32348.1 ELE53627.1 EMV17924.1
EIM75905.1 1 EJU33461.1 ELE58433.1 EMW97460.1
EIQ05553.1 1 EJU35725.1 ELG86729.1 EMX18620.1
EIQ 18545.1 1 EJU55912.1 hi.122617. 1 EMX29475.1
EIQ26058.1 1 EJW 18947.1 ELJ68846.1 EMX36709.1
EIQ34462.1 1 EJZ23180.1 ELP54032.1 \ 1X46863. !
EIQ57268.1 1 EJZ23191 .1 ELP55275.1 EMX83205. 1
]; 10 16 1 . 1 1 EJZ63478.1 ELP55913.1 ENA04653.1
EIQ78422.1 1 EKB46124.1 ELP68231.1 ENA38209.1
EIW 91574. 1 1 EKB47998.1 ELQ87920.1 ENA38530.1
EJE70690.1 1 EKE71933.1 ELQ87969.1 ENA43836.1
EJE72665.1 1 EKF06697.1 ELQ88013.1 ENC90022.1
EJF28964.1 1 EKF20235.1 ELQ88771.1 ENDS 1199.1
EJF37584.1 1 EKF21363.1 ELQ91334. I END90131.1
EJF40496.1 1 EKF42800.1 ELS26448.1 ENG95642.1
EJI91627.1 1 EKF58465.1 EL.S26841.1 E HO 1174.1
EJI91646.1 1 EKI50661.1 ELS27850.1 ENH07605.1
EJL04634.1 1 EKJ96466.1 ELT47152.1 ENY75730.1
EJL08772.1 1 EKM19531.1 ELU52903.1 ENZ85537.1
EJL 13645.1 1 EKM27370.1 ELW31521.1 EOC16726.1
EJL86644.1 1 EKM33126.1 ELW85333.1 EODO 1693.1
EJM95575.1 1 EKS07972.1 ELY27700.1 EOD42238.1
EJ022 40.1 1 EKT55065.1 ELZ99543.1 EON87502.1
EJ055869.1 1 EKT55967.1 EMD08742.1 EOQ46176.1
EJ056522. 1 1 EKT65147. 1 EMI 11336.1 EOQ52661 .1
EJP30929.1 1 EKU51342.1 EMI 14266.1 EOR96368.1
EJS87369.1 1 EKX63786.1 EMP51369, 1 EOU48067.1
EJS88033.1 1 ELC 14265.1 EMR07851. 1 EOU65286.1
EJS88036.1 1 ELC 16835.1 EMS71620.1 EOU78385.1
EJT07171.1 1 ELC37936.1 EMS97913.1 EOU89739.1
EJT86204.1 1 ELC95205.1 EMT40199.1 EOV04148.1
EJU28108.1 1 ELD97255.1 EMU59685.1 EOV47238.1
EJU32316.1 1 ELE41729.1 EMU68325.1 EOV55387.1 EOV76750.1 1 EQC48483.1 ERP09068.1 ESW561 11.1
EOV94389.1 1 EQC49653.1 ERT09144.1 ETA01630.1
EOW04340.1 1 EQF26369.1 ERT14069.1 ETA52029.1
HOW ! 6261 . 1 1 EQI88341.1 ESA61590.1 ETA68210.1
EOW 19941.1 1 EQK40602.1 ESA67356. 1 ETC31136.1
EOW61850.1 1 EQK42131.1 ESA68726.1 ETD59987.1
EOW95130.1 1 EQN24780.1 ESA72701.1 ETE22279.1
EOZ98682.1 1 EQN91648.1 ESA84978.1 ETE48169.1
EPA97273. 1 1 EQO59510.1 ESA92506.1 ETK29277.1
EPA99157. 1 1 EQP47193.1 ESBO 1864.1 ETS33247.1
EPB 97690.1 1 EQQ03969.1 ESC99187.1 ETTO 1045.1
EPC 14082.1 1 EQV89274.1 ESD05523.1 ETT07169.1
EPE98824.1 1 EQX25771.1 ESD21413.1 ETVV14464.1
EPF 13748.1 1 EQX86240.1 ESD37525.1 ETY41683.1
EPF 18896.1 1 EQY17582.1 ESD70932.1 ETZ09941.1
EPR26903.1 1 EQY57338.1 ESD76697.1 EUB72243.1
EPR73838.1 1 EQZ99174.1 ESD90270.1 EUB74618.1
EPR73839.1 1 KRi77294. 1 ESE04815.1 EUB75427.1
EPR76419.1 1 ERG 11045.1 ESE83038.1 EUB84551.1
EPR76420.1 1 ERG42422.1 ESE86248.1 EUB87030.1
EPR77354.1 1 ERG53670.1 ESF53709.1 EUB94968.1
EPX76657.1 1 ERI00623.1 ESG73922.1 EUB98403.1
EPX7901 1.1 1 ERI28937.1 ESJ19424.1 EUC 15772.1
EPX79012.1 1 ERI30693.1 ESK 5534.1 EUC 17426.1
EPX79543. 1 1 ERI31 190.1 ESK34333.1 EUC 19927.1
EPX80066. 1 1 ERI32103.1 ESL70090.1 EUC20682.1
EPX81913. 1 1 ERJ05871.1 ESM15735.1 EUD05937.1
EPX81981. 1 1 ERJ12333, 1 ESN17179.1 EVU13232.1
EPX84862. 1 1 ERKl 1299.1 ESQ21061.1 EWG73750.1
EPX85788.1 1 ERK12088.1 ESQ72660.1 EWH06794.1
EPX87242.1 1 ERL54400.1 ESR24857.1 EWS97919.1
EPZ50642.1 1 ERN41122.1 EST58097.1 EXB27436.1
EPZ55228.1 1 ERN42498.1 ESU79960.1 EXB47610.1 EXL02912.1 1 GAA64202.1 GAL34679.1 KDC51678.1
EXL08805.1 1 GAA65645.1 GAL36803.1 KDF 12959.1
EXU74154.1 1 GAA67376.1 GAL37656. 1 KDF13306.1
EYD75827.1 1 GAA68205.1 GAL45646. 1 KDG93655.1
EYD76005.1 1 GAA78318.1 GAL50932.1 KDM49647.1
EYD76216.1 1 GAA80934.1 GAL56692.1 KDM66049.1
EYD76391.1 1 GABS 1338.1 GAL62430.1 KDN30188.1
EYD83437.1 1 GAC32173.1 GAL66823.1 KDO00731.1
EYR81340.1 1 GAC65341.1 GAL70387.1 KDOO 1789.1
EYT23778, 1 1 GAD00064.1 GAL75242.1 KDR38345.1
EYU15951.1 1 GAD00717.1 GAL79182.1 KDR39580.1
EYV12183.1 1 GAD03916.1 GAL90464.1 KDR40471.1
EYV18352.1 1 GAJ68144.1 GAL93895.1 KDR42489.1
EYZ99018.1 1 GA 28093.1 (jAl. 4496. ] KDR44448.1
EZA32957.1 1 GA 75263.1 GAM12739.1 KDR96261.1
EZD33879.1 1 GA 86396.1 GAM57916.1 K.DU29241.1
EZE09298.1 1 GA 86397.1 GAM57917.1 KDV281 15.1
EZE49621.1 1 GA 92924.1 GAM65556.1 KDV41545.1
EZH78403.1 1 GA 92925.1 GAM68524.1 KDV63795.1
U/j 36630. 1 1 GAK97920.1 GAM76289.1 KDW29938.1
EZJ49363.1 1 GAK99145.1 GAP34694.1 KDX21120.1
EZJ71201.1 1 GAL05071.1 GAP62607.1 KDX45706.1
EZJ83504.1 1 GAL11041.1 GAP64452.1 KEA07283.1
EZJ83557.1 1 GAL 11042.1 GAP73496.1 KEA55087.1
EZK 19944, 1 1 GAL 16782.1 GAR75760.1 KEA56995.1
EZP32763 , 1 1 GAL 16859.1 KAJ04750.1 KEA60549.1
EZP33753.1 1 GAL 19427.1 KAJ55629.1 KEF38453.1
EZP41224, 1 1 GAL26771.1 KCV83816.1 KEI66155.1
EZP51786.1 1 GAL26853.1 KDA43421. 1 KEI66563.1
EZP65628.1 1 GAL30714.1 KDA56888.1 KEI72808.1
EZQ15102.1 1 GAL30715.1 KDA92361.1 KEJ44932.1
GAA61384.1 1 GAL30716.1 KDB06864.1 KEJ59125.1
GAA61578.1 1 GAL32582.1 KDB07503.1 KEJ73413.1 KEL65107.1 1 KFC95287.1 KGD53502.1 KGM71414.1
KEN53758.1 1 KFC98498.1 KGD58420.1 KGM83358.1
KEN6561 5.1 1 KFD07808.1 KGD74931.1 KGM85012.1
KEN98Q30.1 1 KFD17130.1 KGD99322.1 KGM87119.1
KEO08160.1 1 KFD75089.1 KGE84568.1 KGM89320.1
KEO20889.1 1 KFD81 165, 1 KGF68819.1 KGP46486.1
KEO30088.1 1 KFE26876.1 KGF85749.1 KGQ31158.1
KEQ06864.1 1 KFE29856.1 KGF92571.1 KGQ42403.1
KEQ 1 1857.1 1 KFE36379.1 KGF94969.1 KGQ44024.1
KEQ 16616.1 1 KFF88091.1 KGF98296.1 KGQ45909.1
KEQ56848.1 1 KFI27333.1 KGG00684.1 KGQ50254.1
KEQ57225.1 1 KFI27574.1 KGG08593.1 KGQ57329.1
KER03203.1 1 FD2532.1 KGG09329.1 KGQ59396.1
KER05877.1 1 KFJ12154.1 KGGl 3720.1 KGQ63143.1
KER71432.1 1 KFK48033.1 KGGl 4534.1 KGT92054.1
KER73555.1 1 F 53897.1 KGG20576.1 KGT93837.1
KES24087.1 1 F 83392.1 KGG25389.1 KGW03528.1
KEX93107.1 1 KFLOO 125.1 KGJ87252.1 KGW13295.1
KEY59239.1 1 KFL53690.1 KGJ88564.1 KGY09805.1
KEZ05720.1 1 KFM16262.1 KGJ88903.1 KGY14274.1
KEZ05934.1 1 KFM16471.1 KGJ91830.1 KHA72711.1
KFA97525.1 1 KFM17679.1 KGJ98195.1 KHD09963.1
KFB 10431.1 1 KFM18828.1 KGJ99182.1 KHD12613.1
KFB86391.1 1 KFM21 122.1 KGJ99826.1 KHD26206.1
KFC05462.1 1 KFNO 1206, 1 KGK 11 101 . 1 KF1F30311.1
KFC26266.1 1 KFX70429.1 KGK24833. 1 KF1F30312.1
KFC50616.1 1 KGA58376.1 KGL02631.1 KHF32019.1
KFC63916.1 1 KGB51681.1 KGL61018.1 KFII37342.1
KFC75035.1 1 KGB58219.1 KGL63588.1 KHJ20007.1
KFC77790.1 1 KGB82923.1 KGM06104.1 KHJ52626.1
KFC78157.1 1 KGB93469.1 KGM27860.1 KHJ53009.1
KFC79266.1 1 KGB93751.1 KGM47940.1 KHJ67587.1
KFC88526.1 1 KGC 15448.1 KGM62448.1 KHK58158.1 KHL14438.1 1 KIL49701.1 KIX40471.1 KJW52977.1
KHM50825.1 1 KIL52719.1 KIX50426.1 KJX12327.1
KHN63731.1 1 ΚΪΝ13602.1 KIY38310.1 KJX88802.1 i 1062446. 1 1 KI035232.1 KJC02192.1 KJY81950.1
KHS44854.1 1 KIO64041.1 KJC05651.1 KJY91595.1
KHT6521 1.1 1 KI064826.1 KJC 11069.1 KJZ06665.1
KIA76172.1 1 KI064882.1 KJE27066.1 KJZ 10778.1
KIA79272.1 1 KIO74022.1 KJE29094.1 KJZ33490.1
KIC08591. 1 1 KIP13348.1 KJE37105.1 KJZ43182.1
KICl 1 124. 1 1 KIP 19384.1 KJE41321.1 KJZ43642.1
KIC12067.1 1 KIP21434.1 KJE56468.1 KJZ49391.1
KIC20734.1 1 KIP28327.1 KJF68712.1 KJZ65470.1
KIC21142.1 1 KIP77591.1 KJF74388.1 KJZ83769.1
KIC38967.1 1 KIQ47214.1 KJF82240.1 KJZ85311.1
KIC39253.1 1 KIQ67877.1 KJF95975.1 KKA53929.1
KIC42948.1 1 KIQ67879.1 KJF96789.1 KKB03409.1
KIC44583.1 1 KIQ93804.1 KJG26707.1 K.KC64603.1
KIC48940.1 1 KIR21892.1 KJG38238.1 KKC79077.1
KIC81372.1 1 KIS42217.1 KJG58333.1 KKD31623.1
KIDQ1688.1 1 KIS44949.1 KJH08952.1 KKD58710.1
KIDQ7131.1 1 KIS45 I78.1 KJH75111.1 KKD60086.1
KIDI0239.1 1 KIS78067.1 KJH76892.1 KKF35468.1
KID53398.1 1 KIT 15205.1 KJJ85191.1 KKI44370.1 11-44861 . 1 1 ΚΓΓ26177.1 KJJ97017.1 KKJ02095.1
KIF47533.1 1 KIT34215.1 KJK05856.1 KKJ26483.1
KIF60145.1 1 KIT53655.1 KJK 14771 .1 KKJ76863.1
KIG04148.1 1 KIU06086.1 KJM40293.1 KK 014625.1
KIH04246.1 1 KIV63387.1 KJM86390.1 KKT03014.1
Kill 7028.1 1 KIV67945.1 KJN20029.1 KKW50513 1
KII76311.1 1 KIV69114.1 KJR24917.1 KKX34306.1
KIK88030.1 1 KIV76036.1 KJU79826.1 KKX57725. I
KIL14780.1 1 KIX18215.1 KJV49964.1 KKY43328.1
K i 1.44046. 1 1 KIX35343.1 KJW32728.1 KKY65106.1 KKY79844.1 1 KML08951.1 KNA43182.1 KOR21593.1
KKZ 18900.1 1 KML19553.1 KNC 12045.1 KOY02635.1
KKZ94380.1 1 M 1.55768. 1 KNC94638.1 KOY33005.1
KLA23437.1 1 KML63754.1 K D54403.1 KOY45864.1
KLA28450.1 1 KMM44201.1 K D57608.1 KOY61 141.1
KLE26363.1 1 KMM80744.1 KND60713. 1 KP A 10469.1
KLI68355.1 1 KMM88468.1 KNF09788.1 KPA16733.1
KLI96588.1 1 KMN35332.1 KNF69260. 1 KPA20218.1 l .1 .00327 J 1 KMN52710.1 KNF81881. 1 KPA53392.1
KLN47102.1 1 KMN54483.1 K M 1 1 3933. 1 KPBO 1772, 1
KLN59734.1 1 KMN6451 1.1 K H29699. 1 KPC99823.1
KLN96605.1 1 KMN82524.1 K H42940. 1 KPD03212.1
KLQ26950.1 1 KMN90587.1 KNN85891.1 KPD 1 1463.1
KLS52970.1 1 KMO70998.1 KNW74428.1 KPD14945.1
KLT72171 .1 1 KMO75409.1 KNX42579.1 KPD18730.1
KLU 18616.1 1 KMP15844.1 KNX78696.1 K.PF43120.1
KLU 18617.1 1 MP3271 1 .1 KNY25361.1 K.PF561 19.1
KLU21 135.1 1 KMP7681 1 . 1 KNY25362.1 KPF72724.1
KLU63532.1 1 KMP97239. 1 KNY34664.1 KPG94733.1
KLV01 1 10.1 1 KMQ03530.1 KNY78419.1 KPG95797.1
KLV0473 1.1 1 KMQ27939.1 KNZ84105.1 KPH01583.1
KLV10916.1 1 KMQ80607.1 KNZ96650.1 KPH 10681.1
KLV65168.1 1 KMT23186.1 KOA27319.1 KPH60166.1
KLW86529.1 1 KMV32028.1 KOA70223.1 KPH81257.1
KLX57832.1 1 KMV34546.1 KOC89788.1 KPL51015.1
KLX95653.1 1 KMV68971.1 KOC93579.1 KPL87226.1
KLY12051.1 1 KMV72039.1 KOE81497.1 KPL88374.1
KME68567. 1 1 KMW56860.1 KOE86385.1 KPL99047. 1
KMJ45199.1 1 KMW57564.1 KOF22188. 1 KPM59181.1
KMJ52368.1 1 KMW60148.1 KOO07592. 1 KPM65351.1
KMK 123 13.1 1 KMW73818.1 KOO 1 3953. 1 KPM84873.1
KMK65695.1 1 KMY86054.1 KOP04210.1 KPM96585.1
KMK67024. 1 1 KMZ1 1 104.1 KOP34818.1 KPN62270.1 KPN70840.1 KPW02372.1 KUU48154.1 OAJ87923.1
KPN74193.1 KPW04291.1 KWV87278.1 OA068288.1
KPN90785.1 KPZ52050.1 KWZ91247.1 OAO 72922.1
KP018578.1 KPZ54771.1 KXG92414.1 OBX00501.1
KP036864.1 KPZ63440.1 XH00366.1 OCS74956.1
KP046574.1 KPZ65777.1 KXH98341 . 1 OCS95951.1
KPP84622.1 KPZ67737.1 KXI61250.1 OCV53559.1
KPP85678.1 KPZ69053.1 KXJ38653.1 ODH24471.1
KPP85884.1 KPZ72596.1 KXL66969.1 OEG92891.1
KPP89409.1 KQA23172.1 KXQ42781. 1 OEH04368.1
KPQ06101.1 KQA98185.1 KXX90622.1 OEH12481.1
KPQ08097.1 KQB 15598.1 KXY08066.1 OEH14141.1
KPQ13684.1 KQB 16357.1 KXY28981.1 OEH95893.1
KPQ 14340.1 QB91620.1 KXY53137.1 OEI65538.1
KPQ 14479.1 QB98549.1 KXY72091.1 OE 36597.1
KPQ21467.1 QJ 13932.1 KYR44967.1 Oi:N26435.1
KPQ22810.1 QJ46046.1 KYS97777.1 OIR51681.1
KPQ29983.1 KST27455.1 KYV67952.1 OIX27476.1
KPQ32046.1 KSX90871.1 KZD58224.1 SAD71408.1
KPQ36131.1 KTH73166.1 KZD81457.1 SAE32773.1
KPQ37310.1 KTM92472.1 KZD82131.1 SAI34905.1
KPR57622.1 KTO38350.1 KZE06157.1 SAY76569.1
KPU50749.1 KT086996.1 ZJ59530. 1 SAZ57795.1
KPU53876.1 KTP62451.1 OAC43113.1 SBX90640. 1
KPU54584.1 KUH44100, 1 OAE40342.1 SBZ90882.1
KPU54773.1 KUI50798.1 OAE92625.1 SCM53106.1
KPU84621.1 KUQ52563.1 OAH32122. 1
[00109] Representative exaraples of ornithine decarboxylase (EC 4.1.1.17) are given below in Table 9 and identified by their EMBL/GENBA K DDBJ ID numbers. Any of the bacteria given in Table 10 can be engineered with any version of the ornithine decarboxylase (EC 4.1.1.17) set forth in Table 3 and 9. For instance, the bacteria can be engineered with a version of the ornithine decarboxylase enzyme that has at least 50% nucleoti de similarity with any of the versions of ornithine decarboxylase given in Table 9 (e.g., at least nucleotide 60% similarity, at least 70% nucleotide similarity, at least 80% nucleotide similarity, at least 90% nucleotide similarity, at least 91 % nucleotide similarity, at least 92% nucleotide similarity, at least 93%o nucleotide similarity, at least 94% nucleotide similarity, at least 95%t nucleotide similarity, at least 96% nucleotide similarity, at least 97%> nucleotide similarity, at least 98% nucleotide similarity, at least 99%> nucleotide similarity, at least 99.5% nucleotide similarity, at least 99.9%s nucleotide similarity, or 100% nucleotide similarity).
Table 9. Representative Examples of Ornithine Decarboxylase by EMBL/GENBA K DDBJ ID Number
AAA62785.1 AAW60223.1 ABE06188.1 AB 164670, 1
AAA66174.1 AAY39277.1 ABE08804.1 ΛΒ! 732 1 . 1
AAA69133.1 AAY96264.1 ABE29508.1 ABI88035.1
AAC22248.1 AAZ 17903.1 ABE36633.1 ABJ07102.1
AAC73787.1 AAZ21026.1 ABE38094.1 ABJ08721.1
AAC76002.2 AAZ45335.1 ABE44334.1 ABJ70427.1
AAK65018.1 AAZ60071.1 ABE4 1 83. ! ABK39746.1
AAK65019.2 AAZ71105.1 ABE49327.1 ABK49901.1
AAL 19645.1 ABA04186.1 ABE56353.1 ABK50089.1
AAL21989.1 ABA78141.1 ABE64149.1 ABL98620.1
AAL54375.1 ABB 12186.1 ABE73821 .1 ABM01537.1
Λ 1.94697 1 ABB40870.1 ABF62084.1 ABM03233.1
AAM32881.1 ABB75259.1 ARF76724.1 ABM 1 71 84. 1
A W 186897. 1 ABC22493.1 ABF79243.1 ABM33819.1
AAN53399.1 ABC92384.1 ABG 12272.1 ABM37329.1
AAN57109.1 ABD09230.1 ABG 19485.1 ABM42903.1
AAN66489.2 ABD53718.1 ABG64092.1 ABM94883.1
AAN79250.1 ABD69850.1 ABI25841.1 ABN63325.1
AAN82001.1 ABD82224.1 ABI41283.1 ABN63550.1
AAO90264.2 ABD90359.1 ABI41448.1 AB025258.1
AAS63636.1 ABD98955.1 ABI59635.1 AB055514.1
AAV42846.1 ABE0571 1.1 ABI61420.1 ABP59886.1 ABP62042.1 1 ACB26370.1 ACS39829.1 AEF20700.1
ABP74273.1 1 ACB26621.1 ACS86807.1 AEF54819.1
ABP77387.1 1 ACB79112.1 ACT08032.1 AEG05601.1
ABP83569.1 1 ACB94577.1 ACT 11922.1 AEG07021.1
ABQ 13490.1 1 ACC75475.1 ACX89156.1 AEG09620.1
ABQ 18377.1 1 ACD09708.1 ACY53777.1 AEG09845.1
ABQ31378.1 1 ACE89117.1 ACZ75768.1 AEG48476.1
ABQ33584.1 1 ACE92836.1 ADA66726. 1 AEH50365.1
ABQ35247.1 1 ACE99495.1 ADE84258.1 AEH86445.1
ABQ46942.1 1 ACF00856. 1 ADG60285. 1 AEI07722.1
ABQ77056.1 1 ACF62498.1 ADI02315.1 AEJ18813.1
ABQ77881.1 1 ACF64187.1 ADM40347.1 AEK61463.1
ABQ94 06.1 1 ACG58193.1 ADM42835.1 AEM41039.1
ABR63972.1 1 ACH49712.1 ADM42836.1 AEP37160.1
ABR71097.1 1 ACH50260.1 ADM97227.1 AEV60919.1
ABS65893.1 1 ACH63785.1 ADO 10738.1 AFJ59017. 1
ABS77454.2 1 ACI1 1630.1 ADO47055.1 AFL53867.1
ABV20152.1 1 ACI98761.1 ADO49370.1 AFY 17936.1
ABV20217.1 1 ACI991 15.1 AD084265.1 AFY20265.1
ABV32717.1 1 ACJ00377.1 ADP99549.1 AGA64911.1
ABV39617.1 1 ACK48448.1 ADU45025.1 AGG15787.1
ABV43142.1 1 ACK49205.1 ADU70535.1 AGG70048.1
ABV93117.1 1 ACK81873.1 ADU91399.1 AGG70049.1
ABX51330.1 1 ACK83165.1 ADY l 1066. 1 AGH98733.1
ABY29398.1 1 ACL55330.1 ADV56349. 1 AG! 50812.1
ABY96818.1 1 ACL93832.1 ADW75162, 1 AG056945.1
ACAl 5010.1 1 ACN1413 U ADY12020. 1 AGT07607.1
ACA32083.1 1 ACP07980. 1 ADZ25852.1 AHA66979.1
ACA67112.1 1 ACP26670. 1 ADZ25990.1 Al l!) 10069. 1
ACA74794.1 1 ACQ92481.1 AEA25536.1 AHD 10849.1
ACA92668.1 1 ACR70548.1 AEA80789.1 AHE50504.1
ACB 16558.1 1 ACR80274.1 AEB 13218.1 AHE58679.1
ACB 17513.1 1 ACS38696.1 AEE17405.1 ΛΙ 11- 70264. 1 AHF74955.1 1 AKB40448.1 BAA35349.1 CAR04482.1
AHH20127.1 1 AKB43558.1 BAE77028.1 CAR06878.1
AHJ62296.1 1 AKB47010.1 BAT71258.1 CAR09582.2
AHK70374.1 1 AKB51817.1 ΒΑΓ72082.1 CAR14483.1
AHM04085.1 1 AKB55259.1 BAT76414.1 CAR16788.1
AHM 04146.1 1 A B56666.1 BAI96560.1 CAR19506.1
AHM77647.1 1 A B61403.1 BAJ8 775.1 CAR36594.1
AHM83238.1 1 AKB64701.1 BAL83346.1 CAR40820.1
AHY72323.1 1 AKB68292.1 BAN98715.1 CAR 54968. 1
Λ 1.107696 1 1 AKB72738.1 BAQ 17945.1 CAU96547.1
AJJ08459.1 1 AKB75272.1 BAU72598.1 CAU99265.1
AIQ92829.1 1 AKB78060.1 CAD78655.1 CAX18544.1
AIQ93098.1 1 AKB81641.1 CAD84820.1 CAX22758.1
AIR09930.1 1 AKB84150.1 CAG69512.1 CAX24467.1
AIT00368.1 1 AKF49823.1 CAG73878.1 CAX61217.1
AIZ81713.1 1 AKH27073.1 CAi 122470 ! CAX67648.1
AIZ84023.1 1 AKH69183.1 CAI97377.1 CAX67666.1
AJE57512.1 1 Λ 1 199554. 1 CAI98549.1 CAY75622.1
AJF55421.1 1 ΛΚ 077226.1 CAJ 12264.1 CBA19528.1
AJF57769.1 1 AK097889.1 CAK02040.1 CBA28212.1
AJG20615.1 1 ALD27842.1 CAK13937.1 CBA29223.1
AJI87080.1 1 ALV76207.1 CAL 10580.1 CBA33757.1
AJK49051.1 1 ALY14469.1 CAL 13549.1 CBG87473.1
AJQ96966.1 1 ALZ68204.1 CAL 19626.1 CBG91695.1
AKA84438.1 1 ALZ69985. 1 CAL78631 .1 CBI76815.1
AKB 12437.1 1 ANK35386.1 CAL79901 .1 CBI78256.1
AKB 14359.1 1 ANM83745.1 CAM00591.1 CBI78275.1
AKB 18263.1 1 ANM85435.1 CAM03603.1 CBL06633.1
AKB21587.1 1 ANP16911.1 CA097896.1 CBS85874.1
AKB25327.1 1 AOM43847.1 CAQ81820.1 CBS86483.1
AKB28151.1 1 AOT33749.1 CAQ89917.1 CBS89897.1
AKB32085.1 1 APF08471.1 CAQ90401.1 CBW16782.1
AKB37309.1 1 APF13004.1 CAR02067.1 CBW19188.1 CBY25820.1 1 CCJ99535.1 CDL 10022.1 CDX54921.1
CBY25832.1 1 CCK01641.1 CDL20226.1 CDX58455.1
CBY28841.1 1 CCK03853.1 CDL23839.1 CD Y 74095. 1
CCA93756.1 1 CCK06057.1 CDL25819.1 CEF30930.1
CCC57896.1 1 CCK08478.1 CDL25820.1 CEG53321.1
CCC96226.1 1 CCK22783.1 {'1)1.27267. 1 CEI15979, 1
CCC98554.1 1 CCK45849.1 CDL27268.1 CEJ65390.1
CCD02602.1 1 CCK48255.1 CDL27269.1 CEK26252.1
CCD40282.1 1 CCM77346.1 CDL39170.1 CEK27948.1
CCD85313.1 1 CCO07100.1 CDL50778.1 CEL27520.1
CCD87735.1 1 CCQ09200.1 CDL50819.1 CEL88226.1
CCD96638.1 1 CCQ74399.1 CDL86182.1 CEP77894.1
CCE00128.1 1 CCT59416.1 CDL90667.1 CFQ53013.1
CCE04953.1 1 CCU62281.1 CDM25489.1 CFQ53087.1
CCE05308.1 1 CCU62303.1 CDM39302.1 CFQ53093.1
CCE97429.1 1 CCV05533.1 CDM59281.1 CFQ63135.1
CCE98566.1 1 CCV16052.1 CDM60694.1 CNJ42662.1
CCF20520.1 1 CCW 14223.1 CDN08374.1 CNK09967.1
CCG07833.1 1 CCW18613.1 (1)059353 ! ( P 14076. 1
CCG39584.1 1 CDF57711.1 CDP53980.1 CPR26377.1
CCG86023.1 1 CDF82218.1 CDQ 16217.1 CPR26378.1
CCG93567.1 1 CDF92784.1 CDR81373.1 CQH28513.1
CCI82390.1 1 CDF95827.1 CDR83974.1 CQH50344.1
CCJ43 49.1 1 CDG34413.1 CDR89923.1 CRG52628.1
CCJ73160. 1 1 CDG41242.1 CDS49197.1 CRH3071 1 .1
CCJ73613. 1 1 CDI09982.1 CDU34381.1 CRH35440.1
CCJ79388. 1 1 CDK34386.1 CDU39548.1 CRH39733.1
CCJ82552. 1 1 CDK72259.1 CDU41134.1 CRL 10245.1
CCJ86161. 1 1 CDK 72653.1 CDX11380.1 CRL 1 1665, 1
CCJ87942.1 1 CDK75666.1 CDX28277.1 CRL87218.1
CCJ89861.1 1 CDK97758.1 CDX31971.1 CR016551.1
CCJ91600.1 1 CDK98655.1 CDX32761.1 CRP80377.1
CCJ97363.1 CDL07277.1 CDX44074.1 CRY55295.1 CRY56151.1 1 CTQ48990.1 CUH97680.1 EEJ73250.1
CRY73398.1 1 CTQ51582.1 CUI46350.1 EE 80026.1
CRZ77491.1 1 CTQ64509.1 CI 165295. 1 EEO01571.1
CSA30444.1 1 CTQ70679.1 CUJ95194.1 EEO 17726.1
CSB23271.1 1 CTQ77678.1 CUK08178.1 EEQ24327.1
CSB44423. 1 1 CTR81841 . 1 EAA24580.1 EEV22915.1
CSB97832. 1 1 CTR87483. 1 EDL.69175.1 EEW41165.1
CSC29054. 1 1 CTS06036.1 EDM60163.1 EEX49266.1
CSC32042. 1 1 CTS29676.1 EDN58782.1 EEY45602.1
CSC55030. 1 1 CTS78438.1 EDQ31943.2 EEY99726.1
CSC90483.1 1 CTT62185.1 EDQ34501.1 EFC91687.1
CSC91956.1 1 CTT62210.1 EDR33413.1 EFE96168.1
C 8190225.1 1 CTT77363.1 EDS92093.1 EFE96169.1
CSI94697.1 1 CTT83136.1 EDU62245.1 EFE97489.1
CSK70247.1 1 CTT84900.1 EDU6491 1.1 EFG55431.1
CSL03024.1 1 CTT94762.1 EDU91579.1 EFM19932.1
CSL07641.1 1 CTU09480.1 EDU92556.1 EFM60159.1
CSM63721.1 1 CTU43474.1 EDX33853.1 EFP71802.1
CSM98897.1 1 CTU46798.1 EDX36097.1 EFQ23396.1
CSN54919.1 1 CTU67775.1 EDX47281.1 EFQ65259.1
CSP82502.1 1 CTV17999.1 EDX48079.1 EFR18105.1
CSP97222.1 1 CTV22603.1 EDY22541.1 EFR18206.1
CSR81748.1 1 CTV49713.1 EDY26086. 1 EFW49207.1
CSS46262.1 1 CTV56172.1 EDZ45245.1 EFW49866.1
CSS69716.1 1 CTV59366.1 EDZ48441.1 EFW55944.1
CST05596.1 1 CTV99708.1 EDZ60503.1 EFW57461.1
CTQ00658.1 1 CTW90830.1 EEB70922.1 EFW59125.1
CTQ07290.1 1 CTX56302.1 EEB72505.1 EFY04546.1
CTQ 10899.1 1 CTZ36862.1 EEH90224.1 EFZ35827.1
CTQ21239.1 1 CTZ54946.1 EEI47014.1 EGC73182.1
CTQ33367.1 1 CTZ68478.1 EEI67673.1 EGD26721.1
CTQ42919.1 1 CTZ90267.1 EEJ60488.1 EGF12882.1
CTQ43401.1 1 CUH38863.1 EEJ72107.1 EGF 12883.1 EGF 13575.1 1 EHV55210.1 EMU68355.1 ESN64681.1
EGF 13579.1 1 EIC02033.1 EMV17894.1 ESR23196.1
EGI92040.1 1 EI) 31771.1 EMW96757.1 ESR27061.1
EGI93253.1 1 EIK63890.1 EMX18650.1 ESS57441.1
EGI99407.1 1 EIK67948. 1 EMX29506.1 ESU78166.1
EGJO 1620. 1 1 EIK70882.1 EMX36739.1 ETA69456.1
EGK 15386.1 1 EIQ05587.1 EMX46897.1 ETS92400, ]
EGK 19303.1 1 EIQ 18576, 1 EMX83235.1 EUB20316.1
EGK26882.1 1 EIQ26095.1 ENA04683.1 EXJB71374.1
EGK26884.1 1 EIQ71312.1 EN A38238, 1 EUB75197.1
EGK34653.1 1 EIQ76994.1 ENA43866.1 EUB84084.1
EGK34656.1 1 EIQ78394.1 ENC90052.1 EUB97023.1
EGK40304.1 1 EIZ02840.1 ENDS 1232.1 EUC12442.1
EGK58241.1 1 EJI92011.1 END90160.1 EWC58917.1
EGK62838.1 1 EJL03608.1 ENG95671.1 EWC60810.1
EGL98455.1 1 EJL08507.1 ENHO 1203.1 EWG73717.1
I ! 1.98460. 1 1 EJ049529.1 ENH07634.1 EWG77348.1
EGM68475.1 1 EKI50690.1 EODO 1056.1 EYD71048.1
EGM68534.1 1 EKP99013.1 EPA96228.1 EYD71269.1
EG094943.1 1 EKP99014.1 EPC 15663.1 EYD77132.1
EGP08625.1 1 EKQ02803.1 EPC38567.1 EYD83397.1
EGP13188.1 1 EKQ02804.1 EPF66737.1 EZJ36659.1
EHC87901.1 1 EKQ0999 .1 EPX75972.1 EZ.) 49393.1
EHC94859.1 1 EKQ09992.1 EPX79893.1 EZ.) 71231.1
EHC94874.1 1 EKQ 1508.1 EPX85529.1 EZ.) 83500, 1
K! 11)22909 ! 1 EKQ 1509.1 EPX86372.1 EZK 19977.1
EHE87725.1 1 EKQ18817.1 EQC66601 .1 EZP30980.1
EHE90319.1 1 EKQ21433.1 EQC671 19.1 EZP72267.1
EHP88849. 1 1 EKS52809.1 ERJ07090.1 GA078552.1
EHP90237.1 1 ELS26426.1 ERJ12441.1 GAP76203.1
EHU02113.1 1 ELW31551.1 ERL16034.1 KDA56789.1
EHU20119.1 1 EMS72676.1 ERL56578.1 KDE39162.1
EHU26736.1 1 EMU59716.1 ESN64144.1 KDM66230.1 KDM67094.1 1 KFD06768.1 KJL37417.1 KPP86129.1
KDM68717.1 1 KFD07842.1 KJL45196.1 KPQ30708.1
KDR44432.1 1 KFD17151.1 KJW30930. 1 KPW02487.1
KDU29207.1 1 KFE39747.1 KJX8701 1 .1 KPZ58476.1
KDW29935.1 1 KFE40588.1 KLU03251. 1 KPZ73698.1
KDX21151.1 1 KFL92212.1 KLY03824.1 KQJ13961.1
KDX45737.1 1 KGA92942.1 KMK68540.1 KQJ37165.1
KEA62619.1 1 KGB23003.1 KMM41085.1 KRK54316.1
KEC54001.1 1 KGM59804.1 KMM41943.1 KRK64371.1
KEJ45027. ί 1 KGM62416.1 K\ 106761 7 ! KSH09715.1
KEJ59156.1 1 KGM68326.1 KM073993.1 KST27486.1
KEJ73445.1 1 KGM71386.1 KM074679.1 KTZ 13476.1
KEK27105.1 1 KGM77872.1 KMQ 72910.1 KXL65724.1
KEK29881.1 1 KGM80580.1 KMY85028.1 KXQ42753.1
KEL65139.1 1 KGM83330.1 KMZ 12404.1 KYR53760.1
KEN53788.1 1 GM84983.1 K D54388.1 KYV67923.1
KEN65519.1 1 GM87536.1 K D59806.1 KYV72148.1
KEN98059.1 1 KGM88313.1 KNE76189.1 OAC43139.1
KEO08191.1 1 KHJ 19976.1 KNF62494.1 OA! 124264 1
KEO30Q74.1 1 KHN90703.1 K F819I3.1 OAJ89982.1
KEQ53465.1 1 KHQ55244.1 K F82765.1 OCS73051.1
KER02947.1 1 KID27997.1 KNH02424.1 OCV53530.1
KEYS 7491.1 1 KIH04277.1 KNH10085.1 ODH24445.1
KEZ18534.1 1 KIQ45687.1 KNX39995.1 OEI63490.1
KFC03280.1 1 KIQ47241 .1 KNX42257. 1 OEI65510.1
KFC05486.1 1 KIQ68453.1 KOA19269. 1 OFJ34340.1
KFC63691.1 1 KIQ68551 .1 KON65543. 1 OIR53362.1
KFC69417.1 1 KIR02360.1 KPA20904.1 OJF06953.1
KFC77644.1 ! KIR22223.1 KPA88263.1 SAY77725.1
KFC79295.1 1 KIS02883.1 KPO 1 1674.1 SEF59356.1
KFC83942.1 1 KIT 17643.1 KPO 18606.1
KFC88765.1 1 KIV66814.1 KP045157.1
KFC94984.1 1 KIV70876.1 KPO46605.1 [00110] A variety of microbes (e.g., bacteria) can be engineered to produce GAB A (e.g., by engineering one or more of the enzymes set forth in Table 2). For instance, any of the bacteria set forth in Table 10 can be engineered to produce GAB A, In other words, a bacteria having a 16S rDNA nucleotide sequence that is at least 50% similar to that set forth in Table 10 below can be engineered (e.g., with one of the enzymes in Tables 3-9) to produce GAB A. The bacteria may have a 16S rDNA sequence that is at least 60% similar, at least 70% similar, at least 80% similar, at least 90% similar, at least 91% similar, at least 92% similar, at least 93% similar, at least 94% similar, at least 95% similar, at least 96% similar, at least 97% similar, at least 98% similar, at least 99% similar, at least 99.5% similar, or 100% similar to the 16S rDNA nucleotide sequence given in Table 10.
[00111] As set forth in Example 8, E. coli was engineered to overexpress glutamate decarboxylase, which without wishing to be bound by theory, led to the expression of GABA by the engineered E. coli. As shown in Figure 6, the engineered E. coli was able to induce the growth of s. gahavorous KLE1738. GABA can be produced by intestinal epithelial cells and by some bacteria, such as Escherichia coli and Listeria monocytogenes, by decarboxylation of glutamate. In E. coli, the decarboxylation of glutamate can serve as a mechanism to decrease intracellular pH, and therefore in some embodiments GABA production generally occurs at a low pH.
[00112] As set forth in Example 8, Expression, e.g., overexpression of glutamate decarboxylase in E. coli (e.g., gadA or gadB), resulted in induction of E. gahavorous LE1738 growth to levels seen with B. fragilis KLE 1758. For instance, Figure 6A shows induction of E. gahavorous KLE 1738 in the presence of E. coli engineered to express glutamate decarboxylase gadA. Similarly, Figure 6B shows induction of E. gahavorous KLE 1738 in the presence of E. coli engineered to express glutamate decarboxylase gadB. As shown in Figure 6C, the growth of E. gahavorous KLE 1738 was qualitatively similar to that seen in the presence of B. fragilis KLE 1758. In contrast, as shown in Figure 6D, when E. coli was engineered to express gadC, a GABA antiporter, no growth of E. gahavorous KLE 738 was observed. Similarly, no growth of E. gahavorous KLE 1738 was observed in the presence of empty vehicle (Figure 6E). Without wishing to be bound by theory the results of Example 8 demonstrate that bacteria can be engineered to uce GABA (e.g., via the expression or overexpression of giutamate decarboxylase). In some embodiments, the bacteria (e.g., E. coli) can be engineered to produce GABA inside the human aut.
In some embodiments, the present disclosure also provides compromising one or more repressors of GABA production, (e.g., gadX or gadW). In some embodiments, these repressors can regulate the pH restrictions of GABA production in E. coli, is a way to increase native GABA production. This can be achieved, for instance, via gene deletions, insertions, or substitutions, as known by those skilled in the art of molecular biology.
Altering the pH of growth media for KLE1738 did not change the GABA- dependency phenotype. Without wishing to be bound by theory, this suggests that engineering bacteria to overexpress giutamate decarboxylase is an effective way to produce GABA, as well as induce the growth of E. gabavorous.
115] In addition to E. coli, other bacteria can be engineered to produce GABA (e.g., at a physiologically relevant pH, such as between 4.5 and 7.5), For instance, any of the bacteria set forth in Table 10 can be engineered to produce GABA (e.g., at a physiologically relevant pH, such as between 4,5 and 7.5). For example, the bacteria can be engineered to contain DNA that codes for one or more enzymes set forth in Table 3-9. Set forth in Table 10 is also a sequence ID number for the 16S nucleotide sequence of the listed bacteria. In some embodiments, the bacteria that are engineered to produce GABA can have at least 90% 16S sequence similarity to the 16S sequences given in Table 10 (e.g., at least 91% similarity, at least 92% similarity, at least 93%> similarity, at least 94%s similarity, at least 95% similarity, at least 96% similarity, at least 97% similarity, at least 98% similarity, at least 99% similarity, at least 99.5% similarity, at least 99.9% similarity, or 100% similarity).
Table 10. Bacteria Capable of Being Engineered to Produce GABA
Seq. ID
Species
No.
A hiotrophia defecti va 305
A hiotrophia para-adiacens 306
Ahiotrophia sp. 307
A cetanaerobacterium
308
elongatum
Figure imgf000113_0001
Acetivibrio cellulolyticus 309 Acetobacter pomorum 317 Actinobaculum sp. 357
Acetobacter syzygii 318 Actinomyces cardiffensis 358
Acetobacter Iropicalis 319 Actinomyces europaeus 359
Acetohacteraceae bacterium 320 Actinomyces junkei 360
Acholeplasma laidlawii 321 Actinomyces genomosp. 361
Achromobacter denitrificans 22 Actinomyces genomosp. 362
Achromobacter piechaudii 323 Actinomyces genomosp. 363
A chromobacter xvlosoxidans 324 Actinomyces georgiae 364
Acidaminococciis fermentans 325 A ctinomvces israelii 365
Acidaminococcus intestim 326 A ctinomvces massiliensis 366
A cidaminococcus sp. J Actinomyces meyeri 367
A cidi Johns saccharovorans 328 A ctinomyces naeslundii 368
A cidithiobacillus ferrivorans 329 A ctinomyces nasicola 369
Acidovorax sp. 330 A ctinomyces neuii 370
Acidovorax sp. 331 A ctinomyces odoniolyticus 371
Acinetohacter haumannii 332 Actinomyces oricola 7?
Acinetohacter calcoaceticus 333 A ctinomyces orihominis 373
Acinetohacter genomosp. 334 Actinomyces oris 374
Acinetohacter haemolyticus 335 Actinomyces sp. 375
Acinetohacter iohnsonii 336 Actinomyces sp. 376
A cinetohacter jimii 337 Actinomyces sp. 377
Acinetohacter voffii 338 Actinomyces sp. 378
Acinetohacter parvus 339 Actinomyces sp. 379
Acinetohacter radioresistens 340 Actinomyces sp. 380
Acinetohacter schindleri 341 Actinomyces sp. 381
Acinetohacter sp. 342 Actinomyces sp. 382
Acinetohacter sp. 343 Actinomyces sp. 383
A cinetohacter sp. 344 Actinomyces sp. 384
Acinetohacter sp. 345 Actinomyces sp. 385
Acinetohacter sp. 346 Actinomyces sp. 386
Acinetohacter sp. 347 Actinomyces sp. 387
Acinetohacter sp. 348 Actinomyces sp. 388
A ctinobacillus minor 349 Actinomyces sp. 389
Actinohacillus Actinomyces sp. 390
350
pleuropneumoniae Actinomyces sp. 391
Actinohacillus succinogenes 351 Actinomyces sp. 392
Actinohacillus succinogenes 352 Actinomyces sp. 393
Actinohacillus ureae 353 Actinomyces sp. 394
A ctinobaculum, massi!iae 354 Actinomyces sp. 395
A ctinobaculum schaalii 355 Actinomyces sp. 396
Actinobaculum sp. 356 Actinomyces sp. 397
1 1 Actinomyces sp. 398 Alistipes putredinis 437
Actinomyces sp. 399 Alistipes shahii 438
Actinomyces urogenitalis 400 Alistipes sp. 439
A ctinomyces viscosus 401 Alistipes sp. 440
Adlercreutzia equolifaciens 402 Alistipes sp. 441
A erococcus sanguinicola 403 A Ikaliphiliis metalliredigenes 442
Aerococciis urinae 404 A ikaliphiliis oremlandii 443
Aerococciis iirinaeequi 405 A lloscardovia omnicolens 444
A erococcus viridans 406 A lloscardovia sp. 445
Aeromicrobium marinum 407 Anaerobaculum
446
Aeromicrobium sp. 408 hydrogeniformans
A eromonas allosaccharophila 409 Anaerohiospirillum
447
Aeromonas enter opelogenes 410 succinic iproducens
Anaerohiospirillum thomasii 448
A eromonas hydrophila 411
Anaerococcus hydrogenalis 449
Aeromonas jandaei 412
Anaerococcus lactolvticus 450
Aeromonas salmonicida 413
Anaerococcus octavius 451
Aeromonas trota 414
Anaerococcus prevotii 452
Aeromonas veronii 415
Anaerococcus sp. 453
Afipia genomosp. 416
Aggregatibacter Anaerococcus sp. 454
417
actinomyceiemcomitans Anaerococcus sp. 455
Aggregatibacter aphrophilus 418 Anaerococcus sp. 456
Aggregatibacter segnis 419 Anaerococcus sp. 457
Agrobacierium radiobacter 420 Anaerococcus sp. 458
Agrobacierium tumefaciens 421 Anaerococcus sp. 459
Agrococeiis jenensis 422 Anaerococcus sp. 460
Akkermansia miiciniphila 423 Anaerococcus sp. 461
Alcaligenes faecalis 424 Anaerococcus tetradius 462
Alcaligenes sp. 425 Anaerococcus vaginalis 463
Alcaligenes sp. 426 Anaerofusiis stercorihominis 464
AlicycIobaciHus acidocaldarius 427 Anaeroglobus geminatus 465
AlicycIobaciHus acidoterrestris 428 Anaerosporobacter mobilis 466
A licyclobacillus contaminans 429 Anaerostipes caccae 467
A licyclobacillus Anaerostipes sp. 468
430
cycloheptanicus A naerotruncus colihominis 469
A licyclobacillus her bar ins 431 Anaplasma marginale 470
A licyclobacillus pomorum 432 A naplasma phagocy tophi him 471
AlicycIobaciHus sp. 433 Aneurinibacilhis anetirinilytictis 472
Alistipes finegoldii 434 Aneurinibacilhis danictis 473
A listipes indistinctus 435 Aneurinibacilhis migulanus 474
Alistipes onderdonkii 436 Aneurinibacilhis terranovensis 475 Aneurinibacillus Bacillus halodurans 516
476
thermoaerophilus Bacillus herbersieinensis 517
Anoxyhacillus contaminans 477 Bacillus horti 518
Anoxybacill s flavithermus 478 Bacillus idriensis 519
Arcanobacterium haemolyticum 479 Bacillus lentus 520
Arcanobacterium pyogenes 480 Bacillus licheniformis 521
A rcohacter buizleri 481 Bacillus megaterium 522
A rcohacter cryaerophilus 482 Bacillus nealsonii 523
Arthrobacier agilis 483 Bacillus niabensis 524
A rthrobacter arilaitensis 484 Bacillus niacini 525
Arthrobacier bergerei 485 Bacillus pocheonensis 526
Arthrobacier globiformis 486 Bacillus pumilus 527
Arthrobacier nicotianae 487 Bacillus safensis 528
Atopobium miniitum 488 Bacillus simple 529
Atopobium parvulum 489 Bacillus sonorensis 530
Atopobium, rimae 490 Bacillus sp. 53 1
Atopobium sp. 491 Bacillus sp. 53?
Atopobium sp. 492 Bacillus sp. 533
Atopobium sp. 493 Bacillus sp. 534
Atopobium sp. 494 Bacillus sp. 535
A topobi m vaginae 495 Bacillus sp. 536
A urantimonas corah cida 496 Bacillus sp. 537
A ureimonas altamirensis 497 Bacillus sp. 538
Auritibacter ignavus 498 Bacillus sp. 539
A very e Ha dalhousiensis 499 Bacillus sp. 540
Bacillus aeolius 500 Bacillus sp. 541
Bacillus aerophilus 501 Bacillus sp. 542
Bacillus aesiuarii 502 Bacillus sp. 543
Bacillus alcalophilus 503 Bacillus sp. 544
Bacillus amy loliquefac lens 504 Bacillus sp. 545
Bacillus atrophaeus 505 Bacillus sp. 546
Bacillus badius 506 Bacillus sp. 547
Bacillus cereus 507 Bacillus sp. 548
Bacillus circulans 508 Bacillus sp. 549
Bacillus clausii 509 Bacillus sp. 550
Bacillus coagulans 510 Bacillus sp. 551
Bacillus fir mus 51 1 Bacillus sp. 552
Bacillus flexus 512 Bacillus sp. 553
Bacillus fordii 513 Bacillus sp. 554
Bacillus gelatini 514 Bacillus sphaericus 555
Bacillus halmapalus 515 Bacillus sporothermodurans 556
1 1 ς Bacillus subtilis 557 Bacteroides sp. 598
Bacillus thermoamylo vorans 558 Bacteroides sp. 599
Bacillus thurmgiensis 559 Bacteroides sp. 600
Bacillus weihenstephanensis 560 Bacteroides sp. 601
Bacteroidales bacterium 561 Bacteroides sp. 602
Bacteroidales genomosp. 562 Bacteroides sp. 603
Bacteroidales genomosp. 563 Bacteroides sp. 604
Bacteroidales genomosp. 564 Bacteroides sp. 605
Bacteroidales genomosp. 565 Bacteroides sp. 606
Bacteroidales genomosp. 566 Bacteroides sp. 607
Bacteroidales genomosp. 567 Bacteroides sp. 608
Bacteroidales genomosp. 568 Bacteroides sp. 609
Bacteroidales genomosp. 569 Bacteroides sp. 610
Bacteroides acidifaciens 570 Bacteroides sp. 61 1
Bacteroides harnesiae 571 Bacteroides sp. 612
Bacteroides caccae 572 Bacteroides sp. 613
Bacteroides cel!ulosilyticus 573 Bacteroides sp. 614
Bacteroides clarus 574 Bacteroides sp. 615
Bacteroides coagulans 575 Bacteroides sp. 616
Bacteroides coprocola 576 Bacteroides sp. 617
Bacteroides coprophiliis 577 Bacteroides sp. 618
Bacteroides dorei 578 Bacteroides sp. 619
Bacteroides eggerthii 579 Bacteroides sp. 620
Bacteroides faecis 580 Bacteroides sp. 621
Bacteroides finegoldii 581 Bacteroides sp. 622
Bacteroides fluxus 582 Bacteroides sp. 623
Bacteroides fragilis 583 Bacteroides sp. 624
Bacteroides gaiactiironicus 584 Bacteroides sp. 625
Bacteroides helcogenes 585 Bacteroides sp. 626
Bacteroides heparinolyticus 586 Bacteroides sp. 627
Bacteroides intestinalis 587 Bacteroides sp. 628
Bacteroides massiliensis 588 Bacteroides sp. 629
Bacteroides nordii 589 Bacteroides sp. 630
Bacteroides oleiciplenus 590 Bacteroides sp. 631
Bacteroides ovaius 591 Bacteroides stercoris 632
Bacteroides pectmopkihis 592 Bacteroides thetaiotaomicron 633
Bacteroides pleheiiis 593 Bacteroides uniform is 634
Bacteroides pyogenes 594 Bacteroides ureolyticus 635
Bacteroides salanitronis 595 Bacteroides vulgatus 636
Bacteroides salver siae 596 Bacteroides xykmisolvens 637
Bacteroides sp. 597 Bacieroide tes bacterium 638 Bacteroidetes bacterium 639 Blautia glucerasea 678
Bacteroidetes bacterium 640 Blautia glucerasei 679
Barnesiella intestinihominis 641 Blautia hansenii 680
Barnesiella viscericola 642 Blautia hydrogenotrophica 681
Bartonella bacilliformis 643 Blautia luti 682
Bartonella grahamii 644 Blautia producta 683
Bartonella henselae 645 Blautia schinkii 684
Bartonella quiniana 646 Blautia sp. 685
Bartonella tamiae 647 Blautia stercoris 686
Bartonella washoensis 648 Blautia wexlerae 687
Bdellovibrio sp. 649 Brachybacterium alimentarium 688
Bifidohacteriaceae genomosp. 650 Brachybacterium
689
Bifidobacterium adolescentis 651 conglomeratum
Bifidobacterium angu latum 652 Brachybacterium
690
Bifidobacterium animalis 653 tyrofermentans
Brachyspira aal borgi 691
Bifidobacteriu bifid am 654
Brachyspira pilosicoli 692
Bifidobacterium breve 655
Brachyspira sp. 693
Bifidobacterium catenidatum 656
Brachyspira sp. 694
Bifidobacterium gallicum 657
Brachyspira sp. 695
Bifidobacterium infantis 658
Bifidobacterium Brevibacillus agri 696
659
kashiwanohense Brevibacillus h re vis 697
Bifidobacterium longurn 660 Brevibacillus centrosporus 698
Bifidobacterium Brevibacillus choshinensis 699
661
pseudocatemdatum Brevibacillus invocatus 700
Bifidobacterium pseudolongum 662 Brevibacillus laterosporus 701
Bifidobacterium scardovii 663 Brevibacillus parabrevis 702
Bifidobacterium sp. 664 Brevibacillus reuszeri 703
Bifidobacterium sp. 665 Brevibacillus sp. 704
Bifidobacterium sp. 666 Brevibacillus thermoruber 705
Bifidobacterium sp. 667 Brevibacterium aurantiacum 706
Bifidobacterium sp. 668 Brevibacterium casei 707
Bifidobacterium thermophilum 669 Brevibacterium epidermidis 708
Bifidobacterium urinal is 670 Brevibacterium frigoritolerans 709
Bilophila wadsworihia 671 Brevibacterium linens 710
Bisgaard Taxon 672 Brevibacterium mchrellneri 71
Bisgaard Taxon 673 Brevibacterium paucivorans 712
Bisgaard Taxon 674 Brevibacterium sanguinis 713
Bisgaard Taxon 675 Brevibacterium sp. 714
Blastomonas natatoria 676 Brevibacterium sp. 715
Blautia coccoides 677 Brevundimonas subvibrioides 716 Bryantella formatexigens Ill Christensenella minuia 757
Buchnera aphidicola 718 Chromobacterm' m violaceum 758
Bulleidia exiructa 719 Chryseohacterium anthropi 759
Butyricicoccus pullicaecorum 79 η Chryseobacterhim gleum 760
Biityricimonas virosa 111 Chryseobacterhim hominis 761
Btityrivihrio crossotus 7? 9 Citrobacier amalonaticus 762
Butyrivibrio fibrisolvens 723 Citrohacier braakii 763
Caldimonas manganoxidans 724 Citrobacier farmeri 764
Caminicella sporogenes 725 Citrobacier fre ndii 765
Candidates arihromitus 726 Citrobacier gillemi 766
Candidatus sulcia I A I Citrobacier koseri 767
Capnocytophaga canimorsiis 728 Citrobacier murliniae 768
Capnocytophaga genomosp. 729 Citrobacier rodentium 769
C apnocytophaga. gingivalis 730 Citrobacier sedlakii 770
C apnocytophaga granulosa 731 Citrobacier sp. 771
C apnocytophaga. ochracea 732 Citrobacier sp. 77?
Capnocytophaga sp. 733 Citrobacier w erkmanii 773
Capnocytophaga sp. 734 Citrobacier yoimgae 774
Capnocytophaga sp. 735 Cloacibacilliis evr ensis 775
Capnocytophaga sp. 736 Clostridiaceae bacterium 776
Capnocytophaga sp. 737 Clostridiaceae bacterium 777
Capnocytophaga sp. 738 Clost.ridi.al.es bacterium 778
Capnocytophaga sp. 739 Clost.ridial.es bacterium. 779
Capnocytophaga sputigena 740 Clostridial.es bacterium 780
Cardiobacteriii hominis 741 Clostridial.es bacterium 781
Cardiobacteriiim valvarum 742 Clostridiales bacterium 782
Carnobacierium divergens 743 Clostridiales bacterium 783
Carnobacierium Clostridiales bacterium 784
744
maltaromaticum Clostridiales bacterium 785
Catabacter hongkongensis 745 Clostridiales genomosp. 786
Catenibacterium mitsuokai 746 Clostridiales sp. 787
Catonella genomosp. 747 Clostridiales sp. 788
Catonella morbi 748 Clostridiales sp. 789
Catonella sp. 749 Clostridium acetobu licum 790
Cedecea. davisae 750 Clostridium aerotolerans 791
Cellu simicrobium junket 751 Clostridiu aldenense 792
Cetohacterium somerae 752 Clostridiu aldrichii 793
Chlamydiales bacterium 753 Clostridium algidicarnis 794
Chlamydiales bacterium 754 Clostridium algidixy aiwlyticum. 795
Chlamydiales bacterium 755 Clostridium aminovalericum 796
Chloroflexi genomosp. 756 Clostridium amygdalinum 797 Clostridium argeniinense 798 Clostridium irregulare 838
Clostridium asparagiforme 799 Clostridium isaiidis 839
Clostridium baratii 800 Clostridium kluyveri. 840
Clostridium, bar tie itii 801 Clostridium lactatifermentans 841
Clostridium beijerinckii 802 Clostridium lavalense 842
Clostridium bifermentcms 803 Clostridium leptum 843
Clostridium holieae 804 Clostridium limosum 844
Clostridium hutyricum 805 Clostridium magnum 845
Clostridium cadaveris 806 Clostridiu malenominatum 846
Clostridium carboxidi vorans 807 Clostridiu mayombei. 847
Clostridium carnis 808 Clostridium methylpentosum. 848
Clostridium celatum 809 Clostridium nexile 849
Clostridium celerecrescens 810 Clostridium novyi 850
Clostridium, cellulosi 811 Clostridium orbiscindens 851
Clostridium, chauvoei 812 Clostridium oroticum 852
Clostridium ciironiae 813 Clostridium parap. u.tr ificum 853
Clostridium, clariflavum 814 Clostridium phyiofermentans 854
Clostridium, dostridioforme 815 Clostridium piliforme 855
Clostridium coccoides 816 Clostridium putrefaciens 856
Clostridium cochlearium 817 Clostridium q inii 857
Clostridium cocleatum 818 Clostridium ramosum 858
Clostridium col i mis 819 Clostridium rectum 859
Clostridium colinum 820 Clostridiu saccharogumia 860
Clostridium disporicum 821 Clostridium saccharolyticum 861
Clostridium estertheticum 822 Clostridium saccharolyticum 862
Clostridium folia 823 Clostridium sardiniense 863
Clostridium favososporum 824 Clostridium sartagoforme 864
Clostridium, felsineum 825 Clostridium scindens 865
Clostridium frigidicarnis 826 Clostridium sepiicum 866
Clostridium gasigenes 827 Clostridium sordellu 867
Clostridium, ghonii 828 Clostridium sp. 868
Clostridium glycol ic am 829 Clostridium sp. 869
Clostridium, Clostridium sp. 870
830
glycyrrhizinilyticum Clostridium sp. 871
Clostridium haemolyticum 831 Clostridium sp. 872
Clostridium hathewavi 832 Clostridiu sp. 873
Clostridium hiranonis 833 Clostridiu sp. 874
Clostridium, histolyticum 834 Clostridium sp. 875
Clostridium, hylemonae 835 Clostridium sp. 876
Clostridium indolis 836 Clostridium sp. 877
Clostridium innocuum 837 Clostridium sp. 878
1 1 Q Clostridium sp. 879 Coriohacteriaceae bacterium 920
Clostridium sp. 880 Coriohacteriaceae bacterium 921
Clostridium sp. 881 Coryne bacterium accolens 922
Clostridium, sp. 882 Coryne bacterium
923
Clostridium sp. 883 ammoniagenes
Clostridium sp. 884 C orynebacterium appendicis 924
Clostridium sphenoides 885 Coryne bacterium
925
Clostridium spiroforme 886 argentoratense
Coryne bacterium atypicum 926
Clostridium sporogenes 887
Clostridium sporosphaeroides 888 C Orvnebacterium aurimucosum 927
C orynebacterium bovis 928
Clostridium stercorarium 889
C orynebacterium cards 929
Clostridium sticklandii 890
Coryne bacterium casei 930
Clostridium straminisolvens 891
Coryne bac terium confusum 931
Clostridium subterminale 892
Coryne bacterium coyleae 932
Clostridium, sulfidigenes 893
Corynebacterium durum 933
Clostridium symbiosum 894
Corynebacterium efficiens 934
Clostridium, iertiim 895
Coryne bac ter ium falsenii 935
Clostridium, tetani 896
Corynebacterium flavescens 936
Clostridium thermocellum 897
Corynebacterium genitalium 937
Clostridium tyrohutyricum 898
Corynebacterium glauciim 938
Clostridium viride 899
Coryne bac terium
Clostridium xylanolyticum 900 939 glucuronolyticum
Collinsella aerofaciens 901
Corynebacterium gluiamicum 940
Collinsella intestinalis 902
Corynebacterium hansenii 941
Collinsella stercoris 903
Coryne bacterium imitans 942
Collinsella tanakaei 904
Corynebacterium kroppensiedtii 943
Comamonadaceae bacterium 905
Coryne bacterium
Comamonadaceae bacterium 906 944 lipophiloflavum
Comamonadaceae bacterium 907 Corynebacterium macginleyi 945
Comamonadaceae bacterium 908 Coryne bacterium, mastitidis 946
Comamonadaceae bacterium 909 Corynebacterium matruchotii 947
Comamonas sp. 910 Corynebacterium minutissimtim 948
Conchiformibius kuhniae 91 1 Corynebacterium mucifaciens 949
Coprobacillus cateniformis 912 Corynebacterium propinquiim 950
Coprobacillus sp. 913 Coryne bac terium
Coprobacillus sp. 914 951 pseudodiphtheriticum
Coprococcus catus 915 Coryne bacterium
952
Coprococcus comes 916 pseudogenitalium
Coprococcus eutactus 917 Coryne bac terium
953
Coprococcus sp. 918 pseudotuberculosis
Coriohacteriaceae bacterium 919
1 0 Corynebacterium Desulfovibrio fairfieldensis 992
954
pyrtiviciprodticens Desulfovibrio piger 993
Coryne bacterium renale 955 Desulfovibrio sp. 994
Corynebacterium resistens 956 Desulfovibrio vulgaris 995
Corynebacterium riegelii 957 Dialister invisus 996
Corynebacterium simulans 958 Dialister micraerophilus 997
Coryne bactermm singular e 959 Dialister microaerophilus 998
Coryne bactermm sp. 960 Dialister pneumosintes 999
Coryne bac terium sp. 961 Dialister propionicifaciens 1000
Coryne bac terium sp. 962 Dialister sp. 1001
Coryne bacteriu sp. 963 Dialister succinatiphilus 1002
Coryne bacterium sp. 964 Dietzia natronolimnaea 1003
Corynebacterium sundsvallense 965 Dietzia sp. 1004
Coryne bacterium
966 Dietzia sp. 1005 tuber culosiearicum Dietzia timorensis 1006
Coryne bac ter ium tuscaniae 967
Dorea formicigenerans 1007
Corynebacterium ulcer ans 968
Dorea !ongicatena 1008
Coryne bacterium
969 Dysgonomonas gadei 1009 ureicelerivorans
Dysgonomonas mossii 1010
Corynebacterium variabile 970
Edvardsiella tarda 1011
Cronohacier malonaticus 971
Eggerthetta lenta 1012
Cronohacier sakazakii 972
Eggerihella sinensis 1013
Cronohacier turicensis 973
Eggerthetta sp. 1014
Cryptohacterhirn curium. 974
Eggerthetta sp. 1015
Cupriavidus metattidurans 975
Eggerthetta sp. 1016
Cytophaga xylanolytica 976
Eikenetta corrodens 1017
Deferribacteres sp. 977
Enhydrobacter aerosaccus 1018
Deferribacteres sp. 978
Enterobacter aerogenes 1019
Deferribacteres sp. 979
Enterobacter asburiae 1020
De inococcus radiodurans 980
Enterobacter cancerogenus 1021
Deinococcus sp. 981
Enterobacter cloacae 1022
Delftia acidovorans 982
Enterobacter cowanii 1023
Dermabacter hominis 983
Enterobacter hormaechei 1024
Dermacoccus sp. 984
Enterobacter sp. 1025
Desmospora activa 985
Enterobacter sp. 1026
Desmospora sp. 986
Enterobacter sp. 1027
Desu!fitohacterium jrappieri 987
Enterobacter sp. 1028
Desu!fitobacterium hafniense 988
Enterobacter sp. 1029
Desulfohulhus sp. 989
Enterobacteriaceae bacterium 1030
Desulfotomaculum nigrificans 990
Enterohacteriaceae bacterium 1031
Desulfovibrio desulfiiricans 991
Enterobacteriaceae bacterium 1032
1 9 1 Enierococcus avium 1033 Eubacterium coprostanoligen.es 1074
Enierococcus caccae 1034 EMbacteriu cylmdroid.es 1075
Enierococcus casseliflavus 1035 EMbacteriu desmolans 1076
Enierococcus durans 1036 Eubacterium dolichum 1077
Enierococcus faecalis 1037 Eubacterium eligens 1078
Enierococcus faecium 1038 Eubacterium fissicatena 1079
Enierococcus gaUinarum. 1039 Eubacterium hadrum 1080
Enierococcus gilvus 1040 Eubacterium hailii 1081
Enierococcus hawaiiensis 1041 Eubacterium infirmu 1082
Enierococcus hirae 1042 Eubacierium iimosum. 1083
Enierococcus italicus 1043 Eubacterium moniliforme 1084
Enierococcus mundtii 1044 Eubacterium multiforme 1085
Enierococcus raffinosus 1045 Eubacterium nitritogenes 1086
Enierococcus sp. 1046 Eubacterium nodatum 1087
Enierococcus sp. 1047 Eubacterium ramuius 1088
Enierococcus sp. 1048 EMbacteriu rectaie 1089
Enierococcus sp. 1049 Eubacterium ruminantium 1090
Enierococcus thailandicus 1050 Eubacterium saburreum 1091
Eremococcus coleocola 1051 Eubacterium saphenum 1092
Erysipelothrix inopinata 1052 Eubacterium siraeum 1093
Erysipelothrix rhusiopathiae 1053 Eubacterium sp. 1094
Erysipelothrix tonsillarum 1054 Eubacterium sp. 1095
Erysipelotrichaceae bacterium 1055 Eubacierium sp. 1096
Erysipelotrichaceae bacterium 1056 Eubacterium sp. 1097
Escherichia albertii 1057 Eubacterium sp. 1098
Escherichia coli 1058 Eubacterium sp. 1099
Escherichia fergusonii 1059 Eubacterium sp. 1100
Escherichia hermannii 1060 Eubacterium sp. 1101
Escherichia sp. 1061 Eubacterium sp. 1102
Escherichia sp. 1062 Eubacterium sp. 1 103
Escherichia sp. 1063 Eubacterium sp. 1 104
Escherichia vulneris 1064 Eubacterium tenue 1 105
Ethanoligenens harbinense 1065 Eubacterium tortuosum 1 106
Eubacteriaceae bacterium 1066 Eubacterium ventriosum 1 107
Eubacterium. barkeri 1067 Eubacterium xylanophilum 1 108
EjAbacterium biforme 1068 Eubacierium vurii 1 109
EjAbacterium brachy 1069 Ew ingella americana 1110
Eubacterium, budayi 1070 Exiguobacierium acetylicim 1111
Eubacterium, callanderi 1071 Fackiamia hominis 1112
Eubacterium cellulosolvens 1072 Faecalibacterium prausnitzii 1113
Eubacierium contortum 1073 Filifactor alocis 1114
1 9 Fill factor villosus 1115 Gemella haemolysans 1156
Finegoldia. magna 1116 Gemella. morhilloru 1 157
Flavohacteriaceae genomosp. 1117 Gemella. morhilloru 1 158
Flavohacterium sp. 1118 Gemella sanguinis 1 159
Flavonifracior plautii 1119 Gemella sp. 1 160
Flexispira rappini 1 120 Gemella sp. 1 161
Flexistipes sinusarabici 1 121 Gemella sp. 1 162
Francisella novicida 1 122 Gemella sp. 1 163
Francisella philomiragia 1 123 Gemmiger formicilis 1 64
Fulvimonas sp. 1 124 Geobacillus kaustophilus 1 65
Fusohacterium canifelinum 1125 Geohacillus sp. 1166
Fusohacterium genomosp. 1126 Geobacillus sp. 1167
Fusobacteriiim genomosp. 1127 Geobacillus stearothermophilus 1168
Fusohacterhim gonidiaformans 1128 Geohacillus ihermocateniilatus 1169
Fusohacterhim. mortiferum 1129 Geohacillus ihermodenitrificans 1170
Fusohacterhim naviforme 1130 Geobacillus
1 171
F sohacterium. necrogenes 1131 thermoglucosidasius
F sohacterium. necrophorum 1132 Geobacillus thermoleovorans 1172
Fiisohacterium nucleatiim 1133 Geobacter bemidjiensis 1173
Fiisohacterium periodontium 1 134 Gloeobacter violaceiis 1174
Fiisohacterium russii 1 135 Giuconacetobacier
1 175
Fusohacterium sp. 1 136 azotocaptans
Gluconacetobacter
Fusohacterium sp. 1 137 1176 diazotrophicus
Fusobacteriiim sp. 1 138
Gluconacetobacter entanii 1 177
Fusobacteriiim sp. 1139
Gluconacetobacter europaeus 1 178
Fusobacteriiim sp. 1140
Gluconacetobacter hansenii 1 179
Fusobacteriiim sp. 1141
Gluconacetobacter johannae 1 180
Fusohacterhim sp. 1142
Gluconacetobacter ohoediens 1 181
Fusohacterium sp. 1143
Gluconacetobacter xylinus 1 82
Fusohacterium sp. 1144
Gordonia hronchialis 1 83
Fiisohacterium sp. 1145
Gordonia polyisoprenivorans 1184
Fiisohacterium sp. 1146
Gordonia sp. 1185
F sohacterium sp. 1 147
Gordonia sputi 1186
F sohacterium sp. 1 148
Gordonia terrae 1187
Fusohacterium sp. 1 149
Gordonihacter pamelaeae 1188
Fusohacterium sp. 1 150
Gordonibacier pamelaeae 1 189
Fusohacterium sp. 1 151
Gracilibacter thermotolerans 1 190
Fusohacterium sp. 1152
Gramellafor e tii 1 191
Fusohacterium iilcerans 1153
Granulicatella adiacens 1 192
Fusohacterium varium 1154
Granulicatella e legal is 1 193
Gardnerella vaginalis 1155
1 Granidicatella paradiacem 1194 Holdemania filiformis 1234
Granulicatella sp. 1195 Hydrogenoanaerobacterium
1235
Granidicatella sp. 1196 saccharovorans
Granulicatella sp. 1197 Hyperthermia butylicus 1236
Granulicatella sp. 1198 Hyphomicrobium sulfonivorans 1237
Granulicatella sp. 1 199 Hyphomonas neptunium 1238
Grimoniia hollisae 1200 Ignatzschineria indica 1239
Haematobacter sp. 1201 Ignatzschineria sp. 1240
Haemophilus aegyptius 1202 Ignicoccus islandicus 1241
Haemophilus genomosp. 1203 Inquiliniis limosus 1242
Haemophilus genomosp. 1204 Janibacter limosus 1243
Haemophilus haemolytictis 1205 Janibacter melonis 1244
Haemophilus parahaemolyticus 1206 Janthinobacteritim sp. 1245
Haemophilus parainfluemae 1207 Johnsonella ignava 1246
Haemophilus Jonquetella anthropi 1247
1208
paraphrophaemolyticus Kerstersia gytonaii 1248
Haemophilus parasuis 1209 Kingella denitrijicans 1249
Haemophilus somnus 1210 Kingella genomosp. 1250
Haemophilus sp. 1211 Kingella kingae 1251
Haemophilus sp. 1212 Kingella oralis 1252
Haemophilus sp. 1213 Kingella sp. 1253
Haemophilus sp. 1214 Klebsiella sp. 1254
Haemophilus sp. 1215 Klebsiella sp. 1255
Haemophilus sp. 1216 Klebsiella sp. 1256
Haemophilus sp. 1217 Klebsiella sp. 1257
Haemophilus sp. 1218 Klebsiella sp. 1258
Haemophilus sputorum 219 Klebsiella sp. 1259
Hafnia alvei 1220 Klebsiella sp. 1260
Halomonas elongata 1221 Klebsiella sp. 1261
Halomonas johnsoniae 1222 Klebsiella sp. 1262
Halorubrum lipoly ticum 1223 Klebsiella sp. 1263
Helicobacter bills 1224 Klebsiella sp. 1264
Helicobacter canadensis 1225 Klebsiella variicola 1265
Helicobacter cinaedi 1226 Kluyvera ascorbata 1266
Helicobacter pullorum 1227 Kluyvera cryocrescens 1267
Helicobacter sp. 1228 Kocuria marina 1268
Helicobacter winghamensis 1229 Kocuria palustris 1269
Heliobacterium modesticaldti 1230 Kocuria rhizophila 1270
H erbaspirillum seropedicae 1231 Kocuria rosea 1271
Herbaspirillum sp. 1232 Kocuria varians 1272
Histophilus somni 1233 Lachnobacterium bovis 1273
1 94 Lachnospira multipara 1274 LMCtobacillus genomosp. 1315
Lachnospira pectinoschiza 1275 Lactobacillus helve ticus 1316
Lachnospiraceae bacterium 1276 LMCtobacillus hilgardii 1317
Lachnospiraceae bacterium 1277 Lactobacillus hominis 1318
Lachnospiraceae bacterium 1278 Lactobacillus iners 1319
Lachnospiraceae bacterium 1279 Lactobacillus jensenii 1320
Lachnospiraceae bacterium 1280 Lactobacillus johnsonii 1321
Lachnospiraceae bacterium 1281 Lactobacillus kalixensis 1322
Lachnospiraceae bacterium 1282 Lactobacillus kefir anofaciens 1323
Lachnospiraceae bacterium 1283 Lactobacillus kefir i 1324
Lachnospiraceae bacterium 1284 Lactobacillus kimchii 1325
Lachnospiraceae bacterium 1285 Lactobacillus leichmannii 1326
Lachnospiraceae bacterium 1286 Lactobacillus mucosae 1327
Lachnospiraceae bacterium 1287 LMCtobacillus murinus 1328
Lachnospiraceae bacterium 1288 LMCtobacillus nodensis 1329
Lachnospiraceae bacterium 1289 LMCtobacillus oeni 1330
Lachnospiraceae bacterium 1290 Lactobacillus oris 1331
Lachnospiraceae bacterium 1291 Lactobacillus parabrevis 1332
Lachnospiraceae bacterium 1292 Lactobacillus parabuchneri 1333
Lachnospiraceae genomosp. 1293 Lactobacillus paracasei 1334
Lactobacillus acidipiscis 1294 Lactobacillus parakefiri 1335
Lactobacillus acidophilus 1295 Lactobacillus pentosus 1336
Lactobacillus alimentarius 1296 Lactobacillus perolens 1337
Lactobacillus amylolyticus 1297 Lactobacillus plantarum 1338
Lactobacillus amylovorus 1298 Lactobacillus pontis 1339
Lactobacillus antri 1299 LMCtobacillus reuteri 1340
Lactobacillus brevis 1300 LMCtobacillus rhamnosus 1341
Lactobacillus huchneri 1301 LMCtobacillus rogosae 1342
Lactobacillus casei 1302 LMCtobacillus ruminis 1343
Lactobacil las catenaformis 1303 LMCtobacillus sakei 1344
Lactobacillus coleohominis 1304 Lactobacillus salivarius 1345
Lactobacillus coryniformis 1305 Lactobacillus saniviri 1346
Lactobacillus crispatus 306 Lactobacillus senioris 1347
Lactobacillus curvatus 1307 Lactobacillus sp. 1348
Lactobacillus delbrueckii 1308 Lactobacillus sp. 1349
Lactobacillus dextrinicus 1309 Lactobacillus sp. 1350
Lactobacillus farciminis 1310 Lactobacillus sp. 1351
Lactobacillus fermentum 1311 Lactobacillus sp. 1352
Lactobacillus gasseri 1312 Lactobacillus sp. 1353
Lactobacillus gastricus 1313 LMCtobacillus sp. 1354
Lactobacillus genomosp. 1314 LMCtobacillus sp. 1355 Lactobacillus sp. 1356 Leuconostoc kimchii 1397
Lactobacillus sp. 1357 Leuconostoc lactis 1398
Lactobacillus sp. 1358 Leuconostoc mese nteroi.de s 1399
Lactobacillus sp. 1359 Leuconostoc
1400
Lactobacillus sp. 1360 pseudomesenieroid.es
Lactobacillus sp. 1361 Listeria innocua 1401
Lactobacillus sp. 1362 L steria ivanovii 1402
Lactobacillus sp. 1363 LMteococcus sanguinis 1403
Lactobacillus sp. 1364 Lulispora thermophila. 1404
Lactobacillus sp. 1365 Lysinibacillus fusiformis 1405
Lactobacillus tucce ti 1366 Lysinibacilliis sphaericus 1406
Lactobacillus ultunensis 1367 Macrococcus caseolyticus 1407
Lactobacillus vaginalis 1368 Mannheimia haemolytica 1408
Lactobacillus vini 1369 Marvinbryantia formatexigens 1409
Lactobacillus vi in linns 1370 Mass ilia sp. 1410
Lactobacillus zeae 1371 Megamonas funiformis 1411
Lactococcus garvieae 1372 Megamonas hypermegale 1412
Lactococcus lactis 1373 Megasphaera genomosp. 1413
LMCtococcus raffmolactis 1374 Megasphaera genomosp. 1414
LMCtonifactor longoviformis 1375 Megasphaera micronuciformis 1415
I. ari barter kongkongensis 1376 Megasphaera sp. 1416
Lautropia mirabilis 1377 Megasphaera sp. 1417
Lautropia. sp. 1378 Metal. losphaera sedula. 1418
Leminorella grimontii 1379 Methanobacierium. formicicum 1419
Leminorella richardii 1380 Methanobrevibacter
1420
Leptotrichia buccalis 1381 acididurans
Methanobrevibacter
Leptotrichia geno osp. 1382 1421 arboriphilus
Leptotrichia goodfellowii 1383
Methanobrevibacter cnrvatus 1422
Leptotrichia hofstadu 1384
Methanobrevibacter cuticularis 1423
Leptotrichia shahii 1385
Methanobrevibacter filiformis 1424
Leptotrichia sp. 1386
Methanobrevibacter
Leptotrichia sp. 1387 1425 gottschalkii
Leptotrichia sp. 1388 Methanobrevibacter millerae 1426
Leptotrichia sp. 1389 Methanobrevibacter ollevae 1427
Leptotrichia sp. 1390 Methanobrevibacter oralis 1428
Leptotrichia. sp. 1391 Methanobrevibacter
Leptotrichia. sp. 1392 1429 ruminaniium
Leuconostoc carnosum 1393 Methanobrevibacter smithii 1430
Leuconostoc citreum 1394 Methanobrevibacter thaueri 1431
Leuconostoc gasicomitatum 1395 Methanobrevibacter woesei 1432
Leuconostoc inhae 1396
1 9ή Meihanobrevibacter wolinii 1433 Moraxe lla osloensis 1474
Methanosphaera stadtmcmae 1434 Moraxella sp. 1475
Methylobacieriinn extorquens 1435 Moraxella sp. 1476
Methylohacierium podarium 1436 Morganella morgans i 1477
Methyiohacterinm radiotolerans 1437 Morganella sp. 1478
Methyiohacterinm sp. 1438 Morococcus cerebrosus 1479
Methyiohacterinm sp. 1439 Moryella indoligenes 1480
Methyiocella silvestris 1440 Mycobacterium sp. 1481
Meihylophilus sp. 1441 Mycobacterium sp. 1482
Microbacterium chocolaium 1442 Mycobacterium sp. 1483
M icrobacterium flavescens 1443 Mycobacterium sp. 1484
Microbacterium gubbeenense 1444 Mycobacterium sp. 1485
Microbacterium lacticum 1445 Mycobacterium sp. 1486
Microbacterium oleivorans 1446 Mycobacterium sp. 1487
Microbacterium oxydans 1447 Mycobacterium sp. 1488
Microbacteriu paraoxydans 1448 Mycobacterium sp. 1489
Microbacterium phyllosphaerae 1449 Mycobacterium sp. 1490
Microbacterium schleiferi 1450 Mycobacterium sp. 1491
Microbacterium sp. 1451 Mycobacterium sp. 1492
Microbacterium sp. 1452 Mycobacterium sp. 1493
Microbacterium iesiaceum 1453 Mycobacterium sp. 1494
Micrococcus aniarcticus 1454 Mycobacterium sp. 1495
Micrococcus luteus 1455 Mycoplasma agalactiae 1496
Micrococcus lylae 1456 Mycoplasma amphoriforme 1497
Micrococcus sp. 1457 Mycoplasma arthritidis 1498
Microcystis aeruginosa 1458 Mycoplasma hovoculi 1499
Mitsuokella ialaludinii 1459 Mycoplasma faucium 1500
Mitsuokella muitacida 1460 Mycoplasma fermentans 1501
Mitsuokella. sp. 1461 Mycoplasma flocculare 1502
Mitsuokella sp. 1462 Mycoplasma geniialium 1503
Mobiluncus curiisii 1463 Mycoplasma hominis 1504
Mobiluncus mulieris 1464 Mycoplasma or ale 1505
Moellerella wisconse sis 1465 Mycoplasma ovipneumoniae 1 506
Mogibacterium diver sum 1466 Mycoplasma penetrans 1 507
Mogibacterium neglecium 1467 Mycoplasma pneumoniae 1508
Mogibacterium pumilum 1468 Mycoplasma puirefaciens 1509
Mogibacterium timidum 1469 Mycoplasma salivariurn 1510
Mollicutes bacterium 1470 Mycoplasmaiaceae genomosp. 1511
Moorella thermoacetica 1471 Myroides odoratimimus 1512
Moraxella catarrhalis 1472 Myroides sp. 1513
Moraxella lincolnii 1473 Neisseria hacilliformis 1514
1 7 Neisseria cinerea 1515 Olsenetta sp. 1554
Neisseria elongata 1516 Olsenetta sp. 1555
Neisseria flavescens 1517 Olsenetta uli 1556
Neisseria, genomosp. 1518 Opitutus terrae 1557
Neisseria lactamica 1519 Oribacterium sinus 1558
Neisseria macacae 1520 Oribacterium sp. 1559
Neisseria mucosa 1521 Oribacterium sp. 1 560
Neisseria pharyngis 1522 Oribacterium sp. 1561
Neisseria polysaccharea 1523 Oribacterium sp. 1562
Neisseria sicca 1524 Oribacterium sp. 1563
Neisseria sp. 1525 Oribacterium sp. 1564
Neisseria sp. 1526 Oribacterium sp. 1565
Neisseria sp. 1527 Oribacterium sp. 1566
Neisseria sp. 1528 Ornithinibacillus havariensis 1567
Neisseria sp. 1529 OrnithinibaciUus sp. 1568
Neisseria sp. 1530 Oscittibacter sp. 1569
Neisseria sp. 1531 Oscittibacter valericigenes 1570
Neisseria subflava 1532 Oscittospira giiittiermondu 1571
Neorickettsia risiicii 1533 Oxalobacter for mi genes 1572
Neorickettsia sennetsu 1534 Paenibacillus harcinonensis 1573
Nocardia hrasiliensis 1535 Paenibacillus harengoltzii 1574
Nocardia cyriacigeorgica 1536 Paenibacillus chibensis 1575
Nocardia farcinica 1537 Paenibacillus cookii 1576
Nocardia pnris 1538 Paenibacillus dnrus 1577
Nocardia sp. 1539 Paenibacillus glucanolyticus 1578
Nocardiopsis dassonvittei 1540 Paenibacillus lactis 1579
Novosphingobium Paenibacillus lautus 1580
1541
aromaticivorans Paenibacillus ub uli 1581
Oceanohacillus caeni 1542 Paenibacillus poly myxa 1582
Oceanohacillus sp. 1543 Paenibacillus pop ill iae 1583
Ochrobactrum anthropi 1544 Paenibacillus sp. 1584
Ochrobactrum intermedium 1545 Paenibacillus sp. 1585
Ochrobactrum
1546 Paenibacillus sp. 1 586 pseudintermedium Paenibacillus sp. 1 587
Odoribacter laneus 1547
Paenibacillus sp. 1588
Odoribacter splanchnicus 1548
Paenibacillus sp. 1589
Okadael la gastrococcus 1549
Paenibacillus sp. 1590
Oligella ureolytica 1550
Paenibacillus timonensis 1591
Oligella urethral is 1551
Pantoea agglomerans 1592
Olsenetta genomosp. 1552
Pantoea ananatis 1593
Olsenetta profusa 1553
Pantoea hrenneri 1594
1 98 Pantoea citrea 1595 Peptoniphilus sp. 1635
Pantoea conspicua 1596 Peptoniphilus sp. 1636
Pantoea septica 1597 Pepiostreptococcaceae
1637
Papillibacter cinnamivorans 1598 bacterium
Parahacteroides distasonis 1599 Peptostreptococcus anaerobitis 1638
Parabacteroides goldsteinii 1600 Pepiostreptococcus micros 1639
Parahacteroides gordonii 1601 Peptostreptococcus sp. 1640
Parahacteroides johnsonii 1602 Pepiostreptococcus sp. 1641
Parabacteroides merdae 1603 Peptostreptococcus sp. 1642
Parabacteroides sp. 1604 Peptostreptococcus sp. 1643
Parabacteroides sp. 1605 Peptostreptococcus stomaiis 1644
Parachlamydia sp. 1606 Phascolarctobacterium faecium 1645
Paracoccus denitrificans 1607 Phascolarctobacterium sp. 1646
Paracoccus marcusii 1608 Phascolarctobacterium
1647
Paraprevotella clara 1609 succinatutens
P he nylo bacterium ziicine urn 1648
Paraprevotella xylaniphila 1610
Photorhabdus asymbiotica 1649
Parascardovia denticolens 161 1
Parasutterella Pigmentiphaga daeguensis 1650
1612
excrernentihominis Planomicrobium koreense 1651
Parasutterella secunda 1613 Plesiomonas shigelloides 1652
Parvimonas micro 1614 Porphyromonadaceae
1653
Parvimonas sp. 1615 bacterium
Porphyromonas
Pasteur ella bettyae 1616 1654 asaccharolytica
Pastenrella dagmatis 1617
Porphyromonas endodontalis 1655
Pasteur ella multocida 1618
Porphyromonas gingivalis 1656
Pediococciis acidilactici 1619
Porphyromonas levii 1657
Pediococciis pentosaceus 1620
Porphyromonas macacae 1658
Peptococcus niger 1621
Porphyromonas somerae 1659
Peptococcus sp. 1622
Porphyromonas sp. 1660
Peptococcus sp. 1623
Porphyromonas sp. 1661
Peptoniphilus asaccharolyticus 1624
Porphyromonas sp. 1662
P ptoniphilus duerdenii 1625
Porphyromonas sp. 1663
Peptoniphihis harei 1626
Porphyromonas sp. 1664
Peptoniphihis indolicus 1627
Porphyromonas uenonis 1665
Peptoniphihis ivorii 1628
Prevotella albensis 1666
Peptoniphihis lacrimal is 1629
Pre vol i la amnii 1667
Peptoniphihis sp. 1630
Prevotella. bergensis 1668
Peptoniphilus sp. 1631
Prevotella bivia 1669
Peptoniphilus sp. 1632
Prevotella brevis 1670
Peptoniphilus sp. 1633
Prevotella buccae 1671
Peptoniphilus sp. 1634
1 9Q Prevotella buccalis 1672 Prevotella sp. 1713
Prevotella copri. 1673 Prevotella sp. 1714
Pre vote Ha corporis 1674 Prevotella sp. 1715
Prevotella dentalis 1675 Prevotella sp. 1716
Prevotella denticola 1676 FJrevotella sp. 1717
Prevotella disiens 1677 FJrevotella sp. 1 718
Prevotella genomosp. 1678 Prevotella. sp. 1 719
Prevotella genomosp. 1679 Prevotella. sp. 1720
Prevotella genomosp. 1680 Prevotella sp. 1721
Prevotella genomosp. 1681 Prevotella sp. 1722
Prevotella. genomosp. 1682 Prevotella sp. 1723
Prevotella heparinolytica 1683 Prevotella sp. 1724
Prevotella histicola 1684 Prevotella sp. 1725
Prevotella intermedia 1685 Prevotella sp. 1726
Prevotella loescheii 1686 Prevotella sp. 1727
Pre vote Ha maculosa 1687 Prevotella sp. 1728
Prevotella marshii 1688 Prevotella sp. 1729
Pre votella melaninogenica 1689 Prevotella sp. 1730
Prevotella micans 1690 FJrevotella sp. 1731
Prevotella multiformis 1691 FJrevotella sp. 1732
Prevotella multisaccharivora 1692 F'revotella. sp. 1733
Prevotella nance sens is 1693 F'revotella. sp. 1734
Prevotella. nigrescens 1694 Prevotella sp. 1735
Prevotella oralis 1695 Prevotella sp. 1736
Prevotella oris 1696 Prevotella sp. 1737
Prevotella oulorum 1697 Prevotella sp. 1738
Prevotella pattens 1698 Prevotella sp. 1739
Pre votella ruminicola 1699 Prevotella sp. 1740
Prevotella salivae 1700 FJrevotella sp. 1741
Prevotella sp. 1701 FJrevotella sp. 1742
Prevotella sp. 1702 FJrevotella sp. 1743
Prevotella sp. 1703 FJrevotella sp. 1744
Prevotella sp. 1704 FJrevotella sp. 1 745
Prevotella sp. 1705 FJrevotella sp. 1 746
Prevotella sp. 1706 F'revotella. stercorea 1747
Prevotella sp. 1707 Prevotella tannerae 1748
Prevotella sp. 1708 Prevotella timonensis 1749
Prevotella sp. 1709 Prevotella veroralis 1750
Prevotella sp. 1710 Prevotellaceae bacterium 1751
Prevotella sp. 1711 Prochlorococciis marinus 1752
Prevotella sp. 1712 Propionibacteriaceae bacterium 1753
1 XC\ Propionibacierium P sychrobacter arciicus 1792
1754
acidipropionici Psvchrobacier cibarius 1793
Propionibacierium acnes 1755 Psvchrobacier crvohalolentis 1794
Propionibacierium avidum 1756 P sychrobacter faecalis 1795
Propionibacierium
1757 P sychrobacter nivimaris 1796 freudenreichii P 'sychrobacter pulmonis 1797
Propionibacierium granulosum 1758
P sychrobacter sp. 1 798
Propionibacierium jensenii 1759
Pyramidobacter piscolens 1799
Propionibacierium propionicum 1760
Ralsionia pickeitii 1800
Propionibacierium sp. 1761
Ralsionia sp. 1801
Propionibacierium sp. 1762
Raotdtella ornithinolytica 1802
Propionibacierium sp. 1763
Raoultella planticola 1803
Propionibacierium sp. 1764
Raoultella terrigena 1804
Propionibacierium sp. 1765
Rhodohacter sp. 1805
Propionibacierium thoenii 1766
Rhodohacier sphaeroides 1806
Proteus mirabitis 1767 Rhodococcus 1
Proteus penned 1768 l oU /
corvnebacterioides
Proteus sp. 1769 Rhodococcus equi 1808
Proteus vulgaris 1770 Rhodococcus erythropolis 1809
Providencia alcalifaciens 1771 Rhodococcus fascians 1810
Providencia rettgeri 1772 Rhodopseudomonas palustris 181 1
Providencia riisiigianii 1773 Robinsoniella peoriensis 1812
Providencia stuariii 1774 Rose bun a cecicola 1813
P eudoclavihacter sp. 1775 Rose buria fae calls 1814
Pseudoflavonifr actor capillosus 1776 Roseburia faecis 1815
Pseudomonas aeruginosa 1777 Roseburia hominis 1816
Pseudomonas fluorescens 1778 Roseburia intestinalis 1817
Pseudomonas gessardii 1779 Roseburia inulinivorans 1818
Pseudomonas mendocina 1780 Roseburia sp. 1819
Pseudomonas monteilii 1781 Roseburia. sp. 1820
Pseudomonas poae 1782 Roseiflexus castenholzii 1821
Pseudomonas
1783 Roseomonas cervicalis 1822 pseudoalcaligenes Roseomonas mucosa 1823
Pseudomonas putida 1784
Roseomonas sp. 1824
Pseudomonas sp. 1785
Roseomonas sp. 1825
Pseudomonas sp. 1786
Roseomonas sp. 1826
Pseudomonas sp. 1787
Roseomonas sp. 1827
Pseudomonas stutzeri 1788
Rothia aeria 1828
Pseudomonas tolaasu 1789
Rothia dentocariosa 1829
Pseudomonas viridiflava 1790
Rothia mucilaginosa 1830
Pseudoramihacter alaciolyticus 1791
Rothia nasimurium 1831
m Rothia sp. 1832 Selenomonas sp. 1873
Ruminobacier amylophilus 1833 Selenomonas sp. 1874
Ruminococcaceae bacterium 1834 Selenomonas sp. 1875
Ruminococcus al bus 1835 Selenomonas sp. 1876
Riiminococcns bromii 1836 Selenomonas sp. 1877
Ruminococcus callidus 1837 Selenomonas sp. 1878
Ruminococcus champanellensis 1838 Selenomonas sp. 1879
Ruminococcus flavefaciens 1839 Selenomonas sp. 1880
Ruminococcus gnavus 1840 Se lenomonas spuiigena 1881
Ruminococcus ha us an 1841 Serratia fonticola 1882
Ruminococcus lactaris 1842 Serratia liquefaciens 1883
Ruminococcus obeum 1843 Serratia marcescens 1884
Ruminococcus sp. 1844 Serratia odorifera 1885
Ruminococcus sp. 1845 Serratia proieamaculans 1886
Ruminococcus sp. 1846 Shewanella putrefaciens 1887
Ruminococcus sp. 1847 Shuttleworthia satelles 1888
Ruminococcus sp. 1848 Shu ttles or thia sp. 1889
Ruminococcus torques 1849 Shuttleworthia sp. 1890
Saccharomonospora viridis 1850 Simonsiella muelleri 1891
Sarcina ventriculi 1851 Slackia equolifaciens 1892
Scardovia inopinata 1852 Slackia exigua 1893
Scardovia wiggsiae 1853 Slackia faecicanis 1894
Segniliparus rotundus 1854 Slackia heliotrinireducens 1895
Segniliparus rugosus 1855 Slackia isoflavoniconvertens 1896
Selenomonas artemidis 1856 Slackia piriformis 1897
Selenomonas dianae 1857 Slackia sp. 1898
Selenomonas flueggei 1858 Solobacterium moorei 1899
Selenomonas genomosp. 1859 Sphingobacterium faecium 1900
Selenomonas genomosp. 1860 Sphmgobacierium mizuiaii 1901
Selenomonas genomosp. 1861 Sphmgobacierium miiltivorum 1902
Selenomonas genomosp. 1862 Sphingobacterium spiritivorum 1903
Selenomonas genomosp. 1863 Sphingomonas echinoides 1904
Selenomonas genomosp. 1864 Sphingomonas sp. 1905
Selenomonas infeli 1865 Sphingomonas sp. 1906
Selenomonas noxia 1866 Sphingomonas sp. 1907
Selenomonas ruminantium 1867 Sphingomonas sp. 1908
Selenomonas sp. 1868 Sphingopyxis alaskensis 1909
Selenomonas sp. 1869 Spiroplasma insolitum 1910
Selenomonas sp. 1870 Sporobacter term itidis 1911
Selenomonas sp. 1871 Sporolactobacillus inulinus 1912
Selenomonas sp. 1872 Sporolactobacillus nakayamae 1913
1 Χ Sporosarcina newyorkensis 1914 Streptococcus dysgalactiae 1954
Sporosarcina sp. 1915 Streptococcus equi 1955
Staphylococcaceae bacterium 1916 Streptococcus equinus 1956
Staphylococcus aureus 1917 Streptococcus gallo!yticus 1957
Staphylococcus auricularis 1918 Streptococcus genomosp. 1958
Staphylococcus capitis 1919 Streptococcus genomosp. 1959
Staphylococcus caprae 1920 Streptococcus genomosp. 1960
Staphylococcus carnosus 1921 Streptococcus genomosp. 1961
Staphylococcus cohnii 1922 Streptococcus genomosp. 1962
Staphylococcus condiment! 1923 Streptococcus genomosp. 1963
Staphylococcus epidermidis 1924 Streptococcus genomosp. 1964
Staphylococcus equorum 1925 Streptococcus genomosp. 1965
Staphylococcus flew eitii 1926 Streptococcus gordonii 1966
Staphylococcus haemolyticus 1927 Streptococcus infantarius 1967
Staphylococcus hominis 1928 Streptococcus in fu litis 1968
Staphylococcus lugdunensis 1929 Streptococcus intermedins 1969
Staphylococcus pasteuri 1930 Streptococcus lutetiensis 1970
Staphylococcus Streptococcus massiliensis 1971
1931
pseudintermedius Streptococcus milleri 1972
Staphylococcus saccharolyticus 1932 Streptococcus mitis 1973
Staphylococcus saprophyticus 1933 Streptococcus muians 1974
Staphylococcus sciuri 1934 Streptococcus oligofermentans 1975
Staphylococcus sp. 1935 Streptococcus oralis 1976
Staphylococcus sp. 1936 Streptococcus parasanguinis 1 77
Staphylococcus sp. 1937 Streptococcus pasteurianus 1978
Staphylococcus succinus 1938 Streptococcus peroris 1979
Staphylococcus vitulinus 1939 Streptococcus pneumoniae 1980
Staphylococcus warneri 1940 Streptococcus porcinus 1981
Staphylococcus xylosus 1941 Streptococcus
1982
Stenotrophomonas maltophilia 1942 pseudopneumoniae
Stenotrophomonas sp. 1943 Streptococcus pseudoporcinus 1983
Strepiobacillus moniliformis 1944 Streptococcus ratti 1984
Streptococcus agalactiae 1945 Streptococcus salivarius 1985
Streptococcus alactolyticus 1946 Streptococcus sanguinis 1986
Streptococcus anginosus 1947 Streptococcus sinensis 1987
Streptococcus australis 1948 Streptococcus sp. 1988
Streptococcus ho vis 1949 Streptococcus sp. 1989
Streptococcus canis 1950 Streptococcus sp. 1990
Streptococcus constellatus 1951 Streptococcus sp. 1991
Streptococcus cristatus 1952 Streptococcus sp. 1992
Streptococcus downei 1953 Streptococcus sp. 1993
1 1 Streptococcus sp. 1994 Streptococcus sp. 2035
Streptococcus sp. 1995 Streptococcus sp. 2036
Streptococcus sp. 1996 Streptococcus sp. 2037
Streptococcus sp. 1997 Streptococcus sp. 2038
Streptococcus sp. 1998 Streptococcus sp. 2039
Streptococcus sp. 1999 Streptococcus sp. 2040
Streptococcus sp. 2000 Streptococcus suis 2041
Streptococcus sp. 2001 Streptococcus thermophilics 2042
Streptococcus sp. 2002 Streptococcus uberis 2043
Streptococcus sp. 2003 Streptococcus urinalis 2044
Streptococcus sp. 2004 Streptococcus vestibularis 2045
Streptococcus sp. 2005 Streptococcus viridans 2046
Streptococcus sp. 2006 Streptomyces alhus 2047
Streptococcus sp. 2007 Streptornyces griseus 2048
Streptococcus sp. 2008 Streptomyces sp. 2049
Streptococcus sp. 2009 Streptomyces sp. 2050
Streptococcus sp. 2010 Streptomyces sp. 2051
Streptococcus sp. 201 1 Streptomyces sp. 2052
Streptococcus sp. 2012 Streptomyces sp. 2053
Streptococcus sp. 2013 Streptomyces thermoviolaceus 2054
Streptococcus sp. 2014 Suhdoligranulum variahile 2055
Streptococcus sp. 2015 Succinatimonas hippei 2056
Streptococcus sp. 2016 Suiter ella morbirenis 2057
Streptococcus sp. 2017 Sutter ella parvirubra 2058
Streptococcus sp. 2018 Sutterella sanguinus 2059
Streptococcus sp. 2019 Sutter ella sp. 2060
Streptococcus sp. 2020 Sutterella stercoricanis 2061
Streptococcus sp. 2021 Sutterella wadsworthensis 2062
Streptococcus sp. 2022 Synergistes genomosp. 2063
Streptococcus sp. 2023 Synergistes sp. 2064
Streptococcus sp. 2024 Synergistetes bacterium 2065
Streptococcus sp. 2025 Synergistetes bacterium 2066
Streptococcus sp. 2026 Synergistetes bacterium 2067
Streptococcus sp. 2027 Synergistetes bacterium 2068
Streptococcus sp. 2028 Synergistetes bacterium 2069
Streptococcus sp. 2029 Synlrophococcus sucromuians 2070
Streptococcus sp. 2030 Syntrophomonadaceae
2071
Streptococcus sp. 2031 genomosp.
Streptococcus sp. 2032 Tannerella forsythia 2072
Streptococcus sp. 2033 Tanner ella sp. 2073
Streptococcus sp. 2034 Tatlockia micdadei 2074
1 ΊΑ Tatumetta ptyseos 2075 TsukamureUa tyrosinosolvens 21 15
Tessaracoccus sp. 2076 Turicibacier sanguinis 21 16
Tetragenococctis halopkiltis 2077 Ureaplasma parvum 21 17
Tetragenococctis koreensis 2078 Ureaplasma urealyticum 21 18
Thermoanaerobacter UreibaciUus compost i 21 19
2079
pseudethanolicus UreibaciUtis s vonensis 2120
Thermobifida fusca. 2080 UreibaciUus terrenus 2121
Thermofilum pendens 2081 UreibaciUus thermophilus 2122
Ί hermas aquaticus 2082 Ureibacil. las thermosphaericus 2123
Tissierella praeacuia 2083 Vagococcus fiuvialis 2124
Trabulsietta. guamensis 2084 VeilloneUa atypica 2125
Treponema genomosp. 2085 VeilloneUa dispar 2126
Treponema genomosp. 2086 VeilloneUa genomosp. 2127
Treponema genomosp. 2087 VeilloneUa. monipellierensis 2128
Treponema genomosp. 2088 VeilloneUa par vula. 2129
Treponema phagedenis 2089 VeilloneUa. sp. 2130
Treponema sp. 2090 VeilloneUa sp. 2131
Treponema sp. 2091 VeilloneUa sp. 2132
Treponema sp. 2092 VeilloneUa sp. 2133
Treponema sp. 2093 VeilloneUa sp. 2134
Treponema sp. 2094 VeilloneUa sp. 2135
Treponema sp. 2095 VeilloneUa sp. 2136
Treponema, sp. 2096 VeiUonetta sp. 2137
Treponema sp. 2097 VeilloneUa sp. 2138
Treponema sp. 2098 VeilloneUa sp. 2139
Treponema sp. 2099 VeilloneUa sp. 2140
Treponema sp. 2100 VeilloneUa sp. 2141
Treponema sp. 2101 VeilloneUa sp. 2142
Treponema sp. 2102 VeilloneUa sp. 2143
Treponema sp. 2103 VeilloneUa sp. 2144
Treponema sp. 2104 Veillonellaceae bacterium 2145
Treponema sp. 2105 Veillonellaceae bacterium 2146
Treponema sp. 2106 Victivallaceae bacterium 2147
Treponema sp. 2107 I 'icti vail is vadensis 2148
Treponema sp. 2108 Virgibacillus proomii 2149
Treponema, sp. 2109 WeisseUa. heninensis 2150
Treponema, sp. 2110 WeisseUa. cibaria 2 51
Treponema sp. 211 1 WeisseUa confiisa 2152
Tropheryma whipp!ei 2112 WeisseUa hellenica 2153
Trueperella pyogenes 21 13 WeisseUa kandleri 2154
TsukamureUa panrometahola 21 14 WeisseUa koreensis 2155
1 WeisseUa paramesenteroides 2156 Dorea formicigenerans 2196
WeisseUa sp. 2157 Dorea longicaiena 2197
Wolinella succinogenes 2158 Enterococcus faecalis 2198
Xanthomonadaceae hactermm 2159 Erysipelotrichaceae bacterium 2199
Xanthomonas campestris 2160 Escherichia coli 2200
Xanthomonas sp. 2161 E cherichia coli 2201
Xenophilus aerolatus 2162 Eubacterium eligens 2202
Yokenella regensburgei 2163 Eubacterium rectale 2203
Zimmermannella bifida 2164 Eubacterium rectale 2204
Zymomonas mohilis 2165 Faecalibacterium prausnitzii 2205
Ali tipes shahii 2166 Faecalibacterium prausnitzii 2206
Bacteroides caccae 2167 Lachnospiraceae bacterium 2207
Bacteroides eggerthii 2168 Odoribacter splanchnicus 2208
Bacteroides sp. 2169 Odoribacter splanchnicus 2209
Bacteroides sp. 2170 Parahacteroid.es merdae 2210
Bacteroides sp. 2171 Roseburia intestinalis 221 1
Bacteroides uniformis 2172 Ruminococcus hromii 2212
Bacteroides vulgatus 2173 Ruminococcus gnavus 2213
Bacteroides vulgatus 2174 Ruminococcus oheum 2214
Bifidobacterium adolescentis 2175 Ruminococcus torques 2215
Bifidobacteriu Streptococcus thermophilus 2216
2176
pseudocatenulatum Escherichia coli 2217
Blautia. producta 2177 Streptococcus thermophilus 2218
Blautia producta 2178 Escherichia coli 2219
Blautia schinkii 2179
Clostridium bolteae 2180
Clostridium butvricum 2181
Clostridium disporicum 2182
Clostridium hathewayi 2183
Clostridium hylemonae 2184
Clostridium innocuum 2185
Clostridium innocuum 2186
Clostridium mayombei 2187
Clostridium n exile 2188
Clostridium orhiscindens 2189
Clostridium symhiosum 2190
Clostridium iertium 2191
Collinsella aerofaciens 2192
Coprobacillus sp. 2193
Coprococcus catus 2194
Coprococcus comes 2195
1 I , Therapeutic Compositions
[00116] Any of the GABA-producing bacteria described herein (e.g., natural bacteria or engineered bacteria), or any combination thereof (including combinations of natural and engineered bacteria) can be incorporated into a therapeutic composition. For instance, the therapeutic compositions can be administered to a patient in need thereof to treat or alleviate the symptom of a mental illness or central nervous system disease.
Purification of Strains
[00117] In some embodiments, bacteria are purified prior to incorporation into a therapeutic composition. For instance, bacteria can be purified so that the population of bacteria is substantially free of other bacteria (e.g., contains at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%0, at least 96%, at least 97%, or at least 98%, at least 99% of the specific bacterial strain or strains desired in the composition).
[00118] In some embodiments, the therapeutic composition is a probiotic or a medical food comprising at least one GABA-producing bacterial strain. The strain can be administered, for instance, as a probiotic, as capsules, tablets, caplets, pills, troches, lozenges, powders, and/or granules. The strain can also be formulated as a medical food. The GABA-producing bacteria can also be administered as a fecal transplant or suppository.
[00119] In some embodiments, the dose of the therapeutic can contain l x lO4, I x l O5, I x iO6, I x l O7, 1 x 1 0s, 1 10% I x j.O10, i x l 05 ; or greater than } x l 0! ! colony forming units (CPUs) of the desired bacterial species. For instance, the desired bacterial species can be GABA-producing bacteria, bacteria that are capable of inhibiting the growth of GABA- consurnmg bacteria, or a combination thereof.
[00120] In some embodiments, the therapeutic composition or dose unit comprises a pharmaceutically acceptable formulation, including an enteric coating or similar to survive the acidity of the stomach and enabled deli very into the small or large intestines, prebiotics (such as, but not limited to, amino acids (including arginine, glutaraate, and ornithine), biotin, fructooligosacchari.de, gal actooligosaccharides, hemi celluloses (e.g., arabinoxylan, xylan, xyloglucan, and glucomannan), inulin, chitin, lactulose, mannan oligosaccharides, oligofructose-enriched inulin, gums (e.g., guar gum, gum arabic and carregenaan), oligofructose, oligodextrose, tagatose, resistant maltodextrins (e.g., resistant starch), trans- galactooligosaccharide, pectins (e.g., xylogalactouronan, citrus pectin, apple pectin, and rhamnogalacturonan-I), dietary fibers (e.g., soy fiber, sugarbeet fiber, pea fiber, corn bran, and oat fiber) and xylooligosaccharides, poly amines (such as but not limited to spermidine and putrescine), an effective amount of an anti-bacterial agent, anti-fungal agent, anti-viral agent, or anti-parasitic agent, or any combinations of the above. For instance, the therapeutic composition can also be in the form of a yogurt containing one or more purified strains of GABA-producing bacteria.
Disease Indications
[00121] In one or more embodiments of any of the above-aspects, the mental illness or disease of the central nervous system that can be treated by administration of a therapeutic composition described herein is selected from depression, bipolar disorder, schizophrenia, anxiety, anxiety disorders, addiction, social phobia, major depressive disorder, treatment-resistant major depressive disorder (TR-MDD), major depressive disorder and its subtypes (melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder), Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic tremor, Lafora disease, restless leg syndrome, neuropathic pain, pain disorders, dementia, epilepsy, stiff-person syndrome, premenstrual dysphoric disorder, autism spectrum disorder, sleep disorders, and attention deficit hyperactivity disorder (ADHD).
|00122] In some embodiments, the method further comprises decreasing at least one symptom of a mental disorder or disease of the central nervous system in the subject selected from the group consisting of: fatigue, insomnia, motor dysfunction, stress, persistent anxiety, persistent sadness, social withdrawal, substance withdrawal, irritability, thoughts of suicide, thoughts of self-harm, restlessness, low sex drive, lack of focus, loss of appetite, seizures, memory loss, anger, bouts of emotional reactivity, confusion, pain, and muscle spasms.
Methods of Treatment [00123] The therapeutic compositions described herein can be administered to a patient in need thereof, for instance for the treatment of a mental illness or disease of the central nervous system. In some embodiments, the method of treatment can comprise first diagnosing a patient who can benefit from treatment by a therapeutic composition described herein. In some embodiments, the method further comprises administering to the patient a therapeutic composition described herein.
Patient Diagnosis
[00124] In some embodiments, the process of identifying a subject with a mental illness or disease of the central nervous system can be carried out by a trained psychologist, psychiatrist, or neurologist. For instance, a psychiatrist, psychologist, or neurologist can diagnose a subject with a mental illness or disease of the central nervous system evaluating the subject's behavior for symptoms of the mental illness or disease of the central nervous system. One of skill in the art will understand that mental illness can also be identified in a subject with the aid of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), (American Psychiatric Association).
[00125] In one or more embodiments, the process of identifying a subject with a mental illness or disease of the central nervous system can comprise diagnosing the subject with a mental illness or disease of the central nervous system. In some embodiments, the mental illness or disease of the central nervous system is identified or diagnosed using fMRI. In some embodiments, mental illness or disease of the central nervous sy stem can be identified with standard psychological and neurological surveys, or in other methods known to experts in the field.
[00126] In some embodiments, a subject in need of treatment with a therapeutic composition described herein can be identified by identifying low levels of GABA in the subject's blood, serum, stool, or other bodily fluid. In some embodiments, the amount of GABA in the subject's stool (e.g., the initial amount of GABA in the subject's stool) is below about 8 μg GABA per gram of stool. The amount of GABA can be measured using the wet or dry weight of stool by LC/MS or another technique known in the art. In some embodiments, the amount of GABA in the subject's blood or serum (e.g., the initial amount of GABA in the subject's blood or serum) is below about 10 ng/L +/- 5 ng/L GABA per gram of blood or serum (e.g., as measured by LC/MS). In some embodiments, the amount of GABA in the prefrontal cortex, or other areas of the brain, is below about 1.0 mM/kg, as measured by proton magnetic resonance (PMR), or another similar technique.
[00127] In some embodiments, the percentage of GABA-producing bacteria in the subject's gut (e.g., the initial amount) represents about 10% of total 16S sequences as measured by sequencing using such methods as 16S rDNA gene I!lumina sequencing or quantitative PGR. In some embodiments, the percentage of GABA-producing bacteria in the subject's gut represents about 9%, about 8%, about 7%, about 6%, about 5%, about 4%, about 3%, about 2%, about 1 %, or less than about 1% of the total 16S sequences measured in the subject's gut.
[00128] Determination of the initial amount of GABA in a subject's blood, serum, regions of the brain, or stool can help identify subjects that can benefit from treatment by administration of GABA-producing bacteria. In some embodiments, a subject with an initial amount of GABA in the serum or blood below 10 ,iig/L GABA can benefit from administration of GABA-producing bacteria. In some embodiments, a subject with an initial amount of GABA in the serum or blood below 100 g, below 50 ,ug, below 25 fig, below 20 μg, below 15 g, below 10 μg, below 9 g, below 8 μg, below 7 μg, below 6 μg, below 5 μg, below 4 μg, below 3 g, below 2 μg, below 1 μg, below 0.5 μg, below 0.1 μg, below 0.01 μg, below 10 ng, or below 1 ng, or below 0.1 ng per L of blood or serum can benefit from administration of a GABA-producing bacteria.
[001:29] In some embodiments, a subject with an initial amount of GABA in the brain, in regions such as the prefrontal cortex (or other areas of the brain), of about 1.0 mM/kg can benefit from treatment by administration of GABA-producing bacteria. In some embodiments, a subject with an initial amount of GABA in the brain, in such regions as the prefrontal cortex (or other areas of the bram), of below 100 mM, below 50 mM, below 25 mM, below 20 mM, below 15 mM, below 10 mM, below 9 mM, below 8 mM, below 7 mM, below 6 mM, below 5 mM, below 4 mM, below 3 mM, below 2 mM, below 1 mM, below 0,5 mM, below 0.1 mM, or below 0.01 mM, or below 0.001 mM GABA can benefit from treatment by administration of GABA-producing bacteria. [00130] In some embodiments, a subj ect with an initial amount of GABA in stool below 8 x.g GABA per gram of stool (wet or dry weight) can benefit from administration of G AB A- producing bacteria. In some embodiments, a subject with an initial amount of GABA in the stool below 100 μg, below 50 μg, below 25 ,ug, below 20 μg, below 1 5 μg, below 10 μg, below 9 g, below 8 ,ug, below 7 μg, below 6 μg, below 5 μg, below 4 μ-g, below 3 μg, below 2 μg, below I x.g, below 0.5 μ^, below 0.1 μg, below 0.01 μg, below 10 ng, or below 1 ng, or below 0. 1 ng per gram of stool can benefit from administration of a GABA-producing bacteria.
[ΘΘ131] In some embodiments of any of the above aspects, the amount of GABA is increased 0. 1 , I , 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 500, 1000, 2000, 3000, 4000, 5000, or more percent in the subject' s stooi relative to the initial amount of GABA in the subject' s stool, e.g., as measured in step (b) of any of the above-aspects. In some embodiments, the amount of GABA is increased 0, 1 , 1 , 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 500, 1000, 2000, 3000, 4000, 5000, or more percent in the subject's blood or serum relative to the initial amount of GABA in the subject' s blood or serum, e. g. , as measured in step (b) of any of the above-aspects. In some embodiments, the amount of GABA is increased 0.1 , 1 , 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 500, 1 000, 2000, 3000, 4000, 5000, or more percent in regions of the subject' s brain, such as, but not limited to the prefrontal cortex, relative to the initial amount of GABA in the subject's brain, e.g. , as measured in step (b) of any of the above-aspects. In some embodiments, at least one GABA-producing bacteria is increased 0. 1 , 1 , 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 500, 1000, 2000, 3000, 4000, 5000, or more percent in the subject's stool relative to the initial amount of GABA-producing bacteria in the subject's stool, e.g., as measured in step (b) in any of the above-aspects. In some embodiments, the level of expression of at least one GAB A producing enzyme is increased 0.1 , 1 , 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 500, 1000, 2000, 3000, 4000, 5000, or more percent in the subject' s stool relative to the initial level of expression of GABA-producing enzymes in the subject's stool, as measured by qPCR or some other appropriate method, known to those familiar in the field.
[ΘΘ132] In some embodiments of the disclosure, the amount of GABA-consuming bacteria can be reduced, e.g., reduced in the subject's stool, blood serum, and the like. The GABA-consuming bacteria can be, for instance, Evtepia gabavorous or Firmicutes bacterium MGS: 1 14. In some embodiments, GABA-consuming bacteria can be reduced by 0.1 , 1 , 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 500, 1000, 2000, 3000, 4000, 5000, or more percent.
|00133] Accordingly, the present disclosure provides for the treatment of mental illness or disease of the central nervous system comprising administering to the subject GABA- producing bacteria, or prebiotics to stimulate growth or GABA production capabilities of GABA producing bacteria.
Methods of mlturiisig GABA-coiisomisig Bacteria
[00134] In some embodiments, the present disclosure provides a method of culturing bactena that require GABA for survival and replication. In some cases, these bacteria were previously uncultured or unculturable. In some cases, the bacteria are cultured by supplying endogenous GABA to the growth medium. In some embodiments, the bacteria are cultured by co~culturing the bacteria with a different bacterium capable of producing GAB A (e.g., a bacterium as described above).
|0013S] In some embodiments, the previously uncultured bacterium is E. gabavorous. E. gabavorous can be cultured on a suitable substrate such as agar. In some embodiments, the agar can contain added GABA. In some embodiments, the present disclosure provides a method of culturing /·.'. gabavorous comprising co-cultunng /·.'. gabavorous with another bacterial strain, said strain is capable of producing GABA, for instance at conditions that are physiologically relevant and found in to the human gastrointestinal tract (e.g., pH less between about 4.5 and about 7.5).
|00136] Without wishing to be bound by theory, some previously unculturable bacteria (e.g., E. gabavorous) may be able to grow in proximity to cultivable organisms producing growth factors necessary for bacteria to survive or grow. Accordingly, the present disclosure teaches the discovery and culture of E. gabavorous in the presence of GAB A as a necessary growth factor.
[00137] E. gabavorous was identified as a late-growing colony in spatial proximity to Bacleroides fragilis KLE1758. It was found that growth of E. gabavorous KLE1738 was induced in the presence of supernatant derived from Bacleroides fragilis KI.E1758. Chemical analysis via HPLC and NMR of Bacteroides fragiiis KLE1738 supernatant revealed GABA as the necessary growth factor for E. gabavorous .
[00138] As set forth in Figure 1 , and Example 2, E. gabavorous was initially found because it grew in the presence of Bacteroides fragiiis KLE1758. It was proposed that Bacteroides fragiiis LE1758 produces a growth factor that is necessary for the growth and survival of E. gabavorous. Figure 1A shows a photograph of an agar plate containing colonies of bacteria after treatment with human stool. The inset at the top right shows a close-up of a colony of KLE1758 along with a colony of 1738 that is growing in the immediate proximity. Figure IB shows a colony of KLE1758 that is capable of supporting multiple colonies of KLE1738 on an agar plate with no other bacteria. Without wishing to be bound by theory, Bacteroides fragiiis KLE1758 can support the growth of E. gabavorous KLE1738. Without wishing to be bound by theory, Bacteroides fragiiis KLE1758 and E. gabavorous KLE1738 can co-exist in a symbiotic relationship in which E. gabavorous KLE1738 can consume the GABA that is produced by Bacteroides fragiiis KLE1758.
[00139] As shown in Figure 2 and Examples 3-4, the supernatant from a 48-hour culture of Bacteroides fragiiis KLE1758 was found to support the growth of E. gabavorous KLE1738, whereas standard agar was not. After a series of purification and isolation steps of the KLE1758 supernatant, it was discovered that GABA was responsible for the growth of E. gabavorous KLE1738. Figure 2A shows that E. gabavorous KLE1738 grew in the presence of supernatant of Bacteroides fragiiis. However, Figure 2B shows that E. gabavorous KLE1738 did not grow in the presence of sterile vehicle on standard agar. After a first fractionation of the Bacteroides fragiiis KLE1758 spent medium, it was found that the most polar fragment was capable of inducing the growth of E. gabavorous KLE1738 (Figure 2C), but that less polar fragments could not induce growth (Figure 2D). Figures 2E and 2F show close-up views demonstrating that the most polar fraction of the Bacteroides fragiiis KLE1758 supernatant could induce growth of E. gabavorous KLE1738 (Figure 2E), whereas less polar fragments could not (Figure 2F). As shown in Figure 2G, only GABA was identified as being capable of inducing growth of E. gabavorous KLE1738. [00140] The 16S nucleotide sequence of E. gabavorous LE1738 is given in Seq. ID No. 2286.
[00141] The genetic sequence of E. gabavorous KLE1738 was identified as set forth in Example 5. The annotated genome (2,500,009 bp) of E. gabavorous is given in the attached Sequence Listing comprising SEQ. ID Nos. 1-2288 and is given in SEQ ID Nos. 2218- 2285. Without wishing to be bound by theory, the genome revealed no obvious entry' points for metabolism of common sugars or other carbon sources.
[00142] Without wishing to be bound by theory, it was discovered that transport systems for common sugars or other carbon sources were also incomplete. Without wishing to be bound by theory, their absence suggests a recent loss of function. E. gabavorous is predicted to have a limited set of transporters, including those for methionine, branched-chain amino acids, dipeptides, oligopeptides, and choiine/betaine, as predicted in Table 10.
|00143] Table 10: Predicted Transport Systems in E. gabavorous.
Figure imgf000145_0001
Category Subsystem Roie
Sulfur Metabolism Alkanesulfonate assimilation ABC-type nitrate/sulfonate/bicarbonate transport system, ATPase component
Sulfur Metabolism A!kanesu!fonate assimilation Alkanesulfonates ABC transporter ATP-binding protein
[00144] Without wishing to be bound by theory, these amino acids are not usually capable of supporting bacterial growth as single carbon sources, unlike serine, threonine, glutamate, and others. This is supported by the inability of E. gabavorous to grow on the tested amino acids.
[00145] Without wishing to be bound by theory, the metabolic pathway of E. gabavorous is proposed to be similar to that of Clostridium aminobutyricum, as set forth in Figure 3, as all enzymes in this pathway were identified in the E. gabavorous genome (Table 11 ).
Table 11. Enzymes in £'. gabavorous GABA fermentation pathway, predicted by RAST
Figure imgf000146_0001
[00146] The pH dependency of B. jragilis KLE1758's ability to produce GABA was investigated. As set forth in Example 6, B. jragilis KLE1758 was grown at various pH values, and the supernatant from that growth was analyzed using LCMS. As shown in Figure 4A, GABA is produced primarily at relatively lower pH (e.g., about 5.5 and below), compared with glutamate. [001471 Accordingly, it was found that B. fragi!is KLE1758 can produce GABA at low pH, whereas it was found to produce primarily glutamate at relatively high pH. As set forth in Example 6 and Figure 4A, at a pH of about 5 and about 5,5, B. fragilis KLE1758 produced considerably more GABA than glutamate. However, at a pH of about 6 and about 6.5, B. fragilis KLE1758 was found to produce primarily glutamate and relatively low quantities of GABA.
Biological Screens for GABA-Producers
|00148] The present disclosure also teaches methods of identifying bacteria that can produce GABA. Given the strict requirement of GABA for the growth of E. gabavorous, the present disclosure provides methods of screening for bacteria capable of producing GABA using, for instance, E. gabavorous and/or other GABA-dependent bacterial growth as a bioassay. Importantly, by using buffered media (e.g., buffered agar), the assay technique set forth herein can be used to identify bacteria that are capable of producing bacteri at various pH values (e.g., between about 5.5 to about 7.5).
|00149] As set forth in Example 7, a sample that is thought to contain GABA-producing bacteria, such as a human stool sample, can be mixed with molten agar. The agar, containing the bacterial sample, can then be streaked with a dilute solution of E. gabavorous. As shown herein, E. gabavorous cannot grow in the absence of GABA, and therefore any colonies of E. gabavorous that do form will necessarily grow in close spatial proximity to GABA-producers.
[00150] Because GABA production by some bacteria, including E. coli, only occurs at a very low pH (e.g., at a pH not relevant to the human gut), the assay method set forth herein was adapted to control the pH of the media, enabling identification of organisms capable of producing GABA at a pH between about 4.5 and about 7.5. Without wishing to be bound by theor ', the pH of between about 4.5 and about 7.5 is the relevant pH within the human gut. Accordingly, bacteria that can produce GABA at these pH values can in some embodiments be capable of producing GABA in the human gut.
[00151] In other words, by controlling the pH of the growth medium (e.g., by buffering the molten agar), the present disclosure can allow one to distinguish between GABA- producers that are capable of producing GABA at a physiologically relevant pH (e.g., between about 4.5 to about 7.5) from bacteria that are not able to produce GABA at a physiological relevant pH (e.g., bacteria that can only produce substantial quantities of GAB A below pH of about 4,5).
|001S2] Using this method, a number of representatives from multiple genera, including, but not limited to, Bacteroides, Bifidobacterium, Blautia, Coprococcus, Gordonibacter , Dorea, and Clostridium were identified. Figure 4B shows a representative agar plate showing growth of E. gahavorous in the presence of a GAB A-producing bacteria. Figure 4C shows a phylogenetic tree of GABA-producing bacteria that were identified using this method.
[00153] Figure 5 shows the GABA production capabilities of certain strains of GABA producers identified using the techniques described herein. As set forth in Figure 5, eight strains of GABA produers were grown in buffered media (e.g., between about pH 4.5 and about pH 5.0; and between about pH 6.5 and about pH 7.0). Using the method described in Example 6, the GABA-producing capabilities of the GABA-producing bacteria at various pH values were investigated. As set forth in Figure 5, certain bacteria (e.g. , B. dorei KLE1912) produced relatively similar qualities of GABA at lower pH (e.g., between about 4.5 and about 5.0). In contrast, certain bacteria produced different amounts of GABA depending on the pH (e.g., B. vulgatus KLE1910 and B. ovatus KLE1770). Notably, as shown for B. vulgatus KLE1910 and B, ovatus KLE1770, some bacteria were found to produce relatively more GABA at lower pH than at higher pH, whereas some bacteria were found to produce relatively more GABA at higher pH than at lower pH.
[00154] In some embodiments of the method of identifying bacteria capable of producing GABA, the substrate is agar. In some embodiments, the step of contacting the substrate with E. gabavorous comprises streaking the agar with a dilute solution of E. gabavorous. The GABA-producing colonies are then identified by growth induction of E. gabavorous. As set forth above, growth E. gabavorous is used to determine if a bacterial strain produces GABA. However, one of skill in the art will understand that any bacteria that has a strict requirement of GABA for growth and survival can likewise be used as described above to identify bacteria that can produce GABA. Examples
[[0000115555]] TThhee ddiisscclloossuurree iiss ffuurrtthheerr iilllluussttrraatteedd bbyy t thhee ffoolllloowwiinngg eexxaammpplleess aanndd ssyynntthheessiiss eexxaammpplleess,, wwhhiicchh aarree nnoott ttoo bbee ccoonnssttrruueedd aass l liimmiittiinngg tthhiiss ddiisscclloossuurree iinn ssccooppee oorr ssppiirriitt ttoo tthhee ssppeecciifificc pprroocceedduurreess hheerreeiinn ddeessccriribbeedd.. IItt iiss ttoo bbee uunnddeerrssttoooodd tthhaatt tthhee eexxaammpplleess aarree pprroovviiddeedd ttoo iilllluussttrraattee cceertrtaaiinn eemmbbooddiimmeennttss aanndd tthhaatt nnoo lliimmiittaattiioonn ttoo tthhee ssccooppee ooff tthhee ddiisscclloossuurree iiss iinntteennddeedd tthheerreebbyy.. IItt iiss ttoo bbee ffuurrtthheerr uunnddeerrssttoooodd tthhaatt rreessoorrtt mmaayy bbee hhaadd ttoo vvaarriioouuss ootthheerr eemmbbooddiimmeennttss,, mmooddiiffiiccaattiioonnss,, aanndd eeqquuiivvaalleennttss tthheerreeooff wwhhiicchh mmaayy ssuuggggeesstt tthheemmsseellvveess ttoo tthhoossee sskkiilllleedd iinn tthhee aarrtt wwiitthhoouutt ddeeppaarrttiinngg ffrroomm tthhee ssppiirriitt ooff tthhee pprreesseenntt ddiisscclloossuurree a anndd//oorr ssccooppee ooff tthhee aappppeennddeedd ccllaaiimmss..
[[0000115566]] UUnnlleessss ootthheerrwwiissee nnootteedd,, aallll mmaatteerriiaallss wweerree oobbttaaiinneedd ffrroomm ccoommmmeerrcciiaall ssuupppplliieerrss aanndd wweerree uusseedd wwiitthhoouutt ffuurrtthheerr ppuuririfificcaattiioonn.. AAnnhhyyddrroouuss ssoollvveennttss wweerree oobbttaaiinneedd ffrroomm SSiiggmmaa-- AAiiddrriicchh ((MMiillwwaauukkeeee,, W WII)) aanndd uusseedd ddiirreeccttllyy..
[[0000115577]] UUnnlleessss ootthheerrwwiissee ssppeecciififieedd,, PPCCRR wwaass ppeerrffoorrmmeedd uussiinngg tthhee g geenneerraall bbaacctteerriiaall pprriimmeerrss 2277FF ((55''--AAGGAAGGTTTTTTGGAATTCCMMTTGGGGCCTTCCAAGG--33'')) ((sseett ffoortrthh iinn SSeeqq IIDD NNoo.. 22228877)) aanndd 11449922RR ((55''-- TTAACCGGGGYYTTAACCCCTTTTGGTTTTAACCGGAACCTTTT--33'')) ((sseett fofortrthh iinn SSeeqq IIDD NNoo.. 22228888)) ttoo aammpplliiffyy tthhee 1166SS rrRRNNAA ggeennee.. TThhee PPCCRR rreeaaccttiioonn mmiixxttuurree wwaass 1122..55 , μu.Lΐ. GGooTTaaqq MMaasstteerr MMiixx ((PPrroommeeggaa)),, 11 \\iiLL 1100 μμΜΜ 2277FF aanndd 11449922RR pprriimmeerrss,, 99..55 μμίί.. NNuucclleeaassee FFrreeee WWaatteerr ((PPrroommeeggaa)),, aanndd 11 μμΕΐ, ooff aa ccoolloonnyy rreessuussppeennddeedd iinn 110000 μμL·L· sstteerriilliizzeedd ddiissttiilllleedd wwaatteerr.. TThhee aammpplliifificcaattiioonn ccoonnddiittiioonnss w weerree oonnee ccyyccllee ooff 9955°°CC ffoorr 55 mmiinn;; 3300 ccyycclleess ooff 9955°°CC ffoorr 3300 ss,, 5555°°CC ffoorr 3300 ss;; 7722°°CC ffoorr 9900 ss;; aanndd fifinnaallllyy oonnee ccyyccllee ooff 7722°°CC ffoorr 77 mmiinn.. AAmmpplliifificcaattiioonn ooff PPCCRR rreeaaccttiioonnss w weerree tthheenn ccoonnfifirrmmeedd uussiinngg ggeell eelleeccttrroopphhoorreessiiss oonn aa 00..88%% aaggaarroossee ggeell llooaaddeedd ssaattuurraatteedd wwiitthh eetthhiiddiiuumm bbrroommiiddee.. SSuucccceessssffuull PPCCRRss wweerree sseeqquueenncceedd bbyy MMaaccrrooggeenn CCoorrppoorraattiioonn uussiinngg tthhee 2277FF ppririmmeerr uussiinngg tthhee AApppplliieedd BBiioossyysstteemmss 33773300xx11 DDNNAA aannaallyyzzeerr.. QQuuaalliittyy ccoonnttrrooll ffoorr sseeqquueenncceess wwaass ppeerrffoorrmmeedd uussiinngg DDNNAA BBaasseerr ((wwwwww..DDnnaaBBaasseerr..ccoomm)),, iinn wwhhiicchh eennddss wweerree ttrriimmmmeedd uunnttiill tthheerree wweerree mmoorree tthhaann 7755%% ggoooodd bbaasseess ( (ddeefifinneedd bbyy hhaavviinngg aa QQVV ssccoorree ooff hhiigghheerr tthhaann 2255)) iinn aann 1188 bbaassee wwiinnddooww.. IIddeennttiifificcaattiioonn ooff pphhyyllooggeenneettiicc nneeiigghhbboorrss aanndd ccaallccuullaattiioonn ooff ppaaiirrwwiissee sseeqquueennccee ssiimmiillaarriittyy wweerree ccaarrrriieedd oouutt uussiinngg tthhee EEzzTTaaxxoonn sseerrvveerr..
Figure imgf000149_0001
[00158] Stool samples from a healthy human donor were collected using a commercially available stool collection vessel. Within 5 minutes of collection, 1 gram of stool was resuspended in 9 mL of sterile 20% glycerol in PBS and homogenized for 30 seconds using a vortex. 1 mL aliquots of this mixture were loaded in cryotubes and stored at -80°C for cultivation.
Example 2: Cultivation of helper-uncultured pairs from human stool samples
[00159] Ail cultivation work was performed in a Coy Anaerobic Vinyl chamber with an atmosphere of 5% hydrogen, 10% CO?„ 85%» nitrogen. Anaerobically, serial dilutions of thawed stool samples were prepared in PBS and bead spread (7-10 beads/plate) on I X Fastidious Anaerobic Agar (Accumedia) plates with 2.5% yeast extract (FAAy). Plates were incubated at 37°C anaerobically for one week, and each day appearance of colonies were tracked by spotting the outside of the plates with different colored markers. At the end of the week, serial dilutions of late forming colonies (appearance after 4-7 days) were prepared in PBS and bead spread on FAAy plates. Nearby (< 2 cm), early forming colonies (appearance after 1 -3 days) were then resuspended in PBS at a high density. Five of this suspension were spotted on the plates with their respective spread-candidate dependent and incubated for up to one week in the chamber, and observed daily. Growth induction of the dependent organism around the spotted helper indicated a positive hit.
[00160] A fecal sample from a healthy human donor was diluted and spread-plated on rich medium, and newly formed colonies were noted daily for a week. Late forming colonies (3-7 days) were diluted and spread on a nutrient agar plate, and a heavy inoculum of a neighboring, early forming colony (1-2 days) was spotted, as shown in Figure 1A. Using this method, a number of helper-uncultured pairs were identified, in which the spread-plated uncultured isolate formed a gradient of growth around the spotted culturable helper.
[00161] One isolate, E. gabavorous LE1738 (93.22% similar to Flavonifr actor plautii ATCC 29863 by 16S rRNA gene sequence), was dependent on Bacteroides fragilis KLE1758 (100% similar to Bacteroides fragilis ATCC 25852 by 16S rRNA gene sequence) for growth (Fig. IB). E. gabavorous, is a gram positive organism of the Clostridia class.
Example 3: Determination of GABA as Growth Factor for E. gabavorous
[00162] The supernatant of a 48-hour culture of B. fragilis KLE1758 grown in rich medium induced growth of E. gabavorous as shown in Figures 2A and 2B, enabling bioassay-driven purification of the growth factor. The supernatant was solvent-partitioned with ethyl acetate, and the water residue fraction induced the growth of E. gabavorous. The water fraction was then purified using HP-20 column chromatography, and the most polar fraction induced the growth of E. gabavorous as shown in Figure 2C. This active fraction was then further fractionated by preparative HPLC. HPLC yielded one active fraction, and NMR showed that it contained 10 compounds, primarily GAB A, threonine, lactic acid, valine, glutamine, malonic acid, succinic acid, and alanine. All compounds were spotted on plates where E. gabavorous was spread, and only GABA caused growth induction, as shown in Figs. 2E-F. The compounds were identified by NMR analysis including !H, 13C, ¾-¾ COSY, TOCY, HSQC, and HMBC NMR experiments to identify the constituents in the fraction. Ail NMR experiments were carried out on a Varian INOVA 600 MHz NMR spectrometer equipped with an indirect detection probe.
Example 4; Testing other compounds for induction of E. gabavorous
[00163] Multiple compounds were tested for the ability to induce the growth of E.
gabavorous as shown in Figure 2G. Stocks of each compound (purchased from Sigma, excluding the ATCC Mineral and Vitamin mixes) were prepared dependent on solubility in water at the concentrations shown in Figure 2G. Five ,u.L of the stocks were then spotted on FAAy plates spread with E. gabavorous, and incubated anaerobically for one week, and any growth was observed. No compounds induced growth but GABA.
Example 5: Whole genome sequencing and annotation
|00164] DNA from cells of E. gabavorous grown 48 hours anaerobically on FAAy plates with 1.0 mg/mL GABA was isolated for genome sequencing using the PowerSoil® DNA Isolation Kit (Mo Bio, San Diego, CA) to manufacturer specifications, yielding -5.0 ^ig of high quality DNA. Genomic sequencing and de novo assembly was performed by the Genomic Core at Tufts University in Boston, MA, The genome of E. gabavorous was sequenced on an Illumina MiSeq using MiSeq V2 500 cycles chemistry with a paired-end 250 bases format. Briefly, 100 ng of genomic DNA was sheared on a Covaris M220 to an average fragment size of around 600 bases. Using the fragmented DNA as input, a sequencing library was prepared with Illumina TruSeq Nano DNA Sample Preparation Kit per the manufacturer instruction. Base calling and demultiplexing was performed on the raw data from the MiSeq using CASAVA and fastq files were generated. De novo assembly of the genome was performed using Edena V3.131028 with a customized parameter optimization pipeline. The best assembled genome, as assessed by the contig statistic, was reported. Assembly yielded 68 contigs (n), with ail contigs having a sequence length longer than 200 bases (n:200). 7 contigs with a larger value than the N50 (1 19748), and the minimal contig length is 355 (min). The N20, N50 and N20 are 33403, 1 19748 and 204670, respectively. The largest contig length (max) was 344080, and the estimated genome size is 2500009. The draft genome was annotated using the RAST server and the KAAS ( EGG Automatic Annotation Server) analysis tool of the KEGG (Kyoto Encyclopedia of Genes and Genomes) database. The genome of E. gahavorous was annotated using RAST, and the genomes of C AG: 113 and E. gahavorous were compared using RAST.
Example 6: Quantification of Glutamate and GABA Production in B. fragilis
|00165] The absolute amount of glutamate and GABA contained in the B. fragilis KLE1758 supernatant was determined by HPLC, using a fluorophore to aid in detection. Specifically, free amines were labeled for analysis by reacting with the AccQ reagent (Waters) according to manufacturer's protocols. A calibration curve was generated from stock solutions (10 mg/mL) that were prepared by dissolving GABA (2.0 mg) in water (200 ,uL), glutamate (Glu) (10.2 mg) in water (1020 μΐ.,) and cysteic acid (CSA) (16.9 mg) in water (1690 μΕ). These were serially diluted to generate a concentration gradient. Specifically, stocks were made to final concentrations of 0.1 mg/mL, 0.05 mg/mL, 0.01 mg/mL and 0.001 mg/mL. An aliquot of a given stock solution, was added to the AccQ reaction buffer (25 μΐ, final), followed by the addition of the acetonitrile-dissolved AccQ reagent (25 \L). This was reacted for ten minutes at 55-60°C, and then transferred directly to an LCMS vial, fitted with a glass insert. Reaction concentrations of the amino acids were: 20 ng^iL, 10 ng/uL, 5 ng/uL, 2.5 ng uL, 1 ng/ iL, 0.5 ng/ iL, 1 ng/ L and 0 ng^L (control). These samples were injected (10 iL) on an Agilent LCMS, using a gradient of solvent A (water/0.1% formic acid) and B (acetonitriie/0.1% formic acid) over the following time course: 1) 0-40 minutes linear gradient of 2% B to 98% B; 2) 40-45 min isocratic at 98% B; 3) 45-45,5 min linear gradient of 98% B to 2 % B; 4) 45,5-55 mm isocratic at 2% B. The CSA-AccA derivative eiuted at 9.5 min, the Glu- AccQ derivative eluted at 12.1 min and the GABA- AccQ derivative at 12.5 min. The area under the curve, in extracted ion (EIC) mode (m/z = 274 for GABA-AccQ, 318 for Glu- AccQ and 340 for CSA-AccQ), was used to develop a calibration curve by plotting area against amount of original Glu, CSA or GABA. (in ng) injected. An average of two runs for each tested concentration was used to generate the calibration curve. In the case of GABA and Glu, CSA was added to all reactions, to a final concentration of 2.5 g/rriL, and used as an internal standard.
[00166] Triplicate cultures of B. fragilis KLE1758 were grown in BHIych anaerobically for 48 hours, the cells centrifuged, and the supernatant was filtered through a 0.2 μηι filter. Samples were stored at 4 °C until analysis. To analyze the samples, an aliquot (2 μΕ) of each sample was added to AccQ reaction buffer (16 μΐ,), CSA internal standard (2 μΕ of a 50 μg/mL solution in buffer), followed by the addition of the AccQ reagent (20 μΕ). These samples were heated to 55°C for ten minutes, and then transferred directly into an LCMS vial fitted with a glass insert. An aliquot of each sample (10 μΐ.) was injected onto the LCMS, and separated following the same injection program as used for the calibration curve. The total EIC area under curves representing GABA, Glu and CSA was determined using ChemStation software (Agilent). Each injection represented 25% of the original media concentration, therefore the total amount of sample determined (in ng) was multiplied by a factor of four to determine the original concentration (in ng/μΐ.. = μ^-'ηιΕ). All areas were normalized to the area under the curve of the internal standard (CSA), which was held at constant concentration throughout the experiment. The results are given in Figure 4A.
Example 7; Co-culture Screen for GABA Producers Using E. gabavorous
[00167] GABA secretion can allow bacteria to survive acid stress. Decarboxylation of glutamate produces GABA, which is exported from the cell in a protonated form, alkalinizing the cytoplasm. E. coli, as well as some Lactobacillus and Bifidobacterium strains were shown to produce GABA, but these organisms are typically found at a low abundance in the human intestinal tract, and in the case of E. coli, is dependent on low pH (e.g., about 4.2 and below). Bacteroides fragilis, the helper of E. gabavorous, is a common gut bacterium, but it was found that similarly to E. coli, GABA production by Bacteroides fragilis KLE1758 is only observed at a pH less than about 5.5 as shown in Figure 4A. GABA is shown in left-hand columns and glutamate is shown in right-hand columns at each pH value. Without wishing to be bound by theory, it was therefore considered useful to identify microorganisms capable of producing GABA at a physiologically relevant pH for the human large intestine (e.g., pH of about 5.5 to about 7.5, or about pH 5.7 to about 7.4).
|00168] To accomplish this, the strict GABA requirement of E. gabavorous was utilized to screen for bacteria capable of secreting GABA on heavily buffered medium. Metabolic byproducts of bacterial growth may lower the pH of the medium in the absence of buffer. Stool sample was mixed with molten agar and poured in Petri plates in an anaerobic chamber, and E. gabavorous was spread on top of the agar once solidified. By looking for zones of growth induction ofE. gabavorous, and measuring the pH of the agar, bacteria that produce GABA at a pH of between about 6.0 and about 7.0 were identified, as well as those producing GABA at a pH of about 4.5 to about 5.0, as shown in Figure 4B. The full 16S rRNA gene was amplified and sequenced using the 27F and 1492R universal primers, and annotation with EZTaxon revealed a number of representatives from multiple genera, including Bacteroides, Bifidobacterium, Blautia, Coprococcus, Gordonihacter, Dorea, and Clostridium. (Fig. 4C). Of these, only Bifidobacterium adolescentis was previously reported to produce GABA.
Example 8; Using an Engineered Escherichia coli strain to produce GABA asid induce the growth of E. gabavorous
|00169] GABA can be produced by intestinal epithelial cells and by some bacteria, such as Escherichia coli and Listeria monocytogenes, by decarboxylation of glutamate. In E. coli, the decarboxylation of glutamate serves as a mechanism to decrease intracellular pH, and GABA production generally occurs at a low pH. To survey whether E. coli could be engineered to produce GABA, E. coli colones harboring native glutamate decarboxylases (gadA, gadB), or the GABA antiporter, (gadC) in the pCA24N IPTG inducible high-copy number vector, were tested for GABA production via co-cultivation assay with E. gabavorous, Overexpression of glutamate decarboxylase in E. coli (gadA or gadB), resulted in induction of KLE1738 growth to levels seen with B. tragi lis. while expression of the GABA antiporter, gadC, did not (Figure 6). Altering the pH of growth media for KLE1738 did not change the GABA-dependency phenotype. Without wishing to be bound by theory, this suggests that engineering bacteria to overexpress glutamate decarboxylase or other GABA producing enzymes, constitutively or inducibiy, is an effective way to produce GAB A, as well as induce the growth of E. gabavorous.
Equivalents
[00170] While the present disclosure has been described in conjunction with the specific embodiments set forth above, many alternatives, modifications and other variations thereof will be apparent to those of ordinary skill in the art. All such alternatives, modifications and variations are intended to fall within the spirit and scope of the present disclosure.

Claims

Claims:
1. A therapeutic composition comprising at least one purified bacterial popuiation consisting of bacteria capable of producing GAB A in a subject in need thereof.
2. The therapeutic composition of claim 1 , wherein the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. 1 -31 set forth in Table I .
3. The therapeutic composition of claim 1, wherein the at least one purified bacterial population consists of bacteria selected from the group consisting of: Bacteroides caccae KLE1911; Bacteroides clarus KLE1930; Bacteroides dorei KLE1912;
Bacteroides finegoldii KLE1931; Bacteroides fragilis KLE1958; Bacteroides massiliensis LE1932; Bacteroides ovatus KLE1770; Bacteroides stercoris KLE 1933; Bacteroides thetaiotaomicron KLE1934; Bacteroides unijbrrnis KLE1913; Bacteroides vulgaius KLE1910; Bacteroides xylanisolvens KLE1935; Bifidobacterium adolescentis KLE 1879; Blautia obeum KLE1914; Blautia wexlerae KLE1916; Butyricimonas virosa KLE 1938; Clostridium perjringens KLE1937; Clostridium sordelUi KLE1939;
Clostridium sp. KLE1862; Clostridium sp. KLE1918; Coprobacillus sp. KLE1779; Coprococcus sp. KLE1880; Dorea longicatena KLE1917; Eggerthella lenta KLE1926; Eubacierium rectale KLE1922; Gordonibacter pameiaeae KLE1915; Osciilibacter sp. KLE 1928; Parabacteroides distasonis KLE2020; Parabacteroides merdae KLE 1863; Ruminococcus gnavus KLE1940; Turicibacter sanguinis KLE1941, and combinations thereof.
4. The therapeutic composition of claim 1 , wherein the at least one purified bacterial population consists of a bacteria comprising a 16S rDN A sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. 32-274 set forth in Table 2.
5. The therapeutic composition of claim 1 , wherein the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to the 16S rDNA sequence selected from one of Seq. ID. Nos. 305-2217 set forth in Table 10.
6. The therapeutic composition of claim 1 , wherein the at least one purified bacterial population consists of bacteria comprising a DNA sequence which encodes an enzyme selected from: glutamate decarboxylase; puirescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
7. The therapeutic composition of claim 6, wherein the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof, is encoded by a DNA sequence at least 70% similar in DNA sequence to any one of Seq. ID. Nos, 275-304 set forth in Table 3.
8. The therapeutic composition of claim 6, wherein the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 4.
9. The therapeutic composition of claim 6, wherein the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDB J ID found in Table 5.
10. The therapeutic composition of claim 6, wherein the gamma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDBJ ID found in Table 6.
11. The therapeutic composition of claim 6, wherein the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDBJ ID found in Table 7.
12. The therapeutic composition of claim 6, wherein the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENB ANK/DDBJ ID found in Table 8.
13. The therapeutic composition of claim 6, wherein the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENB ANK/DDBJ ID found in Table 9.
14. The therapeutic composition of claim 1, wherein the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to a reference bacterium selected from the group consisting of: Escherichia coii MG1655;
Escherichia coli Nissle 1 917; or a combination thereof.
15. The therapeutic composition of claim 1 , wherein the bacterial population consists of bacteria capable of producing GABA at a physiologically relevant pH.
16. The therapeutic composition of claim 1, wherein the bacterial population consists of bacteria capable of producing GABA at a pH range between about 4.5 and about 7.5.
17. The therapeutic composition of claim 1, wherein the bacterial population consists of bacteria capable of producing GABA inside the human gut.
18. The therapeutic composition of claim 1, wherein the composition is in the form of a probiotic, prebiotic, a capsule, a tablet, a caplet, a pill, a troche, a lozenge, a powders, a granule, a medical food, or a combination thereof.
19. The therapeutic composition of claim 1, wherein the composition is administered as a fecal transplant.
20. The therapeutic composition of claim 1, wherein the bacteria are capable of producing GABA via expression of any combination of glutamate decarboxylase, putrescine aminotransferase, gamma-aminobutyraldehyde dehydrogenase, arginine decarboxylase, agmatinase, and/or ornithine decarboxylase.
21. The therapeutic composition of claim 1, further comprising a purified bacterial strain that is cytotoxic or cytostatic to a GABA-consuming bacteria.
22. The therapeutic composition of claim 21, wherein the GAB A-consuming bacteria is Evtepia gabavorous or Firmicutes bacterium MGS: 114.
23. The therapeutic composition of claim 1 , further comprising a prebiotic capable of stimulating the growth or GABA-production levels of a GABA-producing bacteria.
24. A method of treating a disease or disorder in a subject in need thereof, the method comprising administering to the subject a therapeutic composition comprising at least one purified bacterial population consisting of bacteria capable of producing GABA in a subject in need thereof.
25. The method of claim 24, wherein the disease or disorder is a mental disease or disorder.
26. The method of claim 24, wherein the mental disease or disorder is selected from the group consisting of depression, bipolar disorder, schizophrenia, anxiety, anxiety disorders, addiction, social phobia, treatment-resistant major depressive disorder (TR-MDD), major depressive disorder and its subtypes (melancholic depression, atypical depression, catatonic depression, postpartum depression, and seasonal affective disorder), Neurodegenerative amyloid disorders (Parkinson's, Alzheimer's, and Huntington's diseases) orthostatic tremor, Lafora disease, restless leg syndrome, neuropathic pain, pain disorders, dementia, epilepsy, stiff-person syndrome, premenstrual dysphoric disorder, autism spectrum disorder, sleep disorders, and attention deficit hyperactivity disorder (ADHD), and combinations thereof.
27. The method of claim 24, wherein treating a disease or disorder comprises decreasing at least one symptom of the disease or disorder, such as fatigue, insomnia, motor dysfunction, stress, persistent anxi ety, persistent sadness, social withdrawal, substance withdrawal, irritability, thoughts of suicide, thoughts of self-harm, restlessness, low sex drive, lack of focus, seizures, memory loss, anger, bouts of emotional reactivity, confusion, pain, and muscle spasms, loss of appetite, altered intestine motility, and combinations thereof.
28. The method of claim 24, wherein the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to a 16S rDNA. sequence selected from one of Seq. ID. Nos. 1 -31 set forth in Table 1 .
29. The method of claim 24, wherein the at least one purified bacterial population consists of bacteria selected from the group consisting of: Bacteroides caccae KLE191 1 ; Bacteroides clams KLE1930; Bacteroides dorei LE1912; Bacteroides finego!dii KLE 1931; Bacteroides fragilis KLE 1958; Bacteroides massiliensis
KLE1932; Bacteroides ovatus KLE1770; Bacteroides stercoris KLE1933; Bacteroides thetaiotaomicron KLE1934; Bacteroides uniformis KLE1913; Bacteroides vulga us KLE1910; Bacteroides xylanisolvens KLE1935; Bifidobacterium adolesceniis KLE 1879; Blautia obeum KI.E1914; Blautia. wexlerae KLE1916; Butyricimonas virosa KLE1938; Clostridium perfringens KLE1937; Clostridium sordellii KLE1939;
Clostridium sp. KLE1862; Clostridium sp. KLE1918; Coprobacillus sp. KLE1779; Coprococcus sp. KLE1880; Dorea longica.te.na KLE1917; Eggerthella lenta KLE 1926; Eubacterium rectale LE1922; Gordonibacter pameiaeae KLE1915; Oscillibacter sp. KLE1928; Parabacteroides distasonis KLE2020; Parabacteroides merdae KLE1863; Ruminococcus gnavus KLE1940; Turicibacter sanguinis KLE1941, and combinations thereof.
30. The method of claim 24, wherein the at least one purified bacterial population consists of a bacteria comprising a 16S rDNA. sequence at least about 95% identical to a 16S rDNA sequence selected from one of Seq. ID. Nos. of 32-274 as set forth in Table 2.
31. The method of claim 24, wherein the at least one bacterial population consists of a bacteria comprising a 16S rDNA sequence at least about 95% identical to any one of Seq ID Nos. 305-2217 set forth in Table 10.
32. The method of claim 24, wherein the at least one purified bacterial population consists of bacteria comprising a DNA sequence which encodes an enzyme selected from: glutamate decarboxylase: putrescine aminotransferase: gamma- aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
33. The method of claim 32, wherein the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarbox lase; or a combination thereof, is encoded by a DNA sequence at least 70% similar in DNA sequence selected from one of Seq. ID. Nos. 275-304 set forth in Table 3.
34. The method of claim 32, wherein the glutamate decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 4.
35. The method of claim 32, wherein the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 5.
36. The method of claim 32, wherein the gamma-aminobutyraldehyde dehydrogenase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 6.
37. The method of claim 32, wherein the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBA K/DDBJ ID found in Table 7.
38. The method of claim 32, wherein the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 8,
39. The method of claim 32, wherein the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 9.
40. The method of claim 24, wherein the bacteria is geneti cal ly engineered to produce GAB A.
41. The method of claim 40, wherein the bacteria is engineered to produce GABA via expression of glutamate decarboxylase; putrescine aminotransferase; gamma- aminobutyraldehyde dehydrogenase; arginme decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof.
42. The method of claim 41 , wherein the glutamate decarboxylase; putrescine aminotransferase; gamma-aminobutyraldehyde dehydrogenase; arginine decarboxylase; agmatinase; ornithine decarboxylase; or a combination thereof, is encoded by a DN A sequence at least 70% similar in DNA sequence selected from one of Seq. ID. Nos. 275- 304 set forth in Table 3.
43. The method of claim 41, wherein the glutamate decarboxylase is encoded by a DN A sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 4.
44. The method of claim 41 , wherein the putrescine aminotransferase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 5.
45. The method of claim 41 , wherein the gamma-aminobutyraldehyde dehydrogenase is encoded by a DN A sequence at least 95% similar in DN A sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 6.
46. The method of claim 41, wherein the arginine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 7.
47. The method of claim 41, wherein the agmatinase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a EMBL/GENBANK/DDBJ ID found in Table 8,
48. The method of claim 41, wherein the ornithine decarboxylase is encoded by a DNA sequence at least 95% similar in DNA sequence to a gene with a
EMBL/GENBANK/DDBJ ID found in Table 9.
49. The method of claim 24, wherein the at least one purified bacterial population consists of bacteria comprising a 16S rDNA sequence having at least 95% similarity to a reference bacterium selected from the group consisting of:
Escherichia coli MG1655;
Escherichia coli Nissle 1917; or a combination thereof.
50. The method of claim 24, wherein the bacterial population consists of bacteria capable of producing GAB A at a physiologically relevant pH.
51. The method of claim 24, wherein the bacterial population consists of bacteria capable of producing GABA at a pH range between about 4.5 and about 7.5.
52. The method of claim 24, wherein the bacterial population consists of bacteria capable of producing GABA inside the human gut.
53. The method of claim 24, wherein the composition is administered as a fecal transplant.
54. The method of claim 24, wherein the composition is administered as a probiotic.
55. The method of claim 24 wherein the bacteria are capable of producing GABA via expression any combination of glutamate decarboxylase, putrescine aminotransferase, gamma-aminobutyraldehyde dehydrogenase, arginine decarboxylase, agmatinase, ornithine decarboxylase, and combinations thereof.
56. The method of claim 24, wherein the at least one bacterial strain is cytotoxic or cytostatic to a GABA-consuming bacteria.
57. The method of claim 56, wherein the GABA-consuming bacteria is Evlepia gabavorous or Firmiciit.es bacterium MGS: 114.
58. The method of claim 24, further comprising identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA in the subject's stool.
59. The method of claim 58, wherein the initial amount of GABA in the subject's stool is below about 8 μg per gram of wet or dry stool.
60. The method of claim 58, wherein the amount of GABA in the subject's stool is increased relative to the initial amount after administering the therapeutic
composition.
61. The method of claim 24, further comprising identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA-producing bacteria in the subject's stool.
62. The method of claim 61 , wherein initial amount of GABA-producing bacteria in the subject's stool is less than about 10% of total bacteria as measured by 16S sequence mapping.
63. The method of claim 61 , wherein at least one GABA-producing bacteria is increased in the subject's stool relative to the initial amount of GABA-producing bacteria in the subject's stool after administering the therapeutic composition.
64. The method of claim 24, further comprising identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABA in the subject's blood or serum.
65. The method of claim 64, wherein the amount of GABA in the subject's blood or serum is below about 10 μg per liter of blood.
66. The method of claim 64, wherein the amount of GABA in the subject's blood or serum is increased relative to the initial amount after administering the therapeutic composition.
67. The method of claim 24, further comprising identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an amount of GABA in the subject's brain.
68. The method of claim 67, wherein the amount of GAB A in the subject's brain is below about 1.0 mM/kg.
69. The method of claim 67, wherein the amount of GABA. in the subject's brain is increased relative to the initial amount after administering the therapeutic
composition.
70. The method of claim 24, further comprising identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of expression of GABA- producing enzymes in the subject's stool.
71. The method of claim 70, wherein the GABA-producing enzymes are selected from glutamate decarboxylase, putrescme aminotransferase, gamma- aminobutyraldehyde dehydrogenase, arginine decarboxylase, agmatinase, ornithine decarboxylase, and combinations thereof.
72. The method of claim 70, wherein the initial amount of enzyme expression is measured by qPCR.
73. The method of claim 70, wherein the expression of enzymes is increased relative to the initial amount of enzyme expression after administering the therapeutic composition.
74. The method of claim 24, further comprising identifying a subject in need of treatment by determining whether the subject would benefit from an increase in endogenous GABA by measuring an initial amount of GABAergic response in the subject's brain.
75. The method of claim 74, wherein the amount of the GABAergic response in the subject's brain is increased relative to the initial amount after administering the therapeutic composition.
76. The method of claim 24, wherein the therapeutic composition comprises a prebiotic capable of stimulating the growth or GABA production of GABA- producing bacteria.
77. A method of culturing a G ABA-dependent bacteria, comprising disposing at least one live GABA-dependent bacterial cell on a suitable substrate, and providing a source of GABA.
78. The method of claim 77, wherein the suitable s ubstrate is agar.
79. The method of claim 77, wherein providing a source of GABA comprises co- culturing with another bacterial strain, said strain is capable of producing GABA.
80. The method of claim 77, wherein GABA is added to the substrate.
81. The method of claim 77, wherein the GABA-dependent bacteria is E. gabavorous.
82. A method of identifying a bacterial strain or strains capable of producing GABA at a physiologically relevant pH of the human intestinal tract, comprising:
(a) dispersing a sample believed to contain GABA-producing bacteria within a substrate, the substrate being at least partially permeable to GABA,
(b) contacting the substrate loaded with potential GABA-producing bacteria with a GABA-dependent bacterium; and
(c) identifying a GABA-producing bacteria by observing the formation of a colonies of the GABA-dependent bacteria around potential GABA-producing bacteria in the substrate.
83. The method of claim 82, wherein the substrate is being buffered to maintain the pH at a physiologically range found in the human gastroin estinal tract.
84. The method of claim 82, wherein the GABA-dependent bacteria is E. gabavorous.
85. The method of claim 82, wherein the pH range is between about 4.5 and about 7.5.
PCT/US2017/022091 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system WO2017160711A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP17712676.0A EP3429604A1 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
JP2018549231A JP7216998B2 (en) 2016-03-14 2017-03-13 Modification of the Gut Microbiome to Treat Central Nervous System Psychiatric Disorders or Diseases
AU2017234120A AU2017234120A1 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
CA3016911A CA3016911A1 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
US16/084,511 US11116804B2 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
CN201780029600.2A CN109715177A (en) 2016-03-14 2017-03-13 Alimentary canal microorganism group is adjusted to treat mental disease or central nervous system disease
EP23219448.0A EP4368254A2 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
US17/396,330 US20220040242A1 (en) 2016-03-14 2021-08-06 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
JP2023004452A JP2023038274A (en) 2016-03-14 2023-01-16 Modification of gut microbiome to treat psychiatric disorders or diseases of central nervous system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662307991P 2016-03-14 2016-03-14
US62/307,991 2016-03-14

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US16/084,511 A-371-Of-International US11116804B2 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
US17/396,330 Division US20220040242A1 (en) 2016-03-14 2021-08-06 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system

Publications (1)

Publication Number Publication Date
WO2017160711A1 true WO2017160711A1 (en) 2017-09-21

Family

ID=58387981

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/022091 WO2017160711A1 (en) 2016-03-14 2017-03-13 Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system

Country Status (7)

Country Link
US (2) US11116804B2 (en)
EP (2) EP3429604A1 (en)
JP (2) JP7216998B2 (en)
CN (1) CN109715177A (en)
AU (1) AU2017234120A1 (en)
CA (1) CA3016911A1 (en)
WO (1) WO2017160711A1 (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190038451A (en) * 2017-09-29 2019-04-08 경희대학교 산학협력단 Novel lactic acid bacteria and use thereof
WO2019106181A1 (en) * 2017-12-01 2019-06-06 Lesaffre Et Compagnie Isolation and pure culture of an archaebacterium of order methanomassiliicoccales
WO2019118984A3 (en) * 2017-12-15 2019-08-01 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
WO2019156251A1 (en) * 2018-02-09 2019-08-15 日東薬品工業株式会社 Lipopolysaccharide-regulated enteric bacteria and use thereof
WO2019169138A1 (en) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using paraclostridium benzoelyticum
WO2019169160A1 (en) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using ruminococcus gnavus
WO2019227085A1 (en) * 2018-05-24 2019-11-28 Seres Therapeutics, Inc. Designed bacterial compositions and uses thereof
WO2020002370A1 (en) * 2018-06-25 2020-01-02 4D Pharma Research Limited Compositions comprising bacterial strains
WO2020051379A1 (en) * 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US10596206B1 (en) 2017-03-14 2020-03-24 Cornell University Probiotic compositions and methods of use
WO2020089488A1 (en) * 2018-11-02 2020-05-07 4D Pharma Research Limited Compositions comprising bacterial strains
CN111184748A (en) * 2020-02-10 2020-05-22 农业农村部食物与营养发展研究所 Microbial agent for improving muscular atrophy and application thereof
WO2020109414A1 (en) * 2018-11-28 2020-06-04 Consejo Superior De Investigaciones Cientificas (Csic) Christensenellaceae bacteria including christensenella minuta and uses thereof
US20200171102A1 (en) * 2017-06-14 2020-06-04 4D Pharma Research Limited Compositions comprising bacterial strains
WO2020229428A1 (en) * 2019-05-10 2020-11-19 4D Pharma Research Limited Compositions comprising bacterial strains
CN111961614A (en) * 2020-08-04 2020-11-20 安徽科技学院 Novel bacterial strain cd-1 for producing exopolysaccharides
US10864235B2 (en) 2012-11-23 2020-12-15 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US10881696B2 (en) 2013-03-15 2021-01-05 Seres Therapeutics, Inc. Network-based microbial compositions and methods
KR102215599B1 (en) * 2020-12-28 2021-02-15 주식회사 에이치이엠 A novel strain of bifidobacterium animalis subsp. lactis hem20-01, and composition for treating depression comprising the strain or its culture fluid
WO2021038446A1 (en) * 2019-08-26 2021-03-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Fish skin microbiome
WO2021039932A1 (en) * 2019-08-28 2021-03-04 学校法人順天堂 Method for diagnosing relapsing-remitting multiple sclerosis, secondary-progressive multiple sclerosis, atypical multiple sclerosis, and neuromyelitis optica-related disease, and diagnostic biomarker
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
US11007233B2 (en) 2017-06-14 2021-05-18 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
WO2021151946A1 (en) 2020-01-27 2021-08-05 4D Pharma Research Limited Compositions comprising bacterial strains
US20210268036A1 (en) * 2019-03-08 2021-09-02 The Regents Of The University Of California Compositions and methods for modulating lipid and steroid metabolism
US11123379B2 (en) 2017-06-14 2021-09-21 4D Pharma Research Limited Compositions comprising bacterial strains
US11185562B2 (en) 2013-02-04 2021-11-30 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
WO2022003057A1 (en) 2020-06-30 2022-01-06 4D Pharma Research Limited Compositions comprising bacterial strains
US11224620B2 (en) 2016-07-13 2022-01-18 4D Pharma Plc Compositions comprising bacterial strains
US11266699B2 (en) 2013-11-25 2022-03-08 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11266698B2 (en) 2011-10-07 2022-03-08 4D Pharma Research Limited Bacterium for use as a probiotic for nutritional and medical applications
US11376284B2 (en) 2017-05-22 2022-07-05 4D Pharma Research Limited Compositions comprising bacterial strains
EP3786305A4 (en) * 2018-04-24 2022-07-13 BGI Shenzhen Biomarker for depression and use thereof
EP3723776A4 (en) * 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
US11433106B2 (en) 2015-06-15 2022-09-06 4D Pharma Research Limited Compositions comprising bacterial strains
WO2022184643A1 (en) * 2021-03-04 2022-09-09 Evonik Operations Gmbh Preparations comprising probiotic strains and anthocyanins
US11446336B2 (en) 2018-12-12 2022-09-20 4D Pharma Research Limited Compositions comprising bacterial strains
EP3950929A4 (en) * 2019-03-28 2023-01-04 CJ Bioscience, Inc. Faecalibacterium sp. microbe and anticancer composition comprising same
WO2023001934A1 (en) * 2021-07-20 2023-01-26 Université Catholique de Louvain Prevention and/or treatment of reward dysregulation disorders
WO2023001368A1 (en) * 2021-07-20 2023-01-26 Université Catholique de Louvain Prevention and/or treatment of reward dysregulation disorders
EP3906037A4 (en) * 2019-01-29 2023-03-01 Holobiome, Inc. Methods and compositions for treating and preventing cns disorders and other conditions caused by gut microbial dysbiosis
US11701394B2 (en) 2017-08-14 2023-07-18 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
US11938158B2 (en) 2021-11-22 2024-03-26 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US11980647B2 (en) 2022-11-07 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3978598A1 (en) * 2011-12-01 2022-04-06 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
WO2017180501A1 (en) 2016-04-11 2017-10-19 President And Fellows Of Harvard College Probiotic formulations for improving athletic performance
WO2018187272A1 (en) 2017-04-03 2018-10-11 Gusto Global, Llc Rational design of microbial-based biotherapeutics
EP3773645A4 (en) 2018-04-10 2021-11-24 Siolta Therapeutics, Inc. Microbial consortia
CN110184331A (en) * 2019-05-27 2019-08-30 深圳前海大井医疗股份有限公司 Helicobacter pylori yin and yang attribute and clarithromycin drug resistance synchronization detection method
AU2020309729A1 (en) 2019-07-05 2022-01-27 4D Pharma Research Limited Compositions comprising bacterial strains
CA3147629A1 (en) * 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CN110292585A (en) * 2019-08-13 2019-10-01 西南大学 For treating the intestinal flora capsule and preparation method that crystal methamphetamine habituation is given up
CN114786690A (en) 2019-10-07 2022-07-22 谢尔塔治疗公司 Therapeutic pharmaceutical composition
KR102350360B1 (en) * 2019-10-31 2022-01-12 재단법인 경기도경제과학진흥원 Anti-inflammatory Composition Using a Culture Extract of Streptomyces hydrogenans
CN110669700B (en) * 2019-11-07 2021-11-23 自然资源部第三海洋研究所 Efficient petroleum hydrocarbon degrading bacterium PA16_9 and screening method and application thereof
MX2022006407A (en) * 2019-11-27 2022-08-25 Seres Therapeutics Inc Designed bacterial compositions and uses thereof.
WO2021138562A1 (en) * 2019-12-31 2021-07-08 Assembly Biosciences, Inc. Compositions comprising bacterial species and methods related thereto
US20230112367A1 (en) * 2020-03-13 2023-04-13 Fitbiomics Inc. Probiotic compositions for improving human health and athletic performance
WO2021221110A1 (en) * 2020-04-29 2021-11-04 学校法人慶應義塾 Small intestinal bacterium inducing proliferation or activation of th1 cells and/or th17 cells
TW202214273A (en) * 2020-06-15 2022-04-16 香港中文大學 Use of bacteria in children development assessment and treatment
JP2023542547A (en) * 2020-09-23 2023-10-10 ピービーエルバイオラブ New lactic acid bacteria and their uses
EP4225337A1 (en) * 2020-10-06 2023-08-16 Mayo Foundation for Medical Education and Research Methods and materials for treating gastrointestinal disorders
CA3198416A1 (en) * 2020-10-21 2022-04-28 Gusto Global, Llc Microbial-based compositions for systemic inflammation control
WO2022145710A1 (en) * 2020-12-28 2022-07-07 주식회사 엠디헬스케어 Composition for preventing or treating neurodevelopmental, neurological or psychiatric diseases, comprising extracellular vesicles derived from micrococcus luteus
WO2022164890A2 (en) * 2021-01-26 2022-08-04 Washington State University Bacteria producing gamma-aminobutyric acid (gaba) and uses of the bacteria
CN112956696A (en) * 2021-02-10 2021-06-15 北京华元生物技术研究院 Application of bifidobacterium lactis in preventing and treating mental disorder
CN113462594B (en) * 2021-06-17 2022-04-15 中南民族大学 Kluyveromyces QNX-S26 strain for producing huperzine B and application thereof
CN113881610B (en) * 2021-12-06 2022-02-25 北京量化健康科技有限公司 Bacteroides thetaiotaomicron BP8E and application thereof
WO2023107464A2 (en) * 2021-12-07 2023-06-15 Cornell University Methods and compositions for genetically modifying human gut microbes
CN116262900B (en) * 2021-12-13 2024-03-01 中国石油天然气股份有限公司 Microbial oil displacement bacteria and microbial agent thereof, and preparation method and application thereof
CN114452305A (en) * 2022-03-17 2022-05-10 北京航空航天大学 Application of bacteroides uniformis in preparing medicine for preventing and treating anxiety and depression
CN114642684A (en) * 2022-03-21 2022-06-21 北京航空航天大学 Eubacterium rectal for preventing and treating anxiety and depression
KR20240026346A (en) * 2022-08-18 2024-02-28 동화약품주식회사 New lactic acid bacteria and uses thereof
CN115851524B (en) * 2022-11-21 2023-05-12 东北农业大学 Strain for increasing crop yield and application thereof
KR102547036B1 (en) * 2023-01-10 2023-06-26 주식회사 바이오뱅크힐링 Composition for preventing or treating degenerative brain disease containing Blautia obeum as an active ingredient
KR102627484B1 (en) * 2023-01-11 2024-01-24 에스피씨 주식회사 Lactococcus lactis with excellent FODMAP reduction and fermented flavor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1988155A1 (en) * 2006-02-21 2008-11-05 Kikkoman Corporation Lactic acid bacterium capable of producing -aminobutyric acid
WO2013107913A1 (en) * 2012-01-19 2013-07-25 University College Cork - National University Of Ireland, Cork Gaba-producing culturable bacteria derived from the human gastrointestinal tract

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013270A1 (en) * 2000-06-05 2002-01-31 Bolte Ellen R. Method for treating a mental disorder
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
JP4313615B2 (en) 2003-06-03 2009-08-12 ヒガシマル醤油株式会社 Novel lactic acid bacteria having immunostimulatory activity and γ-aminobutyric acid producing ability, and use thereof.
JP5204771B2 (en) * 2007-06-21 2013-06-05 長瀬産業株式会社 GABAergic neuron activator
ITRM20070398A1 (en) * 2007-07-17 2009-01-18 Giuliani Spa PROCEDURE FOR THE PREPARATION OF BUTIRRIC GAMMA-AMINO ACID (GABA) THROUGH LACTIC BACTERIA (LAB) ON AGRO-FOOD SURPLUS.
WO2011137369A1 (en) * 2010-04-29 2011-11-03 The Regents Of The University Of California Production of gamma-aminobutyric acid by recombinant microorganisms
DK3072524T3 (en) 2010-10-07 2018-04-09 California Inst Of Techn Probiotic treatments for autism
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
US20140199372A1 (en) 2011-05-24 2014-07-17 Northeastern University Microbial growth factors
EP3978598A1 (en) 2011-12-01 2022-04-06 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
WO2013154725A1 (en) * 2012-04-13 2013-10-17 Trustees Of Boston College Prebiotic compositions and methods of use
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
CN110917220A (en) 2013-02-04 2020-03-27 赛里斯治疗公司 Therapeutic compositions and methods of use thereof
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
CN103509831A (en) * 2013-06-14 2014-01-15 乌鲁木齐思科康达科技有限责任公司 Method used for transforming monosodium glutamate into gamma-aminobutyric acid by Aspergillus oryzae coupling separation technology
CA2962466C (en) 2014-10-21 2023-01-10 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
CA2966360C (en) 2014-10-30 2023-09-05 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
JP6868562B2 (en) 2014-10-31 2021-05-19 ペンデュラム セラピューティクス, インコーポレイテッド Methods and compositions for microbial treatment and diagnosis of disorders
WO2018223146A1 (en) 2017-06-02 2018-12-06 uBiome, Inc. Method and system for characterizing microorganism-associated sleep-related conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1988155A1 (en) * 2006-02-21 2008-11-05 Kikkoman Corporation Lactic acid bacterium capable of producing -aminobutyric acid
WO2013107913A1 (en) * 2012-01-19 2013-07-25 University College Cork - National University Of Ireland, Cork Gaba-producing culturable bacteria derived from the human gastrointestinal tract

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
E. BARRETT ET AL: "[gamma]-Aminobutyric acid production by culturable bacteria from the human intestine", JOURNAL OF APPLIED MICROBIOLOGY, vol. 113, no. 2, 15 August 2012 (2012-08-15), pages 411 - 417, XP055066783, ISSN: 1364-5072, DOI: 10.1111/j.1365-2672.2012.05344.x *
FENG SHI ET AL: "Synthesis of Î -aminobutyric acid by expressing-derived glutamate decarboxylase in thestrain ATCC 13032", BIOTECHNOLOGY LETTERS, SPRINGER NETHERLANDS, DORDRECHT, vol. 33, no. 12, 9 August 2011 (2011-08-09), pages 2469 - 2474, XP019978078, ISSN: 1573-6776, DOI: 10.1007/S10529-011-0723-4 *
HAIXING LI ET AL: "Lactic acid bacterial cell factories for gamma-aminobutyric acid", AMINO ACIDS ; THE FORUM FOR AMINO ACID AND PROTEIN RESEARCH, SPRINGER-VERLAG, VI, vol. 39, no. 5, 3 April 2010 (2010-04-03), pages 1107 - 1116, XP019856927, ISSN: 1438-2199, DOI: 10.1007/S00726-010-0582-7 *
KOMATSUZAKI N ET AL: "Production of @c-aminobutyric acid (GABA) by Lactobacillus paracasei isolated from traditional fermented foods", FOOD MICROBIOL, ACADEMIC PRESS LTD, LONDON, GB, vol. 22, no. 6, 1 December 2005 (2005-12-01), pages 497 - 504, XP004866292, ISSN: 0740-0020, DOI: 10.1016/J.FM.2005.01.002 *
MACIAN M C: "Lactobacillus rennini 16S rRNA gene, strain CECT 5922", EMBL,, 16 July 2003 (2003-07-16), XP002515240 *
MARK LYTE: "Microbial endocrinology : Host-microbiota neuroendocrine interactions influencing brain and behavior", GUT MICROBES, vol. 5, no. 3, 29 May 2014 (2014-05-29), United States, pages 381 - 389, XP055379390, ISSN: 1949-0976, DOI: 10.4161/gmic.28682 *
P. B. ECKBURG: "Diversity of the Human Intestinal Microbial Flora", SCIENCE, vol. 308, no. 5728, 10 June 2005 (2005-06-10), pages 1635 - 1638, XP055050950, ISSN: 0036-8075, DOI: 10.1126/science.1110591 *
PARK ET AL: "Cloning, sequencing and expression of a novel glutamate decarboxylase gene from a newly isolated lactic acid bacterium, Lactobacillus brevis OPK-3", BIORESOURCE TECHNOLOGY, ELSEVIER BV, GB, vol. 98, no. 2, 1 January 2007 (2007-01-01), pages 312 - 319, XP005645219, ISSN: 0960-8524, DOI: 10.1016/J.BIORTECH.2006.01.004 *
SATO I ET AL: "Lactobacillus halophilus gene for 16S r RNA, partial sequence", GENBANK, 7 January 2006 (2006-01-07), XP003017201 *
SIRAGUSA S ET AL: "Synthesis of gamma-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses", vol. 73, no. 22, 1 November 2007 (2007-11-01), pages 7283 - 7290, XP002677194, ISSN: 0099-2240, Retrieved from the Internet <URL:http://aem.asm.org/content/73/22/7283> [retrieved on 20070921], DOI: 10.1128/AEM.01064-07 *

Cited By (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11266698B2 (en) 2011-10-07 2022-03-08 4D Pharma Research Limited Bacterium for use as a probiotic for nutritional and medical applications
US10864235B2 (en) 2012-11-23 2020-12-15 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11464812B2 (en) 2012-11-23 2022-10-11 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11458173B2 (en) 2012-11-23 2022-10-04 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11458174B2 (en) 2012-11-23 2022-10-04 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11389490B2 (en) 2012-11-23 2022-07-19 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11185562B2 (en) 2013-02-04 2021-11-30 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
US10881696B2 (en) 2013-03-15 2021-01-05 Seres Therapeutics, Inc. Network-based microbial compositions and methods
US11666612B2 (en) 2013-03-15 2023-06-06 Seres Therapeutics, Inc Network-based microbial compositions and methods
US11918612B2 (en) 2013-11-25 2024-03-05 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11266699B2 (en) 2013-11-25 2022-03-08 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11433106B2 (en) 2015-06-15 2022-09-06 4D Pharma Research Limited Compositions comprising bacterial strains
US11224620B2 (en) 2016-07-13 2022-01-18 4D Pharma Plc Compositions comprising bacterial strains
US10596206B1 (en) 2017-03-14 2020-03-24 Cornell University Probiotic compositions and methods of use
US11376284B2 (en) 2017-05-22 2022-07-05 4D Pharma Research Limited Compositions comprising bacterial strains
US20200171102A1 (en) * 2017-06-14 2020-06-04 4D Pharma Research Limited Compositions comprising bacterial strains
US11123379B2 (en) 2017-06-14 2021-09-21 4D Pharma Research Limited Compositions comprising bacterial strains
US11660319B2 (en) 2017-06-14 2023-05-30 4D Pharma Research Limited Compositions comprising bacterial strains
US11007233B2 (en) 2017-06-14 2021-05-18 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
US11779613B2 (en) 2017-06-14 2023-10-10 Cj Bioscience, Inc. Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
US11701394B2 (en) 2017-08-14 2023-07-18 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
KR20190038451A (en) * 2017-09-29 2019-04-08 경희대학교 산학협력단 Novel lactic acid bacteria and use thereof
KR102260489B1 (en) 2017-09-29 2021-06-04 경희대학교 산학협력단 Novel lactic acid bacteria and use thereof
JP2021503964A (en) * 2017-12-01 2021-02-15 ルサッフル・エ・コンパニーLesaffre Et Compagnie Isolation and pure culture of archaea of the order METHANOMASSILII COCCALES
FR3074501A1 (en) * 2017-12-01 2019-06-07 Lesaffre Et Compagnie ISOLATION AND PURE CULTURE OF AN ARKY OF THE ORDER OF METHANOMASSILICOCCALES
WO2019106181A1 (en) * 2017-12-01 2019-06-06 Lesaffre Et Compagnie Isolation and pure culture of an archaebacterium of order methanomassiliicoccales
JP7424989B2 (en) 2017-12-01 2024-01-30 ルサッフル・エ・コンパニー Isolation and pure culture of archaea of the order METHANOMASSILIICOCCALES
EP3723776A4 (en) * 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
WO2019118984A3 (en) * 2017-12-15 2019-08-01 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
EP3723775A4 (en) * 2017-12-15 2022-04-13 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
US11793841B2 (en) 2017-12-15 2023-10-24 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN112105371A (en) * 2018-02-09 2020-12-18 内斯托尔株式会社 Lipopolysaccharide-controlling intestinal bacteria and uses thereof
JPWO2019156251A1 (en) * 2018-02-09 2021-02-18 Noster株式会社 Lipopolysaccharide-controlled gut bacteria and their uses
JP7325106B2 (en) 2018-02-09 2023-08-14 Noster株式会社 Lipopolysaccharide-regulating intestinal bacteria and uses thereof
WO2019156251A1 (en) * 2018-02-09 2019-08-15 日東薬品工業株式会社 Lipopolysaccharide-regulated enteric bacteria and use thereof
US11730772B2 (en) 2018-02-09 2023-08-22 Noster Inc. Lipopolysaccharide-regulated enteric bacteria and use thereof
WO2019169138A1 (en) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using paraclostridium benzoelyticum
WO2019169160A1 (en) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using ruminococcus gnavus
EP3786305A4 (en) * 2018-04-24 2022-07-13 BGI Shenzhen Biomarker for depression and use thereof
CN112512342A (en) * 2018-05-24 2021-03-16 赛里斯治疗公司 Engineered bacterial compositions and uses thereof
WO2019227085A1 (en) * 2018-05-24 2019-11-28 Seres Therapeutics, Inc. Designed bacterial compositions and uses thereof
JP2022033856A (en) * 2018-06-25 2022-03-02 フォーディー ファーマ リサーチ リミテッド Compositions comprising bacterial strains
CN112912090A (en) * 2018-06-25 2021-06-04 4D制药研究有限公司 Compositions comprising bacterial strains
WO2020002370A1 (en) * 2018-06-25 2020-01-02 4D Pharma Research Limited Compositions comprising bacterial strains
EP3922256A1 (en) * 2018-06-25 2021-12-15 4D Pharma Research Limited Compositions comprising bacterial strains
US11819524B2 (en) 2018-09-05 2023-11-21 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
WO2020051379A1 (en) * 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
WO2020089488A1 (en) * 2018-11-02 2020-05-07 4D Pharma Research Limited Compositions comprising bacterial strains
JP2022512813A (en) * 2018-11-02 2022-02-07 フォーディー ファーマ リサーチ リミテッド Composition containing bacterial strain
US20220000942A1 (en) * 2018-11-28 2022-01-06 Consejo Superior De Investigaciones Cientificas (Csic) Christensenellaceae bacteria including christensenella minuta and uses thereof
WO2020109414A1 (en) * 2018-11-28 2020-06-04 Consejo Superior De Investigaciones Cientificas (Csic) Christensenellaceae bacteria including christensenella minuta and uses thereof
US11446336B2 (en) 2018-12-12 2022-09-20 4D Pharma Research Limited Compositions comprising bacterial strains
EP3906037A4 (en) * 2019-01-29 2023-03-01 Holobiome, Inc. Methods and compositions for treating and preventing cns disorders and other conditions caused by gut microbial dysbiosis
US20210268036A1 (en) * 2019-03-08 2021-09-02 The Regents Of The University Of California Compositions and methods for modulating lipid and steroid metabolism
EP3950929A4 (en) * 2019-03-28 2023-01-04 CJ Bioscience, Inc. Faecalibacterium sp. microbe and anticancer composition comprising same
WO2020229428A1 (en) * 2019-05-10 2020-11-19 4D Pharma Research Limited Compositions comprising bacterial strains
EP4022096A4 (en) * 2019-08-26 2023-12-06 The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Fish skin microbiome
WO2021038446A1 (en) * 2019-08-26 2021-03-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Fish skin microbiome
WO2021039932A1 (en) * 2019-08-28 2021-03-04 学校法人順天堂 Method for diagnosing relapsing-remitting multiple sclerosis, secondary-progressive multiple sclerosis, atypical multiple sclerosis, and neuromyelitis optica-related disease, and diagnostic biomarker
WO2021151946A1 (en) 2020-01-27 2021-08-05 4D Pharma Research Limited Compositions comprising bacterial strains
CN111184748A (en) * 2020-02-10 2020-05-22 农业农村部食物与营养发展研究所 Microbial agent for improving muscular atrophy and application thereof
WO2022003057A1 (en) 2020-06-30 2022-01-06 4D Pharma Research Limited Compositions comprising bacterial strains
CN111961614A (en) * 2020-08-04 2020-11-20 安徽科技学院 Novel bacterial strain cd-1 for producing exopolysaccharides
CN111961614B (en) * 2020-08-04 2022-04-29 安徽科技学院 Bacterium cd-1 for producing exopolysaccharide
WO2022145807A1 (en) * 2020-12-28 2022-07-07 주식회사 에이치이엠파마 Novel bifidobacterium animalis subsp. lactis hem20-01 strain, and composition for treating depression comprising same or culture thereof
KR102215599B1 (en) * 2020-12-28 2021-02-15 주식회사 에이치이엠 A novel strain of bifidobacterium animalis subsp. lactis hem20-01, and composition for treating depression comprising the strain or its culture fluid
WO2022184643A1 (en) * 2021-03-04 2022-09-09 Evonik Operations Gmbh Preparations comprising probiotic strains and anthocyanins
WO2023001368A1 (en) * 2021-07-20 2023-01-26 Université Catholique de Louvain Prevention and/or treatment of reward dysregulation disorders
WO2023001934A1 (en) * 2021-07-20 2023-01-26 Université Catholique de Louvain Prevention and/or treatment of reward dysregulation disorders
US11938158B2 (en) 2021-11-22 2024-03-26 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US11980647B2 (en) 2022-11-07 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause

Also Published As

Publication number Publication date
CA3016911A1 (en) 2017-09-21
US11116804B2 (en) 2021-09-14
CN109715177A (en) 2019-05-03
JP7216998B2 (en) 2023-02-02
US20220040242A1 (en) 2022-02-10
AU2017234120A1 (en) 2018-09-20
EP4368254A2 (en) 2024-05-15
US20190070225A1 (en) 2019-03-07
JP2023038274A (en) 2023-03-16
EP3429604A1 (en) 2019-01-23
JP2019508479A (en) 2019-03-28

Similar Documents

Publication Publication Date Title
WO2017160711A1 (en) Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
Yang et al. Fecal IgA levels are determined by strain-level differences in Bacteroides ovatus and are modifiable by gut microbiota manipulation
US11446341B2 (en) Method for the identification of bacteria
US11266699B2 (en) Synergistic bacterial compositions and methods of production and use thereof
Nguyen et al. Import of aspartate and malate by DcuABC drives H2/fumarate respiration to promote initial Salmonella gut-lumen colonization in mice
US20200164005A1 (en) Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof
Tidjani Alou et al. State of the art in the culture of the human microbiota: new interests and strategies
US20220096574A1 (en) Methods and compositions for treating and preventing central nervous system disorders and other conditions caused by gut microbial dysbiosis
Tanaka et al. Application of a single‐colony coculture technique to the isolation of hitherto unculturable gut bacteria
Mann et al. Oral probiotic activities and biosafety of Lactobacillus gasseri HHuMIN D
Schimmel et al. Breast milk urea as a nitrogen source for urease positive Bifidobacterium infantis
Shiver et al. A mutant fitness compendium in Bifidobacteria reveals molecular determinants of colonization and host-microbe interactions
Hsu et al. Bacteriophages dynamically modulate the gut microbiota and metabolome
Li et al. Impact of a short-term exposure to spaceflight on the phenotype, genome, transcriptome and proteome of Escherichia coli
Conway de Macario et al. Methanogenic archaea in humans and other vertebrates: an update
Li et al. Comparative genomics of in vitro and in vivo evolution of probiotics reveals energy restriction not the main evolution driving force in short term
Bello et al. Phylogenomic and molecular markers based studies on Staphylococcaceae and Gemella species. Proposals for an emended family Staphylococcaceae and three new families (Abyssicoccaceae fam. nov., Salinicoccaceae fam. nov. and Gemellaceae fam. nov.) harboring four new genera, Lacicoccus gen. nov., Macrococcoides gen. nov., Gemelliphila gen. nov., and Phocicoccus gen. nov.
Lou et al. Genomic analysis of cultivated infant microbiomes identifies Bifidobacterium 2'-fucosyllactose utilization can be facilitated by co-existing species
McDonald Development of an in vitro fermentation model to culture the human distal gut microbiota
Oladipo Evaluating the Gastrointestinal Microbiota of Hospitalized Neonates Using Culturomics and Metagenomics
Guerra Human associated Archaea: a neglected microbiome worth investigating
Xu et al. Christensenella minuta interacts with multiple gut bacteria
Liu Differential response of probiotics in perturbed pH and osmolality are correlated with genomic feature abundance
Shen The Role of Gut Microbiota Urease in the Host with Liver Disease
Lamarche Investigations of the heterogeneity of host-associated bacteria during respiratory infections

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 3016911

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2018549231

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2017234120

Country of ref document: AU

Date of ref document: 20170313

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2017712676

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2017712676

Country of ref document: EP

Effective date: 20181015

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17712676

Country of ref document: EP

Kind code of ref document: A1